Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23424.Total Lipids in VLDL,ACY1,Aminoacylase-1,29478,0.164778428058494,0.0041165921198782,0.156709907503532,0.172846948613455,0
NMR metabolomics,X23424.Total Lipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.254691802990857,0.00554062395638689,0.243832180036339,0.265551425945375,0
NMR metabolomics,X23424.Total Lipids in VLDL,ADIPOQ,Adiponectin,24966,-0.191067806832234,0.00448890997476827,-0.19986607038278,-0.182269543281688,0
NMR metabolomics,X23424.Total Lipids in VLDL,AFM,Afamin,24966,0.0525160474863789,0.00129936661743485,0.0499692889162065,0.0550628060565512,0
NMR metabolomics,X23424.Total Lipids in VLDL,AGR3,Anterior gradient protein 3,28764,0.159866741489915,0.00397369855983429,0.15207829231264,0.16765519066719,0
NMR metabolomics,X23424.Total Lipids in VLDL,AGRP,Agouti-related protein,29786,0.273693375640228,0.00326104906939927,0.267301719464206,0.280085031816251,0
NMR metabolomics,X23424.Total Lipids in VLDL,APCS,Serum amyloid P-component,24726,0.116120658620992,0.00227308137044808,0.111665419134913,0.12057589810707,0
NMR metabolomics,X23424.Total Lipids in VLDL,ATRN,"Attractin, Isoform 2",24966,0.0437615909415752,0.00111038804353873,0.0415852303762393,0.0459379515069111,0
NMR metabolomics,X23424.Total Lipids in VLDL,BCHE,Cholinesterase,24528,0.0862016835192137,0.00185214855940977,0.0825714723427706,0.0898318946956568,0
NMR metabolomics,X23424.Total Lipids in VLDL,C9,Complement component C9,24951,-0.14132949579206,0.00354860629621165,-0.148284764132635,-0.134374227451486,0
NMR metabolomics,X23424.Total Lipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.195018314292622,0.00492371168692619,0.185367839386247,0.204668789198997,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCL23,C-C motif chemokine 23,29581,0.135724557190212,0.00273939839325523,0.130355336339432,0.141093778040992,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCL27,C-C motif chemokine 27,29478,0.237457586834651,0.00396802020226516,0.229680267238211,0.245234906431091,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCN1,CCN family member 1,29301,0.376126603403533,0.00468727326965809,0.366939547795004,0.385313659012063,0
NMR metabolomics,X23424.Total Lipids in VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.0949352488467021,0.00197507890348173,0.0910640941958779,0.0988064034975262,0
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.320627547123652,0.00700673258301646,0.30689435126094,0.334360742986364,0
NMR metabolomics,X23424.Total Lipids in VLDL,CES1,Liver carboxylesterase 1,29489,0.298671029690389,0.00526063010113396,0.288360194692167,0.308981864688612,0
NMR metabolomics,X23424.Total Lipids in VLDL,CFH,Complement factor H,23693,0.0656979001508997,0.00155186903776458,0.0626562368368811,0.0687395634649183,0
NMR metabolomics,X23424.Total Lipids in VLDL,CFI,Complement factor I,24966,0.0557489035868694,0.0013254026299214,0.0531511144322235,0.0583466927415154,0
NMR metabolomics,X23424.Total Lipids in VLDL,CFP,Properdin,24966,0.0700444250163637,0.00152327919809216,0.067058797788103,0.0730300522446243,0
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.162464801848376,0.00375085102617214,0.155113133837079,0.169816469859674,0
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN3,Contactin-3,29443,0.0944679875919154,0.00214371934733,0.0902662976711486,0.0986696775126822,0
NMR metabolomics,X23424.Total Lipids in VLDL,CPM,Carboxypeptidase M,29584,0.0988112668904555,0.00227955607176438,0.0943433369897974,0.103279196791114,0
NMR metabolomics,X23424.Total Lipids in VLDL,CRIP2,Cysteine-rich protein 2,29218,0.10020158790354,0.00242082940161598,0.0954567622763729,0.104946413530708,0
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.227262521186661,0.00510316823719339,0.217260311441762,0.23726473093156,0
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.453225949790988,0.0097515928229253,0.434112827858055,0.472339071723922,0
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.280749817688569,0.00572785371123698,0.269523224414545,0.291976410962594,0
NMR metabolomics,X23424.Total Lipids in VLDL,DSG2,Desmoglein-2,29443,-0.0776469389290037,0.00179631135289331,-0.0811677091806746,-0.0741261686773328,0
NMR metabolomics,X23424.Total Lipids in VLDL,ENO3,Beta-enolase,24240,0.160009368643045,0.00401742898054955,0.152135207841168,0.167883529444922,0
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.068951111591384,0.00165355231091144,0.0657101490619976,0.0721920741207704,0
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0632665385932783,0.00128549130542364,0.060746975634648,0.0657861015519087,0
NMR metabolomics,X23424.Total Lipids in VLDL,F10,Coagulation factor X,24951,0.072033261767992,0.00183928229660091,0.0684282684666543,0.0756382550693298,0
NMR metabolomics,X23424.Total Lipids in VLDL,F7,Coagulation factor VII,29544,0.118366043745809,0.0019845134083304,0.114476397465482,0.122255690026137,0
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.0929557771663653,0.00218487701435445,0.0886734182182306,0.0972381361145001,0
NMR metabolomics,X23424.Total Lipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.298169287324875,0.00735147187881859,0.28376040244239,0.312578172207359,0
NMR metabolomics,X23424.Total Lipids in VLDL,FURIN,Furin,29566,0.120436308981966,0.00218876346161388,0.116146332597203,0.124726285366729,0
NMR metabolomics,X23424.Total Lipids in VLDL,GCG,Pro-glucagon,28797,0.421236402267358,0.00817270780833967,0.405217894963012,0.437254909571704,0
NMR metabolomics,X23424.Total Lipids in VLDL,GHR,Growth hormone receptor,24381,0.103304311622752,0.00186384361309418,0.099651178141087,0.106957445104416,0
NMR metabolomics,X23424.Total Lipids in VLDL,GPR37,Prosaposin receptor GPR37,28916,0.193642870352954,0.00439832171040926,0.185022159800552,0.202263580905356,0
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA1,Glutathione S-transferase A1,29426,0.224200559332839,0.00562105469017839,0.21318329214009,0.235217826525589,0
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA3,Glutathione S-transferase A3,28797,0.205307860768967,0.00511426133119119,0.195283908559832,0.215331812978102,0
NMR metabolomics,X23424.Total Lipids in VLDL,GUSB,Beta-glucuronidase,29604,0.167326568776903,0.00397993037870544,0.159525905234641,0.175127232319166,0
NMR metabolomics,X23424.Total Lipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.28760569521816,0.00492078217589956,0.277960962153397,0.297250428282924,0
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.10934955258629,0.00225953734578899,0.104920859388543,0.113778245784036,0
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.166547723229954,0.00415805624309289,-0.174697513466416,-0.158397932993492,0
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0780987180474658,0.00199236397846494,0.0741936846496745,0.082003751445257,0
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF9,Protein turtle homolog A,24922,0.271767680830939,0.0054393560214881,0.261106543028823,0.282428818633056,0
NMR metabolomics,X23424.Total Lipids in VLDL,INHBC,Inhibin beta C chain,29443,0.122948604155258,0.00274097512453869,0.117576292911162,0.128320915399354,0
NMR metabolomics,X23424.Total Lipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.0677569272798928,0.00169601584937382,0.0644327362151201,0.0710811183446655,0
NMR metabolomics,X23424.Total Lipids in VLDL,KLKB1,Plasma kallikrein,24454,0.0670271998497781,0.00167812649530086,0.0637380719189884,0.0703163277805678,0
NMR metabolomics,X23424.Total Lipids in VLDL,KYNU,Kynureninase,29786,0.122980997892548,0.00302927429507982,0.117043620274191,0.128918375510904,0
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0580054388733893,0.00130118321742894,0.0554551197672285,0.06055575797955,0
NMR metabolomics,X23424.Total Lipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0876313516706712,0.00142510092147616,0.0848381538645779,0.0904245494767644,0
NMR metabolomics,X23424.Total Lipids in VLDL,LDLR,Low-density lipoprotein receptor,29500,0.419355221965037,0.00266797885932033,0.414125983400769,0.424584460529305,0
NMR metabolomics,X23424.Total Lipids in VLDL,LPL,Lipoprotein lipase,29478,-0.163174755196358,0.00307994438298559,-0.16921144618701,-0.157138064205707,0
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0545768278857506,0.00137032610843919,0.0518909887132098,0.0572626670582914,0
NMR metabolomics,X23424.Total Lipids in VLDL,MFGE8,Lactadherin,29443,0.221453791667153,0.00271707376518126,0.216128327087397,0.226779256246908,0
NMR metabolomics,X23424.Total Lipids in VLDL,NCS1,Neuronal calcium sensor 1,29725,0.076251331327254,0.00191174985073535,0.0725043016198127,0.0799983610346953,0
NMR metabolomics,X23424.Total Lipids in VLDL,NPY,Pro-neuropeptide Y,29725,0.349433873772745,0.00403404622451722,0.341527143172691,0.357340604372799,0
NMR metabolomics,X23424.Total Lipids in VLDL,NRP1,Neuropilin-1,29628,-0.0867980243022688,0.00183858125993556,-0.0904016435717425,-0.0831944050327951,0
NMR metabolomics,X23424.Total Lipids in VLDL,P4HB,Protein disulfide-isomerase,29313,0.108220667990139,0.00258053265752746,0.103162823981385,0.113278511998893,0
NMR metabolomics,X23424.Total Lipids in VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0842906512589218,0.00182751426422258,0.0807087233010455,0.087872579216798,0
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.168395372572171,0.0039303185801415,-0.176098796989248,-0.160691948155094,0
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.161986598177894,0.0019697098213495,0.158125966928049,0.165847229427739,0
NMR metabolomics,X23424.Total Lipids in VLDL,PLAT,Tissue-type plasminogen activator,29736,0.13973678057504,0.00335040917208282,0.133169978597757,0.146303582552322,0
NMR metabolomics,X23424.Total Lipids in VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.123158370815461,0.00270223572062794,0.11786198880303,0.128454752827892,0
NMR metabolomics,X23424.Total Lipids in VLDL,PROC,Vitamin K-dependent protein C,29545,0.0975252415596737,0.00168030578048523,0.0942318422299227,0.100818640889425,0
NMR metabolomics,X23424.Total Lipids in VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0693305091757348,0.00170122574226917,0.0659961067208873,0.0726649116305824,0
NMR metabolomics,X23424.Total Lipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.158405407376936,0.00395328857327273,0.150656961773321,0.166153852980551,0
NMR metabolomics,X23424.Total Lipids in VLDL,PTH,Parathyroid hormone,24195,0.282556649432454,0.00527013225181451,0.272227190218898,0.292886108646011,0
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.167805011186247,0.00308630680367992,0.161755849851035,0.17385417252146,0
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA4,Kallistatin,24557,0.070143326927729,0.00158265896482479,0.0670413153566724,0.0732453384987856,0
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.0966532834042715,0.00210547061926939,0.0925265609905035,0.10078000581804,0
NMR metabolomics,X23424.Total Lipids in VLDL,SERPIND1,Heparin cofactor 2,24914,0.0738042913323616,0.00188441193293144,0.070110843943816,0.0774977387209072,0
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.164131002876111,0.00353310478247192,0.157206117502466,0.171055888249756,0
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.268847014255277,0.00541128515534893,0.258240895350793,0.279453133159761,0
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.123180887878244,0.00213544077538515,0.11899542395849,0.127366351797999,0
NMR metabolomics,X23424.Total Lipids in VLDL,SNCA,Alpha-synuclein,24381,0.330174678450345,0.00768861963040427,0.315104983974753,0.345244372925937,0
NMR metabolomics,X23424.Total Lipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.318126623069888,0.00760866990488865,0.303213630056307,0.33303961608347,0
NMR metabolomics,X23424.Total Lipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.156763308771607,0.0027692547146369,0.151335569530919,0.162191048012296,0
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.141908708853698,0.00348466163427216,0.135078772050524,0.148738645656871,0
NMR metabolomics,X23424.Total Lipids in VLDL,SYAP1,Synapse-associated protein 1,24381,0.151042667358853,0.00383927038619364,0.143517697401914,0.158567637315793,0
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.117656611870213,0.00206088833388435,0.1136172707358,0.121695953004626,0
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS15,Enteropeptidase,29349,0.267242320012419,0.00599719287413894,0.255487821979107,0.278996818045731,0
NMR metabolomics,X23424.Total Lipids in VLDL,TTR,Transthyretin,24707,0.0788463751532916,0.00167345026358204,0.0755664126366708,0.0821263376699124,0
NMR metabolomics,X23424.Total Lipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.203875225226771,0.00451236436571089,0.195030991069977,0.212719459383564,0
NMR metabolomics,X23424.Total Lipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.243578719243918,0.00526576974485757,0.233257810543997,0.253899627943839,0
NMR metabolomics,X23424.Total Lipids in VLDL,F9,Coagulation factor IX,29545,0.0469760711409706,0.00121612052134264,0.0445924749191391,0.0493596673628022,1.11253692934014e-308
NMR metabolomics,X23424.Total Lipids in VLDL,SORT1,Sortilin,29433,0.0959469381412491,0.0024908910751301,0.0910647916339941,0.100829084648504,1.11253693427324e-308
NMR metabolomics,X23424.Total Lipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0665712343697425,0.0017293795405395,0.0631816504702851,0.0699608182691999,1.11253694276079e-308
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.177948772220449,0.00463651715362183,0.16886119859935,0.187036345841547,1.11255758548033e-308
NMR metabolomics,X23424.Total Lipids in VLDL,GRP,Gastrin-releasing peptide,24240,0.137804955347195,0.00361129746268742,0.130726812320327,0.144883098374062,1.20655802469403e-308
NMR metabolomics,X23424.Total Lipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0557240417571384,0.00146228703737482,0.0528579591638837,0.058590124350393,1.65536464145274e-308
NMR metabolomics,X23424.Total Lipids in VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.14744389459134,0.00387185239633953,0.139855063894515,0.155032725288166,2.06437027702477e-308
NMR metabolomics,X23424.Total Lipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.217360809322208,0.00571229587371159,0.206164709409734,0.228556909234683,9.24196767884877e-308
NMR metabolomics,X23424.Total Lipids in VLDL,NUMB,Protein numb homolog,24229,0.212387918128123,0.00559550241281046,0.201420733399015,0.223355102857232,2.74539703994338e-306
NMR metabolomics,X23424.Total Lipids in VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.313940440187231,0.00831212010951845,0.297648684772575,0.330232195601887,7.42637081554185e-305
NMR metabolomics,X23424.Total Lipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0794654099246144,0.00210454321764635,0.0753405052180276,0.0835903146312013,9.00528645693359e-305
NMR metabolomics,X23424.Total Lipids in VLDL,RBP5,Retinol-binding protein 5,29349,0.141798878514409,0.00375944751385104,0.134430361387261,0.149167395641557,4.66014836283016e-304
NMR metabolomics,X23424.Total Lipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.353743581865812,0.00936112257881684,0.335395781611331,0.372091382120293,7.1910604050835e-304
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.0656741886043703,0.00175121122396863,0.0622418146053918,0.0691065626033488,2.31079920429842e-299
NMR metabolomics,X23424.Total Lipids in VLDL,UPB1,Beta-ureidopropionase,24922,0.229674936060058,0.00612713682011614,0.217665747892631,0.241684124227486,3.29852297406095e-299
NMR metabolomics,X23424.Total Lipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.169655751819402,0.00454501777016971,0.160747516989869,0.178563986648934,7.39873089133251e-298
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0340904784234641,0.000913399690136811,0.032300215030796,0.0358807418161323,1.40022230888177e-296
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR2,Cadherin-related family member 2,29349,0.180878309166716,0.00486089486275232,0.171350955235721,0.19040566309771,3.53263556634344e-296
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0758634996751056,0.00204163685754129,0.0718618914343247,0.0798651079158866,2.15196502814345e-295
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0546721837409806,0.0014804489334565,0.0517705038314058,0.0575738636505553,6.79069260000901e-292
NMR metabolomics,X23424.Total Lipids in VLDL,STAB2,Stabilin-2,24938,0.069875447779682,0.00188890674188251,0.0661731905655922,0.0735777049937717,1.15155184003567e-291
NMR metabolomics,X23424.Total Lipids in VLDL,HEG1,Protein HEG homolog 1,24381,0.0673367582629348,0.00182622399431955,0.0637573592340685,0.0709161572918012,1.1622515780155e-289
NMR metabolomics,X23424.Total Lipids in VLDL,DTYMK,Thymidylate kinase,24922,0.169089707408098,0.00458880903865054,0.160095641692343,0.178083773123853,1.8231707216236e-289
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.0979308858121623,0.00267088804656969,0.0926959452408857,0.103165826383439,7.51916678421132e-288
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.0728434802265818,0.001998440948885,0.0689265359667672,0.0767604244863964,1.64033263104504e-284
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.298008296882576,0.00818032819347892,-0.314041740141795,-0.281974853623357,2.56643691886262e-284
NMR metabolomics,X23424.Total Lipids in VLDL,CCL16,C-C motif chemokine 16,29820,0.126330262694902,0.00351068480176594,0.11944932048344,0.133211204906363,1.28977501347496e-277
NMR metabolomics,X23424.Total Lipids in VLDL,PLTP,Phospholipid transfer protein,29702,-0.086712474096549,0.00241131566276871,-0.0914386527955757,-0.0819862953975224,3.09694806506829e-277
NMR metabolomics,X23424.Total Lipids in VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.291917766756164,0.00810619253737575,0.276029629382908,0.307805904129421,1.10283327648852e-276
NMR metabolomics,X23424.Total Lipids in VLDL,NOMO1,Nodal modulator 1,29443,0.0567033132381396,0.00157935810149453,0.0536077713592103,0.0597988551170689,2.55803326818165e-276
NMR metabolomics,X23424.Total Lipids in VLDL,FCN2,Ficolin-2,29381,0.0984404742460842,0.00275492951403173,0.0930408123985821,0.103840136093586,9.11911010968038e-274
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.218884455034729,0.00613384812088895,0.206862112717786,0.230906797351671,4.31880207750822e-273
NMR metabolomics,X23424.Total Lipids in VLDL,ELN,Elastin,24922,0.084227990528541,0.00235895026699363,0.0796044480052335,0.0888515330518485,2.35122290177405e-272
NMR metabolomics,X23424.Total Lipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.203852998721714,0.00571942738754156,0.192642921042132,0.215063076401295,2.18500076857141e-271
NMR metabolomics,X23424.Total Lipids in VLDL,IL16,Pro-interleukin-16,29786,0.0986516151410678,0.00277672379784075,0.0932092364973,0.104093993784836,8.29062413797361e-271
NMR metabolomics,X23424.Total Lipids in VLDL,EEF1D,Elongation factor 1-delta,24922,0.217900388132505,0.00613162851725085,0.205882396238693,0.229918380026317,7.16126033591086e-270
NMR metabolomics,X23424.Total Lipids in VLDL,SHBG,Sex hormone-binding globulin,24951,-0.123128946494894,0.00346489743930783,-0.129920145475938,-0.116337747513851,7.28303110175331e-270
NMR metabolomics,X23424.Total Lipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0940930087715892,0.00266065459263744,0.0888781257700198,0.0993078917731585,2.60234914316621e-268
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0616311640765372,0.0017489850655313,0.0582031533480959,0.0650591748049786,1.56965778424512e-266
NMR metabolomics,X23424.Total Lipids in VLDL,GLA,Alpha-galactosidase A,24329,0.0889651790710309,0.00252502126380108,0.0840161373939808,0.093914220748081,2.85505334763504e-265
NMR metabolomics,X23424.Total Lipids in VLDL,SOST,Sclerostin,29433,0.0913108692356725,0.00260005187003951,0.0862147675703951,0.0964069709009499,1.02669034269528e-264
NMR metabolomics,X23424.Total Lipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.178489515227351,0.00507710631380952,0.168538386852284,0.188440643602418,3.73818090484121e-264
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0697195194705059,0.00198485118278362,0.06582921115225,0.0736098277887617,7.4072142019286e-264
NMR metabolomics,X23424.Total Lipids in VLDL,FN1,Fibronectin,24966,0.0631777823081879,0.00179890164004303,0.0596519350937035,0.0667036295226722,8.71769671890392e-264
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR5,Cadherin-related family member 5,29478,0.091490436132861,0.0026141279225793,0.0863667454046056,0.0966141268611164,5.81653412837744e-263
NMR metabolomics,X23424.Total Lipids in VLDL,MYH9,Myosin-9,24938,0.265768376016207,0.0075865181914714,0.250898800360923,0.280637951671491,1.71244228253171e-262
NMR metabolomics,X23424.Total Lipids in VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.266425291917152,0.0076441872317651,0.251442684942892,0.281407898891411,7.99839916448295e-261
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS1,Protein MTSS 1,24805,0.260116827219725,0.00745935703387285,0.245496487433334,0.274737167006116,3.88823350720399e-260
NMR metabolomics,X23424.Total Lipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.186353545213963,0.0053452306559404,0.17587689312832,0.196830197299606,5.05664177604542e-260
NMR metabolomics,X23424.Total Lipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.12313584918773,0.00355213881412117,0.116173657112053,0.130098041263408,5.40878838028755e-258
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0791562822649391,0.00229453364640317,-0.0836535682118894,-0.0746589963179889,9.37876632930211e-256
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.168827208814537,0.00489712105319275,0.159228851550279,0.178425566078795,2.59150309602075e-255
NMR metabolomics,X23424.Total Lipids in VLDL,FGF21,Fibroblast growth factor 21,29674,0.273966928363876,0.00797061549546054,0.258344521992773,0.289589334734978,6.37712656795896e-254
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.088067300340233,0.00256423295858114,-0.093093196939052,-0.0830414037414139,1.63819449441474e-253
NMR metabolomics,X23424.Total Lipids in VLDL,FYB1,FYN-binding protein 1,29400,0.212175500126103,0.00618251078497309,0.200057778987556,0.22429322126465,4.14113992890443e-253
NMR metabolomics,X23424.Total Lipids in VLDL,CPB2,Carboxypeptidase B2,24914,0.0522566582493174,0.00152045314811519,0.0492765700790116,0.0552367464196232,5.90671391454697e-253
NMR metabolomics,X23424.Total Lipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.156117121048464,0.0045529265971694,0.147193384918012,0.165040857178916,1.10938775089101e-252
NMR metabolomics,X23424.Total Lipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.109414498274242,0.00319101401493273,0.103160110804974,0.115668885743511,1.26540532371521e-252
NMR metabolomics,X23424.Total Lipids in VLDL,CCL22,C-C motif chemokine 22,29169,0.118968521165517,0.0034748992222751,0.112157718689858,0.125779323641176,6.79031147383132e-252
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.100481405581474,0.00293735627400849,0.0947241872844177,0.106238623878531,1.61696142903131e-251
NMR metabolomics,X23424.Total Lipids in VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.195843557411648,0.00572983802143376,0.184613074889638,0.207074039933659,4.84876502018757e-251
NMR metabolomics,X23424.Total Lipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0728780522558662,0.00213862229659383,0.0686863525545423,0.0770697519571901,1.19843900485694e-249
NMR metabolomics,X23424.Total Lipids in VLDL,DPY30,Protein dpy-30 homolog,29604,0.136690093869511,0.00402242226753754,0.128806146225137,0.144574041513884,2.46006296908169e-248
NMR metabolomics,X23424.Total Lipids in VLDL,GH1,Somatotropin,29433,-0.405063211199045,0.0119385183274998,-0.428462707120945,-0.381663715277146,1.47844435276584e-247
NMR metabolomics,X23424.Total Lipids in VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.24975511685046,0.00734787531748928,0.235353281228181,0.264156952472739,1.48175258883044e-247
NMR metabolomics,X23424.Total Lipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.203661299016268,0.00601751053506623,0.191866978367539,0.215455619664998,2.55253221469875e-246
NMR metabolomics,X23424.Total Lipids in VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0646734821635812,0.00190878309021435,0.0609322673067611,0.0684146970204014,4.69718896438153e-246
NMR metabolomics,X23424.Total Lipids in VLDL,SCLY,Selenocysteine lyase,29632,0.11019474770614,0.00326040203268489,0.103804359722077,0.116585135690202,9.94839139269203e-246
NMR metabolomics,X23424.Total Lipids in VLDL,SORD,Sorbitol dehydrogenase,29595,0.15476957132355,0.00458121330791613,0.145790393240034,0.163748749407065,1.60936414922181e-245
NMR metabolomics,X23424.Total Lipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.114348376270012,0.00338514345073329,0.107713495106575,0.12098325743345,1.97584775527007e-245
NMR metabolomics,X23424.Total Lipids in VLDL,MLN,Promotilin,29434,0.202412287517217,0.00599267372995468,0.190666647006506,0.214157928027928,2.13417379278832e-245
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.0953770456789975,0.00282682828912749,0.0898364622323077,0.100917629125687,6.21509371671508e-245
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.09178334106152,0.00273919511699423,0.0864145186322113,0.0971521634908287,8.62498107749489e-241
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.0966053825942716,0.00289134237040002,0.0909383515482875,0.102272413640256,2.86908057526456e-240
NMR metabolomics,X23424.Total Lipids in VLDL,TJAP1,Tight junction-associated protein 1,29566,0.186215511945873,0.00557506660675739,0.175288381396628,0.197142642495117,3.841963494805e-240
NMR metabolomics,X23424.Total Lipids in VLDL,BTD,Biotinidase,24966,0.0466153933286119,0.0013943524126281,0.0438824625998608,0.049348324057363,9.25713888817123e-240
NMR metabolomics,X23424.Total Lipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.123549963660577,0.00370231370497689,0.116293428798822,0.130806498522331,1.28339842777346e-239
NMR metabolomics,X23424.Total Lipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0618405922416283,0.00187129077026008,0.0581728623319185,0.065508322151338,3.45282335522934e-235
NMR metabolomics,X23424.Total Lipids in VLDL,F11R,Junctional adhesion molecule A,29443,0.12475053161921,0.00378300998827163,0.117335832042198,0.132165231196222,3.25388690918557e-234
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0818916664892588,0.00248432168482002,0.0770223959870115,0.086760936991506,2.88725397121573e-233
NMR metabolomics,X23424.Total Lipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.146398499324321,0.00444282460471869,0.137690563099072,0.155106435549569,4.03883220325843e-233
NMR metabolomics,X23424.Total Lipids in VLDL,KHK,Ketohexokinase,24240,0.142048182786498,0.00431934446485139,0.133582267635389,0.150514097937607,4.32052439663653e-232
NMR metabolomics,X23424.Total Lipids in VLDL,CKB,Creatine kinase B-type,24938,-0.130827065657202,0.00399164300418976,-0.138650685945414,-0.12300344536899,1.04439329872151e-230
NMR metabolomics,X23424.Total Lipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.150505277682896,0.0045917113432705,0.141505523450086,0.159505031915706,1.41227213095151e-230
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.134044571697119,0.00409868472896042,0.126011149628357,0.142077993765882,1.68759192087521e-230
NMR metabolomics,X23424.Total Lipids in VLDL,APOC1,Apolipoprotein C-I,24914,0.0826691055704739,0.00252513653073684,0.0777198379702297,0.0876183731707181,3.35301983782283e-230
NMR metabolomics,X23424.Total Lipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0658243369081257,0.00202038784969297,0.0618643767227275,0.069784297093524,5.04199238657773e-228
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0867095556148209,0.00267220152863217,-0.0919470706109399,-0.0814720406187018,5.61973525688135e-227
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.12562489387745,0.00386417148973865,0.118051117757562,0.133198669997337,5.73705131445332e-227
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.213124342487713,0.00657062142895057,0.20024592448697,0.226002760488457,8.50408863394011e-227
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.185094076893863,0.00569975374011171,0.173922559563244,0.196265594224482,1.76873773971432e-226
NMR metabolomics,X23424.Total Lipids in VLDL,CREG1,Protein CREG1,29079,0.0831705579072557,0.00256712313340172,0.0781389965657883,0.0882021192487231,3.08068914384882e-226
NMR metabolomics,X23424.Total Lipids in VLDL,MME,Neprilysin,29349,0.174268500237277,0.00541056200255622,0.163663798712267,0.184873201762288,1.04916276488116e-223
NMR metabolomics,X23424.Total Lipids in VLDL,EHBP1,EH domain-binding protein 1,24922,0.162327322708663,0.00503875134626843,0.152451370069977,0.172203275347349,4.01215250487821e-223
NMR metabolomics,X23424.Total Lipids in VLDL,DKK1,Dickkopf-related protein 1,29694,0.12850306281248,0.00399974482910996,0.120663562947425,0.136342562677536,1.18264945875935e-222
NMR metabolomics,X23424.Total Lipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0662248621124431,0.00206471544375073,-0.0702717043821946,-0.0621780198426917,3.93773532147547e-221
NMR metabolomics,X23424.Total Lipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.210591196601466,0.00657913607873931,0.197696089887137,0.223486303315795,2.43011845081974e-220
NMR metabolomics,X23424.Total Lipids in VLDL,APOM,Apolipoprotein M,29545,0.0597433484022627,0.00187105071712039,0.0560760889967067,0.0634106078078186,5.60377414089094e-220
NMR metabolomics,X23424.Total Lipids in VLDL,AMBP,Protein AMBP,29683,0.0432495718089748,0.00135667312205516,0.0405904924897467,0.045908651128203,2.62109678660713e-219
NMR metabolomics,X23424.Total Lipids in VLDL,TXLNA,Alpha-taxilin,29218,0.190555925581957,0.00597704005749201,0.178840927069273,0.202270924094642,2.79841384667273e-219
NMR metabolomics,X23424.Total Lipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0434827898331738,0.00136400545157647,0.0408093391480839,0.0461562405182637,2.89924896207336e-219
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.175806152228174,0.00552007921240501,0.16498679697186,0.186625507484488,6.7069301212476e-219
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0436654624446797,0.00137143171828645,0.0409774562768383,0.0463534686125212,9.83240358351545e-219
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.241967993010396,0.00759845813584843,0.227075015064133,0.256860970956658,4.50467654779977e-218
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.174641104735789,0.00548796113995802,0.163884700901471,0.185397508570107,7.58753168498193e-218
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0479978053794245,0.00151078224229053,0.045036672184535,0.0509589385743139,9.07968700913708e-218
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3F,Semaphorin-3F,29478,0.0562562863618692,0.0017771802843096,0.0527730130046224,0.059739559719116,2.74898614619508e-216
NMR metabolomics,X23424.Total Lipids in VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.069829479374743,0.00221370374204414,0.0654906200403365,0.0741683387091495,7.45968608122335e-215
NMR metabolomics,X23424.Total Lipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.134861423120115,0.00427615709096238,0.126480155221829,0.143242691018402,1.18478589214144e-214
NMR metabolomics,X23424.Total Lipids in VLDL,F13B,Coagulation factor XIII B chain,24833,0.0550641997542167,0.00174523193757155,0.0516435451565764,0.0584848543518569,2.93759477522536e-214
NMR metabolomics,X23424.Total Lipids in VLDL,ARF6,ADP-ribosylation factor 6,24805,0.227263313153348,0.00721242526795108,0.213126959628164,0.241399666678532,1.03819262888262e-213
NMR metabolomics,X23424.Total Lipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.11356963956139,0.00361005207040607,0.106493937503395,0.120645341619386,1.1603106486104e-213
NMR metabolomics,X23424.Total Lipids in VLDL,DCXR,L-xylulose reductase,29566,0.113827983051232,0.00361941846761231,0.106733922854712,0.120922043247753,1.43292871483647e-213
NMR metabolomics,X23424.Total Lipids in VLDL,CEP20,Centrosomal protein 20,28797,0.157596905440918,0.00501575208886282,0.147766031346747,0.167427779535089,4.26046958454987e-213
NMR metabolomics,X23424.Total Lipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.206242005146951,0.00656770757347269,0.193369298302944,0.219114711990957,6.31577229594399e-213
NMR metabolomics,X23424.Total Lipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.0499876058362652,0.00159493297009207,0.0468615372148847,0.0531136744576456,4.22895139795213e-212
NMR metabolomics,X23424.Total Lipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.224301062624037,0.00716213491071308,0.210263278199039,0.238338847049035,8.11470474464827e-212
NMR metabolomics,X23424.Total Lipids in VLDL,NPPC,C-type natriuretic peptide,29434,0.101145177800137,0.00323033555850676,0.0948137201054634,0.10747663549481,9.90810921091991e-212
NMR metabolomics,X23424.Total Lipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.110950979751741,0.0035381889947479,0.104016129322035,0.117885830181447,1.03207394141967e-211
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS2,Protein MTSS 2,24793,0.209966755187841,0.00669737008367284,0.196839909823842,0.22309360055184,1.29429476399505e-211
NMR metabolomics,X23424.Total Lipids in VLDL,AXIN1,Axin-1,29434,0.200313703074334,0.00642018435913966,0.18773014173042,0.212897264418247,2.80721817169044e-210
NMR metabolomics,X23424.Total Lipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.166294496287938,0.00532925750306089,0.155849151581939,0.176739840993938,3.01984375970198e-210
NMR metabolomics,X23424.Total Lipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.174817166426528,0.00560260305172449,0.163836064445148,0.185798268407908,1.29398578988837e-209
NMR metabolomics,X23424.Total Lipids in VLDL,CES3,Carboxylesterase 3,29349,0.146275131180051,0.00470888668394223,0.137045713279524,0.155504549080577,1.78925582580282e-208
NMR metabolomics,X23424.Total Lipids in VLDL,CD63,CD63 antigen,29169,0.107633819102834,0.00346591311445477,0.100840629398503,0.114427008807166,2.43422197234119e-208
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.132037629209008,0.00425478487899634,-0.140377007571841,-0.123698250846175,4.55216715476179e-208
NMR metabolomics,X23424.Total Lipids in VLDL,EZR,Ezrin,29694,0.0503314550115287,0.00162223490216477,0.0471518746032858,0.0535110354197717,5.08403966197403e-208
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0565552971787971,0.00182294849886071,0.0529823181210301,0.0601282762365641,5.86395090541571e-208
NMR metabolomics,X23424.Total Lipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.152015609767714,0.00490226811317034,0.1424071642659,0.161624055269528,8.54815601757886e-208
NMR metabolomics,X23424.Total Lipids in VLDL,CCL17,C-C motif chemokine 17,29414,0.189623885148573,0.00613957401949199,0.177590320070369,0.201657450226777,3.69967022387995e-206
NMR metabolomics,X23424.Total Lipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0545306064894787,0.0017635999396354,0.0510739506077933,0.0579872623711641,6.42401079640568e-206
NMR metabolomics,X23424.Total Lipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.225322689276622,0.00729334182000468,0.211027739309413,0.239617639243831,1.11175602985323e-205
NMR metabolomics,X23424.Total Lipids in VLDL,BECN1,Beclin-1,24240,0.125800065867448,0.00407230160919237,0.117818354713431,0.133781777021465,1.49672039836475e-205
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN1,Perilipin-1,28774,0.0725474984214887,0.00235394590282739,0.067933764451947,0.0771612323910303,3.13799103404743e-205
NMR metabolomics,X23424.Total Lipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.138256825477133,0.00450468913567972,0.1294276347712,0.147086016183065,1.40636514203465e-203
NMR metabolomics,X23424.Total Lipids in VLDL,NT5E,5'-nucleotidase,29566,0.116316134730194,0.00379206325318157,0.108883690753958,0.12374857870643,1.99296027813125e-203
NMR metabolomics,X23424.Total Lipids in VLDL,DAB2,Disabled homolog 2,29725,0.22873128949389,0.00746099084501825,0.214107747437655,0.243354831550126,3.14406088374012e-203
NMR metabolomics,X23424.Total Lipids in VLDL,TCTN3,Tectonic-3,24922,0.0618014581328624,0.00201359975511513,0.0578548026128367,0.065748113652888,4.3940965015594e-203
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.147792713561785,0.00482573452775338,0.138334273887388,0.157251153236181,9.94228308292649e-203
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0569911759604692,0.00185997187652884,0.0533456310824727,0.0606367208384657,2.07616181132365e-202
NMR metabolomics,X23424.Total Lipids in VLDL,KAZN,Kazrin,24805,0.215314202400824,0.00703968876361125,0.201516412424146,0.229111992377502,1.05732437652412e-201
NMR metabolomics,X23424.Total Lipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.0977361111766381,0.0031959058685536,0.091472135674273,0.104000086679003,1.17702499278877e-201
NMR metabolomics,X23424.Total Lipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.0975962256950176,0.00319209639070872,0.0913397167692286,0.103852734620807,1.72366622141065e-201
NMR metabolomics,X23424.Total Lipids in VLDL,THOP1,Thimet oligopeptidase,29343,0.0634989473314797,0.00208343410587965,0.0594154164839556,0.0675824781790038,6.95781836374919e-201
NMR metabolomics,X23424.Total Lipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.106220382316903,0.00348882841384373,0.0993822786257689,0.113058486008036,2.06922476593751e-200
NMR metabolomics,X23424.Total Lipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.101896313092375,0.00334219080430208,0.0953456191159425,0.108447007068807,2.18429138526566e-200
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNA4,Plexin-A4,29434,0.167559850267546,0.00551264485796453,0.156755066345935,0.178364634189156,7.7807810271881e-200
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.0770910721926803,0.00253637717984762,-0.0820623714651817,-0.072119772920179,8.08652060509422e-200
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.196771536321108,0.00647845645896953,0.184073761661528,0.209469310980689,1.41450398972003e-199
NMR metabolomics,X23424.Total Lipids in VLDL,NPL,N-acetylneuraminate lyase,24922,0.0921922466449835,0.00303303907302993,0.0862474900618448,0.0981370032281221,2.70401709283565e-199
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.114019355454336,0.00375883349808689,0.106652041798086,0.121386669110587,4.6682192953484e-199
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0729743166409961,0.00240643683629189,0.068257700441864,0.0776909328401282,6.16655530339654e-199
NMR metabolomics,X23424.Total Lipids in VLDL,HJV,Hemojuvelin,24867,0.0905656317273251,0.00299101692905645,0.0847032385463745,0.0964280249082757,8.41867303626061e-198
NMR metabolomics,X23424.Total Lipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.112326669654073,0.00371676847494066,0.105041803443189,0.119611535864957,1.56889780162804e-197
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.254979202494423,0.00845274822254818,0.238411815978229,0.271546589010618,6.5567284996928e-197
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.147938225322158,0.00490448357127165,0.138325437522465,0.15755101312185,2.99455930975972e-196
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN1,Dynactin subunit 1,29725,0.131945323018389,0.00438489173359881,0.123350935220535,0.140539710816242,5.59092110687489e-196
NMR metabolomics,X23424.Total Lipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.218058377117173,0.00725540421962972,0.203837784846699,0.232278969387647,5.74645229481558e-195
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.230232956877701,0.00768443764445363,0.215171459094572,0.24529445466083,2.67295664260572e-194
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.135103142820771,0.00451498193024143,0.126253778237498,0.143952507404045,7.64678486342569e-194
NMR metabolomics,X23424.Total Lipids in VLDL,S100A4,Protein S100-A4,29566,0.115149200412543,0.00385097187840943,0.10760129553086,0.122697105294225,1.45257350574838e-193
NMR metabolomics,X23424.Total Lipids in VLDL,CD2AP,CD2-associated protein,29478,0.128224761384393,0.00429178762522322,0.119812857638955,0.13663666512983,3.02266729114698e-193
NMR metabolomics,X23424.Total Lipids in VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.129093880908539,0.00432144955096251,0.120623839788653,0.137563922028426,3.95426795489288e-193
NMR metabolomics,X23424.Total Lipids in VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.172489601848045,0.00576858758231472,0.161183170186708,0.183796033509382,5.02217555403524e-193
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFC,Platelet-derived growth factor C,28797,0.0583479765746506,0.00195575446123497,0.05451469783063,0.0621812553186711,1.21844711276022e-192
NMR metabolomics,X23424.Total Lipids in VLDL,SELP,P-selectin,29594,0.11433760644115,0.00383785756717949,0.106815405609478,0.121859807272822,3.43788704854385e-192
NMR metabolomics,X23424.Total Lipids in VLDL,CD6,T-cell differentiation antigen CD6,29760,0.105671883076655,0.00355944870610431,0.0986953636126904,0.112648402540619,6.77352181867406e-191
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.219063721835374,0.00737476978343518,0.204609173059841,0.233518270610907,1.49439955975794e-190
NMR metabolomics,X23424.Total Lipids in VLDL,ERBIN,Erbin,29349,0.204968393057121,0.00692085616296892,0.191403514977702,0.21853327113654,5.83623370617399e-190
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0716964430560573,0.00242650311224895,0.0669404969560493,0.0764523891560652,4.03304968363824e-189
NMR metabolomics,X23424.Total Lipids in VLDL,PAXX,Protein PAXX,24381,0.0914837395267695,0.00309750415891441,0.0854126313752972,0.0975548476782417,2.15579510073562e-188
NMR metabolomics,X23424.Total Lipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.124510443638992,0.00422098778245893,0.116237307585372,0.132783579692611,6.67974918474103e-188
NMR metabolomics,X23424.Total Lipids in VLDL,MVK,Mevalonate kinase,28931,0.158267846635622,0.00538465659922382,0.147713919701143,0.168821773570101,3.9014395393223e-187
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.11024787535019,0.00375751179167904,0.102883152238499,0.117612598461881,4.77389647390933e-186
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.0658335545695535,0.0022505410530822,0.0614224941055124,0.0702446150335946,1.86591411120928e-185
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0796676670544207,0.00272378086800453,-0.0850062775557096,-0.0743290565531318,2.09449898921273e-185
NMR metabolomics,X23424.Total Lipids in VLDL,TPD52L2,Tumor protein D54,24381,0.214612206917795,0.00732909299099721,0.20024718465544,0.228977229180149,2.82294212908815e-185
NMR metabolomics,X23424.Total Lipids in VLDL,STC1,Stanniocalcin-1,29694,0.0857707960933174,0.00293957407947205,0.0800092308975521,0.0915323612890826,1.49688018919556e-184
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.166283963759697,0.00569312204997089,0.155125444541754,0.17744248297764,2.01137598535973e-184
NMR metabolomics,X23424.Total Lipids in VLDL,FUOM,Fucose mutarotase,24381,0.125901390710068,0.00431062129677679,0.117452572968385,0.13435020845175,2.3541529044932e-184
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.204713502614457,0.00701970176503437,0.190954887154989,0.218472118073924,2.43173662259725e-184
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R9B,Neurabin-2,29786,0.185686542189707,0.00637509155885336,0.173191362734354,0.198181721645059,6.26379080400987e-184
NMR metabolomics,X23424.Total Lipids in VLDL,NUCB2,Nucleobindin-2,29652,0.0732993309687659,0.00252112307525048,0.068357929741275,0.0782407321962569,2.86986448063353e-183
NMR metabolomics,X23424.Total Lipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.174050837442558,0.0059843211896323,0.162321567910879,0.185780106974237,6.58004286069974e-183
NMR metabolomics,X23424.Total Lipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0572556061730895,0.00197191628321504,0.053390650257988,0.0611205620881909,8.26751841687976e-183
NMR metabolomics,X23424.Total Lipids in VLDL,BCR,Breakpoint cluster region protein,29434,0.179722317490895,0.00619510602744845,0.167579909677096,0.191864725304694,1.81411987754275e-182
NMR metabolomics,X23424.Total Lipids in VLDL,ISM1,Isthmin-1,29434,0.0771469034685331,0.00265957812789242,0.071934130337864,0.0823596765992023,1.98421527448742e-182
NMR metabolomics,X23424.Total Lipids in VLDL,MINK1,Misshapen-like kinase 1,24845,0.18212079634243,0.00628228124031647,0.16980752511141,0.194434067573451,9.47939221130372e-182
NMR metabolomics,X23424.Total Lipids in VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.132829263285392,0.00458082838564634,0.123850839649525,0.141807686921258,9.53738583969381e-182
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.123926434844529,0.00427596503706839,0.115545543371875,0.132307326317183,1.1629998090111e-181
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.113304533520408,0.00391467680514242,0.105631766982329,0.120977300058487,1.24749482891937e-181
NMR metabolomics,X23424.Total Lipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0967847755792287,0.00334686961642802,0.0902249111310297,0.103344640027428,2.78511869172512e-181
NMR metabolomics,X23424.Total Lipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.119294966370755,0.00414102734664936,0.111178552771322,0.127411379970187,6.13458797872027e-180
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0456715127051006,0.00158733184082472,0.0425603422970842,0.0487826831131171,1.45757686931736e-179
NMR metabolomics,X23424.Total Lipids in VLDL,CMIP,C-Maf-inducing protein,24793,0.161633003297685,0.00561196665488147,0.150633548654117,0.172632457941252,1.85928600641502e-179
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0387379862488181,0.00134714564003298,0.0360975807943534,0.0413783917032827,2.35757631276138e-179
NMR metabolomics,X23424.Total Lipids in VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.205029461923858,0.00713988256704616,0.191035292092448,0.219023631755269,6.89042952068823e-179
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.144623275112697,0.00503602889163914,0.134752658485085,0.15449389174031,2.31175309477341e-178
NMR metabolomics,X23424.Total Lipids in VLDL,SLA2,Src-like-adapter 2,24867,0.203201895559687,0.00708681666841065,0.189311734889602,0.217092056229772,6.48519505007294e-178
NMR metabolomics,X23424.Total Lipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.265770594802034,0.00929359108023626,0.247555156284771,0.283986033319297,1.9881527349545e-177
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.134330522227904,0.00469891533819504,0.125120648165042,0.143540396290767,2.81490395642244e-177
NMR metabolomics,X23424.Total Lipids in VLDL,PPY,Pancreatic prohormone,29400,0.196874946651422,0.0068878328327105,0.18337479429931,0.210375099003535,2.92347578857042e-177
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.183812755380155,0.00643642202380397,0.171197368213499,0.19642814254681,5.65094374582075e-177
NMR metabolomics,X23424.Total Lipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.077513353811751,0.00271350917507917,0.0721948758285958,0.0828318317949062,1.30024523995474e-176
NMR metabolomics,X23424.Total Lipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.144112459588892,0.0050454190581669,0.134223438234885,0.154001480942899,1.62797332412516e-176
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.198588902855356,0.00695889397292241,0.184949470668428,0.212228335042284,3.30521604458142e-176
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA5,Integrin alpha-5,29443,0.0481633484318213,0.00169455924333849,0.0448420123148779,0.0514846845487648,2.51232055996885e-175
NMR metabolomics,X23424.Total Lipids in VLDL,AAMDC,Mth938 domain-containing protein,24240,0.10297182145667,0.00361783151155005,0.0958808716940318,0.110062771219308,2.62975390329616e-175
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.166961552051696,0.00587976610237839,0.155437210491034,0.178485893612357,5.18405604137652e-175
NMR metabolomics,X23424.Total Lipids in VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.176110260825719,0.00620203443694632,0.163954273329304,0.188266248322134,5.2820082572452e-175
NMR metabolomics,X23424.Total Lipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.200910642599737,0.00709080881178579,0.187012657328637,0.214808627870837,2.96784410162787e-174
NMR metabolomics,X23424.Total Lipids in VLDL,CCN2,CCN family member 2,29478,0.109365760235921,0.00386173327679407,0.101796763013405,0.116934757458437,4.18568469424683e-174
NMR metabolomics,X23424.Total Lipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.200173802059334,0.0070713234172526,-0.21403359595715,-0.186314008161519,5.91889902362309e-174
NMR metabolomics,X23424.Total Lipids in VLDL,CTBS,Di-N-acetylchitobiase,24653,0.0522508888208141,0.00184637693963261,0.0486319900191342,0.055869787622494,2.10079154017082e-173
NMR metabolomics,X23424.Total Lipids in VLDL,SRPK2,SRSF protein kinase 2,29434,0.160228949385567,0.00567401278868743,0.14910788431974,0.171350014451395,3.96648389868825e-173
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0754680602022747,0.00267359112816795,0.0702278215910656,0.0807082988134839,5.13857473753558e-173
NMR metabolomics,X23424.Total Lipids in VLDL,DOK2,Docking protein 2,29478,0.232226043877786,0.00823289836614484,0.216089563080142,0.24836252467543,9.49441898194936e-173
NMR metabolomics,X23424.Total Lipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0624824875885237,0.0022203905582056,0.0581305220944408,0.0668344530826067,5.81396979767388e-172
NMR metabolomics,X23424.Total Lipids in VLDL,AGRN,Agrin,29581,0.0655292480759084,0.00233051175210926,0.0609614450417742,0.0700970511100425,1.07757218330966e-171
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.102409690049288,0.00365389567638539,0.0952480545235731,0.109571325575004,1.3267098434393e-170
NMR metabolomics,X23424.Total Lipids in VLDL,CCL5,C-C motif chemokine 5,29594,0.189930141931068,0.00679495688281003,0.17661202644076,0.203248257421376,1.01556576840325e-169
NMR metabolomics,X23424.Total Lipids in VLDL,CDH2,Cadherin-2,29478,0.0669668600456684,0.00239702572596969,0.0622686896227678,0.071665030468569,1.52329418931659e-169
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.186856786671456,0.00669784337968255,0.173729013647278,0.199984559695633,4.23393045495975e-169
NMR metabolomics,X23424.Total Lipids in VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.136759656154152,0.00490059021104406,0.127154499340506,0.146364812967799,8.83597754424983e-169
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO1,Forkhead box protein O1,29434,0.161031508932521,0.00578908655690888,0.14968489928098,0.172378118584062,4.13162209009399e-168
NMR metabolomics,X23424.Total Lipids in VLDL,CTSD,Cathepsin D,27442,0.0765497327708458,0.00275360632338771,0.0711526643770058,0.0819468011646857,9.25478155021861e-168
NMR metabolomics,X23424.Total Lipids in VLDL,MMP10,Stromelysin-2,29439,-0.111020985946178,0.00400044395402075,-0.118861856096059,-0.103180115796298,2.35461484976797e-167
NMR metabolomics,X23424.Total Lipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.210694253258519,0.00760471755402869,0.195789006852623,0.225599499664415,8.27850476172965e-167
NMR metabolomics,X23424.Total Lipids in VLDL,RTBDN,Retbindin,29349,0.0556124878122257,0.00200848029958472,0.0516758664250396,0.0595491091994118,1.32530282704617e-166
NMR metabolomics,X23424.Total Lipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0521227544341128,0.00188406001808001,0.048429996798676,0.0558155120695496,2.47162828179116e-166
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINH1,Serpin H1,24445,0.241163172191436,0.00871640002863872,0.224079028135304,0.258247316247568,6.16606908243325e-166
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0716827846444237,0.00259562116941337,0.0665953671523735,0.0767702021364739,8.66175016856149e-166
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0613580685488515,0.00222211652034073,0.0570027201689837,0.0657134169287193,1.03703302019846e-165
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD5,Programmed cell death protein 5,29694,0.108175994799449,0.00391989031255263,0.100493009786846,0.115858979812052,1.50564783504678e-165
NMR metabolomics,X23424.Total Lipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.213468329054976,0.00772831709785649,0.198320827543178,0.228615830566775,1.93160891501722e-165
NMR metabolomics,X23424.Total Lipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.119644938777086,0.00433859111458807,0.111141300192494,0.128148577361679,2.9712975130964e-165
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.202955573692111,0.0073557120017286,0.188538378168723,0.217372769215499,4.38207092696329e-165
NMR metabolomics,X23424.Total Lipids in VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.0599917007696362,0.00217470275554626,0.0557292833687656,0.0642541181705069,6.38218678345513e-165
NMR metabolomics,X23424.Total Lipids in VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.0963369211069603,0.00350165367208463,0.0894736799096745,0.103200162304246,1.67409119692805e-164
NMR metabolomics,X23424.Total Lipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0436256589688799,0.00158602777415789,0.0405170445315304,0.0467342734062294,1.75256593347775e-164
NMR metabolomics,X23424.Total Lipids in VLDL,USO1,General vesicular transport factor p115,29349,0.167143173504765,0.00608396966691817,0.155218592957605,0.179067754051925,4.45599570439012e-164
NMR metabolomics,X23424.Total Lipids in VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.109561732720055,0.00398953992635525,0.101742234464399,0.117381230975711,1.39255426297738e-163
NMR metabolomics,X23424.Total Lipids in VLDL,CCL13,C-C motif chemokine 13,29732,0.128118845563085,0.00467561880696795,0.118954632701428,0.137283058424742,2.82904602264682e-163
NMR metabolomics,X23424.Total Lipids in VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.0526043213318451,0.00192043119165526,-0.0563683664674894,-0.0488402761962008,3.73853792727925e-163
NMR metabolomics,X23424.Total Lipids in VLDL,BACH1,Transcription regulator protein BACH1,29434,0.136675036643914,0.00499035134779307,0.126893948002239,0.146456125285588,4.26614026683294e-163
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.167753348539029,0.00612773341431048,0.15574299104698,0.179763706031077,1.37102275705433e-162
NMR metabolomics,X23424.Total Lipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.211357187479102,0.00773175487464996,0.196202947924788,0.226511427033416,3.99949231046602e-162
NMR metabolomics,X23424.Total Lipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.150232117199283,0.00550501758773984,0.139442282727312,0.161021951671253,5.88852900676169e-162
NMR metabolomics,X23424.Total Lipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.12961440711044,0.00475885134386297,0.120287058476469,0.138941755744412,2.61633380583841e-161
NMR metabolomics,X23424.Total Lipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.117285103692505,0.00432151869984355,0.108814927040812,0.125755280344198,7.07317143694139e-160
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.156050806857082,0.00574983760285549,0.144781125155485,0.167320488558678,8.27426135010967e-160
NMR metabolomics,X23424.Total Lipids in VLDL,FETUB,Fetuin-B,29545,0.0606213440960625,0.00223688494231532,0.0562370496091244,0.0650056385830005,8.71514813196638e-160
NMR metabolomics,X23424.Total Lipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.127387853584427,0.00469955394443825,0.118176727853328,0.136598979315526,1.7358611345501e-159
NMR metabolomics,X23424.Total Lipids in VLDL,CES2,Cocaine esterase,29349,0.100122052734817,0.00370483528451134,0.0928605755771747,0.107383529892459,6.71182679005688e-159
NMR metabolomics,X23424.Total Lipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.151106216989091,0.00559600408793698,0.140138048976735,0.162074385001448,1.31115824030282e-158
NMR metabolomics,X23424.Total Lipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.14114535928893,0.00522544132222068,0.130903494297378,0.151387224280483,2.09218063926134e-158
NMR metabolomics,X23424.Total Lipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.17284255304507,0.00641911243509546,0.160261092672283,0.185424013417857,9.17081481975659e-158
NMR metabolomics,X23424.Total Lipids in VLDL,LEP,Leptin,29478,0.122445688222167,0.00455232874120121,0.113523123889413,0.131368252554922,1.88534010618698e-157
NMR metabolomics,X23424.Total Lipids in VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.137773097691517,0.00512703542790026,0.127724108252833,0.147822087130202,3.52359431078605e-157
NMR metabolomics,X23424.Total Lipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.165437024977601,0.0061519246770733,0.153379252610537,0.177494797344665,4.89038785039129e-157
NMR metabolomics,X23424.Total Lipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.203164671693371,0.0075718111322795,0.188323921874103,0.218005421512639,1.10714899978665e-156
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0945467412467108,0.00352421322286257,0.0876392833299001,0.101454199163521,1.1630016601438e-156
NMR metabolomics,X23424.Total Lipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.131929570343754,0.00492165974243403,0.122283117248584,0.141576023438925,4.51776177007939e-156
NMR metabolomics,X23424.Total Lipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.048377081103643,0.00181167929859718,0.0448261896783925,0.0519279725288935,3.06897328550525e-155
NMR metabolomics,X23424.Total Lipids in VLDL,SEC31A,Protein transport protein Sec31A,24240,0.139454328586976,0.00522006286033159,0.129223005380726,0.149685651793226,5.53291257591499e-155
NMR metabolomics,X23424.Total Lipids in VLDL,CEP43,Centrosomal protein 43,28705,0.125823692065686,0.00471828822545817,0.116575847143788,0.135071536987584,8.7300446761801e-155
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.154727884643783,0.0058039855512081,0.143352072963415,0.166103696324151,9.55630975371301e-155
NMR metabolomics,X23424.Total Lipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.173550666071995,0.00650273974354624,0.160805296174645,0.186296035969346,9.74193629115119e-155
NMR metabolomics,X23424.Total Lipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.15255436653559,0.00572906774796272,0.141325393749583,0.163783339321597,2.20128193668329e-154
NMR metabolomics,X23424.Total Lipids in VLDL,NIT2,Omega-amidase NIT2,24813,0.134451510619836,0.00505255769054195,0.124548497546374,0.144354523693298,7.41042005168071e-154
NMR metabolomics,X23424.Total Lipids in VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.131465486230922,0.00494542415256503,0.121772454891895,0.14115851756995,7.52594771052452e-154
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0505495445888464,0.00190364123854146,0.0468184077613051,0.0542806814163877,1.48066347348918e-153
NMR metabolomics,X23424.Total Lipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.163373783666706,0.00614830314653207,0.151323109499504,0.175424457833909,1.96109386318304e-153
NMR metabolomics,X23424.Total Lipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0998984797243775,0.00376945332340672,0.0925103512105004,0.107286608238255,5.47463691984473e-153
NMR metabolomics,X23424.Total Lipids in VLDL,GHRL,Appetite-regulating hormone,29478,0.145133172064915,0.005476692085584,0.13439885557717,0.155867488552659,6.00781808019909e-153
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.120356418687249,0.00454277975779041,0.111452570361979,0.129260267012518,6.72482973929015e-153
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB3,Plexin-B3,29383,0.0850113432950762,0.00320898223635717,0.0787217381118161,0.0913009484783362,7.58106225798082e-153
NMR metabolomics,X23424.Total Lipids in VLDL,C1S,Complement C1s subcomponent,24966,0.0376271495015877,0.00142054231666272,0.0348428865609288,0.0404114124422467,1.71694141028118e-152
NMR metabolomics,X23424.Total Lipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.12026751603576,0.00454559675841357,0.111358146389269,0.12917688568225,1.97475946778435e-152
NMR metabolomics,X23424.Total Lipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.114452030464249,0.00432688639085046,0.105971333138182,0.122932727790315,2.13846320420765e-152
NMR metabolomics,X23424.Total Lipids in VLDL,DAG1,Dystroglycan,29581,0.0850034784251027,0.00321502387207284,0.07870203163584,0.0913049252143655,2.85191458076895e-152
NMR metabolomics,X23424.Total Lipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0678128025068022,0.00256582890699704,0.062783777849088,0.0728418271645164,3.7933688792602e-152
NMR metabolomics,X23424.Total Lipids in VLDL,OGFR,Opioid growth factor receptor,29349,0.0585733343808959,0.00221623126326799,0.0542295211048907,0.0629171476569012,3.83266201753986e-152
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE4,Ribonuclease 4,24194,0.0493944130298566,0.00186768989147203,0.0457337408425715,0.0530550852171418,5.75935458649953e-152
NMR metabolomics,X23424.Total Lipids in VLDL,CLUL1,Clusterin-like protein 1,29435,-0.0807290306607485,0.00305706573739278,-0.0867208795060384,-0.0747371818154587,6.66946815272392e-152
NMR metabolomics,X23424.Total Lipids in VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.14291373178946,0.00540652686785242,0.132316939128469,0.153510524450451,8.04045300656136e-152
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0805254561771429,0.00304896506868154,-0.0865014277117587,-0.0745494846425271,1.27615427503992e-151
NMR metabolomics,X23424.Total Lipids in VLDL,LEFTY2,Left-right determination factor 2,29674,0.0928233917650812,0.00352028768548695,0.0859236279015268,0.0997231556286356,1.77806169803592e-151
NMR metabolomics,X23424.Total Lipids in VLDL,BID,BH3-interacting domain death agonist,29434,0.119097210507551,0.00452027198493877,0.110237477417071,0.127956943598031,3.13765022663856e-151
NMR metabolomics,X23424.Total Lipids in VLDL,THPO,Thrombopoietin,28916,0.0688695046864697,0.00261776095436309,0.0637386932159181,0.0740003161570214,9.15105861323095e-151
NMR metabolomics,X23424.Total Lipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.170991338341314,0.00650034769149953,0.158250656865975,0.183732019816653,1.0039421960688e-150
NMR metabolomics,X23424.Total Lipids in VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.0716456840597046,0.00272532870065923,0.0663040398064125,0.0769873283129967,1.41633106133571e-150
NMR metabolomics,X23424.Total Lipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.183171235648028,0.00696044013844631,0.169528772976674,0.196813698319383,1.47009601648504e-150
NMR metabolomics,X23424.Total Lipids in VLDL,DLK1,Protein delta homolog 1,29820,0.099324549305111,0.00377917310114229,0.0919173700268721,0.10673172858335,1.60047464559381e-150
NMR metabolomics,X23424.Total Lipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.136717510294293,0.0052019791655755,0.126521631129765,0.146913389458821,1.71507454435547e-150
NMR metabolomics,X23424.Total Lipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.101612766099772,0.00386331044935526,0.0940406776190353,0.109184854580508,2.36384735234539e-150
NMR metabolomics,X23424.Total Lipids in VLDL,METAP2,Methionine aminopeptidase 2,29674,0.102212131083877,0.00389569724471876,0.094576564484228,0.109847697683526,5.17266472691284e-150
NMR metabolomics,X23424.Total Lipids in VLDL,FKBPL,FK506-binding protein-like,24805,0.10546916878019,0.00401693324378377,0.0975959796223741,0.113342357938006,6.81678777923868e-150
NMR metabolomics,X23424.Total Lipids in VLDL,HGF,Hepatocyte growth factor,29786,0.0611820399568934,0.00233291836661461,0.0566095199583287,0.065754559955458,6.87453153196797e-150
NMR metabolomics,X23424.Total Lipids in VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.136570359287918,0.00520173006467733,0.126374968361151,0.146765750214686,7.05564595056797e-150
NMR metabolomics,X23424.Total Lipids in VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.043056447145652,0.0016426781067381,0.0398367980564453,0.0462760962348587,1.04078830987936e-149
NMR metabolomics,X23424.Total Lipids in VLDL,GPC5,Glypican-5,29218,0.100032895905549,0.00381636308274705,0.0925528242633648,0.107512967547733,1.0602571071155e-149
NMR metabolomics,X23424.Total Lipids in VLDL,CTSO,Cathepsin O,29786,0.053936905357355,0.00205804562127157,0.0499031359396627,0.0579706747750472,1.08299308219626e-149
NMR metabolomics,X23424.Total Lipids in VLDL,FABP5,Fatty acid-binding protein 5,29624,0.120794200980498,0.00461379220995599,0.111751168248984,0.129837233712012,2.194200889271e-149
NMR metabolomics,X23424.Total Lipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.138738639751192,0.00529881521769964,0.128352961924501,0.149124317577883,4.78932688357239e-149
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.182714268250311,0.00698724065572845,0.169019276565084,0.196409259935539,4.91487534934568e-149
NMR metabolomics,X23424.Total Lipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.13739967782757,0.00525647173080484,0.127096993235192,0.147702362419947,1.3359713710627e-148
NMR metabolomics,X23424.Total Lipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0944777386254722,0.00361548651553508,0.0873913850550235,0.101564092195921,1.75979978739116e-148
NMR metabolomics,X23424.Total Lipids in VLDL,HEXIM1,Protein HEXIM1,29434,0.143741191414323,0.00550822820777743,0.13294506412708,0.154537318701567,1.99888138342771e-148
NMR metabolomics,X23424.Total Lipids in VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.133862000990742,0.00513224607714629,0.123802798679535,0.143921203301948,5.6427502188704e-148
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.166151539330062,0.00638193394719964,0.153642948793551,0.178660129866573,9.46734940043366e-148
NMR metabolomics,X23424.Total Lipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.172221008291916,0.00661284212266261,0.159259837731497,0.185182178852335,1.71534892891059e-147
NMR metabolomics,X23424.Total Lipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.122506278270802,0.00471191244080553,0.113270929886824,0.131741626654781,5.24224175957428e-147
NMR metabolomics,X23424.Total Lipids in VLDL,SH2B3,SH2B adapter protein 3,28797,0.172480967953614,0.00664971129588736,0.159447533813675,0.185514402093553,1.20248814625839e-146
NMR metabolomics,X23424.Total Lipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.111180107369885,0.00428600632659425,0.10277953496976,0.11958067977001,2.09015433149757e-146
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINC1,Antithrombin-III,24914,0.0260421542698465,0.00100462179525372,0.0240730955511492,0.0280112129885438,3.24761900767072e-146
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR,GMP reductase 1,29786,0.0871671896228863,0.00336697416607033,0.0805679202573884,0.0937664589883841,3.69450970344957e-146
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.0628505637149571,0.00243549687647121,0.0580769898370736,0.0676241375928407,3.17483351536743e-145
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH2,Neutral ceramidase,29218,0.0925957960358752,0.00359310674661333,0.0855533068125131,0.0996382852592373,7.94147752414368e-145
NMR metabolomics,X23424.Total Lipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.185124250156068,0.00718430655765869,0.171043009303057,0.199205491009079,1.73164146961955e-144
NMR metabolomics,X23424.Total Lipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.110503279125413,0.00429426564864062,0.102086518454077,0.118920039796748,2.16472264580952e-144
NMR metabolomics,X23424.Total Lipids in VLDL,STAMBP,STAM-binding protein,29163,0.11138287472504,0.00433836029588179,0.102879688545111,0.119886060904968,9.07714715876198e-144
NMR metabolomics,X23424.Total Lipids in VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.127271612204789,0.00495464541141034,0.117560507198425,0.136982717211154,1.20231552096222e-143
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.181290580811253,0.00706619146222348,0.167440845545295,0.195140316077211,1.35262800207019e-143
NMR metabolomics,X23424.Total Lipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.124860890837618,0.00486880736352232,0.115318028405114,0.134403753270121,3.80369685757666e-143
NMR metabolomics,X23424.Total Lipids in VLDL,EREG,Proepiregulin,29163,0.139362689923918,0.00544610441035033,0.128688325279631,0.150037054568205,7.57823357386977e-143
NMR metabolomics,X23424.Total Lipids in VLDL,GOLM2,Protein GOLM2,29694,0.0392196145662642,0.00153377383406194,0.0362134178515028,0.0422258112810256,1.13761861018632e-142
NMR metabolomics,X23424.Total Lipids in VLDL,DNMBP,Dynamin-binding protein,29218,0.105933207315417,0.0041486949639885,0.097801765185999,0.114064649444834,3.00798078245716e-142
NMR metabolomics,X23424.Total Lipids in VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.14611734621589,0.00572330983423724,0.134899658940785,0.157335033490995,3.26300539688304e-142
NMR metabolomics,X23424.Total Lipids in VLDL,F2,Prothrombin,24966,0.0257218114977104,0.00100692333441089,0.0237482417622651,0.0276953812331558,4.19225658173801e-142
NMR metabolomics,X23424.Total Lipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0762544661117272,0.00299006893181729,0.0703939310053653,0.0821150012180891,6.51207689558112e-142
NMR metabolomics,X23424.Total Lipids in VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.115423866425646,0.00452730336347262,0.10655035183324,0.124297381018053,7.54385697288337e-142
NMR metabolomics,X23424.Total Lipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.174752507980427,0.00685704744294671,0.161312694992251,0.188192320968602,9.97664123736995e-142
NMR metabolomics,X23424.Total Lipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0728377338490712,0.0028602544405269,0.0672316351456385,0.0784438325525039,1.58299230518007e-141
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0495010520031613,0.00194453219903236,0.0456897688930579,0.0533123351132648,1.95306098043854e-141
NMR metabolomics,X23424.Total Lipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.124825719366938,0.00490245380372272,0.115216909911642,0.134434528822235,3.41113602654109e-141
NMR metabolomics,X23424.Total Lipids in VLDL,QDPR,Dihydropteridine reductase,29345,0.0744091367443077,0.00292558870252936,0.0686749828873501,0.0801432906012652,3.61608925882061e-141
NMR metabolomics,X23424.Total Lipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0598974467197504,0.00235605558168268,0.0552795777796523,0.0645153156598484,5.02487220457769e-141
NMR metabolomics,X23424.Total Lipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.161177291173495,0.00634291210723035,0.148745183443324,0.173609398903667,6.80015450105428e-141
NMR metabolomics,X23424.Total Lipids in VLDL,MITD1,MIT domain-containing protein 1,29218,0.166285946202425,0.0065555227098671,0.153437121691086,0.179134770713765,2.00056749812015e-140
NMR metabolomics,X23424.Total Lipids in VLDL,SNX15,Sorting nexin-15,24381,0.0932921016300438,0.00367507281976976,0.086088958903295,0.100495244356792,2.45593537384276e-140
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.142042563561239,0.00561357332386395,0.131039959846466,0.153045167276012,1.85197123682399e-139
NMR metabolomics,X23424.Total Lipids in VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.104204748337983,0.00412968908648233,0.0961105577284773,0.112298938947488,5.64526736810217e-139
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.146996385472727,0.00582824048045181,0.135573034131042,0.158419736814413,6.99514816923557e-139
NMR metabolomics,X23424.Total Lipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.198779112206564,0.00789442047658268,0.183306048072462,0.214252176340666,1.97910245420193e-138
NMR metabolomics,X23424.Total Lipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.136919949192774,0.00543581323899067,0.126265755244353,0.147574143141196,2.9068205300729e-138
NMR metabolomics,X23424.Total Lipids in VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.218568235408228,0.0086897878126194,0.201536251295494,0.235600219520962,3.7294476951925e-138
NMR metabolomics,X23424.Total Lipids in VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.0945084040209746,0.00375503842178708,0.087148528714272,0.101868279327677,4.76151103978747e-138
NMR metabolomics,X23424.Total Lipids in VLDL,TBCC,Tubulin-specific chaperone C,29218,0.137954114558443,0.00548820952648818,0.127197223886526,0.148711005230359,5.83676363711305e-138
NMR metabolomics,X23424.Total Lipids in VLDL,IST1,IST1 homolog,24636,0.169910064523722,0.00675338621397257,0.156673427544336,0.183146701503109,6.19034004124353e-138
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0641409811713569,0.00254974373994506,0.0591434834410645,0.0691384789016492,7.01063297914847e-138
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.130904837877249,0.00521799897338832,0.120677559889408,0.14113211586509,1.91664953083044e-137
NMR metabolomics,X23424.Total Lipids in VLDL,CNST,Consortin,29478,0.184355952788384,0.00734927461757025,0.169951374537946,0.198760531038821,2.01601082604896e-137
NMR metabolomics,X23424.Total Lipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.156207414057024,0.00623303876433018,0.143990658078937,0.168424170035111,3.84909346651644e-137
NMR metabolomics,X23424.Total Lipids in VLDL,MYDGF,Myeloid-derived growth factor,24922,0.170189380984789,0.00679169539005848,0.156877658020274,0.183501103949304,7.00879597097682e-137
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX2,Heme oxygenase 2,28774,0.0793265200307565,0.00317002373717502,0.0731132735058934,0.0855397665556195,9.76238866401621e-137
NMR metabolomics,X23424.Total Lipids in VLDL,CRKL,Crk-like protein,29491,0.179912444635773,0.0071958317528693,0.165808614400149,0.194016274871396,1.53099886280135e-136
NMR metabolomics,X23424.Total Lipids in VLDL,OPHN1,Oligophrenin-1,24845,0.182829495488844,0.00730610573353712,0.168509528251111,0.197149462726577,1.63933100882424e-136
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.053825113996737,0.00215288933225641,0.0496054509055144,0.0580447770879596,3.15317377111932e-136
NMR metabolomics,X23424.Total Lipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.128743675979032,0.00516569473406609,0.118618914300262,0.138868437657801,1.93917215652946e-135
NMR metabolomics,X23424.Total Lipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0376237699792042,0.0015128753447005,0.0346585343035912,0.0405890056548172,3.84981450136477e-135
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GLB2,Endophilin-B2,24845,0.11244301551531,0.00452021130041356,0.1035834013665,0.121302629664121,6.13659539004119e-135
NMR metabolomics,X23424.Total Lipids in VLDL,DBNL,Drebrin-like protein,29581,0.155903404530867,0.00627639653480071,0.143601667322658,0.168205141739077,8.08942279417697e-135
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.149232919333814,0.00600451821488254,0.137464063632644,0.161001775034984,1.15640015920934e-134
NMR metabolomics,X23424.Total Lipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0847534080710447,0.003410090609856,0.0780696304757269,0.0914371856663625,1.16541913540172e-134
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.150344392140019,0.00605034846961219,0.138485709139579,0.162203075140459,1.18192539700945e-134
NMR metabolomics,X23424.Total Lipids in VLDL,SDC4,Syndecan-4,29478,0.0780593492718086,0.00314604796468453,0.0718930952610269,0.0842256032825903,1.60818569985811e-134
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.111089503426209,0.00447333561332375,0.102321765624095,0.119857241228324,1.69259267315378e-134
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D23,TBC1 domain family member 23,29349,0.151206163262125,0.00609475688921476,0.139260439759264,0.163151886764986,1.73939636261092e-134
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.185168541270768,0.00746540152725038,0.170536354277357,0.199800728264179,1.94751116520037e-134
NMR metabolomics,X23424.Total Lipids in VLDL,PYY,Peptide YY,24111,0.1640967572396,0.00660837530495329,0.151144341641892,0.177049172837309,1.9997208765477e-134
NMR metabolomics,X23424.Total Lipids in VLDL,BRAP,BRCA1-associated protein,24565,0.185082455622351,0.00745449262861559,0.170471650070264,0.199693261174438,2.01953991823021e-134
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.218665612924169,0.00881966611811096,0.201379067332672,0.235952158515667,2.52071324034235e-134
NMR metabolomics,X23424.Total Lipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0453755153423753,0.00182858015684666,0.0417914982349559,0.0489595324497948,2.65636537638991e-134
NMR metabolomics,X23424.Total Lipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0752204098233617,0.00303785535893027,0.0692662133198583,0.081174606326865,5.61516237709741e-134
NMR metabolomics,X23424.Total Lipids in VLDL,ARSB,Arylsulfatase B,29349,0.0927052170072629,0.00374446526783659,0.0853660650823032,0.100044368932223,6.05316440790115e-134
NMR metabolomics,X23424.Total Lipids in VLDL,SELE,E-selectin,29820,0.0846198899063996,0.00341952195191736,0.0779176268806415,0.0913221529321576,7.67690293372198e-134
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4R,Reticulon-4 receptor,29725,0.0567382855889794,0.00229634675565679,0.052237445947892,0.0612391252300667,1.95206111156236e-133
NMR metabolomics,X23424.Total Lipids in VLDL,FAM13A,Protein FAM13A,24805,0.113526267393344,0.0045934994366808,0.10452300849745,0.122529526289239,3.05978531038304e-133
NMR metabolomics,X23424.Total Lipids in VLDL,KLK10,Kallikrein-10,29466,0.0670464194225025,0.00271657662995127,0.061721929227798,0.072370909617207,3.91276506879227e-133
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD1,COMM domain-containing protein 1,24240,0.102969364388709,0.0041687272133622,0.0947986590505193,0.111140069726899,4.68472128937565e-133
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0819065186291495,0.00332580993091474,0.0753879311645567,0.0884251060937424,1.49268835668693e-132
NMR metabolomics,X23424.Total Lipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.126619392981503,0.00514148268062579,0.116542086927476,0.136696699035529,1.51160406280674e-132
NMR metabolomics,X23424.Total Lipids in VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.108565288686776,0.00441382281663792,0.0999141959661659,0.117216381407387,2.9016084662837e-132
NMR metabolomics,X23424.Total Lipids in VLDL,VNN1,Pantetheinase,24951,0.121728783829997,0.00494785072060159,0.112030996417618,0.131426571242376,4.47924057050281e-132
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.197960819458202,0.00804848489162079,0.182185789070625,0.213735849845778,5.27799403186286e-132
NMR metabolomics,X23424.Total Lipids in VLDL,DDHD2,Phospholipase DDHD2,24867,0.110800867549832,0.00450528011707544,0.101970518520365,0.1196312165793,5.60203321296699e-132
NMR metabolomics,X23424.Total Lipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.178788342584139,0.00727874656446911,0.16452199931778,0.193054685850498,1.16576040052735e-131
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.138704108274854,0.00564865172157522,0.127632750900567,0.149775465649142,1.4212125965033e-131
NMR metabolomics,X23424.Total Lipids in VLDL,AMN,Protein amnionless,28931,0.0790333183777591,0.00322425615317589,0.0727137763175344,0.0853528604379839,2.40873630758364e-131
NMR metabolomics,X23424.Total Lipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.120336409762338,0.00491438399275688,0.110704217136535,0.129968602388142,4.16975495262552e-131
NMR metabolomics,X23424.Total Lipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.202786776434856,0.0082832714471453,0.186551564398452,0.219021988471261,5.24383458902589e-131
NMR metabolomics,X23424.Total Lipids in VLDL,CD36,Platelet glycoprotein 4,24229,0.0755283045154122,0.00308377839409688,0.0694840988629823,0.081572510167842,7.01196244394528e-131
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY4,Protein canopy homolog 4,29349,0.124402654512854,0.00508975062124513,0.114426743295213,0.134378565730494,1.24915111593254e-130
NMR metabolomics,X23424.Total Lipids in VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.10492352324189,0.00429383282139383,0.0965076109119578,0.113339435571822,2.46405635195841e-130
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0462975897407628,0.00189817404668886,0.0425771686092526,0.0500180108722729,4.26244937893811e-130
NMR metabolomics,X23424.Total Lipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.149832337534208,0.00613727284963367,0.137803282748926,0.16186139231949,4.59271580574686e-130
NMR metabolomics,X23424.Total Lipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.101372234753467,0.00415814501761009,0.0932222705189516,0.109522198987983,5.55650676858851e-130
NMR metabolomics,X23424.Total Lipids in VLDL,EGLN1,Egl nine homolog 1,29434,0.0899450674135208,0.00369120107520127,0.0827103133061263,0.0971798215209153,7.35855701627533e-130
NMR metabolomics,X23424.Total Lipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.142569772457022,0.00585555506420945,0.131092884531172,0.154046660382873,1.16534873168492e-129
NMR metabolomics,X23424.Total Lipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0781189413654904,0.00321454696029388,0.0718184293233144,0.0844194534076664,6.06962034585371e-129
NMR metabolomics,X23424.Total Lipids in VLDL,RILPL2,RILP-like protein 2,24922,0.161750654368313,0.00666139090080538,0.148694328202735,0.174806980533892,9.58125018339629e-129
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.084306741997839,0.00347666312498592,0.0774924822728666,0.0911210017228114,1.23221667218976e-128
NMR metabolomics,X23424.Total Lipids in VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.14901695279853,0.00614092055707365,0.136980748506666,0.161053157090395,1.52620880204433e-128
NMR metabolomics,X23424.Total Lipids in VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.0610796506907257,0.00252063642417672,0.0561392032993394,0.0660200980821121,1.91519400396806e-128
NMR metabolomics,X23424.Total Lipids in VLDL,SIAE,Sialate O-acetylesterase,29495,0.0765160436629539,0.00316640061751404,0.0703098984526264,0.0827221888732814,9.10569202913265e-128
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS8,Galectin-8,29694,0.0995417494320141,0.00411960993862063,0.0914673139523177,0.107616184911711,9.3880658834022e-128
NMR metabolomics,X23424.Total Lipids in VLDL,PXN,Paxillin,28774,0.0844460644519269,0.0034983227231167,0.0775893519146181,0.0913027769892356,1.80961915547286e-127
NMR metabolomics,X23424.Total Lipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0457704717887375,0.00189993111181833,0.0420466068095735,0.0494943367679014,5.69485290934248e-127
NMR metabolomics,X23424.Total Lipids in VLDL,COCH,Cochlin,24922,0.0757290404417935,0.00314899099171759,0.069557018098027,0.08190106278556,2.37832954287147e-126
NMR metabolomics,X23424.Total Lipids in VLDL,GTPBP2,GTP-binding protein 2,24195,0.132276144629865,0.00550123525686435,0.121493723526411,0.143058565733319,2.87313802098601e-126
NMR metabolomics,X23424.Total Lipids in VLDL,FGF19,Fibroblast growth factor 19,29581,0.125736096393709,0.00523586105183588,0.115473808732111,0.135998384055308,3.18779704230686e-126
NMR metabolomics,X23424.Total Lipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0815047171715076,0.00339487589283262,0.0748507604215557,0.0881586739214596,3.61365353168268e-126
NMR metabolomics,X23424.Total Lipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.138411984734935,0.00576509476106729,0.127112399003243,0.149711570466627,3.93771346604888e-126
NMR metabolomics,X23424.Total Lipids in VLDL,ST13,Hsc70-interacting protein,24381,0.0910935639048721,0.00379989840507226,0.0836457630309305,0.0985413647788137,1.52640030269202e-125
NMR metabolomics,X23424.Total Lipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0806876392231224,0.00337190586870224,0.074078703720466,0.0872965747257788,4.29368466949143e-125
NMR metabolomics,X23424.Total Lipids in VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.060085729321139,0.00251952220583621,0.0551474657977,0.065023992844578,1.61517341669764e-124
NMR metabolomics,X23424.Total Lipids in VLDL,MUC13,Mucin-13,28774,0.0833766326302879,0.00349852692725605,0.076519519852866,0.0902337454077097,2.50703458329256e-124
NMR metabolomics,X23424.Total Lipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.237940675469718,0.00998230551304386,0.218375356664152,0.257505994275284,3.51237231694303e-124
NMR metabolomics,X23424.Total Lipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.139043823151391,0.0058342641207115,0.127608665474797,0.150478980827986,4.09919727302568e-124
NMR metabolomics,X23424.Total Lipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.109368077786506,0.00459418251400374,0.100363480059058,0.118372675513953,7.09387229225241e-124
NMR metabolomics,X23424.Total Lipids in VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.125728169129743,0.0052810886192227,0.115377235436066,0.136079102823419,7.4473064527761e-124
NMR metabolomics,X23424.Total Lipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0963674916092812,0.00405570498220227,0.0884183098441648,0.104316673374398,2.03025896134459e-123
NMR metabolomics,X23424.Total Lipids in VLDL,TWF2,Twinfilin-2,24938,0.135588643236997,0.00570848339684668,0.124400015779178,0.146777270694817,2.45273833244726e-123
NMR metabolomics,X23424.Total Lipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.071660108058952,0.00301747378619287,0.065745859438014,0.07757435667989,2.74776753604957e-123
NMR metabolomics,X23424.Total Lipids in VLDL,IDUA,Alpha-L-iduronidase,29725,0.0743183721246623,0.00313319901413402,0.0681773020569596,0.0804594421923649,3.16777041771549e-123
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA11,Annexin A11,29373,0.10764967176685,0.00453997628621611,0.0987513182458665,0.116548025287834,3.95133095413626e-123
NMR metabolomics,X23424.Total Lipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.053529406664071,0.00225583584896164,0.0491079684001061,0.0579508449280358,4.8040940090951e-123
NMR metabolomics,X23424.Total Lipids in VLDL,MTDH,Protein LYRIC,24229,0.150426357924113,0.00634010973748096,0.13799974283865,0.162852973009575,4.91427263150745e-123
NMR metabolomics,X23424.Total Lipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.121751765405644,0.00513973062741661,0.111677893375908,0.131825637435381,6.81966664184694e-123
NMR metabolomics,X23424.Total Lipids in VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.0695162516466426,0.00293246250751883,0.0637686251319057,0.0752638781613795,8.01233713832832e-123
NMR metabolomics,X23424.Total Lipids in VLDL,OGA,Protein O-GlcNAcase,24805,0.113995550877813,0.00481184425370431,0.104564336140552,0.123426765615073,1.04150856476652e-122
NMR metabolomics,X23424.Total Lipids in VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.132234760257047,0.00559207553162254,0.121274292215066,0.143195228299027,2.83458155531227e-122
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.0854438502870947,0.00361746067293756,0.0783536273681371,0.0925340732060523,3.31264091329437e-122
NMR metabolomics,X23424.Total Lipids in VLDL,WASHC3,WASH complex subunit 3,24845,0.121172997449387,0.00513089079956265,0.111116451482244,0.13122954341653,5.79090177404026e-122
NMR metabolomics,X23424.Total Lipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.0916120434269477,0.00388398656681159,0.083999429755997,0.0992246570978984,7.08499524143496e-122
NMR metabolomics,X23424.Total Lipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.124810266961877,0.00529172106427524,0.114438493675898,0.135182040247857,7.70590974779568e-122
NMR metabolomics,X23424.Total Lipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0816133736139764,0.00346300956216245,0.074825874872138,0.0884008723558148,1.19290584086345e-121
NMR metabolomics,X23424.Total Lipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.099986279844108,0.00423915858219973,0.0916775290229965,0.108295030665219,1.27157672343205e-121
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0629789851417158,0.00267478238280365,0.0577364116714206,0.0682215586120109,1.9445971941843e-121
NMR metabolomics,X23424.Total Lipids in VLDL,SPART,Spartin,24381,0.124007495783123,0.00526924145801325,0.113679782525417,0.134335209040829,4.09017791759125e-121
NMR metabolomics,X23424.Total Lipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0320421434115436,0.00136268259776305,0.029371285519928,0.0347130013031592,6.15283240253476e-121
NMR metabolomics,X23424.Total Lipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.115572879423541,0.00492037472610294,0.10592894496038,0.125216813886703,6.92206716564924e-121
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.112375149209401,0.0047845396819728,0.102997451432734,0.121752846986068,7.16518458737468e-121
NMR metabolomics,X23424.Total Lipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0735249171363427,0.00313120314027768,0.0673877589813984,0.0796620752912869,8.18134137689854e-121
NMR metabolomics,X23424.Total Lipids in VLDL,CASC3,Protein CASC3,24195,0.0671210510273842,0.00285693992985474,0.0615214487648689,0.0727206532898995,1.05657962205779e-120
NMR metabolomics,X23424.Total Lipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0607386707219322,0.0025897983271491,0.05566266600072,0.0658146754431445,1.58522135446105e-120
NMR metabolomics,X23424.Total Lipids in VLDL,NIT1,Deaminated glutathione amidase,24240,0.0754043381231004,0.0032233237427429,0.0690866235873243,0.0817220526588765,1.06083342309969e-119
NMR metabolomics,X23424.Total Lipids in VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.0404771864787802,0.00173240927263,-0.043872708653135,-0.0370816643044254,1.18319995370969e-119
NMR metabolomics,X23424.Total Lipids in VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0272066586957308,0.001164381506995,0.0249244709420206,0.029488846449441,1.82899701592347e-119
NMR metabolomics,X23424.Total Lipids in VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.123882809420101,0.00530703570177379,0.113481019444624,0.134284599395577,3.1066175784103e-119
NMR metabolomics,X23424.Total Lipids in VLDL,CCL11,Eotaxin,29786,0.0596938356876714,0.00256087118373432,0.0546745281675521,0.0647131432077906,4.10468742537862e-119
NMR metabolomics,X23424.Total Lipids in VLDL,RWDD1,RWD domain-containing protein 1,29694,0.100472590082996,0.0043146937434255,0.0920157903458819,0.10892938982011,7.14048904651542e-119
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS9,Galectin-9,29453,0.0504624687822205,0.00216854232213145,0.0462121258308428,0.0547128117335981,1.04879210349815e-118
NMR metabolomics,X23424.Total Lipids in VLDL,DOK1,Docking protein 1,24845,0.216515349845444,0.00930144255649023,0.198284522434723,0.234746177256165,1.39208304873989e-118
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.131482240259942,0.00565917655865753,0.120390254204973,0.14257422631491,2.42692699620501e-118
NMR metabolomics,X23424.Total Lipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0703977295559949,0.00303038638118058,0.064458172248881,0.0763372868631089,2.74269335264986e-118
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.0911347469972306,0.00392486373791888,0.0834420140709096,0.0988274799235516,3.2572545082551e-118
NMR metabolomics,X23424.Total Lipids in VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0866570063492175,0.00373015315706529,0.0793459061613696,0.0939681065370655,4.28518094101814e-118
NMR metabolomics,X23424.Total Lipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0787078075348632,0.00339430529966882,0.0720549691475123,0.0853606459222141,6.83691758847221e-118
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0524465722006322,0.00226216801848519,0.0480127228844012,0.0568804215168632,7.49939341783045e-118
NMR metabolomics,X23424.Total Lipids in VLDL,GLB1,Beta-galactosidase,29218,0.0659009852803199,0.00284712351508114,0.0603206231907609,0.0714813473698789,1.8022452106837e-117
NMR metabolomics,X23424.Total Lipids in VLDL,F11,Coagulation factor XI,24606,0.0489564799330887,0.00211330912697188,0.0448143940442238,0.0530985658219536,1.82540395763945e-117
NMR metabolomics,X23424.Total Lipids in VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.176848143291947,0.00763521805077331,0.161883115912432,0.191813170671463,2.03528127279343e-117
NMR metabolomics,X23424.Total Lipids in VLDL,TALDO1,Transaldolase,24888,0.0702176091120379,0.00303200654932171,0.0642748762753673,0.0761603419487084,2.0718358796724e-117
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.125526222006114,0.00542850388037563,0.114886354400577,0.13616608961165,2.97667887864027e-117
NMR metabolomics,X23424.Total Lipids in VLDL,MAX,Protein max,28774,0.165400313772959,0.00715345984838799,0.151379532470118,0.179421095075799,3.28805951619547e-117
NMR metabolomics,X23424.Total Lipids in VLDL,SPON2,Spondin-2,29311,-0.0547984992284381,0.00237072999490561,-0.0594451300184531,-0.0501518684384231,3.69681341484421e-117
NMR metabolomics,X23424.Total Lipids in VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0471004659557798,0.00204097265838051,0.043100159545354,0.0511007723662056,8.82844070019895e-117
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0958128941355137,0.00415496615597228,0.0876691604698081,0.103956627801219,1.26997628241588e-116
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.0578632720797315,0.00251236441316966,0.052939037829919,0.062787506329544,2.36609143270001e-116
NMR metabolomics,X23424.Total Lipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.0864531610407811,0.00375454691911269,0.0790942490793202,0.0938120730022419,2.83347106964e-116
NMR metabolomics,X23424.Total Lipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0888107456760979,0.00385758871505445,0.0812498717945912,0.0963716195576046,2.97005176682994e-116
NMR metabolomics,X23424.Total Lipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.095189245811372,0.00413153453533508,0.0870914381221152,0.103287053500629,3.08565253734752e-116
NMR metabolomics,X23424.Total Lipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.0930947562897179,0.00404649789542889,0.0851636204146773,0.101025892164759,4.30875459481412e-116
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.105958999623153,0.00461057295954857,0.0969222766224376,0.114995722623868,7.30262219594025e-116
NMR metabolomics,X23424.Total Lipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0909737576253502,0.0039562075813684,0.0832195907658681,0.0987279244848323,8.89999188931296e-116
NMR metabolomics,X23424.Total Lipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.145146579692137,0.0063190800949746,0.132761182705987,0.157531976678287,1.02297420199566e-115
NMR metabolomics,X23424.Total Lipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0954363068194665,0.00416138342591968,0.0872799953046639,0.103592618334269,2.17969824278666e-115
NMR metabolomics,X23424.Total Lipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.079914763477427,0.00348219349100521,0.0730896642350568,0.0867398627197972,2.37328572681099e-115
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.123706794146496,0.00539153018783734,0.113139394978335,0.134274193314657,2.63169110892013e-115
NMR metabolomics,X23424.Total Lipids in VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.132393102324064,0.00577914191031153,0.121065984179853,0.143720220468274,4.08133179572635e-115
NMR metabolomics,X23424.Total Lipids in VLDL,PLG,Plasminogen,24421,0.0346254097342483,0.00151046867213095,0.0316648911368716,0.0375859283316249,4.43912800105894e-115
NMR metabolomics,X23424.Total Lipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.142839643207537,0.00623960711939178,0.130610013253529,0.155069273161545,5.89127521297283e-115
NMR metabolomics,X23424.Total Lipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0876968225281366,0.00383438878967955,0.0801814205003646,0.0952122245559085,9.04357878029167e-115
NMR metabolomics,X23424.Total Lipids in VLDL,ICA1,Islet cell autoantigen 1,28931,0.123752971519843,0.00541294394349022,0.113143601390603,0.134362341649084,1.14492456760521e-114
NMR metabolomics,X23424.Total Lipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.10068711358562,0.00440506338031193,0.0920531893602088,0.109321037811032,1.24403989710401e-114
NMR metabolomics,X23424.Total Lipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0899538105865042,0.00394047282159057,0.0822304838561867,0.0976771373168217,2.34612134093092e-114
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.161979220888985,0.00709964116113194,0.148063924213167,0.175894517564804,3.18657001024164e-114
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.136884414661679,0.0060058455361671,0.125112957410792,0.148655871912567,5.4072642277845e-114
NMR metabolomics,X23424.Total Lipids in VLDL,UBXN1,UBX domain-containing protein 1,24381,0.107174678914304,0.00469949159225752,0.0979636753934791,0.116385682435129,6.29312601994417e-114
NMR metabolomics,X23424.Total Lipids in VLDL,MGLL,Monoglyceride lipase,29536,0.13436120469029,0.00589747564212384,0.122802152431727,0.145920256948853,6.52782048703141e-114
NMR metabolomics,X23424.Total Lipids in VLDL,RBM17,Splicing factor 45,24867,0.11842483898391,0.00520920770742468,0.108214791877357,0.128634886090462,2.97208208731133e-113
NMR metabolomics,X23424.Total Lipids in VLDL,SNCG,Gamma-synuclein,29218,0.103269000910024,0.00454725603333551,0.0943563790846866,0.112181622735362,3.40358087915175e-113
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4D,Semaphorin-4D,29694,0.0462806851387644,0.00203824971867271,0.0422857156901659,0.050275654587363,3.5981615796585e-113
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.043704012369593,0.0019250370643701,0.0399309397234276,0.0474770850157584,3.86609299405373e-113
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.122465679969509,0.00539790678123708,0.111885782678284,0.133045577260734,5.6344984672376e-113
NMR metabolomics,X23424.Total Lipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.074484634156566,0.00328314835618503,0.0680496633784434,0.0809196049346887,8.50166203721381e-113
NMR metabolomics,X23424.Total Lipids in VLDL,CRADD,Death domain-containing protein CRADD,29163,0.116774735963505,0.00515592736519148,0.10666911832773,0.126880353599281,1.35069796529399e-112
NMR metabolomics,X23424.Total Lipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.117491338080826,0.0051918556378737,0.107315301030593,0.127667375131058,2.10786806123039e-112
NMR metabolomics,X23424.Total Lipids in VLDL,NUDC,Nuclear migration protein nudC,29786,0.0974580245578556,0.00430840016494158,0.0890135602345701,0.105902488881141,2.4166266138936e-112
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR2,GMP reductase 2,24381,0.103659649018524,0.00457860357655681,0.0946855860084722,0.112633712028575,2.52358174377685e-112
NMR metabolomics,X23424.Total Lipids in VLDL,ANG,Angiogenin,29435,0.051859784825404,0.00229357657557966,0.0473643747372679,0.0563551949135402,3.06988271772276e-112
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0599440482283825,0.00264897153342679,0.054752064022866,0.065136032433899,3.21030127480457e-112
NMR metabolomics,X23424.Total Lipids in VLDL,YJU2,Splicing factor YJU2,24793,0.050044780731988,0.00221206668493396,0.0457091300295174,0.0543804314344585,3.48297455407237e-112
NMR metabolomics,X23424.Total Lipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0516343687266112,0.00228525601804861,0.0471552669312359,0.0561134705219864,4.37170785077755e-112
NMR metabolomics,X23424.Total Lipids in VLDL,CD22,B-cell receptor CD22,29786,0.0642621422217996,0.00284715490979567,0.0586817185986001,0.0698425658449991,7.32402077185799e-112
NMR metabolomics,X23424.Total Lipids in VLDL,PENK,Proenkephalin-A,24381,0.047530876283706,0.00210636408436037,0.0434024026783597,0.0516593498890524,1.32169500403275e-111
NMR metabolomics,X23424.Total Lipids in VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.118184841920616,0.00524421818051429,0.107906174286808,0.128463509554424,1.61233054321838e-111
NMR metabolomics,X23424.Total Lipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.193019793358194,0.00855815235139668,0.176245814749456,0.209793771966931,1.70331391773337e-111
NMR metabolomics,X23424.Total Lipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0461084836509491,0.00204826648905465,0.0420938813324019,0.0501230859694962,2.88984618255533e-111
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.108490015005538,0.00482173784974164,0.099039408820044,0.117940621191031,3.56367920331706e-111
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0780500322537192,0.00346958565165741,0.0712496443764707,0.0848504201309677,4.17683730072842e-111
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS1,Galectin-1,29478,0.0523112363893421,0.0023312314408292,0.0477420227653169,0.0568804500133673,1.37691573811567e-110
NMR metabolomics,X23424.Total Lipids in VLDL,CETN3,Centrin-3,24805,0.118516149474204,0.00528622779634803,0.108155142993362,0.128877155955046,3.14860983088571e-110
NMR metabolomics,X23424.Total Lipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.102625214899067,0.00458372386515606,0.0936411161233613,0.111609313674773,6.46632843840915e-110
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH9,Protocadherin-9,24805,0.0515948985720282,0.00230821295277642,0.0470708011845864,0.05611899595947,1.37513789415227e-109
NMR metabolomics,X23424.Total Lipids in VLDL,CST3,Cystatin-C,29530,0.0430600223324579,0.00192854511484216,0.0392800739073673,0.0468399707575485,1.60726951942592e-109
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.13152192305604,0.0058878653559321,0.119981706958413,0.143062139153667,1.91155006236367e-109
NMR metabolomics,X23424.Total Lipids in VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.193062973068225,0.0086970237204148,0.176016806576212,0.210109139560238,2.73285412049556e-108
NMR metabolomics,X23424.Total Lipids in VLDL,LPP,Lipoma-preferred partner,24111,0.100793871016945,0.00453810409451468,0.0918991869916961,0.109688555042194,3.31037394118923e-108
NMR metabolomics,X23424.Total Lipids in VLDL,SPRY2,Protein sprouty homolog 2,28931,0.13953484404961,0.00628886868588876,0.127208661425268,0.151861026673952,3.62341154958524e-108
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.095039058621097,0.00428428555859405,0.0866418589262527,0.103436258315941,3.78790696491421e-108
NMR metabolomics,X23424.Total Lipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.085131878659603,0.00383934709160342,0.0776067583600603,0.0926569989591457,4.784816630591e-108
NMR metabolomics,X23424.Total Lipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.104275519467308,0.00470303123359899,0.0950575782494535,0.113493460685162,7.60949022960288e-108
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1A,Meprin A subunit alpha,24805,0.108840849285655,0.00490981618214986,0.0992176095686417,0.118464089002669,7.81313773579751e-108
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0635436957168416,0.00286740649935262,0.0579235789781105,0.0691638124555728,9.17453749427648e-108
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS8,Prostasin,29347,0.0618315686558484,0.002792408677721,0.0563584476475152,0.0673046896641816,9.37504764110565e-108
NMR metabolomics,X23424.Total Lipids in VLDL,APOA2,Apolipoprotein A-II,24951,-0.0730295154830174,0.00329686598586454,-0.0794913728153119,-0.0665676581507229,1.11121066742229e-107
NMR metabolomics,X23424.Total Lipids in VLDL,KIFBP,KIF-binding protein,29349,0.124057748619806,0.00560668814828598,0.113068639849165,0.135046857390446,1.32872942586142e-107
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.10912479739444,0.00492879881189875,0.0994643517231184,0.118785243065762,1.51806513618818e-107
NMR metabolomics,X23424.Total Lipids in VLDL,DLG4,Disks large homolog 4,24845,0.106914698501256,0.0048365426389465,0.0974350749289212,0.116394322073591,3.02478367107816e-107
NMR metabolomics,X23424.Total Lipids in VLDL,FUS,RNA-binding protein FUS,28765,0.0594403737445264,0.00269122597828204,0.0541655708270936,0.0647151766619592,3.30878034019485e-107
NMR metabolomics,X23424.Total Lipids in VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.0841387879550977,0.00381239310822667,0.0766664974629734,0.0916110784472219,4.56561345203147e-107
NMR metabolomics,X23424.Total Lipids in VLDL,C19orf12,Protein C19orf12,28774,0.0968473240422189,0.00438832219802009,0.0882462125340996,0.105448435550338,4.82804202990407e-107
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0745304709359052,0.0033750344600724,0.0679154033941633,0.0811455384776471,5.14823229275336e-107
NMR metabolomics,X23424.Total Lipids in VLDL,ELOA,Elongin-A,29349,0.0782174134229305,0.0035568825368439,0.0712459236507165,0.0851889031951446,2.57353399783848e-106
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.127892126509388,0.00581704150750715,0.116490725154674,0.139293527864102,4.23992971063087e-106
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0720943842281696,0.00328085868866326,0.0656639011983896,0.0785248672579496,5.19501549577188e-106
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0793318709676536,0.0036125096749839,0.0722513520046852,0.0864123899306221,7.05716114190227e-106
NMR metabolomics,X23424.Total Lipids in VLDL,TP53,Cellular tumor antigen p53,28797,0.0652469778894521,0.00297362486274483,0.0594186731584722,0.0710752826204319,7.64204360955684e-106
NMR metabolomics,X23424.Total Lipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0893448262754876,0.00407477145871627,0.0813582742164037,0.0973313783345715,1.06003302830838e-105
NMR metabolomics,X23424.Total Lipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0864571719264787,0.0039458659514139,0.0787232746617075,0.0941910691912499,2.16590998967173e-105
NMR metabolomics,X23424.Total Lipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.143126868019599,0.00653800639021127,0.130312375494785,0.155941360544413,2.17498117664079e-105
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.11672884906327,0.00533607008799789,0.106270151690794,0.127187546435745,3.12103806434102e-105
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.145684942888848,0.00665516592346229,0.132640817678862,0.158729068098834,3.16621474623813e-105
NMR metabolomics,X23424.Total Lipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.16295097161983,0.00745274757685574,0.148343586369192,0.177558356870467,3.90114191889037e-105
NMR metabolomics,X23424.Total Lipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.114760091532253,0.00525054424635001,0.104469024809407,0.125051158255099,4.59618888433682e-105
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.116840478688111,0.00534557449410115,0.106363152679672,0.127317804696549,4.73621493216232e-105
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0468096424053989,0.00214281377765085,0.0426097274012032,0.0510095574095945,8.43263041946098e-105
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0945519993297285,0.00432930967680146,0.0860665523631976,0.103037446296259,9.79181236853217e-105
NMR metabolomics,X23424.Total Lipids in VLDL,NEXN,Nexilin,24951,0.10254836834671,0.00469676354265299,0.0933427118031099,0.11175402489031,1.06019883484576e-104
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0651344344926216,0.00298836215056354,0.0592772446775171,0.0709916243077261,1.75760937010753e-104
NMR metabolomics,X23424.Total Lipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0564267240836534,0.00258767788050899,0.0513548754378558,0.061498572729451,1.95689795987954e-104
NMR metabolomics,X23424.Total Lipids in VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0723318715192022,0.00332570700465382,0.0658134857900807,0.0788502572483236,6.94628323436479e-104
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.127745658505505,0.00588741197834658,0.116206331027946,0.139284985983064,1.46718868335882e-103
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0571347649297879,0.00263468953208849,0.0519707734468945,0.0622987564126813,1.79993110208077e-103
NMR metabolomics,X23424.Total Lipids in VLDL,CD207,C-type lectin domain family 4 member K,28835,0.0570923547390558,0.00263284236077796,0.051931983711931,0.0622527257661806,1.92406653545697e-103
NMR metabolomics,X23424.Total Lipids in VLDL,FOXJ3,Forkhead box protein J3,24229,0.0656375325267527,0.0030270069314752,0.0597045989410614,0.0715704661124441,2.79394176888242e-103
NMR metabolomics,X23424.Total Lipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.107294422700595,0.00495015090227257,0.0975921269321412,0.11699671846905,3.17235212361547e-103
NMR metabolomics,X23424.Total Lipids in VLDL,KLK13,Kallikrein-13,28845,0.0649939780153025,0.00300261762866156,0.0591088474631258,0.0708791085674791,4.41527400017078e-103
NMR metabolomics,X23424.Total Lipids in VLDL,RRAS,Ras-related protein R-Ras,24195,0.192879473509104,0.00891797352919039,0.17540024539189,0.210358701626317,9.19355605247343e-103
NMR metabolomics,X23424.Total Lipids in VLDL,CD226,CD226 antigen,24229,0.0621286719677934,0.00287625893387405,0.0564912044574003,0.0677661394781866,1.64965685434e-102
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC3B,Tetranectin,24381,0.0315046313355159,0.00146149756338265,0.0286400961112859,0.0343691665597459,4.14883737233118e-102
NMR metabolomics,X23424.Total Lipids in VLDL,EGF,Pro-epidermal growth factor,29379,0.151212336652295,0.00702781059233587,0.137437827891317,0.164986845413274,6.7213878760624e-102
NMR metabolomics,X23424.Total Lipids in VLDL,CCL7,C-C motif chemokine 7,29434,0.0859564409590576,0.00399711348740609,0.0781220985237417,0.0937907833943735,8.5780390390943e-102
NMR metabolomics,X23424.Total Lipids in VLDL,TMED8,Protein TMED8,24805,0.150868412253858,0.00701526061495898,0.137118501448539,0.164618323059178,1.16896831100076e-101
NMR metabolomics,X23424.Total Lipids in VLDL,EHD3,EH domain-containing protein 3,24240,0.172197355590809,0.00801414392608331,0.156489633495686,0.187905077685933,1.8375212755514e-101
NMR metabolomics,X23424.Total Lipids in VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.122398832914698,0.00570146524574213,0.111223961033043,0.133573704796352,1.8663300581875e-101
NMR metabolomics,X23424.Total Lipids in VLDL,VSNL1,Visinin-like protein 1,24845,0.0558691805101646,0.0026049542619159,0.0507634701568095,0.0609748908635198,4.00741605223163e-101
NMR metabolomics,X23424.Total Lipids in VLDL,SPARC,SPARC,29566,0.10256804925251,0.00478857765428541,0.0931824370501105,0.111953661454909,5.18332180382996e-101
NMR metabolomics,X23424.Total Lipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0899008965163338,0.00419441604957663,0.0816798410591636,0.098121951973504,5.64869023910948e-101
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0749478868105892,0.00349962257322229,0.0680886265670735,0.0818071470541049,7.78574216528136e-101
NMR metabolomics,X23424.Total Lipids in VLDL,F12,Coagulation factor XII,24966,0.0607137445231584,0.0028360908571412,0.0551550064431617,0.0662724826031552,9.16902945862645e-101
NMR metabolomics,X23424.Total Lipids in VLDL,CD69,Early activation antigen CD69,29344,0.127649440765438,0.00597168539826162,0.115944937384845,0.13935394414603,1.31692051952023e-100
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2,Microtubule-associated protein 2,24845,0.067447126589883,0.00315346070401828,0.0612663436100072,0.0736279095697589,1.38927870204515e-100
NMR metabolomics,X23424.Total Lipids in VLDL,C3,Complement C3,23779,0.0679059661783788,0.00317648480615356,0.0616800559583178,0.0741318763984398,1.9037283720656e-100
NMR metabolomics,X23424.Total Lipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0847297340913937,0.00397100830046571,0.0769465578224809,0.0925129103603065,3.08805064113069e-100
NMR metabolomics,X23424.Total Lipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.1240002046708,0.0058156647760342,0.112601501709773,0.135398907631827,5.61324886441675e-100
NMR metabolomics,X23424.Total Lipids in VLDL,PMVK,Phosphomevalonate kinase,28757,0.158847272858127,0.00747367505338815,0.144198869753486,0.173495675962768,1.75842660971676e-99
NMR metabolomics,X23424.Total Lipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0658946144291465,0.00310038890705778,0.0598178521713132,0.0719713766869797,2.4631688111583e-99
NMR metabolomics,X23424.Total Lipids in VLDL,PGF,Placenta growth factor,29786,0.0379057946824876,0.00178674614902786,0.034403772230393,0.0414078171345822,3.76947557356636e-99
NMR metabolomics,X23424.Total Lipids in VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.123533461738594,0.00582433808398055,0.112117759093992,0.134949164383196,4.30153755381556e-99
NMR metabolomics,X23424.Total Lipids in VLDL,IMPACT,Protein IMPACT,24845,0.0806414679969619,0.00380030326771935,0.073192873592232,0.0880900624016919,4.75939619719083e-99
NMR metabolomics,X23424.Total Lipids in VLDL,IL7,Interleukin-7,29434,0.0929598507825118,0.00438932414121392,0.0843567754657325,0.101562926099291,8.230067889068e-99
NMR metabolomics,X23424.Total Lipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0818200450293515,0.00386479573349604,0.0742450453916993,0.0893950446670037,9.59095858711894e-99
NMR metabolomics,X23424.Total Lipids in VLDL,PF4,Platelet factor 4,24822,0.140608867736679,0.00663710386414422,0.127600144162957,0.153617591310402,9.79064434026169e-99
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN3,Ataxin-3,24845,0.0892413745197261,0.00421344778790789,0.0809830168554266,0.0974997321840256,1.0879164063673e-98
NMR metabolomics,X23424.Total Lipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.0796010273251353,0.00376065246306878,0.0722301484975205,0.0869719061527501,1.44198293430922e-98
NMR metabolomics,X23424.Total Lipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.14112889477049,0.0066923569535685,0.128011875141496,0.154245914399484,5.64703132999374e-98
NMR metabolomics,X23424.Total Lipids in VLDL,BAG6,Large proline-rich protein BAG6,28916,0.0522914308217598,0.00248011958788378,0.0474303964295076,0.057152465214012,6.07353730979742e-98
NMR metabolomics,X23424.Total Lipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.0965969050673729,0.00458724755785503,0.0876058998539771,0.105587910280769,1.0042770895351e-97
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0690887288695698,0.00327862704433537,0.0626626198626725,0.0755148378764672,1.01970090313186e-97
NMR metabolomics,X23424.Total Lipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0508109283267353,0.00241384945950446,0.0460797833861066,0.055542073267364,1.20989479477269e-97
NMR metabolomics,X23424.Total Lipids in VLDL,GDF2,Growth/differentiation factor 2,29478,0.0511198705315303,0.002428579274002,0.0463598551544864,0.0558798859085742,1.21675079089306e-97
NMR metabolomics,X23424.Total Lipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0955367235281572,0.00453954935897685,0.0866392067845625,0.104434240271752,1.84706011589783e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CASP7,Caspase-7,24845,0.120627574784226,0.00573231971494765,0.109392228142928,0.131862921425523,1.86536116146575e-97
NMR metabolomics,X23424.Total Lipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0774621704157413,0.0036844771228078,0.070240595255038,0.0846837455764446,2.07560721201049e-97
NMR metabolomics,X23424.Total Lipids in VLDL,ATOX1,Copper transport protein ATOX1,29566,0.102148972269218,0.00486261285945514,0.0926182510646857,0.11167969347375,2.91298667950769e-97
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.0837076638967034,0.00398586195805237,0.0758953744589207,0.0915199533344861,4.48873858274736e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CCL8,C-C motif chemokine 8,29683,0.0864613722367753,0.00412011878786512,0.0783859394125597,0.094536805060991,4.55311714883242e-97
NMR metabolomics,X23424.Total Lipids in VLDL,YWHAQ,14-3-3 protein theta,24381,0.105850501709093,0.00504365006694842,0.0959649475778736,0.115736055840311,6.23251721205927e-97
NMR metabolomics,X23424.Total Lipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.159867892314043,0.00762281089880366,0.144927182952388,0.174808601675699,6.25294400465746e-97
NMR metabolomics,X23424.Total Lipids in VLDL,RFC4,Replication factor C subunit 4,24793,0.0304330244967189,0.00145105508519384,0.027588956529739,0.0332770924636988,8.03267409405244e-97
NMR metabolomics,X23424.Total Lipids in VLDL,ADD1,Alpha-adducin,24381,0.100182326305567,0.00477736954627103,0.0908186819948755,0.109545970616258,8.79921297589192e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CTF1,Cardiotrophin-1,28916,0.120558511755008,0.00575467801980084,0.109279342836199,0.131837680673818,9.91054722124009e-97
NMR metabolomics,X23424.Total Lipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0667589145921941,0.00318484407075078,0.0605166202135225,0.0730012089708656,1.01643723603621e-96
NMR metabolomics,X23424.Total Lipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.170038312173304,0.00811499381524381,0.154132924295426,0.185943700051182,1.23913765274397e-96
NMR metabolomics,X23424.Total Lipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.126554458659159,0.00604180282089475,0.114712525130205,0.138396392188113,1.37612667787681e-96
NMR metabolomics,X23424.Total Lipids in VLDL,CCL4,C-C motif chemokine 4,29498,0.09300438326342,0.00444521706469352,0.0842917578166207,0.101717008710219,1.68738629350064e-96
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.102286630211294,0.00489009123410308,0.0927020513924522,0.111871209030136,1.84766239545437e-96
NMR metabolomics,X23424.Total Lipids in VLDL,OXT,Oxytocin-neurophysin 1,29694,0.198043227821883,0.00947063241165035,0.179480788295048,0.216605667348718,2.09782453005208e-96
NMR metabolomics,X23424.Total Lipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.135196855158103,0.00646574317390607,0.122523998537247,0.147869711778959,2.19420410655911e-96
NMR metabolomics,X23424.Total Lipids in VLDL,TBCB,Tubulin-folding cofactor B,29218,0.14310384478874,0.0068494814527996,0.129678861141253,0.156528828436227,3.16329891027924e-96
NMR metabolomics,X23424.Total Lipids in VLDL,RBKS,Ribokinase,28795,0.0708295990084928,0.00339108420168038,0.0641830739731992,0.0774761240437863,3.63892871431843e-96
NMR metabolomics,X23424.Total Lipids in VLDL,COMT,Catechol O-methyltransferase,28591,0.11982484681102,0.00573978606943053,0.108574866114936,0.131074827507104,4.60139481156686e-96
NMR metabolomics,X23424.Total Lipids in VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.0880137664556645,0.00421684001067297,0.0797487600347455,0.0962787728765836,4.96700863006395e-96
NMR metabolomics,X23424.Total Lipids in VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0487031758761696,0.00233410576575651,-0.0532780231770523,-0.0441283285752868,5.42387334793541e-96
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0677812005713762,0.00324663167775599,0.0614178024829745,0.074144598659778,5.7099082687475e-96
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.132999639436489,0.00637321150734984,0.120508144882083,0.145491133990895,6.87759310146005e-96
NMR metabolomics,X23424.Total Lipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.12058744145493,0.0057841187754195,0.109250568655108,0.131924314254753,8.1236533221306e-96
NMR metabolomics,X23424.Total Lipids in VLDL,CACYBP,Calcyclin-binding protein,24329,0.146560411743621,0.00702535065598876,0.132790724457883,0.160330099029359,8.25895425180169e-96
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0973118124103422,0.00466811457879457,0.0881623078359048,0.10646131698478,1.15722072231527e-95
NMR metabolomics,X23424.Total Lipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.141217901903325,0.00677443321112779,0.127940012809515,0.154495790997136,1.16646235118973e-95
NMR metabolomics,X23424.Total Lipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.046126619114796,0.00221991192940249,0.0417755917331671,0.0504776464964249,3.28494421686991e-95
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE2,Glia-derived nexin,24922,0.0913618372801894,0.00439633724274706,0.0827450162844052,0.0999786582759737,4.09717094509883e-95
NMR metabolomics,X23424.Total Lipids in VLDL,PKD2,Polycystin-2,24111,0.0837851084098054,0.00403174293901804,0.0758828922493301,0.0916873245702808,4.35776637432575e-95
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0322665987484476,0.00155399171725645,0.0292207749826249,0.0353124225142702,4.42112003060723e-95
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0578644398332212,0.0027905904947295,0.0523948824635514,0.063333997202891,8.02957756134155e-95
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0919408703748066,0.00443713852347417,0.0832440788687972,0.100637661880816,1.47081799455889e-94
NMR metabolomics,X23424.Total Lipids in VLDL,CETN2,Centrin-2,28774,0.0952553970736302,0.0046013435371026,0.0862367637409091,0.104274030406351,1.6384584422678e-94
NMR metabolomics,X23424.Total Lipids in VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.0977699014943555,0.00472335853537522,0.08851211876502,0.107027684223691,2.28421668324089e-94
NMR metabolomics,X23424.Total Lipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.129266208374153,0.00625102989204789,0.117014189785739,0.141518226962566,2.50335742660135e-94
NMR metabolomics,X23424.Total Lipids in VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0386606932796669,0.00187341474164038,0.0349888003860517,0.042332586173282,5.86792412698705e-94
NMR metabolomics,X23424.Total Lipids in VLDL,PPBP,Platelet basic protein,24816,0.119251253849253,0.00577541318330228,0.10793144400998,0.130571063688525,6.26773464049581e-94
NMR metabolomics,X23424.Total Lipids in VLDL,CD244,Natural killer cell receptor 2B4,29786,0.0380033019307827,0.0018440291488992,0.0343890047989403,0.0416175990626251,1.03252186090619e-93
NMR metabolomics,X23424.Total Lipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.066510996122157,0.00322665543930041,0.0601867514611282,0.0728352407831857,1.27491320067247e-93
NMR metabolomics,X23424.Total Lipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.103691592955509,0.00503507963425645,0.0938228368723666,0.113560349038652,1.47684414970796e-93
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.140163844076585,0.00681191383667145,0.126812492956709,0.153515195196461,2.03887553043595e-93
NMR metabolomics,X23424.Total Lipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0800696140773267,0.00388972962817796,0.0724457440060979,0.0876934841485555,2.26759420458485e-93
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0766836786364077,0.00372881019370882,0.0693752106567384,0.083992146616077,2.62199792877303e-93
NMR metabolomics,X23424.Total Lipids in VLDL,C2,Complement C2,29545,0.0327101662944479,0.00159113804374955,0.0295915357286988,0.035828796860197,2.95653458283863e-93
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.156281268836031,0.00761685486225227,0.141352233306016,0.171210304366045,6.63498558937896e-93
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.051747043964469,0.00252085014795467,0.0468061776744779,0.0566879102544602,7.45267990488799e-93
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB6,Serpin B6,29623,0.0826724489653559,0.00403290230373733,0.0747679604500307,0.0905769374806811,9.59636867672768e-93
NMR metabolomics,X23424.Total Lipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.102834395831038,0.00501526704827851,0.0930044724164119,0.112664319245664,1.20716632233971e-92
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0863254417151679,0.00421159603778929,0.0780707134811009,0.0945801699492349,1.32901651349942e-92
NMR metabolomics,X23424.Total Lipids in VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0420038129276855,0.00205097018751136,0.0379839113601632,0.0460237144952077,1.41990731446183e-92
NMR metabolomics,X23424.Total Lipids in VLDL,FST,Follistatin,29536,0.0704120184344965,0.00344322460110221,0.0636632982163362,0.0771607386526568,2.65369399834245e-92
NMR metabolomics,X23424.Total Lipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.102760305373,0.00502444300189014,0.0929123970892956,0.112608213656705,3.40928599250921e-92
NMR metabolomics,X23424.Total Lipids in VLDL,TADA3,Transcriptional adapter 3,24793,0.0552462825792733,0.00270154660573341,0.0499512512320359,0.0605413139265108,3.47741690730019e-92
NMR metabolomics,X23424.Total Lipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.111438769716132,0.00545060123655472,0.100755591292485,0.122121948139779,3.9818805975042e-92
NMR metabolomics,X23424.Total Lipids in VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.0658870579698817,0.00322614523499498,0.0595638133092916,0.0722103026304719,5.92910769785242e-92
NMR metabolomics,X23424.Total Lipids in VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0914249433315888,0.0044935070743588,0.0826176694658456,0.100232217197332,2.14166333537345e-91
NMR metabolomics,X23424.Total Lipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0936202674466803,0.00460423705443004,0.0845959628199974,0.102644572073363,2.75404535050284e-91
NMR metabolomics,X23424.Total Lipids in VLDL,MESD,LRP chaperone MESD,29443,0.168092259841072,0.00826754649865844,0.151887868703701,0.184296650978442,2.8676047523646e-91
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0637731057196794,0.00313780839189658,0.0576230012715621,0.0699232101677967,4.52825911272563e-91
NMR metabolomics,X23424.Total Lipids in VLDL,ESYT2,Extended synaptotagmin-2,24845,0.114008627497752,0.0056179768819256,0.102997392809178,0.125019862186326,8.00465253962348e-91
NMR metabolomics,X23424.Total Lipids in VLDL,AFP,Alpha-fetoprotein,29132,0.0940857726217828,0.00464043230329239,0.0849905253073298,0.103181019936236,9.02337134149841e-91
NMR metabolomics,X23424.Total Lipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.124099181288617,0.00611895909237675,0.112106021467558,0.136092341109675,1.02143822212913e-90
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.106058818481453,0.0052316802375713,0.0958047252158131,0.116312911747093,1.27322451451375e-90
NMR metabolomics,X23424.Total Lipids in VLDL,CASP10,Caspase-10,28774,0.0986882166435072,0.00487328471510228,0.0891365786019067,0.108239854685108,1.49598386367432e-90
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB1,Heat shock protein beta-1,29039,0.0948433900423664,0.00468693536810437,0.0856569967208818,0.104029783363851,1.99997108865385e-90
NMR metabolomics,X23424.Total Lipids in VLDL,BLMH,Bleomycin hydrolase,29820,0.043860867029703,0.00216805181957103,0.0396114854633438,0.0481102485960622,2.13580759544751e-90
NMR metabolomics,X23424.Total Lipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0738054327440291,0.00364585039370122,0.0666595659723747,0.0809512995156835,2.3146029462021e-90
NMR metabolomics,X23424.Total Lipids in VLDL,BIN2,Bridging integrator 2,29443,0.124048563109908,0.00613334714857779,0.112027202698696,0.136069923521121,2.41620670737642e-90
NMR metabolomics,X23424.Total Lipids in VLDL,SUGT1,Protein SGT1 homolog,28797,0.111209456099167,0.00549812204195042,0.100433136896944,0.12198577530139,2.4176697901726e-90
NMR metabolomics,X23424.Total Lipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.143853982985596,0.00711134905793205,0.129915738832049,0.157792227139142,3.01219557877202e-90
NMR metabolomics,X23424.Total Lipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0486310670072753,0.00240509140505849,0.0439170878533606,0.0533450461611899,3.48652520635967e-90
NMR metabolomics,X23424.Total Lipids in VLDL,IL18,Interleukin-18,29335,0.0632879649687404,0.00313410319912881,0.0571451226984479,0.0694308072390328,4.59745304774604e-90
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT1,Angiopoietin-1,29322,0.11558452725286,0.00573479029952285,0.104344338265795,0.126824716239925,9.88650109886376e-90
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS2,Trypsin-2,29594,0.0734952411008773,0.00364679441751391,0.06634752404255,0.0806429581592045,1.00749201715682e-89
NMR metabolomics,X23424.Total Lipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0606245815721793,0.0030077634422201,0.0547293652254279,0.0665197979189307,1.27796931846387e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CERT,Ceramide transfer protein,28774,0.0842812925910668,0.00418661718595634,0.0760755229065924,0.0924870622755413,1.63221551605114e-89
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0822733136269627,0.0040874234301682,0.074261963703833,0.0902846635500924,1.72088729994237e-89
NMR metabolomics,X23424.Total Lipids in VLDL,GZMA,Granzyme A,29786,0.0475438874525591,0.0023627664790359,0.0429128651536487,0.0521749097514694,1.86089966640777e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.032317522686314,0.00160613328807755,0.029169501441682,0.035465543930946,1.8910115609681e-89
NMR metabolomics,X23424.Total Lipids in VLDL,THTPA,Thiamine-triphosphatase,24755,0.121168046386708,0.00601876038208612,0.109371276037819,0.132964816735597,2.02642406615326e-89
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0784700575017711,0.00390175213231281,0.0708226233224379,0.0861174916811042,2.40903822456701e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0471245057998549,0.00234379239809847,0.0425306726995819,0.0517183389001279,2.57217302640306e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.039580539493716,0.00196805045256917,0.0357231606066804,0.0434379183807516,3.10103325736791e-89
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.112094685225028,0.005584379525401,-0.123040069094814,-0.101149301355242,5.00773095789156e-89
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6AP2,Renin receptor,28797,0.0555406065242765,0.00276723945133704,0.0501168171996559,0.0609643958488971,5.40973295128658e-89
NMR metabolomics,X23424.Total Lipids in VLDL,DNM3,Dynamin-3,24867,0.0751785739087501,0.00374725470472282,0.0678339546874934,0.0825231931300069,7.96569248305367e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.128579154553814,0.00641672980092725,0.116002364143996,0.141155944963631,1.00699179506364e-88
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0831337568686828,0.00415094197658768,0.074997910594571,0.0912696031427947,1.57251452432238e-88
NMR metabolomics,X23424.Total Lipids in VLDL,CCL3,C-C motif chemokine 3,29434,0.0824468204244926,0.00412492766918039,0.074361962192899,0.0905316786560861,2.73368451872235e-88
NMR metabolomics,X23424.Total Lipids in VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0908848285795965,0.00455065049793577,0.0819655536036424,0.0998041035555507,4.75542678593595e-88
NMR metabolomics,X23424.Total Lipids in VLDL,PALM2,Paralemmin-2,24845,0.051584338383997,0.00258699866377266,0.0465138210030026,0.0566548557649914,8.94071001022059e-88
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.105561643296331,0.00529572812159317,0.095182016178008,0.115941270414653,1.01425399991235e-87
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.135643057172623,0.00680486221910383,0.122305527223179,0.148980587122066,1.01770453054525e-87
NMR metabolomics,X23424.Total Lipids in VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0544776105191975,0.00273527525134329,0.0491164710265646,0.0598387500118303,1.09846351074963e-87
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.121092087147347,0.00608041340609226,0.109174476871407,0.133009697423288,1.14390315778317e-87
NMR metabolomics,X23424.Total Lipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.103566483864685,0.00520138897495358,0.0933717614737764,0.113761206255594,1.2226695419372e-87
NMR metabolomics,X23424.Total Lipids in VLDL,CIAPIN1,Anamorsin,29566,0.0849280364848146,0.0042708664341058,0.0765571382739673,0.093298934695662,2.03216772865889e-87
NMR metabolomics,X23424.Total Lipids in VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.0554973426861236,0.00279226324726032,0.0500245067214934,0.0609701786507538,2.51441348559064e-87
NMR metabolomics,X23424.Total Lipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0633390792351324,0.00318859597695727,0.0570894311202962,0.0695887273499687,3.06473667122317e-87
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB9,Serpin B9,29218,0.0449630138750109,0.0022639929936597,0.0405255876074378,0.0494004401425839,3.39960083364708e-87
NMR metabolomics,X23424.Total Lipids in VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0373118531630211,0.00187943086927354,0.033628168659245,0.0409955376667973,4.92003367351338e-87
NMR metabolomics,X23424.Total Lipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0845972940892139,0.00427103928645634,0.0762260570877595,0.0929685310906684,9.37930608756527e-87
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0782707892140647,0.00395196506792136,0.0705249376809388,0.0860166407471906,1.0096187535827e-86
NMR metabolomics,X23424.Total Lipids in VLDL,DTNB,Dystrobrevin beta,24752,0.0588054607418545,0.00296853123050627,0.0529871395300622,0.0646237819536468,1.15632812190494e-86
NMR metabolomics,X23424.Total Lipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.13836930597722,0.00698638787925101,0.124675985733888,0.152062626220552,1.29292259803005e-86
NMR metabolomics,X23424.Total Lipids in VLDL,BGLAP,Osteocalcin,24938,0.119837368709782,0.00605570563941451,0.107968185656529,0.131706551763034,1.70475741005091e-86
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0722711968094101,0.00366013896242494,0.0650973244430572,0.079445069175763,4.13776405168146e-86
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0593075980807319,0.00300570049384889,0.053416425112788,0.0651987710486757,4.19746014078341e-86
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0865482889025819,0.00438682581459633,0.0779501103059731,0.0951464674991907,5.54148454267116e-86
NMR metabolomics,X23424.Total Lipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0647479860013366,0.00328171448158516,0.0583158256174297,0.0711801463852436,5.65176282857835e-86
NMR metabolomics,X23424.Total Lipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.145596407396598,0.00738013392485293,0.131131344903886,0.160061469889309,6.09026909440897e-86
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0991335961300058,0.00502694646958706,0.0892807810496152,0.108986411210396,6.51784266001186e-86
NMR metabolomics,X23424.Total Lipids in VLDL,HPSE,Heparanase,24688,0.126499278373986,0.00641662530135255,0.113922692783335,0.139075863964637,7.44990312245339e-86
NMR metabolomics,X23424.Total Lipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.12704341550503,0.00644707279283593,0.114407152831072,0.139679678178989,8.76837821224563e-86
NMR metabolomics,X23424.Total Lipids in VLDL,CASP2,Caspase-2,29434,0.091102737510977,0.00462852940794299,0.0820308198714087,0.100174655150545,1.07769339977287e-85
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.122082856973079,0.00620004955394085,0.109930759847355,0.134234954098804,1.2146168663289e-85
NMR metabolomics,X23424.Total Lipids in VLDL,MSTN,Growth/differentiation factor 8,28916,0.0705901946645977,0.00358863934660943,0.0635564615452432,0.0776239277839522,1.40342149002192e-85
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM106A,Transmembrane protein 106A,24793,0.0949367545483896,0.00483058488284788,0.0854688081780078,0.104404700918771,2.42351719408486e-85
NMR metabolomics,X23424.Total Lipids in VLDL,CCL18,C-C motif chemokine 18,29166,0.0941088393159205,0.00479182612564588,0.0847168601096546,0.103500818522186,2.53711338191278e-85
NMR metabolomics,X23424.Total Lipids in VLDL,MIF,Macrophage migration inhibitory factor,29386,0.0909338530384823,0.00463781788992262,0.0818437299742339,0.100023976102731,4.71677150050614e-85
NMR metabolomics,X23424.Total Lipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0764194358682494,0.00390795511252495,0.0687598438477005,0.0840790278887983,1.29384547927624e-84
NMR metabolomics,X23424.Total Lipids in VLDL,HNMT,Histamine N-methyltransferase,29082,0.0628000686444304,0.00321356566766275,0.0565014799358114,0.0690986573530493,1.67837142099232e-84
NMR metabolomics,X23424.Total Lipids in VLDL,STX8,Syntaxin-8,29434,0.0643967999553739,0.00329709651263484,0.0579344907906096,0.0708591091201382,2.03813817338522e-84
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.0543720121376257,0.00278475256509489,0.0489138971100398,0.0598301271652117,2.2733152527945e-84
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0898253914768648,0.0046041992009514,0.0808011610430001,0.0988496219107296,3.19764346228332e-84
NMR metabolomics,X23424.Total Lipids in VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.0849569695068806,0.00435873743068234,-0.093500094871018,-0.0764138441427432,5.50432784645052e-84
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D5,TBC1 domain family member 5,29434,0.103660908214604,0.00532704751915009,0.0932198950770694,0.114101921352138,8.17964488324553e-84
NMR metabolomics,X23424.Total Lipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.122484020441611,0.00629258061078169,0.110150562444479,0.134817478438744,9.52708488456849e-84
NMR metabolomics,X23424.Total Lipids in VLDL,JAM3,Junctional adhesion molecule C,24381,0.0672883387917476,0.00346230133749568,0.0605022281702561,0.0740744494132391,1.6891190264788e-83
NMR metabolomics,X23424.Total Lipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.143108476371768,0.00736437477996353,0.12867430180304,0.157542650940497,1.71477499988877e-83
NMR metabolomics,X23424.Total Lipids in VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0883106337689314,0.00454533841031728,0.0794017704847095,0.0972194970531532,1.91622669254701e-83
NMR metabolomics,X23424.Total Lipids in VLDL,KITLG,Kit ligand,29478,-0.0493515875467826,0.00254424387739175,-0.0543383055464705,-0.0443648695470948,2.69076605897475e-83
NMR metabolomics,X23424.Total Lipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.0635922489001448,0.003276499446964,0.0571703099840954,0.0700141878161943,2.69711424187256e-83
NMR metabolomics,X23424.Total Lipids in VLDL,STX4,Syntaxin-4,29349,0.0783759591065301,0.00404584412663064,0.070446104618334,0.0863058135947261,4.40235247625679e-83
NMR metabolomics,X23424.Total Lipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0863805443313853,0.00446054195111679,0.0776378821071964,0.0951232065555742,4.91709784267858e-83
NMR metabolomics,X23424.Total Lipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0799315998830159,0.00412625631888566,0.071844137498,0.0880190622680318,5.65949893353576e-83
NMR metabolomics,X23424.Total Lipids in VLDL,GMFG,Glia maturation factor gamma,24922,0.094983630544383,0.00490439988578292,0.0853710067682485,0.104596254320518,5.97297450298567e-83
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.10606849887034,0.00547986615636253,0.0953279612038694,0.116809036536811,7.68354762332948e-83
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.124083482685187,0.00642445456877802,0.111491551730383,0.136675413639992,1.33672975883213e-82
NMR metabolomics,X23424.Total Lipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.157148567403468,0.00814240110812382,0.141189461231546,0.173107673575391,1.7290066511389e-82
NMR metabolomics,X23424.Total Lipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.115151962313058,0.00596455231208313,0.103461439781375,0.126842484844741,1.97346778490924e-82
NMR metabolomics,X23424.Total Lipids in VLDL,RP2,Protein XRP2,29349,0.0550808245715124,0.00285600237369205,0.049483059919076,0.0606785892239489,2.28172059228766e-82
NMR metabolomics,X23424.Total Lipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.11554074558568,0.00599040489829121,0.103799551985029,0.127281939186331,2.73695563289444e-82
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.115115892091347,0.00597935076902599,0.103396364584056,0.126835419598638,5.37977349142319e-82
NMR metabolomics,X23424.Total Lipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0554505013427915,0.00288023673175544,0.0498052373485509,0.0610957653370322,5.51656779250462e-82
NMR metabolomics,X23424.Total Lipids in VLDL,FMNL1,Formin-like protein 1,28774,0.0804978031102535,0.00418793809762292,0.0722894444389125,0.0887061617815944,8.00673724185067e-82
NMR metabolomics,X23424.Total Lipids in VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0865445585566285,0.00450804702433988,0.0777087863889224,0.0953803307243347,1.24512628733518e-81
NMR metabolomics,X23424.Total Lipids in VLDL,PARK7,Parkinson disease protein 7,29443,0.0682676750862738,0.00356049140373226,0.0612891119349586,0.075246238237589,1.92987803244857e-81
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0735243322805713,0.00383533471925281,0.0660070762308358,0.0810415883303068,2.07722651736472e-81
NMR metabolomics,X23424.Total Lipids in VLDL,CTSZ,Cathepsin Z,29487,0.0412818752145987,0.00215390130883276,0.0370602286492865,0.045503521779911,2.22448508370308e-81
NMR metabolomics,X23424.Total Lipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0817928481926842,0.00427241793132408,0.073418909047289,0.0901667873380795,4.13870876915844e-81
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO3,Forkhead box protein O3,28797,0.125880002826886,0.00657892204445548,0.112985315619753,0.138774690034019,4.21360020508116e-81
NMR metabolomics,X23424.Total Lipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0470712856406433,0.00246136085070536,0.0422470183732608,0.0518955529080258,4.93485978566849e-81
NMR metabolomics,X23424.Total Lipids in VLDL,DCTD,Deoxycytidylate deaminase,24381,0.124192520942883,0.00649028623852755,0.111471559915369,0.136913481970397,5.06294174778045e-81
NMR metabolomics,X23424.Total Lipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.106617080859852,0.00557711250546757,0.0956859403491356,0.117548221370568,5.66454908857745e-81
NMR metabolomics,X23424.Total Lipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.127028133597475,0.00664668594479624,0.114000629145674,0.140055638049275,7.97548401161082e-81
NMR metabolomics,X23424.Total Lipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.164959515134511,0.00864154788760697,0.148022081274802,0.181896948994221,1.17589119951991e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CASP3,Caspase-3,29820,0.114452054496852,0.00599969555272562,0.10269265121351,0.126211457780194,1.20306802666959e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0796960053660535,0.00417840396642754,0.0715063335918555,0.0878856771402515,1.64299115278425e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.0588187497550922,0.00309115633724129,0.0527600833340992,0.0648774161760851,3.10800899474403e-80
NMR metabolomics,X23424.Total Lipids in VLDL,MICALL2,MICAL-like protein 2,24195,0.0889292555281483,0.00467364675381746,0.0797689078906661,0.0980896031656305,3.86870651126518e-80
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.129081468228702,0.00679203864385769,0.115769072486741,0.142393863970663,5.74809525223517e-80
NMR metabolomics,X23424.Total Lipids in VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0768480890309401,0.00405461707294383,0.0689010395679702,0.0847951384939101,1.23090324192612e-79
NMR metabolomics,X23424.Total Lipids in VLDL,CPA1,Carboxypeptidase A1,29820,0.0785931872143689,0.00414740038350763,0.0704642824626939,0.0867220919660438,1.29929815882209e-79
NMR metabolomics,X23424.Total Lipids in VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.0243332672042152,0.00128496897181176,0.0218147280194642,0.0268518063889663,2.05111089828357e-79
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0840255102474579,0.00443720977866999,0.0753285790812647,0.0927224414136511,2.06873594288891e-79
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0451086963634379,0.00238670970323223,-0.0497866473817731,-0.0404307453451027,3.36700369923273e-79
NMR metabolomics,X23424.Total Lipids in VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.0802850446080562,0.00424774135919254,0.0719594715440388,0.0886106176720736,4.04694604029555e-79
NMR metabolomics,X23424.Total Lipids in VLDL,APP,Amyloid-beta precursor protein,29395,0.0857396255937147,0.00453964742040719,0.0768419166497166,0.0946373345377128,4.30913970600823e-79
NMR metabolomics,X23424.Total Lipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0859795062400401,0.00456040680492945,0.0770411089023784,0.0949179035777018,1.01512763465837e-78
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0686098121085947,0.00364086394551541,0.0614737187753845,0.0757459054418049,1.15754053160361e-78
NMR metabolomics,X23424.Total Lipids in VLDL,F2R,Proteinase-activated receptor 1,29536,0.0736251033937868,0.00391023438105888,0.0659610440069114,0.0812891627806622,1.26779104552988e-78
NMR metabolomics,X23424.Total Lipids in VLDL,CCL24,C-C motif chemokine 24,29536,0.106368980118322,0.00564976325752358,0.0952954441335761,0.117442516103068,1.30776669333077e-78
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0727572455588609,0.00386379072757184,0.0651842157328201,0.0803302753849017,1.54539963870515e-78
NMR metabolomics,X23424.Total Lipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.12618484858259,0.00670305740911975,0.113046856060716,0.139322841104465,1.65506395558474e-78
NMR metabolomics,X23424.Total Lipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0514633961379145,0.00273778702996643,0.0460973335591803,0.0568294587166487,2.77126056274737e-78
NMR metabolomics,X23424.Total Lipids in VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.0425997296014652,0.00226656475182777,0.0381572626878828,0.0470421965150477,3.0026669089231e-78
NMR metabolomics,X23424.Total Lipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.073864370986358,0.00393331249726524,0.0661550784917181,0.0815736634809979,3.30068082677295e-78
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA2,Integrin alpha-2,24381,0.0440473567919251,0.00234668460638155,0.0394478549634173,0.048646858620433,4.72158311102113e-78
NMR metabolomics,X23424.Total Lipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0665540708241044,0.00354886089046883,0.0595983034787855,0.0735098381694233,5.15559514508657e-78
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB1,Beta-crystallin B1,24922,0.0837925950246539,0.00446635784589709,0.0750385336466956,0.0925466564026122,5.45008994590577e-78
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.0686058203568512,0.00366460636103893,-0.0757884488244875,-0.0614231918892149,9.55922577413413e-78
NMR metabolomics,X23424.Total Lipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0852976174843447,0.00455668245178719,0.0763665198788418,0.0942287150898475,1.22732701585375e-77
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA3,Annexin A3,29640,0.0889167302658647,0.00475386763346379,0.0795991497042757,0.0982343108274537,1.28522225603363e-77
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.073436981134609,0.00392829476663282,0.0657375233920087,0.0811364388772094,1.56165318567591e-77
NMR metabolomics,X23424.Total Lipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.102368263411591,0.00547848721440963,0.0916304284713478,0.113106098351834,2.27615242116975e-77
NMR metabolomics,X23424.Total Lipids in VLDL,NRGN,Neurogranin,24951,0.116502678022256,0.0062407628652202,0.104270782806424,0.128734573238087,3.03252906021983e-77
NMR metabolomics,X23424.Total Lipids in VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0291442722810379,0.00156197882905283,0.0260827937760944,0.0322057507859815,3.71393146901045e-77
NMR metabolomics,X23424.Total Lipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.058269404959116,0.00312749923738547,-0.0643993034643915,-0.0521395064538405,4.93148482332409e-77
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL1,Growth-regulated alpha protein,29420,0.120981321151428,0.00649883306205041,0.108243608349809,0.133719033953047,6.62143442752649e-77
NMR metabolomics,X23424.Total Lipids in VLDL,WDR46,WD repeat-containing protein 46,24793,0.0458642734813478,0.00246298383589949,0.0410368251629848,0.0506917217997108,7.21516349311704e-77
NMR metabolomics,X23424.Total Lipids in VLDL,GP5,Platelet glycoprotein V,24381,0.0460682919080429,0.00247405283965288,0.0412191483423233,0.0509174354737625,7.47884459702189e-77
NMR metabolomics,X23424.Total Lipids in VLDL,CPB1,Carboxypeptidase B,29820,0.0749406683753279,0.00402757901797165,0.0670466135001034,0.0828347232505523,7.70869868269492e-77
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0666571019901587,0.00358212425586322,0.0596361384486668,0.0736780655316507,7.7851695579721e-77
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0387707657036386,0.00208373663437119,0.034686641900271,0.0428548895070061,7.86712880525518e-77
NMR metabolomics,X23424.Total Lipids in VLDL,CCL2,C-C motif chemokine 2,29169,0.0666579287504148,0.00358269430323715,0.05963584791607,0.0736800095847596,8.08015567181009e-77
NMR metabolomics,X23424.Total Lipids in VLDL,SDHB,Succinate dehydrogenase,24805,0.0875653835803058,0.00470404771972879,0.0783454500496373,0.0967853171109742,8.13169979913575e-77
NMR metabolomics,X23424.Total Lipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0829792312898941,0.00446005877649115,0.0742375160879715,0.0917209464918168,8.27312965873218e-77
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0509136640083301,0.00273966968556657,0.0455439114246197,0.0562834165920406,1.43113636468213e-76
NMR metabolomics,X23424.Total Lipids in VLDL,GET3,ATPase GET3,24922,0.0700404507985764,0.00377000352167478,0.0626512438960938,0.077429657701059,1.58389720760903e-76
NMR metabolomics,X23424.Total Lipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.105899594329349,0.00570466133330975,0.0947184581160616,0.117080730542636,1.72268422817093e-76
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0819818719676313,0.00441950074064526,0.0733196505159666,0.090644093419296,2.67918395622094e-76
NMR metabolomics,X23424.Total Lipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.0506863304090985,0.00273734132820927,0.0453211414058084,0.0560515194123887,4.14704148088223e-76
NMR metabolomics,X23424.Total Lipids in VLDL,CD164,Sialomucin core protein 24,29443,0.0338305525822118,0.00182788294026211,0.030247902019298,0.0374132031451255,4.80897845938104e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN9,Septin-9,29349,0.0358806487911406,0.00193881718405856,0.0320805671103859,0.0396807304718954,4.96691531865097e-76
NMR metabolomics,X23424.Total Lipids in VLDL,EGFR,Epidermal growth factor receptor,29820,0.0206923589457881,0.00111942480956293,0.0184982863190448,0.0228864315725315,7.27309145488441e-76
NMR metabolomics,X23424.Total Lipids in VLDL,APOL1,Apolipoprotein L1,24951,0.0759163073811623,0.00410614872398402,0.0678682558821536,0.0839643588801709,8.22267354195574e-76
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.110300357632014,0.00597069894762516,0.0985977876946687,0.122002927569359,9.00074686966777e-76
NMR metabolomics,X23424.Total Lipids in VLDL,LAP3,Cytosol aminopeptidase,28931,0.0613266983065297,0.00331979418752044,0.0548199016989896,0.0678334949140698,9.29622798015643e-76
NMR metabolomics,X23424.Total Lipids in VLDL,C1R,Complement C1r subcomponent,24966,0.0245157732815046,0.00132746084749798,0.0219139500204085,0.0271175965426006,1.19039226602089e-75
NMR metabolomics,X23424.Total Lipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.041098212398487,0.00222696660401037,0.0367333578546267,0.0454630669423473,1.26374537044528e-75
NMR metabolomics,X23424.Total Lipids in VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0575048215942876,0.00311589779134634,0.0513976619232487,0.0636119812653264,1.51438891569743e-75
NMR metabolomics,X23424.Total Lipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0673192152910566,0.00365385040089638,0.0601576685052997,0.0744807620768135,2.23990091383857e-75
NMR metabolomics,X23424.Total Lipids in VLDL,LARP1,La-related protein 1,24793,0.0791562232130743,0.00429516281529216,0.0707377040951016,0.0875747423310469,2.4459116137041e-75
NMR metabolomics,X23424.Total Lipids in VLDL,DBI,Acyl-CoA-binding protein,29329,0.0984415927114266,0.00534955663300653,0.0879564617107338,0.108926723712119,3.37142624912558e-75
NMR metabolomics,X23424.Total Lipids in VLDL,APOE,Apolipoprotein E,24966,0.09143449712631,0.0049731733654299,0.0816870773300674,0.101181916922553,5.3697909215503e-75
NMR metabolomics,X23424.Total Lipids in VLDL,TTF2,Transcription termination factor 2,24195,0.061739333588404,0.00335795423977503,0.0551577432784449,0.068320923898363,5.52133853625516e-75
NMR metabolomics,X23424.Total Lipids in VLDL,GIP,Gastric inhibitory polypeptide,24240,0.064320995251305,0.00349998795261656,0.0574610188641766,0.0711809716384335,6.43083681608824e-75
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.139113652241305,0.00757957710634148,0.124257681112876,0.153969623369734,8.20742484316085e-75
NMR metabolomics,X23424.Total Lipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.104484388709207,0.00569029204562806,0.0933314162997765,0.115637361118638,8.31928452150319e-75
NMR metabolomics,X23424.Total Lipids in VLDL,OCLN,Occludin,24867,0.0550817917289304,0.00300233479341209,0.0491972155338427,0.0609663679240181,1.10027480740187e-74
NMR metabolomics,X23424.Total Lipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0939548370417832,0.00513340663068586,0.0838933600456389,0.104016314037928,2.42385265429958e-74
NMR metabolomics,X23424.Total Lipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.057289388475137,0.00313552455803168,0.0511437603413949,0.063435016608879,3.60267117540223e-74
NMR metabolomics,X23424.Total Lipids in VLDL,ATG4A,Cysteine protease ATG4A,28797,0.0733825250521532,0.00401934867558576,0.0655046016480051,0.0812604484563013,4.74246211824523e-74
NMR metabolomics,X23424.Total Lipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0389867621145959,0.00213577888070691,-0.0431728887207814,-0.0348006355084104,4.90247810428181e-74
NMR metabolomics,X23424.Total Lipids in VLDL,DDT,D-dopachrome decarboxylase,24938,0.0509993057206787,0.00279303411881451,0.0455249588478023,0.0564736525935552,5.28896050874912e-74
NMR metabolomics,X23424.Total Lipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.149685104988581,0.00821199350585322,0.133589597717109,0.165780612260054,7.94968138919393e-74
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.035485620859544,0.0019492736260628,0.0316650445524609,0.0393061971666271,1.42613286745538e-73
NMR metabolomics,X23424.Total Lipids in VLDL,DPT,Dermatopontin,29820,0.0327186499915095,0.00179904093952452,0.0291925297500414,0.0362447702329775,1.64419770123593e-73
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0758340335001139,0.0041723108891018,0.0676563041574744,0.0840117628427534,2.03527152257321e-73
NMR metabolomics,X23424.Total Lipids in VLDL,MATN2,Matrilin-2,29497,0.03682169257016,0.00203080824144026,0.0328413084169371,0.0408020767233829,4.48617247281073e-73
NMR metabolomics,X23424.Total Lipids in VLDL,AMOT,Angiomotin,24381,0.0498355121732154,0.00275669670052482,0.0444323866401868,0.0552386377062441,1.41716989271626e-72
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.06240714218521,0.00345471637845999,0.0556358980834284,0.0691783862869916,1.76592327044486e-72
NMR metabolomics,X23424.Total Lipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0854898160543301,0.00473935306632067,0.0762006840443415,0.0947789480643186,2.91587999965208e-72
NMR metabolomics,X23424.Total Lipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0601085900101964,0.00333294390401023,0.0535760199583363,0.0666411600620564,3.00868493425199e-72
NMR metabolomics,X23424.Total Lipids in VLDL,PAEP,Glycodelin,29218,-0.162278088611416,0.00900352610528916,-0.179924999777783,-0.144631177445049,3.12215728712839e-72
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.121062623605255,0.0067180013444601,0.107895340970113,0.134229906240397,3.87661574292826e-72
NMR metabolomics,X23424.Total Lipids in VLDL,SPOCK1,Testican-1,29218,0.031654937233639,0.00175929019018049,0.0282067284608853,0.0351031460063928,5.41484686651502e-72
NMR metabolomics,X23424.Total Lipids in VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.068613929726681,0.00381566485839202,0.0611352266042326,0.0760926328491294,6.65721023503388e-72
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0373895230006256,0.00207837268920455,0.0333159125297847,0.0414631334714665,6.74550758441607e-72
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0832374239351219,0.0046330692417166,0.0741566082213573,0.0923182396488864,8.63063349499343e-72
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0346465718039022,0.00192981830389092,0.030864127928276,0.0384290156795284,1.3169448951679e-71
NMR metabolomics,X23424.Total Lipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.14848995128714,0.00828367332900216,0.132253951562296,0.164725951011985,1.78790824850405e-71
NMR metabolomics,X23424.Total Lipids in VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0947086753487682,0.00528068605639677,0.0843585306782305,0.105058820019306,1.82613902606016e-71
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.10732365602799,0.00599457891489832,0.0955742813547889,0.11907303070119,2.65605840604441e-71
NMR metabolomics,X23424.Total Lipids in VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0924227722540777,0.00516559307446047,0.0822982098281352,0.10254733468002,3.32146951829102e-71
NMR metabolomics,X23424.Total Lipids in VLDL,SMTN,Smoothelin,24776,0.115660581375123,0.00646600190778958,0.102987217635855,0.12833394511439,4.13913454981197e-71
NMR metabolomics,X23424.Total Lipids in VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.027723060892719,0.00155044019295621,0.0246841981145249,0.0307619236709132,4.64554272476446e-71
NMR metabolomics,X23424.Total Lipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0641518203435287,0.00358860413568638,0.0571181562375834,0.071185484449474,5.14260888607812e-71
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0598208535906088,0.00334692917559606,0.0532608724064406,0.0663808347747771,5.44065408631802e-71
NMR metabolomics,X23424.Total Lipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0866352263562907,0.00484926650649153,0.0771306640035673,0.0961397887090141,6.05893391709575e-71
NMR metabolomics,X23424.Total Lipids in VLDL,NID1,Nidogen-1,29518,0.0462011414124158,0.00258953932378907,0.0411256443377892,0.0512766384870424,7.94239125960515e-71
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0515927763917872,0.00289286076363053,0.0459227692950714,0.057262783488503,8.90268982736879e-71
NMR metabolomics,X23424.Total Lipids in VLDL,CFB,Complement factor B,24538,0.0401132134382108,0.0022482635790601,0.035706616823253,0.0445198100531686,9.37113354751046e-71
NMR metabolomics,X23424.Total Lipids in VLDL,CALCA,Calcitonin,29163,0.075600395462314,0.00424420449715314,0.0672817546478939,0.0839190362767342,1.33651113823552e-70
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0458369331031093,0.00257329619452107,0.040793272561848,0.0508805936443706,1.34827409470482e-70
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.0577046774637388,0.00323957908643262,0.0513551024543309,0.0640542524731467,1.60581715406031e-70
NMR metabolomics,X23424.Total Lipids in VLDL,TBCA,Tubulin-specific chaperone A,24381,0.104380112614291,0.00586231318744381,0.0928899787669015,0.115870246461681,1.79923283331487e-70
NMR metabolomics,X23424.Total Lipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.0557681524240039,0.00313554369754243,0.0496224867768207,0.061913818071187,2.11389009776771e-70
NMR metabolomics,X23424.Total Lipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0293636817862613,0.00165137626416117,0.0261269843085054,0.0326003792640172,2.30963000952962e-70
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0403706402821814,0.00227147234552414,0.0359185544849541,0.0448227260794087,2.68066486412274e-70
NMR metabolomics,X23424.Total Lipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.03347887855713,0.0018848381146586,0.0297845958523991,0.0371731612618608,3.75837554045323e-70
NMR metabolomics,X23424.Total Lipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0370964247001096,0.00208991498905909,0.0330001913215538,0.0411926580786654,3.96433903504014e-70
NMR metabolomics,X23424.Total Lipids in VLDL,DBN1,Drebrin,24229,0.0624008441048719,0.00351478196963756,0.0555118714443823,0.0692898167653615,4.47950716602104e-70
NMR metabolomics,X23424.Total Lipids in VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0520248507559672,0.00293075879872687,0.0462805635104626,0.0577691380014719,4.65175390969225e-70
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0926385537265988,0.00522061278336973,0.0824061526711941,0.102870954782003,5.1310222332998e-70
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRD2,Protein ZNRD2,24805,0.083358886837343,0.00470206736979646,0.0741428347925419,0.092574938882144,6.87232421683208e-70
NMR metabolomics,X23424.Total Lipids in VLDL,GP6,Platelet glycoprotein VI,29400,0.106360235404279,0.00600626172114872,0.0945879624308273,0.11813250837773,8.3587696718679e-70
NMR metabolomics,X23424.Total Lipids in VLDL,MMP7,Matrilysin,28870,0.0602278008529055,0.00341170694383626,0.0535408552429865,0.0669147464628246,2.2259290771466e-69
NMR metabolomics,X23424.Total Lipids in VLDL,FADD,FAS-associated death domain protein,29478,0.0917068678847717,0.00520816957489983,0.081498855517968,0.101914880251575,4.80955845093638e-69
NMR metabolomics,X23424.Total Lipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0292129555726542,0.00165997560022087,0.0259594033962213,0.0324665077490871,5.71824702002708e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0593164795086384,0.00337781898932375,-0.0659370047277129,-0.0526959542895638,1.10707173237827e-68
NMR metabolomics,X23424.Total Lipids in VLDL,SCG2,Secretogranin-2,29559,0.0390951953537681,0.0022272129371778,0.0347298579968996,0.0434605327106366,1.25019829761363e-68
NMR metabolomics,X23424.Total Lipids in VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.0923191366979717,0.00526300112706721,0.08200365448892,0.102634618907023,1.55122462969257e-68
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0430367717972599,0.00245699649566919,0.0382210586657483,0.0478524849287715,2.85741046343252e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.067161163970373,0.00383612178278336,0.0596423652761176,0.0746799626646284,3.30287830266507e-68
NMR metabolomics,X23424.Total Lipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0382028661366031,0.00218796394184095,0.0339144568105949,0.0424912754626114,6.30450148870358e-68
NMR metabolomics,X23424.Total Lipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0813589834407683,0.00466045970321895,0.0722244824224592,0.0904934844590775,7.90131590758742e-68
NMR metabolomics,X23424.Total Lipids in VLDL,CA13,Carbonic anhydrase 13,29114,0.124108788566825,0.00712092024321408,0.110151784890126,0.138065792243525,1.10258207071664e-67
NMR metabolomics,X23424.Total Lipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0516717791679621,0.00296403967024006,0.0458622614142915,0.0574812969216326,1.20457617471778e-67
NMR metabolomics,X23424.Total Lipids in VLDL,ABHD14B,Protein ABHD14B,29121,0.0681036284520971,0.00391649250614659,0.0604273031400498,0.0757799537641445,2.19426803611528e-67
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0289588955750282,0.00166890951540903,0.0256878329248265,0.0322299582252299,4.12000280259417e-67
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.063673632893336,0.00367475542852563,0.0564711122534258,0.0708761535332463,6.40240979094431e-67
NMR metabolomics,X23424.Total Lipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0831547832082507,0.00480732022988514,0.0737324355576759,0.0925771308588256,1.21126454503619e-66
NMR metabolomics,X23424.Total Lipids in VLDL,ACYP1,Acylphosphatase-1,24297,0.077685184028458,0.00449331564301839,0.0688782853681419,0.086492082688774,1.42504135735373e-66
NMR metabolomics,X23424.Total Lipids in VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0730797726958919,0.00422741965846299,0.0647940301653044,0.0813655152264793,1.44729469334192e-66
NMR metabolomics,X23424.Total Lipids in VLDL,CTRB1,Chymotrypsinogen B,29443,0.0656679535297076,0.00380119517328577,0.0582176109900675,0.0731182960693477,1.53039216593444e-66
NMR metabolomics,X23424.Total Lipids in VLDL,BLNK,B-cell linker protein,24229,0.0472249955781412,0.0027324959226632,0.0418693035697214,0.0525806875865611,1.59215685954612e-66
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN4,Cerebellin-4,29725,0.0374750005747931,0.00216959026544084,0.0332226036545291,0.0417273974950572,1.5932076608232e-66
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1B,Meprin A subunit beta,29478,0.137733635357158,0.00798104760695642,0.122090782047524,0.153376488666793,2.082683732461e-66
NMR metabolomics,X23424.Total Lipids in VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0559169873171111,0.00324125117843835,0.0495641350073719,0.0622698396268502,2.32050546375592e-66
NMR metabolomics,X23424.Total Lipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.106990297299547,0.00619880456593249,0.0948406403503197,0.119139954248775,2.3564895215859e-66
NMR metabolomics,X23424.Total Lipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0286095013366241,0.00166073888617998,0.0253544531197114,0.0318645495535369,3.51074258186357e-66
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.082751222930755,0.00481296235581154,0.0733178167133644,0.0921846291481456,7.35714666164783e-66
NMR metabolomics,X23424.Total Lipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0450380797447991,0.00262489997501149,0.0398932757937766,0.0501828836958216,1.30800458488354e-65
NMR metabolomics,X23424.Total Lipids in VLDL,TSNAX,Translin-associated protein X,24111,0.0462556046757101,0.0026968753452538,0.0409697289990127,0.0515414803524076,1.50006342465345e-65
NMR metabolomics,X23424.Total Lipids in VLDL,TMSB10,Thymosin beta-10,29443,0.0887966264514778,0.00518125728503569,0.0786413621728079,0.0989518907301477,1.60674124295226e-65
NMR metabolomics,X23424.Total Lipids in VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0776842232265613,0.00453966224562384,0.0687864852251386,0.086581961227984,2.84484225840212e-65
NMR metabolomics,X23424.Total Lipids in VLDL,CDCP1,CUB domain-containing protein 1,29218,0.0607597660307864,0.00355722649966083,0.0537876020914512,0.0677319299701216,4.28560248431903e-65
NMR metabolomics,X23424.Total Lipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0892819655391504,0.00522733957035905,0.0790363799812467,0.0995275510970541,4.94480683963644e-65
NMR metabolomics,X23424.Total Lipids in VLDL,GBP1,Guanylate-binding protein 1,24816,0.0755157489311208,0.00442255943118018,0.0668475324460077,0.084183965416234,5.35123822579157e-65
NMR metabolomics,X23424.Total Lipids in VLDL,RAB10,Ras-related protein Rab-10,24922,0.062541016396294,0.00366419052393554,0.0553592029693804,0.0697228298232077,5.99842803906978e-65
NMR metabolomics,X23424.Total Lipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0746243509314724,0.00437822622988293,0.0660430275209019,0.083205674342043,8.00872893591622e-65
NMR metabolomics,X23424.Total Lipids in VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.0970322968473711,0.00569131918475884,0.0858773112452438,0.108187282449498,8.26715318666362e-65
NMR metabolomics,X23424.Total Lipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0761563837570507,0.00448615218239429,0.0673635254795579,0.0849492420345435,2.54049962574188e-64
NMR metabolomics,X23424.Total Lipids in VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0478503638508429,0.00281944316170172,0.0423242552539075,0.0533764724477783,2.7354455704952e-64
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF6,SLAM family member 6,28797,0.0441850234323459,0.00261456508570371,0.0390604758643667,0.0493095710003252,9.20639870170409e-64
NMR metabolomics,X23424.Total Lipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0541589243904354,0.00320894186819615,0.047869398328771,0.0604484504520999,1.33324387567639e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CTSS,Cathepsin S,23389,0.0282153087568984,0.00167324803393192,0.0249357426103918,0.0314948749034049,2.01115389026679e-63
NMR metabolomics,X23424.Total Lipids in VLDL,NBN,Nibrin,28931,0.0603922437439491,0.00358656101888985,0.0533625841469249,0.0674219033409732,2.55498852795116e-63
NMR metabolomics,X23424.Total Lipids in VLDL,SCRN1,Secernin-1,29434,0.0642155881347165,0.00381580906110096,0.0567366023749586,0.0716945738944744,2.96770854735345e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0235300867299265,0.00139912686902358,-0.0262723753932127,-0.0207877980666403,3.56294836552293e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0404527878400978,0.00240606471021036,0.0357369010080855,0.0451686746721101,3.87293126207072e-63
NMR metabolomics,X23424.Total Lipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0603915605748905,0.00359333282745581,0.0533486282330771,0.0674344929167039,4.37071901709645e-63
NMR metabolomics,X23424.Total Lipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0694725890578666,0.00413569793394485,0.0613666211073347,0.0775785570083985,4.95463483930855e-63
NMR metabolomics,X23424.Total Lipids in VLDL,MARCO,Macrophage receptor MARCO,29478,0.0302038601289425,0.00179821322332651,0.0266793622112225,0.0337283580466625,5.08046406941339e-63
NMR metabolomics,X23424.Total Lipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0345166064808306,0.00205583838494864,0.0304871632463312,0.0385460497153299,5.71883353509513e-63
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0608447218466619,0.00362702238374208,0.0537357579745275,0.0679536857187964,8.3601542337252e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CCL26,C-C motif chemokine 26,29434,0.10207935423353,0.00609199283997116,0.0901390482671865,0.114019660199873,9.95544937097099e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0640586412823389,0.00382160093166219,0.056568303456281,0.0715489791083968,1.03058635116567e-62
NMR metabolomics,X23424.Total Lipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.136709301529192,0.00816078068305325,0.120714171390407,0.152704431667976,1.0677490352561e-62
NMR metabolomics,X23424.Total Lipids in VLDL,SWAP70,Switch-associated protein 70,24805,0.0410080274618309,0.00245332250320066,0.0361995153555576,0.0458165395681042,2.22755877343379e-62
NMR metabolomics,X23424.Total Lipids in VLDL,POMC,Pro-opiomelanocortin,24240,0.080937490076868,0.00484258872999166,0.0714460161660844,0.0904289639876517,2.33026871225554e-62
NMR metabolomics,X23424.Total Lipids in VLDL,CD40LG,CD40 ligand,29786,0.0886562046907489,0.00530860995937066,0.0782513291703824,0.0990610802111154,2.50099422266003e-62
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0494460510367097,0.00296181440584584,0.0436408948012519,0.0552512072721676,2.8015626438738e-62
NMR metabolomics,X23424.Total Lipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.045174642552089,0.00270749586011285,0.0398679506662678,0.0504813344379102,3.30351731547631e-62
NMR metabolomics,X23424.Total Lipids in VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0635468643744661,0.00380877205373319,0.056081671149149,0.0710120575997831,3.34115141265595e-62
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0622693727310401,0.00374130244690005,0.054936419935116,0.0696023255269642,7.41074765355598e-62
NMR metabolomics,X23424.Total Lipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0501201634888521,0.00301629766930216,0.0442082200570199,0.0560321069206844,1.01561335739395e-61
NMR metabolomics,X23424.Total Lipids in VLDL,BTC,Probetacellulin,28797,0.084399591700863,0.00508468618070656,0.0744336067866782,0.0943655766150479,1.3759246973908e-61
NMR metabolomics,X23424.Total Lipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0428618111949191,0.00258252385983479,0.0378000644296429,0.0479235579601953,1.42001139640932e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.038690517592876,0.00234134292315732,0.0341014854634876,0.0432795497222643,4.59908091886646e-61
NMR metabolomics,X23424.Total Lipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.119844399284661,0.00726468306634706,0.10560562047462,0.134083178094701,8.14775528581864e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CTSL,Cathepsin L1,29478,0.0273671203283929,0.00166325024815427,0.0241071498420106,0.0306270908147753,1.46333957437952e-60
NMR metabolomics,X23424.Total Lipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0971750869505621,0.00592082446565007,0.085570270997888,0.108779902903236,3.29654422324109e-60
NMR metabolomics,X23424.Total Lipids in VLDL,FSHB,Follitropin subunit beta,24240,0.0727680769847404,0.00443519940437107,0.0640750861521732,0.0814610678173077,3.603062597702e-60
NMR metabolomics,X23424.Total Lipids in VLDL,OPLAH,5-oxoprolinase,24240,0.0771228492380205,0.0047016468148951,0.0679076214808261,0.0863380769952149,3.81915282021726e-60
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0529402321111659,0.00322800809970236,0.0466133362357493,0.0592671279865825,3.94898103378132e-60
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0456796262929562,0.00278745641913073,0.0402162117114599,0.0511430408744524,4.3214462969759e-60
NMR metabolomics,X23424.Total Lipids in VLDL,KLF4,Krueppel-like factor 4,24101,0.0446385375675094,0.00272311105386279,0.0393012399019383,0.0499758352330805,4.57948729366717e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0315012314233287,0.00192390343652624,0.0277303806877372,0.0352720821589201,5.41754687165083e-60
NMR metabolomics,X23424.Total Lipids in VLDL,NPPB,Natriuretic peptides B,28916,-0.149966583236376,0.00916146029156649,-0.167923045407846,-0.132010121064906,5.90183300037855e-60
NMR metabolomics,X23424.Total Lipids in VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0845932963027724,0.00516892006697843,0.0744622129714947,0.0947243796340502,6.99784317535177e-60
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO2,Roundabout homolog 2,29694,0.0258466330197519,0.00158288217174062,0.0227441839631403,0.0289490820763635,1.12104504315934e-59
NMR metabolomics,X23424.Total Lipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.0974011099284166,0.00596568520182447,0.0857083669328406,0.109093852923993,1.32296568570059e-59
NMR metabolomics,X23424.Total Lipids in VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0666758917179883,0.004085629971914,0.0586680569730369,0.0746837264629398,1.46164706246444e-59
NMR metabolomics,X23424.Total Lipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0537955932234265,0.00329815020188012,0.0473312188277415,0.0602599676191115,1.52873095027943e-59
NMR metabolomics,X23424.Total Lipids in VLDL,TREH,Trehalase,24938,0.0837411204986104,0.00513249781557793,0.0736814247800777,0.0938008162171432,1.55009511098828e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0321060870155824,0.00197041958687852,0.0282440646253005,0.0359681094058643,1.98408112579459e-59
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0487683179985282,0.00299506521164612,0.0428979901837018,0.0546386458133546,2.40616805605613e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0753293183102093,0.00462614009342129,0.0662620837271036,0.084396552893315,2.68512989632051e-59
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0839812175652086,0.00516382895009516,0.0738601128230221,0.0941023223073951,3.30061772026353e-59
NMR metabolomics,X23424.Total Lipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0664241783309857,0.00408526427214601,0.0584170603575795,0.0744312963043919,3.51578957355589e-59
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0915766063547615,0.00563739252638194,0.0805273170030529,0.10262589570647,4.41959638688672e-59
NMR metabolomics,X23424.Total Lipids in VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.0409893622195813,0.00252433730993566,0.0360416610921074,0.0459370633470552,4.92187607909535e-59
NMR metabolomics,X23424.Total Lipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0484566105692634,0.00298606724893263,0.0426039187613555,0.0543093023771714,6.58715764626697e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ARFIP1,Arfaptin-1,24867,0.07648574103525,0.00471430620238563,0.0672457008785742,0.0857257811919259,6.83349267501489e-59
NMR metabolomics,X23424.Total Lipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.114776082531142,0.0070791050764189,0.100901036581361,0.128651128480923,8.14839311306819e-59
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0701473391461108,0.00433022125951025,0.0616601054774707,0.0786345728147508,9.13100819908851e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA6,Integrin alpha-6,29434,0.0576910568095075,0.00356199196393914,0.0507095525601868,0.0646725610588282,9.62120602321888e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ASS1,Argininosuccinate synthase,24111,0.0880335488950233,0.00543679381968911,0.0773774330084327,0.098689664781614,1.16873827998472e-58
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAL,Integrin alpha-L,24229,0.048265231773587,0.00298977387523614,0.0424052749781242,0.0541251885690499,2.54738746110764e-58
NMR metabolomics,X23424.Total Lipids in VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0573545516646487,0.00355664088885104,0.0503835355225007,0.0643255678067967,3.00769552610191e-58
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0319869575589632,0.00198466629490103,0.0280970116209572,0.0358769034969692,3.42959134190024e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0866623091797829,0.00538248320017244,0.0761126421074449,0.0972119762521209,4.43990590981477e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FGF2,Fibroblast growth factor 2,29434,0.074219393991444,0.00461209671912805,0.065179684421953,0.083259103560935,5.11057300456785e-58
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0527939726981886,0.0032824158218449,0.0463604376873725,0.0592275077090046,6.50337546471411e-58
NMR metabolomics,X23424.Total Lipids in VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0492099343819013,0.00306287659617511,0.0432066962533981,0.0552131725104045,8.71059241287782e-58
NMR metabolomics,X23424.Total Lipids in VLDL,EPPK1,Epiplakin,24240,0.0811875450948646,0.00505355561086505,0.0712825760975691,0.0910925140921601,8.86832598352888e-58
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0479290979832632,0.00298763152791038,0.0420733401885588,0.0537848557779676,1.25896126671843e-57
NMR metabolomics,X23424.Total Lipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0963431181485723,0.00600561475040035,0.0845721132377876,0.108114123059357,1.2652381093267e-57
NMR metabolomics,X23424.Total Lipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0544363341935999,0.00339373966317945,0.0477846044537681,0.0610880639334316,1.34544053105058e-57
NMR metabolomics,X23424.Total Lipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0445260673794771,0.00277663805519978,0.0390838567912855,0.0499682779676687,1.42377728453854e-57
NMR metabolomics,X23424.Total Lipids in VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0812606842594084,0.00507743457686987,0.0713089124887435,0.0912124560300734,2.33552908505052e-57
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.0749995099619202,0.00469226127293705,0.0658026778669635,0.0841963420568768,2.88840139171867e-57
NMR metabolomics,X23424.Total Lipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0237513622086153,0.0014877410770485,0.0208353896976002,0.0266673347196303,3.91950371669706e-57
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH7,Protocadherin-7,24805,0.0380369507149086,0.00238594759446357,0.03336049342976,0.0427134080000572,6.20833709296676e-57
NMR metabolomics,X23424.Total Lipids in VLDL,ING1,Inhibitor of growth protein 1,28719,0.0500174271820237,0.00314493449267466,0.0438533555763814,0.056181498787666,1.03690939037872e-56
NMR metabolomics,X23424.Total Lipids in VLDL,ENO2,Gamma-enolase,29694,0.0711442814945394,0.00447626160245654,0.0623708087537245,0.0799177542353542,1.20111594341965e-56
NMR metabolomics,X23424.Total Lipids in VLDL,KLB,Beta-klotho,28774,-0.0805270690313932,0.00506666994372151,-0.0904577421210874,-0.0705963959416991,1.22559685771159e-56
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0476099103426542,0.00299636921656608,0.0417370266781847,0.0534827940071238,1.31105572282204e-56
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0867132320816747,0.00545690919395884,0.0760176900615154,0.097408774101834,1.40127320220404e-56
NMR metabolomics,X23424.Total Lipids in VLDL,SNX9,Sorting nexin-9,29478,0.0740883921672071,0.00466680826829241,0.064941447961354,0.0832353363730603,1.60489606594164e-56
NMR metabolomics,X23424.Total Lipids in VLDL,ACRBP,Acrosin-binding protein,24793,0.0420843576261852,0.00265563435013594,0.0368793142999187,0.0472894009524516,2.77958441733064e-56
NMR metabolomics,X23424.Total Lipids in VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0501149660705558,0.00317087436044718,0.0439000523240794,0.0563298798170323,4.8763257200034e-56
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3,Galectin-3,29544,0.0321901398296476,0.00203734409671955,0.0281969454000773,0.0361833342592179,5.27536455976922e-56
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0415302553132857,0.00263037766409887,0.0363747150916519,0.0466857955349195,6.96288179022203e-56
NMR metabolomics,X23424.Total Lipids in VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0558673936427197,0.0035529466738433,-0.0628311691234525,-0.0489036181619868,1.90672137638437e-55
NMR metabolomics,X23424.Total Lipids in VLDL,CORO1A,Coronin-1A,28847,0.0956029785327823,0.00610998545124606,0.08362740704834,0.107578550017225,5.86317420453163e-55
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0422999533065969,0.00270893748316779,0.0369904358395881,0.0476094707736058,9.55241804374312e-55
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0521253317494687,0.00333697104277427,0.0455848685056311,0.0586657949933063,9.62694065286621e-55
NMR metabolomics,X23424.Total Lipids in VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0354811330724935,0.00227280350280889,-0.0399358279379989,-0.031026438206988,1.01075226986228e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1F,Protein phosphatase 1F,24922,0.0564009703342603,0.00361310478836302,0.0493192849490688,0.0634826557194518,1.12861899776552e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.04782186346639,0.00306432664911116,0.0418157832341321,0.0538279436986478,1.22367360693555e-54
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.032432204282921,0.00208088266614915,0.0283536742572687,0.0365107343085733,1.64404576740339e-54
NMR metabolomics,X23424.Total Lipids in VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0474995581011233,0.00304782875467678,0.0415258137419568,0.0534733024602898,1.6784626897755e-54
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0270179405635415,0.00173370735471118,0.0236198741483076,0.0304160069787754,1.69444312383092e-54
NMR metabolomics,X23424.Total Lipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0619903583000651,0.00398428036513843,0.0541811687843937,0.0697995478157364,2.29560852181105e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX6,Peroxiredoxin-6,29725,-0.0635629515148277,0.00409073291934687,-0.0715807880367476,-0.0555451149929079,3.1243440666134e-54
NMR metabolomics,X23424.Total Lipids in VLDL,UNC79,Protein unc-79 homolog,24016,0.0597503734941689,0.00385018918816473,0.052204002685366,0.0672967443029718,4.73948182932497e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.0534018849323738,0.00344536320059229,0.0466489730592129,0.0601547968055347,5.70480218310201e-54
NMR metabolomics,X23424.Total Lipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0774139935894893,0.00500621623584886,0.0676018097672255,0.0872261774117531,9.99354235173038e-54
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.0300035787874692,0.00194216091084501,0.026196943402213,0.0338102141727255,1.25909375837423e-53
NMR metabolomics,X23424.Total Lipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0931725280013821,0.00603396706608901,0.0813459525518476,0.104999103450917,1.41300992354345e-53
NMR metabolomics,X23424.Total Lipids in VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.0934967899361973,0.00605967103293613,0.0816198347116425,0.105373745160752,1.83969590008379e-53
NMR metabolomics,X23424.Total Lipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.027483167951593,0.00178533265962499,-0.030982419964458,-0.023983915938728,3.16250055573856e-53
NMR metabolomics,X23424.Total Lipids in VLDL,ARSA,Arylsulfatase A,29443,0.0470770207630184,0.00306212115106789,0.0410752633069253,0.0530787782191115,3.93776528900758e-53
NMR metabolomics,X23424.Total Lipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.103400316365207,0.00672959962106891,0.0902103011079122,0.116590331622502,4.5098172350457e-53
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN6,Dynactin subunit 6,28774,0.0749528109866757,0.00487877545773981,0.0653904110895057,0.0845152108838457,4.70808958986472e-53
NMR metabolomics,X23424.Total Lipids in VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0640674216853232,0.00417120622043778,0.0558918574932652,0.0722429858773813,4.93759871728978e-53
NMR metabolomics,X23424.Total Lipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0295021288600197,0.00192122938989299,0.0257365192558295,0.03326773846421,5.76784860436074e-53
NMR metabolomics,X23424.Total Lipids in VLDL,CD84,SLAM family member 5,29434,0.0326279672692407,0.00213766419027357,0.0284381454563044,0.0368177890821769,2.13052520921534e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0701767465134484,0.00459760669336733,0.0611654373944485,0.0791880556324484,2.14066719623273e-52
NMR metabolomics,X23424.Total Lipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0412107484139489,0.00270290681937613,0.0359130510479717,0.0465084457799261,2.76176778207226e-52
NMR metabolomics,X23424.Total Lipids in VLDL,POSTN,Periostin,24938,-0.0396292651441423,0.0025991688274727,-0.0447236360459888,-0.0345348942422958,2.97242923295686e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH1,Acid ceramidase,24732,0.0486887541688543,0.00319358238416221,0.0424293326958963,0.0549481756418122,3.03552081799455e-52
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.102155217743917,0.00670940237953637,0.0890047890800262,0.115305646407809,3.79110964595047e-52
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0927603121163169,0.00609786224394199,0.0808085021181906,0.104712122114443,5.1108756819748e-52
NMR metabolomics,X23424.Total Lipids in VLDL,DNM1,Dynamin-1,24805,0.119161854782772,0.00783686386101869,0.103801601615176,0.134522107950369,5.59854840443988e-52
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA9,Serpin A9,29227,0.0750420627990139,0.00494764176826691,0.0653446849332108,0.0847394406648171,9.18039306327572e-52
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0436126846935528,0.00287843386091816,0.0379709543261532,0.0492544150609524,1.15737024336534e-51
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0329338222729208,0.00217644498284461,0.0286679901065453,0.0371996544392962,1.57569792307939e-51
NMR metabolomics,X23424.Total Lipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0296580400550082,0.00196267376141216,0.0258111994826403,0.033504880627376,2.13625342960955e-51
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR5,Complement factor H-related protein 5,24623,0.043318351705134,0.00286561608505487,0.0377017441784264,0.0489349592318415,2.14268024700988e-51
NMR metabolomics,X23424.Total Lipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0431529404250242,0.00285886979782128,0.0375495556212945,0.0487563252287539,2.9768687750936e-51
NMR metabolomics,X23424.Total Lipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0203861511945323,0.00135151751024652,-0.0230351255146155,-0.0177371768744491,3.21830367091024e-51
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0477800365555096,0.00316849009844377,0.0415697959625598,0.0539902771484594,3.42098761187286e-51
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0741962045920169,0.00492845063971234,0.0645364413381807,0.0838559678458531,5.02341596782425e-51
NMR metabolomics,X23424.Total Lipids in VLDL,CTSE,Cathepsin E,24381,0.0539312012941953,0.00358209650226293,0.04691029214976,0.0609521104386307,5.36793220002829e-51
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0943752497302941,0.00627155522630772,0.0820830014867309,0.106667497973857,5.95584386824574e-51
NMR metabolomics,X23424.Total Lipids in VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.0349852444587631,0.00233183195745844,0.0304148538221446,0.0395556350953816,1.08297618075292e-50
NMR metabolomics,X23424.Total Lipids in VLDL,TCOF1,Treacle protein,24922,0.0321944004238993,0.0021455583250985,0.0279891061067062,0.0363996947410923,1.13183836727806e-50
NMR metabolomics,X23424.Total Lipids in VLDL,TLR3,Toll-like receptor 3,29786,0.0626042497672938,0.00417915086934003,0.0544131140633874,0.0707953854712003,1.5137354415188e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0326180313940764,0.00218018048911605,0.0283448776354089,0.0368911851527438,2.18435457982779e-50
NMR metabolomics,X23424.Total Lipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0365608446609621,0.00244940236101907,0.0317600160333648,0.0413616732885595,3.66005552842304e-50
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0456919390955123,0.00306234155104347,0.0396897496554671,0.0516941285355575,4.04477411260255e-50
NMR metabolomics,X23424.Total Lipids in VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0615862637897484,0.00412954382968037,0.0534923578835749,0.0696801696959219,4.49985615047247e-50
NMR metabolomics,X23424.Total Lipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0706997730271321,0.00474288604611727,0.0614037163767422,0.0799958296775219,4.56290118241133e-50
NMR metabolomics,X23424.Total Lipids in VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0535119953153041,0.00359057640278306,0.0464744655658493,0.0605495250647589,4.74995323698938e-50
NMR metabolomics,X23424.Total Lipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0353234877152117,0.00237162196982535,0.030675108654354,0.0399718667760694,5.4474225447911e-50
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0516005077790718,0.00346628351984156,0.0448065920801824,0.0583944234779613,6.19775090014447e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0687706797014937,0.00463860823725681,0.0596790075564703,0.077862351846517,1.64053079045152e-49
NMR metabolomics,X23424.Total Lipids in VLDL,FXN,"Frataxin, mitochondrial",29725,0.0741819420127867,0.00501435402710926,0.0643538081196525,0.0840100759059208,2.40338918869762e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CALB2,Calretinin,28774,0.0308671292271606,0.00208987580017897,0.0267709726588098,0.0349632857955114,3.47309250241087e-49
NMR metabolomics,X23424.Total Lipids in VLDL,FCN1,Ficolin-1,24919,0.0566948844180485,0.00384027440561928,0.0491679465830347,0.0642218222530623,4.07975378513933e-49
NMR metabolomics,X23424.Total Lipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0600318498751314,0.00406685281390272,0.0520608183598821,0.0680028813903808,4.2567845630053e-49
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0374930422945058,0.00254100728602623,0.0325126680138944,0.0424734165751173,4.64047991628044e-49
NMR metabolomics,X23424.Total Lipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0341496513077978,0.00231891417901972,0.0296045795169191,0.0386947230986764,6.5085352168535e-49
NMR metabolomics,X23424.Total Lipids in VLDL,NFASC,Neurofascin,29786,0.0285227708304351,0.001938483320576,0.0247233435221061,0.0323221981387641,7.78720187689285e-49
NMR metabolomics,X23424.Total Lipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.025843882374496,0.0017576774700525,0.0223988345331931,0.0292889302157989,9.83331011593389e-49
NMR metabolomics,X23424.Total Lipids in VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0487231310232457,0.00331595335647457,0.0422238624445556,0.0552223996019359,1.13830241231917e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.042708379825739,0.00290876428788585,0.0370072018214827,0.0484095578299952,1.2465627217713e-48
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA4,Annexin A4,29341,0.0723091947821167,0.00492557082105972,0.0626550759728397,0.0819633135913938,1.28176743406154e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0627383101181385,0.00428118087156544,0.0543471956098703,0.0711294246264068,2.00745319520754e-48
NMR metabolomics,X23424.Total Lipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0324546337350851,0.00221671010181543,0.0281098819355269,0.0367993855346434,2.44658977211428e-48
NMR metabolomics,X23424.Total Lipids in VLDL,IL12A_IL12B,Interleukin-12,29349,0.077726448937298,0.00531061007597485,0.0673176531883873,0.0881352446862087,2.44917957052547e-48
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0462311432727572,0.00315934106477471,0.0400388347857988,0.0524234517597157,2.5745748874264e-48
NMR metabolomics,X23424.Total Lipids in VLDL,STX16,Syntaxin-16,28797,0.0581566035958964,0.00397441880411055,0.0503667427398397,0.0659464644519531,2.59071964602294e-48
NMR metabolomics,X23424.Total Lipids in VLDL,HRG,Histidine-rich glycoprotein,24833,0.0314956924350594,0.00215275485336705,0.02727629292246,0.0357150919476588,2.85547881012798e-48
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0318360345329287,0.00217741752769435,-0.0361037728872096,-0.0275682961786478,3.03238861039081e-48
NMR metabolomics,X23424.Total Lipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0383110920750222,0.00262064783972472,0.0331746223091617,0.0434475618408826,3.16899258990334e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CLTA,Clathrin light chain A,28916,0.047048808737455,0.00322039139559463,0.0407368416020895,0.0533607758728204,3.62108092623884e-48
NMR metabolomics,X23424.Total Lipids in VLDL,LAMB1,Laminin subunit beta-1,24240,0.0304772238343854,0.00208714808061678,0.0263864135963765,0.0345680340723943,4.34614043054631e-48
NMR metabolomics,X23424.Total Lipids in VLDL,MENT,Protein MENT,24381,-0.0226885385250609,0.00155510346868233,-0.0257365413236782,-0.0196405357264435,5.20565861387668e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TREML2,Trem-like transcript 2 protein,29443,0.0338453299946729,0.00232084690595482,0.0292964700590014,0.0383941899303443,5.28652242992894e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TNF,Tumor necrosis factor,28868,0.0380910829468229,0.00261721810489187,0.0329613354612348,0.0432208304324109,8.13601408910183e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0684329384842149,0.0047004489563275,0.059220058529813,0.0776458184386168,8.15454596448129e-48
NMR metabolomics,X23424.Total Lipids in VLDL,ENAH,Protein enabled homolog,28931,0.0474565272235789,0.00326314206790927,0.0410607687704767,0.053852285676681,9.51312044275057e-48
NMR metabolomics,X23424.Total Lipids in VLDL,LGMN,Legumain,29581,0.035603083960648,0.00245132504382005,0.0307984868747607,0.0404076810465353,1.24572627347538e-47
NMR metabolomics,X23424.Total Lipids in VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.0194337633372771,0.00133817358878081,0.0168109431032667,0.0220565835712875,1.36400550889766e-47
NMR metabolomics,X23424.Total Lipids in VLDL,XCL1,Lymphotactin,29725,0.0550843037502167,0.00379452405551462,0.0476470366014081,0.0625215708990254,1.38069657983573e-47
NMR metabolomics,X23424.Total Lipids in VLDL,FEN1,Flap endonuclease 1,28797,0.0624897023080933,0.00430894204717601,0.0540441758956283,0.0709352287205583,1.72266173258604e-47
NMR metabolomics,X23424.Total Lipids in VLDL,PVR,Poliovirus receptor,29694,0.036736125539693,0.00253328484597301,0.0317708872415858,0.0417013638378001,1.72636455965889e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CCN4,CCN family member 4,29725,0.0397360557845631,0.0027423302495499,0.0343610884954453,0.0451110230736809,2.0377204920361e-47
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS27,Serine protease 27,29395,0.0398539531273302,0.00275501383112344,0.0344541260183283,0.0452537802363322,2.8904455787781e-47
NMR metabolomics,X23424.Total Lipids in VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.0452973541439814,0.00313932268551218,0.0391442816803775,0.0514504266075852,4.93019714937644e-47
NMR metabolomics,X23424.Total Lipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0503383371608269,0.00349099235679593,0.0434959921415069,0.057180682180147,5.63717109579085e-47
NMR metabolomics,X23424.Total Lipids in VLDL,KLK7,Kallikrein-7,23801,0.0387333890517579,0.0026855190631921,0.0334697716879014,0.0439970064156144,5.84970154691054e-47
NMR metabolomics,X23424.Total Lipids in VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0269264760116252,0.00186930975362272,-0.0305903231287258,-0.0232626288945247,6.99240560117312e-47
NMR metabolomics,X23424.Total Lipids in VLDL,NID2,Nidogen-2,29443,0.0720719024695655,0.00501522355156976,0.0622420643084887,0.0819017406306422,1.13860714043551e-46
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0225679771265748,0.00157078122909185,0.0194892459175547,0.0256467083355948,1.19460294961668e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ADA,Adenosine deaminase,29786,0.0341736827739115,0.00238104393015344,0.0295068366708108,0.0388405288770123,1.47241655476587e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0359001965696295,0.00250440984317706,0.0309915532770025,0.0408088398622565,2.0591852415978e-46
NMR metabolomics,X23424.Total Lipids in VLDL,NGRN,Neugrin,24845,0.0217847616488137,0.00152017686944718,0.0188052149846972,0.0247643083129301,2.16397793953214e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0312105708381603,0.00217874747364525,0.0269402257898156,0.035480915886505,2.17799954137582e-46
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3C,Protein FAM3C,29433,0.0293756144250973,0.00205226470826397,0.0253531755968999,0.0333980532532947,2.56978003935576e-46
NMR metabolomics,X23424.Total Lipids in VLDL,DMD,Dystrophin,24240,0.0507397907791348,0.00354614996387176,0.0437893368499462,0.0576902447083235,2.99328499645157e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CD83,CD83 antigen,29434,0.0332769564784972,0.00232726258978092,0.0287155218025266,0.0378383911544678,3.18342883269445e-46
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.02235441704269,0.00156381260457287,0.0192893443377272,0.0254194897476529,3.58982031624669e-46
NMR metabolomics,X23424.Total Lipids in VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0251726733977026,0.00176333935675986,0.0217165282584533,0.028628818536952,4.44728712863202e-46
NMR metabolomics,X23424.Total Lipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0656245374308119,0.00459843833174962,0.0566115983005827,0.0746374765610412,5.04131739742708e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0332006774188864,0.00232676198404091,0.0286402239301663,0.0377611309076066,5.22431639383782e-46
NMR metabolomics,X23424.Total Lipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0500388726995474,0.00351117829643759,0.0431569632385297,0.0569207821605651,6.30889605463528e-46
NMR metabolomics,X23424.Total Lipids in VLDL,NADK,NAD kinase,29478,0.052614655441657,0.00369769607130676,0.0453671711418957,0.0598621397414182,8.58360725081484e-46
NMR metabolomics,X23424.Total Lipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0651234615946127,0.00458370856432169,0.0561393928085422,0.0741075303806832,1.17132307470139e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0707852771289218,0.00498251845877082,0.061019540949731,0.0805510133081126,1.18773312784326e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0707368627774533,0.00498612612767569,0.0609640555672089,0.0805096699876977,1.56613518465769e-45
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3B,Protein FAM3B,29349,0.03459992284838,0.00243932886901369,0.0298188382651132,0.0393810074316469,1.62347844602385e-45
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA4,Laminin subunit alpha-4,29581,0.0323950426335895,0.00228684388346077,0.0279128286220064,0.0368772566451726,2.09957543669791e-45
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX,Glutaredoxin-1,29291,0.0543328635801857,0.00383756914336338,0.0468112280591935,0.061854499101178,2.34839655314915e-45
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA2,Annexin A2,23907,0.0689926617806294,0.00487221971796354,0.0594431111334209,0.078542212427838,2.45711987307321e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0838794391676068,0.00592527377497984,0.0722659025686463,0.0954929757665672,2.56624411050507e-45
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN2,Dynactin subunit 2,29349,0.0910558398672408,0.00645199656718203,0.078409926595564,0.103701753138918,4.44879296663295e-45
NMR metabolomics,X23424.Total Lipids in VLDL,PTGR1,Prostaglandin reductase 1,24922,0.0790236064727942,0.00559875853011324,0.0680500397537722,0.0899971731918161,4.61453232114977e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CD46,Membrane cofactor protein,29331,0.027653804969202,0.00196042008006945,0.0238113816122658,0.0314962283261381,4.893846628456e-45
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0290585278975489,0.00206586375392075,0.0250094349398642,0.0331076208552336,9.11377573170742e-45
NMR metabolomics,X23424.Total Lipids in VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.0831917790359963,0.00591904799045041,0.0715904449747135,0.0947931130972791,1.00247950835361e-44
NMR metabolomics,X23424.Total Lipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0573065950932018,0.00408099886198737,0.0493078373237066,0.0653053528626971,1.27121501167111e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CASP8,Caspase-8,29632,0.0590450622045808,0.0042114458340429,0.0507906283698567,0.0672994960393049,1.62947809298333e-44
NMR metabolomics,X23424.Total Lipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0315471814351717,0.00225146448354747,0.0271343110474186,0.0359600518229247,1.8280736192449e-44
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0352402047351862,0.00251888482921429,0.0303031904699262,0.0401772190004462,2.62876612112948e-44
NMR metabolomics,X23424.Total Lipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0835179953457627,0.00597094671393537,0.0718149397864494,0.095221050905076,2.75859121418065e-44
NMR metabolomics,X23424.Total Lipids in VLDL,GLO1,Lactoylglutathione lyase,28916,0.0553612334533257,0.00396369499106328,0.0475923912708417,0.0631300756358097,3.44742901942036e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0383580024896135,0.00274558183608819,0.0329766620908806,0.0437393428883463,3.45430596456267e-44
NMR metabolomics,X23424.Total Lipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.02534251620962,0.00181668857374026,0.0217818066050891,0.0289032258141509,4.61879858534079e-44
NMR metabolomics,X23424.Total Lipids in VLDL,SCRIB,Protein scribble homolog,24240,0.0864517859175861,0.00620846219523557,0.0742832000149244,0.0986203718202478,6.61034255538379e-44
NMR metabolomics,X23424.Total Lipids in VLDL,DKK4,Dickkopf-related protein 4,29169,0.0436874127440243,0.00314136517788765,0.0375303369953645,0.0498444884926841,7.91520489130456e-44
NMR metabolomics,X23424.Total Lipids in VLDL,C5,Complement C5,24966,0.0144597255938492,0.00104019301576335,0.0124209472829531,0.0164985039047454,9.09752799636937e-44
NMR metabolomics,X23424.Total Lipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0610112542984609,0.00439298427083738,0.0524010051276196,0.0696215034693022,1.09645988340143e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0394077639448154,0.00283858375286722,0.0338441397891957,0.0449713881004352,1.17966512021421e-43
NMR metabolomics,X23424.Total Lipids in VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.0459398047171334,0.00331108649709192,0.0394500751828332,0.0524295342514336,1.24920447054019e-43
NMR metabolomics,X23424.Total Lipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0385567887634,0.0027813765578088,0.0331052907100947,0.0440082868167052,1.56831950020677e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SPAG1,Sperm-associated antigen 1,24867,0.0550102751053203,0.00396993021608391,0.0472292118817959,0.0627913383288448,1.6814934585937e-43
NMR metabolomics,X23424.Total Lipids in VLDL,DENR,Density-regulated protein,24229,0.0546401041461934,0.00394409629388132,0.046909675410186,0.0623705328822008,1.77213034499244e-43
NMR metabolomics,X23424.Total Lipids in VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.0211801764974585,0.00153044210821689,0.0181805099653534,0.0241798430295636,2.1414687557915e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0245786452993284,0.00177661216110464,0.0210964854635633,0.0280608051350935,2.28074473915046e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL1,Fc receptor-like protein 1,29478,0.0429634926675219,0.00310851007729925,0.0368708129160153,0.0490561724190284,2.59099995425845e-43
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0263027316002787,0.0019046450912959,0.0225696272213387,0.0300358359792186,3.24795998332042e-43
NMR metabolomics,X23424.Total Lipids in VLDL,HEPH,Hephaestin,24922,0.0250338931076477,0.00181314770222557,0.0214801236112856,0.0285876626040098,3.34308999810579e-43
NMR metabolomics,X23424.Total Lipids in VLDL,SLIT2,Slit homolog 2 protein,28774,0.0491574469888246,0.00356342943156552,0.0421731253029562,0.056141768674693,3.75020656221928e-43
NMR metabolomics,X23424.Total Lipids in VLDL,IL32,Interleukin-32,29434,-0.0409743071106451,0.00298144634562395,-0.046817941948068,-0.0351306722732221,7.60099146342081e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CCL25,C-C motif chemokine 25,29786,0.046200701283779,0.00336404773265053,0.039607167727784,0.0527942348397741,8.62050534052917e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN3,Calsyntenin-3,24845,0.0285974510277797,0.00209449048107311,0.0244922496848764,0.032702652370683,2.72976799763618e-42
NMR metabolomics,X23424.Total Lipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0237795450384392,0.00174623315393644,0.0203569280567238,0.0272021620201546,4.22454199132435e-42
NMR metabolomics,X23424.Total Lipids in VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0210791068649247,0.00155419643974053,-0.0241253318868162,-0.0180328818430333,8.88178089240932e-42
NMR metabolomics,X23424.Total Lipids in VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.0679783859011352,0.00502082595752581,0.0581375670243846,0.0778192047778857,1.21798961741608e-41
NMR metabolomics,X23424.Total Lipids in VLDL,FGF23,Fibroblast growth factor 23,29693,0.052487174353915,0.00388760385993251,0.0448674707884473,0.0601068779193827,2.04030516814845e-41
NMR metabolomics,X23424.Total Lipids in VLDL,KIF22,Kinesin-like protein KIF22,24111,0.113906313992566,0.00843982064448242,0.0973642655293805,0.130448362455752,2.324763794959e-41
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0237693617264864,0.00176194746675483,0.020315944691647,0.0272227787613259,2.36412357723826e-41
NMR metabolomics,X23424.Total Lipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0353333820684603,0.00261925758147806,0.0301996372087633,0.0404671269281573,2.38237304360701e-41
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.032349997194201,0.00239992557456375,0.027646143068056,0.0370538513203459,2.89756273460141e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0543113611045596,0.00403186626759977,0.0464089032200641,0.0622138189890552,3.25420014248098e-41
NMR metabolomics,X23424.Total Lipids in VLDL,ADM,Pro-adrenomedullin,29725,0.0244483480961991,0.00181860124952269,0.0208838896471347,0.0280128065452636,4.43389414912083e-41
NMR metabolomics,X23424.Total Lipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0440482936258833,0.00327613011117309,0.037627078607984,0.0504695086437826,4.57303465987399e-41
NMR metabolomics,X23424.Total Lipids in VLDL,VGF,Neurosecretory protein VGF,24867,0.0279742958673338,0.00208235342799011,0.0238928831484732,0.0320557085861945,5.31579325795353e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0882483600800303,0.00657905145595015,0.075353419226368,0.101143300933693,6.66265959334465e-41
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA1,BolA-like protein 1,24101,0.0502783499586154,0.00374899240258167,0.0429303248495553,0.0576263750676754,7.29198391832912e-41
NMR metabolomics,X23424.Total Lipids in VLDL,CCL19,C-C motif chemokine 19,29694,0.11263398467571,0.0084130927871213,0.0961443228129523,0.129123646538468,9.34074261318865e-41
NMR metabolomics,X23424.Total Lipids in VLDL,PTN,Pleiotrophin,28916,0.0458261133684826,0.00342590671275139,0.0391113362114899,0.0525408905254753,1.09873666296958e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PPL,Periplakin,24229,0.030054418047629,0.00224656011806549,0.0256511602162207,0.0344576758790374,1.13446819244223e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0504831888172367,0.00378196205092289,0.0430705431974278,0.0578958344370455,1.68721140020457e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0211317085680325,0.0015851138622013,0.018024885398118,0.0242385317379471,1.98642703977076e-40
NMR metabolomics,X23424.Total Lipids in VLDL,LY75,Lymphocyte antigen 75,29434,0.0354641278201999,0.00266104398203335,0.0302484816154145,0.0406797740249852,2.1081506769072e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PALM,Paralemmin-1,24657,0.0272944194392063,0.00205175902130629,0.023272971757446,0.0313158671209667,3.0641417444117e-40
NMR metabolomics,X23424.Total Lipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0355125734986105,0.00267106500146143,0.0302772860957461,0.040747860901475,3.41079468294942e-40
NMR metabolomics,X23424.Total Lipids in VLDL,S100P,Protein S100-P,28916,0.0486145368703634,0.00366783405551049,0.0414255821215629,0.055803491619164,5.57600992997004e-40
NMR metabolomics,X23424.Total Lipids in VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0529462711511457,0.00399505633994578,-0.0607765815774394,-0.045115960724852,5.6413681752612e-40
NMR metabolomics,X23424.Total Lipids in VLDL,THBD,Thrombomodulin,29478,0.0259956725744102,0.00196159734500622,0.022150941778198,0.0298404033706224,5.695969151279e-40
NMR metabolomics,X23424.Total Lipids in VLDL,MDK,Midkine,29455,0.0460818578783819,0.0034805223743076,0.039260034024739,0.0529036817320248,6.71131616147828e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PSAP,Prosaposin,24761,0.0258509669884027,0.00195255341101414,0.022023962302815,0.0296779716739905,7.08605463609595e-40
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0464283821072985,0.00351540987199721,0.039538178758184,0.0533185854564131,1.03298658087832e-39
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0468300369279981,0.00356766652930582,0.0398374105305587,0.0538226633254376,3.00931019262421e-39
NMR metabolomics,X23424.Total Lipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0484629290563127,0.00369232988800451,0.0412259624758239,0.0556998956368016,3.21223253773992e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.103032108588214,0.0078621417023769,-0.118441906324873,-0.0876223108515552,3.98408199999153e-39
NMR metabolomics,X23424.Total Lipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0286903711862051,0.00218952544446577,0.0243989013150522,0.032981841057358,4.2535420577591e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CSTB,Cystatin-B,29030,0.0381514288296815,0.00291286397170612,0.0324422154451375,0.0438606422142255,4.38955688845761e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ACAN,Aggrecan core protein,29192,0.0253692325781037,0.00193739828995628,0.0215719319297894,0.029166533226418,4.56384089227457e-39
NMR metabolomics,X23424.Total Lipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0637993557804262,0.00487270642344409,0.0542488511904758,0.0733498603703766,4.63976932702871e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.0594490885364992,0.0045406039553294,0.0505495047840536,0.0683486722889448,4.68686910764092e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0293661208808959,0.00224727957291425,0.024961452917984,0.0337707888438078,6.78883620989636e-39
NMR metabolomics,X23424.Total Lipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0508896996981082,0.0038972087017368,0.0432511706427041,0.0585282287535123,7.38031637372807e-39
NMR metabolomics,X23424.Total Lipids in VLDL,XRCC4,DNA repair protein XRCC4,28774,0.0330138293010885,0.00253662175803336,0.0280420506553431,0.0379856079468339,1.29477012751786e-38
NMR metabolomics,X23424.Total Lipids in VLDL,TREML1,Trem-like transcript 1 protein,24951,0.0471406339022961,0.00362140744868858,0.0400426753028665,0.0542385925017257,1.30520400319434e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0232772620428577,0.00178956130294538,0.0197697218890847,0.0267848021966306,1.48579642517535e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CR1,Complement receptor type 1,24903,0.0320510331274873,0.00246661173081384,0.0272164741350922,0.0368855921198824,1.76679287686693e-38
NMR metabolomics,X23424.Total Lipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0668741503286935,0.00514783765481515,0.0567843885252558,0.0769639121321312,1.85225956123437e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CDA,Cytidine deaminase,24890,0.0416170121771119,0.00320607307311905,0.0353331089537985,0.0479009154004252,2.09909190748533e-38
NMR metabolomics,X23424.Total Lipids in VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.0504729607647505,0.00388964415322819,0.0428492582244232,0.0580966633050777,2.13926837594695e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CPA2,Carboxypeptidase A2,29577,0.0577915073751209,0.00446655336627356,0.0490370627772247,0.066545951973017,3.45545096927661e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PMM2,Phosphomannomutase 2,24111,0.0533743702278577,0.00413010700597623,0.0452793604961443,0.0614693799595712,4.45451651661592e-38
NMR metabolomics,X23424.Total Lipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0497150819108877,0.00384720586709108,0.0421745584113891,0.0572556054103862,4.47953663886316e-38
NMR metabolomics,X23424.Total Lipids in VLDL,HDGF,Hepatoma-derived growth factor,29688,0.0825288156121332,0.00640169598545453,0.0699814914806423,0.0950761397436241,6.33724865242651e-38
NMR metabolomics,X23424.Total Lipids in VLDL,LEPR,Leptin receptor,29478,-0.0273895834667657,0.0021261278844442,-0.0315567941202764,-0.0232223728132551,7.15937625175806e-38
NMR metabolomics,X23424.Total Lipids in VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.0553142577364568,0.00430377000853207,0.046878868519734,0.0637496469531797,1.05155122994365e-37
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.097695418558663,0.00761414168549413,-0.112619136262231,-0.0827717008550945,1.47596500192322e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PER3,Period circadian protein homolog 3,24229,0.105685380638267,0.00824514091192138,0.0895249044509013,0.121845856825633,1.72385476502988e-37
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0343369171188347,0.00267976022426831,0.0290845870792689,0.0395892471584006,1.73345966469153e-37
NMR metabolomics,X23424.Total Lipids in VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0447668915435938,0.00349862081646146,0.0379095947433293,0.0516241883438582,2.29677552393126e-37
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA4,Ephrin-A4,29169,0.026928459542601,0.00210673865816766,0.0227992517725924,0.0310576673126096,2.60149028341255e-37
NMR metabolomics,X23424.Total Lipids in VLDL,MMP3,Stromelysin-1,29443,-0.0429137738276221,0.00335934395967549,-0.0494980879885861,-0.0363294596666581,2.86114800396547e-37
NMR metabolomics,X23424.Total Lipids in VLDL,APOD,Apolipoprotein D,23787,-0.038209848219961,0.0029912366255193,-0.0440726720059788,-0.0323470244339431,3.040124669963e-37
NMR metabolomics,X23424.Total Lipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0610420338950775,0.00478639371139597,0.0516607022207414,0.0704233655694136,3.93796465911172e-37
NMR metabolomics,X23424.Total Lipids in VLDL,C7,Complement component C7,24374,-0.0284598676197077,0.00223176688508495,-0.0328341307144742,-0.0240856045249412,3.98566551536506e-37
NMR metabolomics,X23424.Total Lipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0994236495682641,0.00780562694747113,0.0841246207512207,0.114722678385308,4.78595627171141e-37
NMR metabolomics,X23424.Total Lipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0358433057643688,0.00281457836971547,0.0303267321597265,0.0413598793690111,4.94650279007087e-37
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0138172047778365,0.00108569744463491,0.0116892377863521,0.0159451717693209,5.25524352149195e-37
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO1,Roundabout homolog 1,29497,0.0209839301736598,0.00164983774271826,0.017750248197932,0.0242176121493876,5.81690784534624e-37
NMR metabolomics,X23424.Total Lipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.061605648252891,0.00484669104067606,0.052106133813166,0.0711051626926161,6.73592572987987e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.102800450455738,0.00809031459781435,0.0869434338440219,0.118657467067454,7.08290814521605e-37
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB6,Integrin beta-6,28931,0.0264512215496429,0.00208349247139002,0.0223675763057185,0.0305348667935673,7.84349992388171e-37
NMR metabolomics,X23424.Total Lipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0580487311890868,0.00457497239788229,0.0490817852892375,0.0670156770889361,8.55618892304397e-37
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0372813815657914,0.00294046578962102,0.0315180686181342,0.0430446945134486,1.00880436689615e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MMP1,Interstitial collagenase,28424,0.0793457512829389,0.00626751916071448,0.0670614137279385,0.0916300888379393,1.23985145988344e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0305955557847542,0.00241750422148282,0.0258572475106479,0.0353338640588606,1.30051807682224e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.0284783366985992,0.00225752898590465,0.0240535798862261,0.0329030935109723,2.26005811970255e-36
NMR metabolomics,X23424.Total Lipids in VLDL,IL17D,Interleukin-17D,28931,0.0295174154921886,0.00234069145121259,0.024929660247812,0.0341051707365653,2.30270478529488e-36
NMR metabolomics,X23424.Total Lipids in VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.0698416685564722,0.00554532667301446,0.0589728282773639,0.0807105088355806,2.93431018904663e-36
NMR metabolomics,X23424.Total Lipids in VLDL,DHPS,Deoxyhypusine synthase,24793,0.0351553991971487,0.00279697245268248,0.029673333189891,0.0406374652044063,4.02568821178845e-36
NMR metabolomics,X23424.Total Lipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0571123840741496,0.00454440193593193,0.048205356279723,0.0660194118685762,4.09691147158659e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.0250963828212552,0.00199855625858505,0.0211792125544285,0.0290135530880819,4.50211647850111e-36
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR2,Folate receptor beta,29694,-0.0251404845034395,0.00200601180441089,-0.0290722676400849,-0.0212087013667942,6.10865513584277e-36
NMR metabolomics,X23424.Total Lipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0627444631024958,0.00501141739589515,0.0529220850065413,0.0725668411984503,7.13532883312167e-36
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB6,Heat shock protein beta-6,29725,0.0329507810560507,0.00263193294512619,0.0277921924836034,0.0381093696284981,7.18477356084788e-36
NMR metabolomics,X23424.Total Lipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0306816847716708,0.00245248685919347,0.0258748105276516,0.03548855901569,8.11395956199834e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0418216531729742,0.00335542784997726,0.0352450145870187,0.0483982917589296,1.44487591479491e-35
NMR metabolomics,X23424.Total Lipids in VLDL,RBP2,Retinol-binding protein 2,29349,-0.0655417516875514,0.00526337404733818,-0.0758579648203342,-0.0552255385547686,1.66836746668778e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CCL20,C-C motif chemokine 20,29786,0.0748101214514601,0.00600844260559392,0.063033573944496,0.0865866689584242,1.69657079096811e-35
NMR metabolomics,X23424.Total Lipids in VLDL,TPR,Nucleoprotein TPR,24111,0.040809287319373,0.00327967516785391,0.0343811239903793,0.0472374506483666,1.95968265367072e-35
NMR metabolomics,X23424.Total Lipids in VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0463468306680314,0.00372823468339058,0.0390394906885859,0.0536541706474769,2.16371916193418e-35
NMR metabolomics,X23424.Total Lipids in VLDL,SMS,Spermine synthase,24101,0.0545728816208731,0.00439345811101985,0.0459617037232742,0.063184059518472,2.56655615656555e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0478804201006251,0.00385577152679943,0.0403231079080983,0.055437732293152,2.67251891957615e-35
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.03062600795507,0.0024666005651394,0.0257914708473968,0.0354605450627433,2.73125856742221e-35
NMR metabolomics,X23424.Total Lipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0477417152267949,0.0038470930618083,-0.0552820176279391,-0.0402014128256506,2.83342966391583e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0780260274677025,0.00628604210275231,0.065705384946308,0.0903466699890971,2.85924146908451e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL8,Interleukin-8,29218,0.0575105277987216,0.0046443454117019,0.0484076107917859,0.0666134448056574,3.96243889054702e-35
NMR metabolomics,X23424.Total Lipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0321932633595415,0.00260041192570379,0.027096455985162,0.0372900707339209,4.08914790158352e-35
NMR metabolomics,X23424.Total Lipids in VLDL,STX6,Syntaxin-6,28797,0.0569318207488501,0.00460894942604239,0.047898279873807,0.0659653616238932,5.79504344372041e-35
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0300725876358398,0.00243703098582913,0.0252960069036148,0.0348491683680649,6.75229215703774e-35
NMR metabolomics,X23424.Total Lipids in VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0403720841581907,0.00327208812732529,0.0339587914286331,0.0467853768877482,6.88168840877932e-35
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.0444164895901194,0.00359998403355364,0.0373605208843542,0.0514724582958845,7.19986345685256e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0433206211988975,0.00351285980938558,0.0364354159725018,0.0502058264252932,7.42767823689907e-35
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0223965434072283,0.00181717190799643,0.0188348864675553,0.0259582003469013,8.0974307335702e-35
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0357247060147108,0.00290046786446015,0.0300397890003689,0.0414096230290527,9.33829002030911e-35
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0203158268008404,0.00165041299396556,0.0170810173326679,0.0235506362690129,1.02212922036197e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0539964677581314,0.00439043779789068,0.0453912096742656,0.0626017258419971,1.16883877192916e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0256534735632684,0.00208803757392182,0.0215609199183817,0.0297460272081552,1.31206500772741e-34
NMR metabolomics,X23424.Total Lipids in VLDL,TEK,Angiopoietin-1 receptor,29566,0.0183721116034347,0.00149657107224912,0.0154388323018264,0.021305390905043,1.47721973887032e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0400244338702858,0.00325998810933565,0.0336348571759879,0.0464140105645836,1.50715148194118e-34
NMR metabolomics,X23424.Total Lipids in VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0310295640061951,0.00253272462414062,0.0260654237428795,0.0359937042695107,2.08899392128206e-34
NMR metabolomics,X23424.Total Lipids in VLDL,VIT,Vitrin,24922,0.0316313967300909,0.00258579401809211,0.0265632404546304,0.0366995530055514,2.60659343249851e-34
NMR metabolomics,X23424.Total Lipids in VLDL,DAPK2,Death-associated protein kinase 2,24229,0.0451024713891303,0.00368745742618837,0.037875054833801,0.0523298879444595,2.67013194794353e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0396995681982956,0.00324805592075245,0.0333333785936208,0.0460657578029704,2.86470592735883e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0481081990955105,0.00394278062381114,0.0403803490728407,0.0558360491181803,3.67840655735197e-34
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0449908167169555,0.00368811266878326,0.0377621158861403,0.0522195175477706,3.80421316353674e-34
NMR metabolomics,X23424.Total Lipids in VLDL,TXN,Thioredoxin,24647,0.0366843923979809,0.00300694928829809,0.0307907717929166,0.0425780130030451,3.90622030581342e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CD302,CD302 antigen,29349,0.0254636647540002,0.00209090706076658,0.0213654869148977,0.0295618425931026,4.90289634928217e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR4,Complement factor H-related protein 4,24892,0.0611121944983047,0.00503138661350463,0.0512506767358356,0.0709737122607738,7.49485723956493e-34
NMR metabolomics,X23424.Total Lipids in VLDL,RPL14,60S ribosomal protein L14,24240,0.0334886636096951,0.00276645283903535,0.0280664160451859,0.0389109111742044,1.23870979989744e-33
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0362254841237728,0.00300523872210953,0.0303352162284381,0.0421157520191075,2.21825907221231e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CASP9,Caspase-9,24229,0.0521682571722371,0.00432860444691133,0.0436841924562909,0.0606523218881833,2.35921173678575e-33
NMR metabolomics,X23424.Total Lipids in VLDL,RGMB,RGM domain family member B,29694,0.0222273204471956,0.00184498397891591,0.0186111518485204,0.0258434890458708,2.39376579900393e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ELOB,Elongin-B,24111,0.0327659688915043,0.0027244711825111,0.0274260053737826,0.0381059324092261,3.20879748146561e-33
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0227130065680246,0.00188916746171901,-0.0264157747929938,-0.0190102383430553,3.22569396084827e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.028699459320328,0.00239044631358125,0.0240141845457087,0.0333847340949472,3.95689171579609e-33
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0279140429870439,0.00232602325877898,0.0233550373998371,0.0324730485742507,4.19810119419189e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CLU,Clusterin,24966,0.0261690184612322,0.00218092637594276,0.0218944027643844,0.03044363415808,4.43340959089424e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0508794054302763,0.004244601519482,0.0425599864520916,0.059198824408461,5.16999192844407e-33
NMR metabolomics,X23424.Total Lipids in VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.055878381311362,0.00467117222457518,0.0467228837511947,0.0650338788715294,6.88645246424296e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CHAD,Chondroadherin,24381,0.0424102895249432,0.0035605845593804,0.0354315437885576,0.0493890352613288,1.27713791833827e-32
NMR metabolomics,X23424.Total Lipids in VLDL,LTA,Lymphotoxin-alpha,29434,0.0327096494721629,0.00274733240322528,0.0273248779618413,0.0380944209824844,1.3093451645618e-32
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0352913336647086,0.00296467420418291,0.0294805722245101,0.0411020951049071,1.38516077348364e-32
NMR metabolomics,X23424.Total Lipids in VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0289393862118152,0.00243345530255141,0.0241698138188144,0.033708958604816,1.54566519239366e-32
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0337606910249546,0.00283900074523354,0.0281962495642969,0.0393251324856124,1.61100475089528e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0204124671400994,0.00172241922272547,0.0170365254635575,0.0237884088166413,2.60740728951395e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR3,Small proline-rich protein 3,24845,0.055210557053835,0.00466600430781656,0.0460651886105145,0.0643559254971555,3.23587363392592e-32
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0388377931887347,0.00328612290248388,0.0323969922998663,0.0452785940776031,3.70929372262016e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0235391048769277,0.00199162973762146,0.0196355105911896,0.0274426991626658,3.79827072536125e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0592967916439624,0.00502044569778163,0.0494567180763104,0.0691368652116144,4.06046151267453e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0347449146296613,0.00294201177062324,0.0289785715592398,0.0405112577000829,4.22961371867349e-32
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0439152612573714,0.00373019684485201,0.0366040754414614,0.0512264470732813,6.57315780594804e-32
NMR metabolomics,X23424.Total Lipids in VLDL,STX7,Syntaxin-7,24229,0.0401569497176216,0.00341423918941327,0.0334650409063716,0.0468488585288716,7.51509422038866e-32
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0480494536900794,0.00409211720546907,0.0400289039673601,0.0560700034127988,9.17132824188356e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CD276,CD276 antigen,29454,-0.0288826839404076,0.00246349337234748,-0.0337111309502087,-0.0240542369306065,1.12575395554971e-31
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB8,Serpin B8,29786,0.0451718520483682,0.00385655527285925,0.037613003713564,0.0527307003831723,1.28287206123087e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CCL14,C-C motif chemokine 14,29435,0.0317655316483946,0.00271273195842364,0.0264485770098843,0.0370824862869049,1.33470248559297e-31
NMR metabolomics,X23424.Total Lipids in VLDL,BGN,Biglycan,28750,-0.0961132092595981,0.00820850155053138,-0.11220187229864,-0.0800245462205566,1.35263973420051e-31
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS1,Nephrin,24229,0.0274310855889013,0.00234322660850654,0.0228383614362285,0.0320238097415741,1.43537065091254e-31
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0398206167681968,0.00340587047053422,0.0331451106459498,0.0464961228904439,1.70672158695943e-31
NMR metabolomics,X23424.Total Lipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0496950092857091,0.00425489116684094,0.0413554225987008,0.0580345959727173,1.97070659760322e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0611576720221341,0.00524218682567587,0.0508829858438094,0.0714323582004588,2.29751239818836e-31
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0267356965587854,0.00229434619310138,0.0222387780203067,0.0312326150972641,2.60902371583552e-31
NMR metabolomics,X23424.Total Lipids in VLDL,TF,Serotransferrin,24966,0.0172877267842735,0.00148454384879089,0.0143780208406433,0.0201974327279036,2.92652104932938e-31
NMR metabolomics,X23424.Total Lipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0271277049845473,0.00235203229974118,-0.03173768829204,-0.0225177216770546,1.06836271264777e-30
NMR metabolomics,X23424.Total Lipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.027871799115534,0.0024181095138945,-0.0326112937627672,-0.0231323044683008,1.16931833415516e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0629989649637833,0.00549676165460233,0.0522253121207627,0.0737726178068039,2.39940964536209e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0497111708658844,0.00433665923009982,0.0412113187748887,0.05821102295688,2.4108249964783e-30
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0520627781960123,0.00455249250620714,0.0431398928838463,0.0609856635081783,3.30274842190543e-30
NMR metabolomics,X23424.Total Lipids in VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.0467341368879219,0.00409478617513151,0.0387083559846641,0.0547599177911796,4.29605015590508e-30
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.0328141904169403,0.00287590997824754,0.0271774068595751,0.0384509739743055,4.31380594102886e-30
NMR metabolomics,X23424.Total Lipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0412168851934604,0.00361623610916103,0.0341290624195048,0.048304707967416,5.09585684958934e-30
NMR metabolomics,X23424.Total Lipids in VLDL,BSG,Basigin,29760,0.0160298855729085,0.00140727335406517,0.0132716297989408,0.0187881413468763,5.3664051206629e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CBS,Cystathionine beta-synthase,24240,0.0400516540709494,0.00352087676366501,0.033150735614166,0.0469525725277328,6.59830431241689e-30
NMR metabolomics,X23424.Total Lipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0611328850548856,0.00537549181950663,-0.0716688490211186,-0.0505969210886526,6.61654371816154e-30
NMR metabolomics,X23424.Total Lipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0424338170704366,0.00375191560551585,0.0350800624836255,0.0497875716572476,1.34990111748237e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ALCAM,CD166 antigen,29820,0.0150886901046266,0.00134096922691928,0.0124603904198648,0.0177169897893884,2.59200487824552e-29
NMR metabolomics,X23424.Total Lipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0283123584952062,0.00251724459359307,0.0233785590917637,0.0332461578986486,2.73419491589589e-29
NMR metabolomics,X23424.Total Lipids in VLDL,PKD1,Polycystin-1,24922,0.0205403793564104,0.00182595342116253,0.0169615106509318,0.024119248061889,2.7522670033072e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SNX5,Sorting nexin-5,24240,0.0230558612585462,0.00205193150295139,0.0190340755127615,0.0270776470043309,3.19939657418622e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CPQ,Carboxypeptidase Q,24920,0.0284322165956361,0.0025343770903392,0.0234648374985713,0.0333995956927009,3.88084487915362e-29
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0439256485755796,0.0039225549416607,0.0362374408899246,0.0516138562612346,4.77443924306115e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SCT,Secretin,24195,0.036110025734026,0.00322399780424621,0.0297909900377034,0.0424290614303486,4.78643915391158e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI2,Serpin I2,24805,0.0435933741622322,0.00390045396984022,0.0359484843813454,0.051238263943119,6.23330124914422e-29
NMR metabolomics,X23424.Total Lipids in VLDL,UMOD,Uromodulin,29750,-0.0413175620633382,0.00369769051509965,-0.0485650354729335,-0.0340700886537429,6.25068781557291e-29
NMR metabolomics,X23424.Total Lipids in VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.0382188270706908,0.00342074882371795,0.0315141593762036,0.044923494765178,6.51028509949677e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0416359886623228,0.00372711986847637,0.0343308337201091,0.0489411436045365,6.62248265468064e-29
NMR metabolomics,X23424.Total Lipids in VLDL,AHCY,Adenosylhomocysteinase,29478,0.0516586418726985,0.00462647290484501,0.0425907549792022,0.0607265287661947,6.84578490635585e-29
NMR metabolomics,X23424.Total Lipids in VLDL,FABP6,Gastrotropin,28872,0.042965426660799,0.00385643123729342,0.0354068214357039,0.0505240318858941,9.04525343200673e-29
NMR metabolomics,X23424.Total Lipids in VLDL,GRN,Progranulin,29313,0.0187947227579704,0.00169107165165505,0.0154802223207265,0.0221092231952143,1.22245625219955e-28
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0196933126789359,0.00177448666185807,0.0162153188216941,0.0231713065361778,1.4594244343876e-28
NMR metabolomics,X23424.Total Lipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0464076340993517,0.00418307123551758,-0.0546064537209661,-0.0382088144777372,1.56895662280348e-28
NMR metabolomics,X23424.Total Lipids in VLDL,KLK4,Kallikrein-4,29725,-0.0478353545426434,0.00431298689968394,-0.056288808866024,-0.0393819002192629,1.57827595033558e-28
NMR metabolomics,X23424.Total Lipids in VLDL,COLEC12,Collectin-12,29454,0.0200053640861273,0.00180629777680272,0.0164650204435939,0.0235457077286606,1.88094539552946e-28
NMR metabolomics,X23424.Total Lipids in VLDL,APLP1,Amyloid-like protein 1,29478,-0.0388446599790249,0.00352449807170885,-0.0457526761995742,-0.0319366437584755,3.42369573754347e-28
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0429160572649787,0.00389514524275393,0.035281572589181,0.0505505419407764,3.56079334168272e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0622459812610814,0.00564926424589055,0.051173423339136,0.0733185391830269,3.6208734044433e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.032632077592672,0.00297190840605591,0.0268071371168024,0.0384570180685416,5.39464157773654e-28
NMR metabolomics,X23424.Total Lipids in VLDL,KLK6,Kallikrein-6,29519,0.0229992635659515,0.00209904045883919,0.0188851442666267,0.0271133828652763,6.95833002128076e-28
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0449020244863887,0.0040992592277009,0.036867476400095,0.0529365725726825,7.41613795188022e-28
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0310050108967521,0.00283235999469342,0.025453585307153,0.0365564364863512,7.81557826854468e-28
NMR metabolomics,X23424.Total Lipids in VLDL,GRSF1,G-rich sequence factor 1,23862,0.0607935373608108,0.00555407375091922,0.0499075528090091,0.0716795219126124,8.11035466152856e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PVALB,Parvalbumin alpha,29599,0.0841285682649929,0.00769290554321249,0.0690504734002964,0.0992066631296893,8.77874881420415e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.028146015057182,0.00257525198844156,0.0230985211598366,0.0331935089545275,9.42854691163958e-28
NMR metabolomics,X23424.Total Lipids in VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.0724022418555887,0.00664214206507944,-0.0854208403031444,-0.059383643408033,1.29533555226498e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL1,Chordin-like protein 1,29536,0.0235076003995989,0.00215907101460836,0.0192758212109666,0.0277393795882313,1.48638209353064e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.0886559346127462,0.00814104894859903,0.0726994786734921,0.104612390552,1.49159736726501e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX1,Peroxiredoxin-1,28669,-0.0673194715985262,0.00618802076713136,-0.0794479923021037,-0.0551909508949487,1.64297515485138e-27
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0284793325350964,0.00261736740253967,0.0233492924261187,0.0336093726440741,1.64383178604214e-27
NMR metabolomics,X23424.Total Lipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0722992259393079,0.00666824052459233,0.0592294745111069,0.0853689773675089,2.44331779075382e-27
NMR metabolomics,X23424.Total Lipids in VLDL,INSR,Insulin receptor,24229,0.0126640210292263,0.00116783820676689,0.0103750581439632,0.0149529839144894,2.46148262610171e-27
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA12,Serpin A12,28628,0.0830311393379539,0.00766827629319233,0.0680013178032969,0.0980609608726108,2.86879760151622e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0270915297642352,0.00250308746675459,0.0221854783293962,0.0319975811990742,3.01475067354168e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0307139242838507,0.00283867131442084,0.0251501285075858,0.0362777200601155,3.12691437558531e-27
NMR metabolomics,X23424.Total Lipids in VLDL,STAM,Signal transducing adapter molecule 1,24793,0.0273624046504114,0.00253230703587802,0.0223990828600905,0.0323257264407323,3.73399996601192e-27
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_E,,29434,0.0214717497345705,0.00198879935954594,0.0175737029898604,0.0253697964792805,4.02715045703202e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0395875116283375,0.00366780486418685,0.0323986140945313,0.0467764091621438,4.25346758127061e-27
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0253674186175737,0.00235171311800285,-0.0299767763288593,-0.0207580609062881,4.47595375477448e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CST5,Cystatin-D,28890,0.0410968874203693,0.00381114955077657,0.0336270343008472,0.0485667405398914,4.64697854077305e-27
NMR metabolomics,X23424.Total Lipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0192851443786207,0.00178994936685912,0.0157768436195769,0.0227934451376646,5.23459587393359e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB2,Plexin-B2,29701,0.0175934665796934,0.00163597325842296,0.0143869589931844,0.0207999741662024,6.35276082081952e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0183510145359724,0.00170726149201735,0.0150047820116184,0.0216972470603264,6.74298882741934e-27
NMR metabolomics,X23424.Total Lipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0470545135400806,0.00437759230946672,0.0384744326135258,0.0556345944666354,6.74301057698181e-27
NMR metabolomics,X23424.Total Lipids in VLDL,FGA,Fibrinogen alpha chain,24407,0.0228514623776416,0.00212580638562978,0.0186848818618073,0.027018042893476,6.84161288320002e-27
NMR metabolomics,X23424.Total Lipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0292439898969718,0.0027209484999556,0.0239109308370588,0.0345770489568848,6.98904937002514e-27
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0375630709348071,0.00350668834516449,0.0306899617782847,0.0444361800913295,1.02931804192797e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0362263640008397,0.00338747557818909,0.0295869118675891,0.0428658161340903,1.21159138219551e-26
NMR metabolomics,X23424.Total Lipids in VLDL,S100A12,Protein S100-A12,29023,0.0549811948671507,0.00514193165501738,0.0449030088233166,0.0650593809109847,1.23438203753715e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CTSF,Cathepsin F,29566,0.0293731693836802,0.00274854865406351,0.0239860140217157,0.0347603247456447,1.3126553511107e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CIT,Citron Rho-interacting kinase,24195,0.0332685190233816,0.00311520161356474,0.0271627238607947,0.0393743141859685,1.45645969277821e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0544257188011545,0.0051035109180477,0.044422837401781,0.064428600200528,1.67043687678057e-26
NMR metabolomics,X23424.Total Lipids in VLDL,S100A13,Protein S100-A13,24229,0.0257597905970834,0.00241890602356511,0.0210187347908957,0.030500846403271,2.00892681956538e-26
NMR metabolomics,X23424.Total Lipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0346276792918898,0.0032531473010494,0.028251510581833,0.0410038480019467,2.07443935942831e-26
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI1,Neuroserpin,24329,0.0223881552636683,0.00210363211830315,0.0182650363117941,0.0265112742155425,2.15772154107996e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TSHB,Thyrotropin subunit beta,29478,0.0560764855034109,0.00527178578971903,0.0457437853555617,0.0664091856512602,2.2362230308286e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CA4,Carbonic anhydrase 4,29820,-0.0173197835111823,0.00162986952778745,-0.0205143277856457,-0.0141252392367189,2.50148100594274e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CRYGD,Gamma-crystallin D,24845,0.070623933460386,0.00665016439599768,0.0575896112442306,0.0836582556765415,2.74298234360311e-26
NMR metabolomics,X23424.Total Lipids in VLDL,REN,Renin,29478,-0.0553287884403156,0.00521103889869719,-0.0655424246817621,-0.0451151521988691,2.75342462708083e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0441161352637554,0.00415540022875281,0.0359715508153999,0.0522607197121109,2.84362097794561e-26
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0417220465256869,0.00394462790001766,0.0339905758416522,0.0494535172097215,4.25541786880167e-26
NMR metabolomics,X23424.Total Lipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0404942381748336,0.00383220593748099,0.0329831145373709,0.0480053618122964,4.84198261828866e-26
NMR metabolomics,X23424.Total Lipids in VLDL,GPR15L,Protein GPR15L,24805,0.0442548736355913,0.00420275767918919,0.0360174685843805,0.0524922786868021,7.12898677236096e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.0247205495982254,0.00235063268329986,0.0201133095389577,0.0293277896574932,8.20966118760075e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0174391504509216,0.00166390731883616,0.0141778921060028,0.0207004087958405,1.17343178971983e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ANPEP,Aminopeptidase N,29531,0.0200850357974281,0.00192373879630016,0.0163145077566798,0.0238555638381764,1.79151306064262e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CCL15,C-C motif chemokine 15,29820,0.0314797734492904,0.00301663180685983,0.0255671751078451,0.0373923717907357,1.89052712193753e-25
NMR metabolomics,X23424.Total Lipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0490365465232851,0.00469843712123061,0.0398276097656731,0.0582454832808971,1.90197445758205e-25
NMR metabolomics,X23424.Total Lipids in VLDL,XG,Glycoprotein Xg,29693,0.0229850391315257,0.00220743244517362,0.0186584715389854,0.027311606724066,2.40275865649198e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0426101412675426,0.00409742212476789,0.0345791939029975,0.0506410886320876,2.76503962293778e-25
NMR metabolomics,X23424.Total Lipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0266120044753978,0.00255977131075484,0.0215948527063183,0.0316291562444773,2.9148492148332e-25
NMR metabolomics,X23424.Total Lipids in VLDL,GC,Vitamin D-binding protein,24966,0.0184920151699486,0.00177909841156074,0.0150049822832895,0.0219790480566076,2.97220474904877e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CA12,Carbonic anhydrase 12,29349,-0.0232213018440084,0.00223541626999367,-0.027602717733196,-0.0188398859548208,3.11310560960001e-25
NMR metabolomics,X23424.Total Lipids in VLDL,INSL3,Insulin-like 3,24845,0.053841844831185,0.00518908664706326,0.043671235002941,0.064012454659429,3.59061776212288e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0207770926038252,0.00200349607210635,-0.0247039449051537,-0.0168502403024968,3.73591061086394e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.0388116269508084,0.00374377612005242,0.0314738257555057,0.0461494281461112,3.94210660163695e-25
NMR metabolomics,X23424.Total Lipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0257220229332037,0.00248384971510715,0.0208536774915937,0.0305903683748137,4.35543204096601e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.023471372258186,0.00227034036781622,0.0190215051372662,0.0279212393791058,5.33207626817464e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL,Podocalyxin,29349,0.0107408249046423,0.00103923896754959,0.00870391652824506,0.0127777332810394,5.3867159553453e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0185894284592273,0.00179949646525037,0.0150624153873366,0.022116441531118,5.76897781827079e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0248022808366002,0.00240720168526498,0.0200841655334809,0.0295203961397196,7.65737185259878e-25
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0253726203197572,0.00246555336819852,0.0205401357180881,0.0302051049214263,8.53751197639147e-25
NMR metabolomics,X23424.Total Lipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0261603735213203,0.00254887681456047,0.0211645749647818,0.0311561720778588,1.15316224452804e-24
NMR metabolomics,X23424.Total Lipids in VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0430966490147536,0.00419969837842347,0.0348652401930436,0.0513280578364636,1.17595646997931e-24
NMR metabolomics,X23424.Total Lipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0316382807958092,0.00308841733015587,0.0255849828287037,0.0376915787629147,1.41168171971726e-24
NMR metabolomics,X23424.Total Lipids in VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.0580938259247745,0.00569049240383211,0.0469404608132635,0.0692471910362854,1.98671155725438e-24
NMR metabolomics,X23424.Total Lipids in VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0589958336777879,0.00578243486008943,0.0476622613520126,0.0703294060035631,2.16135974302535e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CA2,Carbonic anhydrase 2,29368,0.0479416606277117,0.00470621978223722,0.0387174698545267,0.0571658514008966,2.49130417033629e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0455942457246283,0.00447909132269614,0.0368152267321439,0.0543732647171127,2.69072976018445e-24
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0377220038144118,0.00370932484109171,0.030451727125872,0.0449922805029515,2.98037916094443e-24
NMR metabolomics,X23424.Total Lipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0587237887222224,0.00577562078450542,0.0474035719845918,0.070044005459853,3.04270765887058e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0302184181847038,0.00297258936278297,0.0243921430336492,0.0360446933357584,3.09395098841346e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TGFA,Protransforming growth factor alpha,29434,0.0325490125479307,0.00320352078919559,0.0262701118011073,0.0388279132947541,3.26626551944534e-24
NMR metabolomics,X23424.Total Lipids in VLDL,SNX2,Sorting nexin-2,24793,0.0567071582338565,0.00558941683491314,0.0457519012374267,0.0676624152302862,3.87017702857542e-24
NMR metabolomics,X23424.Total Lipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.0283092490510882,0.0027921405701835,0.0228366535335285,0.0337818445686478,4.06805900947387e-24
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL2,Fc receptor-like protein 2,29645,0.0342044698004619,0.00337949458510595,0.0275806604136542,0.0408282791872695,4.86955918301156e-24
NMR metabolomics,X23424.Total Lipids in VLDL,COPB2,Coatomer subunit beta',24111,0.0299607403591299,0.00296029891409797,0.0241585544874979,0.035762926230762,4.98770968360435e-24
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN2,Nectin-2,29433,0.0206292583966498,0.00204245754200983,0.0166260416143105,0.0246324751789891,6.03101355688691e-24
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0462593388626371,0.00458360612536137,0.0372754708569288,0.0552432068683454,6.53194361842893e-24
NMR metabolomics,X23424.Total Lipids in VLDL,GAS2,Growth arrest-specific protein 2,24445,0.036648007965968,0.00363307397147269,0.0295271829818815,0.0437688329500545,7.00069204553844e-24
NMR metabolomics,X23424.Total Lipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0406940142849673,0.00404300055347871,0.032769733200149,0.0486182953697855,8.61127774879573e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0215556510008384,0.00214258790753181,-0.0257551232996007,-0.017356178702076,9.12298738805291e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CAT,Catalase,24587,0.0370007841432093,0.00367829489029544,0.0297913261582303,0.0442102421281884,9.30051055166972e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0310626454614194,0.003095945085363,-0.0371306978287309,-0.024994593094108,1.18707744145569e-23
NMR metabolomics,X23424.Total Lipids in VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.0193567266749912,0.00192989472058565,0.0155741330226434,0.0231393203273391,1.24944457804307e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ASPN,Asporin,24922,0.0189647608231377,0.00189333845498189,0.0152538174513732,0.0226757041949023,1.42847121418079e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LF,CMRF35-like molecule 1,29725,0.041378269710671,0.00413613176959142,0.0332714514422718,0.0494850879790702,1.59311372133457e-23
NMR metabolomics,X23424.Total Lipids in VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0279654249794728,0.00279951437263781,0.0224783768091027,0.0334524731498429,1.8833096376974e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CD300A,CMRF35-like molecule 8,24381,0.0205930647868391,0.00206163686003614,0.0165522565411683,0.02463387303251,1.8951358920331e-23
NMR metabolomics,X23424.Total Lipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0704164213208711,0.00705999723293252,0.0565788267443233,0.0842540158974188,2.19251073362671e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CRH,Corticoliberin,28751,0.0593776026110407,0.00595715370873196,0.047701581341926,0.0710536238801553,2.30925572396103e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CAPG,Macrophage-capping protein,29174,0.0398578025681698,0.00399890859465255,0.0320199417226508,0.0476956634136888,2.31270598039922e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR2,Complement factor H-related protein 2,24789,0.0390551074398636,0.00392220980830587,0.0313675762155841,0.0467426386641432,2.58901826126181e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0266336340057855,0.00267698859275097,0.0213867363639936,0.0318805316475774,2.7694151744414e-23
NMR metabolomics,X23424.Total Lipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0263543428018923,0.00265465798985096,0.0211512131417845,0.0315574724620002,3.49736331354539e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MDM1,Nuclear protein MDM1,24195,0.0213403303623415,0.00215321599197042,0.0171200270180795,0.0255606337066036,4.13102286430852e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0343478713627577,0.00346919450802997,0.027548250127019,0.0411474925984965,4.49487784148051e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0291074279597562,0.00294211936780115,0.0233408739988659,0.0348739819206465,4.8309522465838e-23
NMR metabolomics,X23424.Total Lipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0284449993647521,0.00287587660027187,0.0228082812282192,0.034081717501285,5.02715124858575e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PRTG,Protogenin,29725,0.0168854001798801,0.00170902643209838,0.0135357083729673,0.020235091986793,5.50864307334326e-23
NMR metabolomics,X23424.Total Lipids in VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0663353630937294,0.00671611819026215,0.0531717714408156,0.0794989547466433,5.77291776211283e-23
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0536766796734083,0.00544134867394571,0.0430116362724747,0.0643417230743419,6.44530618931333e-23
NMR metabolomics,X23424.Total Lipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.0119167936217144,0.00120839322064976,0.00954834290924085,0.0142852443341879,6.62118919900694e-23
NMR metabolomics,X23424.Total Lipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0286233097594036,0.00290775877458552,0.022924102561216,0.0343225169575912,7.92579527226738e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1A,Protein phosphatase 1A,28797,0.0209815109949403,0.00213613909879553,0.0167946783613011,0.0251683436285795,9.81367371426162e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0200614616025723,0.00205447440651134,0.0160346917658101,0.0240882314393346,1.72424699248949e-22
NMR metabolomics,X23424.Total Lipids in VLDL,C8B,Complement component C8 beta chain,24966,0.0203949506875152,0.0020909081864492,0.0162967706420748,0.0244931307329556,1.94286166207798e-22
NMR metabolomics,X23424.Total Lipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0371741087952603,0.00381962968191451,0.0296876346187078,0.0446605829718127,2.40561683891782e-22
NMR metabolomics,X23424.Total Lipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0291910438739467,0.00300179127090335,0.0233075329829761,0.0350745547649172,2.60333358294665e-22
NMR metabolomics,X23424.Total Lipids in VLDL,BRK1,Protein BRICK1,28774,0.0298413068561699,0.0030697750190134,0.0238245478189036,0.0358580658934361,2.65532203605083e-22
NMR metabolomics,X23424.Total Lipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0387039411644932,0.0039850817760794,0.0308931808833776,0.0465147014456088,2.88880297345313e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0359739559162697,0.00371356623189757,0.0286953661017504,0.0432525457307889,3.69033120898338e-22
NMR metabolomics,X23424.Total Lipids in VLDL,RCOR1,REST corepressor 1,28916,0.0296631043365189,0.00306346564023906,0.0236587116816503,0.0356674969913874,3.85333267436007e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0170049265424601,0.00175605147734205,-0.0204467874380505,-0.0135630656468697,3.88043965978362e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0281624820128551,0.00291901556128755,0.0224412115127315,0.0338837525129787,5.4056384445122e-22
NMR metabolomics,X23424.Total Lipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0339910596580112,0.00352391000055131,0.0270841960569306,0.0408979232590918,5.60698736696288e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ENSA,Alpha-endosulfine,24793,0.0349347819463092,0.0036302747671052,0.027819443402783,0.0420501204898354,6.97105437503791e-22
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.013822153497577,0.00143823536654227,0.0110032121791541,0.0166410948159998,7.77554496570632e-22
NMR metabolomics,X23424.Total Lipids in VLDL,APOB,Apolipoprotein B-100,24951,0.0148578913978746,0.00154741860376868,0.011824950934488,0.0178908318612612,8.57476982118808e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CABP2,Calcium-binding protein 2,24195,0.0431221702051068,0.0044911935731616,0.0343194308017101,0.0519249096085036,8.61739363796166e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1,Integrin beta-1,29474,0.0142593173412075,0.00148958400295043,0.0113397326954247,0.0171789019869904,1.12015504942629e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH1,Protocadherin-1,29713,0.0139244336797002,0.00145593925464756,0.011070792740591,0.0167780746188094,1.21863225758505e-21
NMR metabolomics,X23424.Total Lipids in VLDL,THBS4,Thrombospondin-4,29518,0.0295708116542797,0.00310062806500807,0.0234935806468639,0.0356480426616956,1.57859101106459e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0292642117498815,0.00306952478190031,0.0232479431773569,0.0352804803224062,1.65414706248343e-21
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2,Brorin,29114,0.0260859399738388,0.0027366798427022,0.0207220474821425,0.0314498324655351,1.65907519769778e-21
NMR metabolomics,X23424.Total Lipids in VLDL,DSC2,Desmocollin-2,29135,-0.0224342897531431,0.00235785733374509,-0.0270556901272834,-0.0178128893790027,1.95807622976674e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0279477084508151,0.00293716831141875,0.0221908585604344,0.0337045583411958,1.97721144163794e-21
NMR metabolomics,X23424.Total Lipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0455885332127849,0.00480235560162903,0.036175916233592,0.0550011501919778,2.44614190822252e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0304947498159707,0.00322180327314031,0.0241800154006157,0.0368094842313257,3.14900951228055e-21
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0351553146291109,0.00371530961079648,0.0278733077919498,0.042437321466272,3.23361543893283e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0318567477266968,0.00336930291318719,0.0252529140168499,0.0384605814365437,3.5070368204787e-21
NMR metabolomics,X23424.Total Lipids in VLDL,NFIC,Nuclear factor 1 C-type,24867,0.028928731636415,0.00306001749204583,0.0229310973520051,0.0349263659208248,3.54718893256956e-21
NMR metabolomics,X23424.Total Lipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0379666587861259,0.0040250443319671,0.0300775718954704,0.0458557456767814,4.34873874196013e-21
NMR metabolomics,X23424.Total Lipids in VLDL,EBI3_IL27,Interleukin-27,29674,-0.0200042460300964,0.00212122463988331,-0.0241618463242677,-0.0158466457359251,4.36794936137025e-21
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0218815109721651,0.00232022783645667,0.0173338644127101,0.0264291575316202,4.41470136407433e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.0233854839710643,0.00248102447093598,0.0185226760080298,0.0282482919340988,4.57692191076636e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0218509710807023,0.00232292667032004,0.0172980348068751,0.0264039073545296,5.48076256393121e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0253181791569439,0.00270715683418054,0.02001215176195,0.0306242065519377,9.27560542527121e-21
NMR metabolomics,X23424.Total Lipids in VLDL,LTB,Lymphotoxin-beta,24793,0.0223967812770831,0.00240124474696822,0.0176903415730254,0.0271032209811408,1.17564117823036e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0209993140414931,0.00225173469494916,0.0165859140393927,0.0254127140435934,1.18963388275597e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0348399554562974,0.00374670657699787,0.0274964105653816,0.0421835003472133,1.53668211324762e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0462481385689375,0.00497686620573161,0.0364934808057035,0.0560027963321714,1.62724966412051e-20
NMR metabolomics,X23424.Total Lipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0493432203015405,0.00531257055743367,0.0389305820089705,0.0597558585941105,1.70013996370852e-20
NMR metabolomics,X23424.Total Lipids in VLDL,APOF,Apolipoprotein F,24951,-0.0159526098813363,0.00171887562741683,-0.0193216061110733,-0.0125836136515993,1.81410679443927e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0179267454011378,0.001935117635366,0.0141339148358204,0.0217195759664551,2.12989341632174e-20
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.0158409216611249,0.00171114860565583,-0.0191947729282103,-0.0124870703940395,2.2290846802023e-20
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0253063253685911,0.0027334254517361,0.0199488114831883,0.0306638392539939,2.24847756297433e-20
NMR metabolomics,X23424.Total Lipids in VLDL,LCP1,Plastin-2,24938,0.030166901429841,0.00326261559613941,0.0237721748614078,0.0365616279982743,2.50619336166553e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PRL,Prolactin,29694,-0.0479278438017975,0.0051977535580289,-0.0581154407755341,-0.0377402468280608,3.13592314969971e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CDH5,Cadherin-5,29820,-0.0190221895297464,0.00208289266103122,-0.0231046591453676,-0.0149397199141253,7.09936383523065e-20
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE3,Eosinophil cationic protein,29343,0.0678952849865513,0.00744766702215778,0.0532978576231221,0.0824927123499805,8.2541526047183e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ICOSLG,ICOS ligand,29349,0.0119317319552294,0.00131034336910206,0.00936345895178934,0.0145000049586694,9.09129922544704e-20
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM3,Myomesin-3,24381,-0.0584601087403513,0.00642335796023095,-0.0710498903424039,-0.0458703271382986,9.6022837718424e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CTSH,Pro-cathepsin H,28852,0.0457625063554013,0.00502934762825673,0.0359049850040181,0.0556200277067845,9.6792454208765e-20
NMR metabolomics,X23424.Total Lipids in VLDL,S100A11,Protein S100-A11,29208,0.028367977347928,0.00312090332269169,0.0222510068354523,0.0344849478604037,1.05458081253352e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SBSN,Suprabasin,24905,-0.0214834080586653,0.00237149874562026,-0.026131545600081,-0.0168352705172495,1.41074587679525e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.0104844332264003,0.00115895960260922,0.00821287240528626,0.0127559940475144,1.58222705287483e-19
NMR metabolomics,X23424.Total Lipids in VLDL,JAM2,Junctional adhesion molecule B,29694,0.0165343560718126,0.00183195924341387,0.0129437159547214,0.0201249961889038,1.89390512657924e-19
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0199219994367658,0.00221028519647444,0.0155898404516759,0.0242541584218556,2.1159986919086e-19
NMR metabolomics,X23424.Total Lipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0312722576608576,0.0034793737986101,0.0244526850155818,0.0380918303061334,2.66704167339102e-19
NMR metabolomics,X23424.Total Lipids in VLDL,AGT,Angiotensinogen,24951,0.0142379616977195,0.00158828884574212,0.0111249155600649,0.017351007835374,3.3350707428113e-19
NMR metabolomics,X23424.Total Lipids in VLDL,BAX,Apoptosis regulator BAX,28722,0.0554116876848851,0.00619541658636918,0.0432686711756015,0.0675547041941687,3.97419217201307e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LUZP2,Leucine zipper protein 2,24793,0.027414173870746,0.00307950541837005,0.0213783432507407,0.0334500044907513,5.84507690712589e-19
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0231034937749641,0.00259565052622312,0.0180160187435668,0.0281909688063614,5.85853477749585e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CD93,Complement component C1q receptor,28353,-0.0192199290009005,0.00215958127570484,-0.023452708301282,-0.014987149700519,5.91855375241402e-19
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH1,Neurexophilin-1,28774,0.0233049679549157,0.00262181825748878,0.0181662041702377,0.0284437317395937,6.52661833590766e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.0182859387228449,0.00205943850614866,0.0142494392507935,0.0223224381948963,7.18741083265794e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0181305270794066,0.00204223819708168,0.0141277402131265,0.0221333139456867,7.20272630584952e-19
NMR metabolomics,X23424.Total Lipids in VLDL,IL1B,Interleukin-1 beta,28745,0.0342694462897167,0.00386377531932835,0.0266964466638331,0.0418424459156003,7.76936203792844e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0278933376400615,0.00314664230260236,0.0217259187269609,0.0340607565531622,8.20705788413939e-19
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0182230390375173,0.00205987435732837,0.0141856852971536,0.0222603927778809,9.51064750743706e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0246763107581632,0.00280319099979522,0.0191820563985646,0.0301705651177618,1.40593446861377e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0234195302101918,0.00266156382729261,0.0182028651086983,0.0286361953116853,1.45133020494005e-18
NMR metabolomics,X23424.Total Lipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0207392109510796,0.00235878808345452,0.0161159863075088,0.0253624355946505,1.54350404008167e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1,Programmed cell death protein 1,29661,0.0257810662344476,0.00294277736127942,0.0200132226063399,0.0315489098625552,2.03998490139896e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0233414316873821,0.00267002600990138,0.0181081807079754,0.0285746826667889,2.4100145778054e-18
NMR metabolomics,X23424.Total Lipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0185596468819953,0.00212310565436742,0.0143983597994352,0.0227209339645555,2.44147444750875e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IDS,Iduronate 2-sulfatase,29786,0.00532791288455274,0.000609781877024759,0.00413274040558421,0.00652308536352126,2.50781969905929e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ECM1,Extracellular matrix protein 1,24349,0.0220542812290013,0.00253044095675756,0.0170946169537564,0.0270139455042461,3.07355802545882e-18
NMR metabolomics,X23424.Total Lipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.020845994986641,0.00239977484750751,0.0161424362855263,0.0255495536877557,3.92017760083502e-18
NMR metabolomics,X23424.Total Lipids in VLDL,MMP12,Macrophage metalloelastase,29466,0.0314952674916473,0.00364183445031622,0.0243572719690276,0.0386332630142671,5.49329086471133e-18
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0231432269842418,0.00267676211384939,0.017896773241097,0.0283896807273866,5.60145038407642e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0181689032810409,0.0021072520217616,-0.0222991172436937,-0.0140386893183882,6.97410677786217e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0261871013399924,0.00303972294665822,-0.0321449583154426,-0.0202292443645423,7.41833340452084e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH3,Neurexophilin-3,24229,0.0179331422859669,0.00208352306726765,0.0138494370741223,0.0220168474978115,7.93948288168451e-18
NMR metabolomics,X23424.Total Lipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0216324824148193,0.00251342417116569,0.0167061710393346,0.026558793790304,7.96572967271897e-18
NMR metabolomics,X23424.Total Lipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0454427901821113,0.00529694919398805,0.0350607697618947,0.0558248106023279,1.01311845066904e-17
NMR metabolomics,X23424.Total Lipids in VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.0214462753807138,0.00250018773197236,0.016545907426048,0.0263466433353796,1.02376786313709e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0218811893198325,0.00255225456481454,0.016878770372796,0.026883608266869,1.06346779447137e-17
NMR metabolomics,X23424.Total Lipids in VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.01588997058181,0.00185962457535314,0.0122451064141179,0.0195348347495022,1.36137260835852e-17
NMR metabolomics,X23424.Total Lipids in VLDL,GNLY,Granulysin,29443,0.030553537047601,0.00358037002131953,0.0235360118058147,0.0375710622893872,1.4853837236278e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0181067173624533,0.00212167900343104,0.0139482265157285,0.0222652082091782,1.49349466664088e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CD59,CD59 glycoprotein,28277,0.0134612342598814,0.00158180053546984,0.0103609052103606,0.0165615633094023,1.82299123361597e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0225074008822342,0.00264455232547411,0.017324078324305,0.0276907234401635,1.82566783081871e-17
NMR metabolomics,X23424.Total Lipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0251981443414062,0.00296207779711271,0.0193924718590653,0.0310038168237471,1.87113693555172e-17
NMR metabolomics,X23424.Total Lipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.140058902919056,0.0164689453662439,0.107779770001218,0.172338035836894,1.92626076780311e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PRELP,Prolargin,29454,0.0135574647693923,0.00159559087407813,0.0104301066561992,0.0166848228825855,2.03888962195559e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAV,Integrin alpha-V,29725,0.0096651824466484,0.00113886247244729,0.00743301200065172,0.0118973528926451,2.22326969320083e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF7,SLAM family member 7,29434,-0.0339574277781232,0.00402080275816701,-0.0418382011841305,-0.0260766543721158,3.16656612435798e-17
NMR metabolomics,X23424.Total Lipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0404797019668791,0.00479416286604402,0.0310831427494328,0.0498762611843253,3.21929534224305e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DKK3,Dickkopf-related protein 3,29820,-0.0170024841159793,0.00201928726909708,-0.0209602871634096,-0.0130446810685491,3.92991776017678e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.0185010847434795,0.00219839135452323,0.014192237688614,0.0228099317983451,4.11728191365869e-17
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB2,Lamin-B2,24845,0.0161730456314816,0.00192564514609526,0.0123987811451348,0.0199473101178283,4.74992459470178e-17
NMR metabolomics,X23424.Total Lipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0144070773345509,0.00171693152406904,-0.0177722631217262,-0.0110418915473756,5.07242412818419e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS53,Serine protease 53,24845,0.0215042686412922,0.00256988306892347,0.0164672978262022,0.0265412394563822,6.17547573602221e-17
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0308706955433519,0.00369233616475838,0.0236337166604255,0.0381076744262783,6.55547487827436e-17
NMR metabolomics,X23424.Total Lipids in VLDL,DGCR6,Protein DGCR6,24101,0.0251605153555162,0.00301323226305125,0.0192545801199357,0.0310664505910966,7.18864871823373e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0211813853654527,0.00254005482179387,0.0162028779147367,0.0261598928161686,7.88941748919431e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CENPF,Centromere protein F,24445,0.0311144623914941,0.00373177702220227,0.0238001794279777,0.0384287453550106,7.96900304154721e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0175966940616811,0.00211523744919922,-0.0217425594621115,-0.0134508286612506,9.25521633558656e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0567580585227144,0.0068469699363368,0.0433379974474943,0.0701781195979345,1.19578550959187e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DSG4,Desmoglein-4,29242,0.0281594049790997,0.00340184386018696,0.0214917910131333,0.0348270189450662,1.30878916412957e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0255854261588804,0.00309492309231549,0.0195193768979421,0.0316514754198188,1.44303298555669e-16
NMR metabolomics,X23424.Total Lipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0233398791639963,0.00282570134686187,0.017801504524147,0.0288782538038455,1.5204286137769e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PZP,Pregnancy zone protein,24966,0.0302763085709846,0.00367012594720849,0.023082861714456,0.0374697554275133,1.66974882859858e-16
NMR metabolomics,X23424.Total Lipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0378570148635463,0.00459800520948084,0.0288449246529639,0.0468691050741288,1.91215175027995e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.020452838510392,0.00248517035048787,0.0155819046234358,0.0253237723973482,1.95035758048435e-16
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0199030670707262,0.00241852853896955,0.0151627511343459,0.0246433830071065,1.97296029414951e-16
NMR metabolomics,X23424.Total Lipids in VLDL,APOA1,Apolipoprotein A-I,24966,-0.0155542917246878,0.00189033999253919,-0.0192593581100646,-0.011849225339311,1.9905855171167e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CA7,Carbonic anhydrase 7,24445,-0.0194277035648538,0.00236640955598332,-0.0240658662945811,-0.0147895408351265,2.32435038054742e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX1,Neuronal pentraxin-1,29443,0.0228886953506217,0.0027903623930761,0.0174195850601925,0.0283578056410508,2.44387764107072e-16
NMR metabolomics,X23424.Total Lipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.0161269655716135,0.00196723314151733,0.0122711886142395,0.0199827425289875,2.5494315642217e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0651990921526843,0.00799848984041351,0.0495220520654738,0.0808761322398948,3.73978143227142e-16
NMR metabolomics,X23424.Total Lipids in VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.0188034559011217,0.00230877242762056,0.0142782619429854,0.023328649859258,3.96379337142334e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0496714459796305,0.00610979758181889,0.0376962427192655,0.0616466492399955,4.46666947683463e-16
NMR metabolomics,X23424.Total Lipids in VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0276293537020628,0.0034091296324822,0.0209474596223977,0.0343112477817279,5.49857352478632e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.0149851121730356,0.00184922978671663,-0.0186096025550002,-0.011360621791071,5.5480836041266e-16
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0189811242173905,0.00234287690115925,0.0143890854911184,0.0235731629436627,5.67062961128006e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CA9,Carbonic anhydrase 9,29725,-0.0253005394406639,0.00313783330031869,-0.0314506927092886,-0.0191503861720393,7.71813966040086e-16
NMR metabolomics,X23424.Total Lipids in VLDL,DSG3,Desmoglein-3,29589,0.0188943574361182,0.00234659720268402,0.0142950269188575,0.0234936879533789,8.4615838346269e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CX3CL1,Fractalkine,29218,-0.0186294969836813,0.0023189578157128,-0.0231746543024784,-0.0140843396648843,9.8220204035731e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CHGA,Chromogranin-A,24938,-0.0485115322818517,0.00604251392733676,-0.0603548595794318,-0.0366682049842717,1.0310473453827e-15
NMR metabolomics,X23424.Total Lipids in VLDL,RALY,RNA-binding protein Raly,24793,0.0265408002060567,0.0033097878559329,0.0200536160084282,0.0330279844036852,1.113925148834e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD300C,CMRF35-like molecule 6,29694,0.0190060127999828,0.00237223430965165,0.0143564335530656,0.0236555920469,1.17094886659564e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0186294720806022,0.00232559170491115,0.0140713123389764,0.0231876318222281,1.18294704119524e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.021141465511276,0.0026435225530871,0.0159601613072252,0.0263227697153267,1.32522318468237e-15
NMR metabolomics,X23424.Total Lipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0463037060589931,0.00579383048142616,0.0349477983153978,0.0576596138025884,1.3771021923293e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CA1,Carbonic anhydrase 1,28867,0.0326226531394792,0.00409704486454383,0.0245924452049733,0.0406528610739851,1.74777603264624e-15
NMR metabolomics,X23424.Total Lipids in VLDL,LYZL2,Lysozyme-like protein 2,24016,0.0197591031418001,0.00248227674529335,0.0148938407210251,0.024624365562575,1.7950251481117e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CFC1,Cryptic protein,28797,0.0256822063973012,0.00322931867850546,0.0193527417874305,0.0320116710071719,1.88947454632991e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0245327283026866,0.00308592408308455,0.0184843170998409,0.0305811395055323,1.93323109422805e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0238133021246223,0.00299668935253478,-0.0296868132555905,-0.0179397909936541,1.98572700649755e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0216815149399703,0.00273063436046439,0.0163294715934601,0.0270335582864805,2.10528002055435e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.010104145849738,0.00127429511432926,0.00760652742565266,0.0126017642738234,2.29737126775959e-15
NMR metabolomics,X23424.Total Lipids in VLDL,PSPN,Persephin,29434,0.0510978649184936,0.00644937234015379,0.0384570951317922,0.063738634705195,2.4013799669902e-15
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0154535283413551,0.00195417413011517,-0.0192837096363808,-0.0116233470463294,2.70743270367512e-15
NMR metabolomics,X23424.Total Lipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0221634879039089,0.00280355727783454,-0.0276584601684646,-0.0166685156393532,2.7619824185623e-15
NMR metabolomics,X23424.Total Lipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0136171874472652,0.0017289853652809,0.0102283761313146,0.0170059987632158,3.50091722645049e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.0124271764531263,0.00157960903386044,-0.0155232101594928,-0.00933114274675988,3.74914839845056e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0188485198901328,0.00240042711058038,0.0141436827533952,0.0235533570268703,4.22637027323951e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0125546995886742,0.00159954655489522,0.00941958834107954,0.0156898108362688,4.33722661721446e-15
NMR metabolomics,X23424.Total Lipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0210250640365005,0.00268490790660903,-0.0262874835334542,-0.0157626445395468,5.00882073113015e-15
NMR metabolomics,X23424.Total Lipids in VLDL,GAST,Gastrin,24845,0.0701000532281233,0.00895886999006967,0.0525406680475868,0.0876594384086599,5.29250126112081e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0322324493639951,0.00412848496947441,0.0241406188238253,0.040324279904165,6.03549938252014e-15
NMR metabolomics,X23424.Total Lipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0141504226232729,0.00181437982498157,0.010594238166309,0.0177066070802368,6.44245383540737e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0194932959913972,0.00250089922170203,0.0145915335168612,0.0243950584659331,6.68195696132196e-15
NMR metabolomics,X23424.Total Lipids in VLDL,MTPN,Myotrophin,28916,0.0174933282632194,0.00225063687600891,0.0130820799862419,0.0219045765401968,7.94284451573612e-15
NMR metabolomics,X23424.Total Lipids in VLDL,MPO,Myeloperoxidase,29443,0.0244313334136769,0.00314964748870714,0.0182580243358109,0.0306046424915429,8.9873502292952e-15
NMR metabolomics,X23424.Total Lipids in VLDL,GZMB,Granzyme B,29434,0.034662262580466,0.00447586062753947,0.0258895757504886,0.0434349494104434,9.92141204582596e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.011820839912,0.00152827707824477,0.00882541683864021,0.0148162629853597,1.06911090991793e-14
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0333709592745349,0.00433122903015851,0.0248817503754242,0.0418601681736456,1.36006988479244e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0206310859734817,0.00268321903531681,0.0153719766642607,0.0258901952827026,1.540063367691e-14
NMR metabolomics,X23424.Total Lipids in VLDL,FGF16,Fibroblast growth factor 16,24229,0.0252894296093229,0.00329870896910187,0.0188239600298832,0.0317548991887625,1.83433826088931e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0158851699755268,0.00207372608821586,0.0118206668426237,0.0199496731084298,1.91460301930876e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PRUNE2,Protein prune homolog 2,24445,0.0153621443262784,0.00201204249262214,0.011418541040739,0.0193057476118178,2.33894607551962e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CR2,Complement receptor type 2,29594,0.0243864458245179,0.00319505777338197,0.0181241325886892,0.0306487590603465,2.37070274016328e-14
NMR metabolomics,X23424.Total Lipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.0276087687033811,0.00362787133203178,0.0204981408925988,0.0347193965141634,2.8206713290696e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0301056843923208,0.00396598860769778,0.0223323467212332,0.0378790220634085,3.27139956219246e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.0334203826940962,0.00441750897124073,0.0247620651104643,0.042078700277728,4.00091013977397e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.01504897785022,0.00198965859236253,0.0111492470091894,0.0189487086912506,4.03420481062771e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.0133880053016174,0.00177020476343614,0.00991840396528256,0.0168576066379522,4.05393568694281e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.0308566198998911,0.00408102867112624,0.0228578037044836,0.0388554360952985,4.1387262334716e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CYTL1,Cytokine-like protein 1,24938,0.0125144989420536,0.00166186099239569,0.00925725139695809,0.0157717464871492,5.22946835813953e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CD300E,CMRF35-like molecule 2,29642,0.0210279013966013,0.00279495991042534,0.0155497799721676,0.0265060228210349,5.48373328382629e-14
NMR metabolomics,X23424.Total Lipids in VLDL,LPA,Apolipoprotein(a),24484,-0.0923109909906231,0.0122916889772448,-0.116402701386023,-0.0682192805952233,6.1131825191905e-14
NMR metabolomics,X23424.Total Lipids in VLDL,IL34,Interleukin-34,28722,0.0185682976982924,0.00248134243017157,0.0137048665351562,0.0234317288614287,7.46310511812675e-14
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0248785377238161,0.00332803877100609,0.0183555817326441,0.031401493714988,7.9570097199806e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GBP4,Guanylate-binding protein 4,28774,0.0251791719622131,0.00337144453799886,0.0185711406677353,0.0317872032566908,8.35016433942319e-14
NMR metabolomics,X23424.Total Lipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.020967882772796,0.00281011201539925,0.0154600632226135,0.0264757023229785,8.82993237525833e-14
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0175783062998401,0.00235942551871136,0.0129538322831658,0.0222027803165144,9.57305558576194e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.019356917431669,0.00260342845661659,-0.0244596372066376,-0.0142541976567005,1.0781263691237e-13
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0172549460231811,0.00232337652644684,0.0127011280313453,0.0218087640150169,1.15045007311751e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CCN5,CCN family member 5,29443,0.0197948611631807,0.00266972304984001,0.0145622039854943,0.0250275183408671,1.25300914389205e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MILR1,Allergin-1,28931,-0.025674597526685,0.00346480546191386,-0.0324656162320361,-0.0188835788213338,1.29642860924437e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CA6,Carbonic anhydrase 6,29372,-0.0320443186060571,0.00433590501412894,-0.0405426924337499,-0.0235459447783644,1.50223804483978e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GPC1,Glypican-1,29725,0.0149226575008948,0.00202105266876454,0.0109613942701163,0.0188839207316733,1.58098696720134e-13
NMR metabolomics,X23424.Total Lipids in VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.0179066113237815,0.00242588975794686,0.0131518673982056,0.0226613552493573,1.61475693707034e-13
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0431347328165286,0.00584735290017498,0.0316739211321856,0.0545955445008716,1.66522013553005e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM2,Myomesin-2,24111,-0.0258858936968309,0.00351527469354446,-0.032775832096178,-0.0189959552974837,1.84436766645813e-13
NMR metabolomics,X23424.Total Lipids in VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.0155053789337159,0.00211295198293716,-0.0196467648202727,-0.0113639930471591,2.23149098496507e-13
NMR metabolomics,X23424.Total Lipids in VLDL,RAB37,Ras-related protein Rab-37,28931,0.041253020712993,0.00564715647495444,0.0301845940220823,0.0523214474039037,2.84225965801224e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0136274513312056,0.00186556891310986,-0.0172839664009009,-0.00997093626151027,2.86262289444006e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CCN3,CCN family member 3,29795,0.0169632898642974,0.00232293955454308,0.0124103283373929,0.0215162513912018,2.89520072300879e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0263669426226878,0.00361134342205997,-0.0334451757299254,-0.0192887095154503,2.92556331986277e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0268560292732791,0.00368326187707865,0.0196368359942049,0.0340752225523532,3.14740957113362e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0179087617633293,0.00246879229735395,0.0130699288605156,0.0227475946661431,4.16688735662276e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0199890039668933,0.00275681653007623,0.0145856435679438,0.0253923643658427,4.26525236675983e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0287510112591792,0.00396640464634143,0.02097685815235,0.0365251643660084,4.31593844890309e-13
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0133764231249358,0.00184785671258192,0.0097546239682752,0.0169982222815963,4.63407102706038e-13
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.0144188553145543,0.00199262861285631,0.010513303233356,0.0183244073957527,4.75526127408085e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NEO1,Neogenin,24867,0.0109137590263216,0.00150879421417304,0.00795652236654243,0.0138709956861007,4.84576921103599e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0186349862170121,0.00257990507732043,0.013578372265464,0.0236916001685601,5.2306638995636e-13
NMR metabolomics,X23424.Total Lipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0425791485829005,0.00589544671881449,0.0310240730140241,0.0541342241517769,5.26028772603622e-13
NMR metabolomics,X23424.Total Lipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0260017960471545,0.00361058976999487,0.0189250400979646,0.0330785519963445,6.09975246149744e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CLC,Galectin-10,29426,-0.0327000441323417,0.00455021691896653,-0.0416184692935162,-0.0237816189711673,6.80647504079503e-13
NMR metabolomics,X23424.Total Lipids in VLDL,EGFLAM,Pikachurin,24805,0.0151476848284891,0.00211991221418241,0.0109926568886916,0.0193027127682867,9.21948145251612e-13
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.0160639519275259,0.00224838322879972,0.0116571207990785,0.0204707830559734,9.23009076014356e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN2,Prefoldin subunit 2,28774,0.0272813016256066,0.00381886924094847,0.0197963179133476,0.0347662853378656,9.29321910192163e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ULBP2,UL16-binding protein 2,29218,0.0186848819275656,0.00262156109633362,0.0135466221787517,0.0238231416763795,1.04664133561108e-12
NMR metabolomics,X23424.Total Lipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0219725481399399,0.00308293253248585,0.0159300003762676,0.0280150959036121,1.04827528715781e-12
NMR metabolomics,X23424.Total Lipids in VLDL,S100A14,Protein S100-A14,24867,0.0258437357485144,0.00363833043343714,0.0187126080989776,0.0329748633980512,1.25197391892547e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0133927987242087,0.00188895561297227,0.00969044572278302,0.0170951517256343,1.37045270593374e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0159648062682417,0.0022534787303946,0.0115479879566683,0.0203816245798151,1.42690500245554e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GFAP,Glial fibrillary acidic protein,28753,0.022483904422395,0.0031748499877138,0.0162611984464759,0.028706610398314,1.45480496837299e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0299466189628182,0.00422947616013954,0.0216568456889448,0.0382363922366917,1.47639309297995e-12
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0134239690276051,0.00189762761103941,0.00970461890996786,0.0171433191452423,1.53883303787393e-12
NMR metabolomics,X23424.Total Lipids in VLDL,AGR2,Anterior gradient protein 2 homolog,28553,0.0489706546267057,0.00692315835379746,0.0354012642532627,0.0625400450001487,1.54602925290671e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CST1,Cystatin-SN,21656,0.0511296363466372,0.00724082483088857,0.0369376196780956,0.0653216530151788,1.69944380438745e-12
NMR metabolomics,X23424.Total Lipids in VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0208724905643128,0.00295885293795232,0.0150731388059262,0.0266718423226993,1.78201925871183e-12
NMR metabolomics,X23424.Total Lipids in VLDL,RNASET2,Ribonuclease T2,29697,0.0128139729699903,0.00182215854741509,0.00924254221705672,0.0163854037229239,2.07544767237429e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LXN,Latexin,29117,-0.0324213484925822,0.00461856675454102,-0.0414737393314826,-0.0233689576536818,2.27077695799426e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0132893400753813,0.00189433793858318,0.0095764377157583,0.0170022424350044,2.35332979614818e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN8,Tetraspanin-8,24805,0.0483249945617448,0.00689180838849891,0.034817050120287,0.0618329390032027,2.4105309366019e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0275755525748953,0.00394783930915082,-0.0353133176208309,-0.0198377875289598,2.90962321945528e-12
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.0223795180365885,0.00321459101355885,0.0160789196500132,0.0286801164231638,3.4286290275173e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.012926123951174,0.00186063920899753,0.00927927110153886,0.0165729768008092,3.80502464305126e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.0316165525737698,0.00455933090894315,0.0226802639922412,0.0405528411552984,4.1611778567052e-12
NMR metabolomics,X23424.Total Lipids in VLDL,AZU1,Azurocidin,28534,0.0364318512930395,0.00525553319962242,0.0261310062217796,0.0467326963642994,4.23478042856303e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.024568199937291,0.00354467687154315,0.0176206332690664,0.0315157666055156,4.266416390757e-12
NMR metabolomics,X23424.Total Lipids in VLDL,AREG,Amphiregulin,29349,-0.0217254051398787,0.00313481241661654,-0.0278696374764471,-0.0155811728033103,4.28417633353984e-12
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.019506737339609,0.00281570458656962,-0.0250255183292854,-0.0139879563499325,4.3613056781889e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0156363680196055,0.002273680739966,-0.0200927822699389,-0.0111799537692722,6.25187566314606e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0170972292807863,0.00248885994259947,0.0122190637932914,0.0219753947682813,6.59862796177935e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA1,Annexin A1,24281,0.0202111227099843,0.00294510668408074,0.014438713609186,0.0259835318107826,6.92401379636169e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN2,Alpha-actinin-2,24111,-0.0279925861978609,0.0040824103237443,-0.0359941104323997,-0.0199910619633221,7.20823300773562e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAP,Cartilage-associated protein,24195,0.0229954198622933,0.00335727375542996,0.0164151633016505,0.029575676422936,7.59206898429134e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN8,Septin-8,24801,0.0151224335091105,0.00221368889381183,0.0107836032772393,0.0194612637409817,8.60787445427634e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0157589943530284,0.0023076580735301,0.0112359845289094,0.0202820041771474,8.71545076413799e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0136593442191199,0.00200188384616018,-0.0175830365575938,-0.00973565188064594,9.07152238880048e-12
NMR metabolomics,X23424.Total Lipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.017969144791745,0.00263488815994871,-0.0231335255852445,-0.0128047639982455,9.29772190148919e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN1,Nectin-1,24229,0.0151809383978376,0.00223009031893202,0.0108099613727308,0.0195519154229443,1.0175610003957e-11
NMR metabolomics,X23424.Total Lipids in VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.0132214499113782,0.00194418173309687,0.00941085371450833,0.0170320461082481,1.06230501491895e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2,Ataxin-2,24101,0.0518880135916595,0.00763680024693069,0.0369198851076754,0.0668561420756437,1.1124488245952e-11
NMR metabolomics,X23424.Total Lipids in VLDL,FABP9,Fatty acid-binding protein 9,29434,0.0260920537197009,0.00384508246735617,0.0185556920836828,0.033628415355719,1.17613094605365e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.023799875238974,0.00352057411745753,-0.0307002005091908,-0.0168995499687573,1.40339907381535e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0164855452235468,0.00244103909119719,-0.0212699818422933,-0.0117011086048003,1.47500455098538e-11
NMR metabolomics,X23424.Total Lipids in VLDL,BCAM,Basal cell adhesion molecule,29443,-0.0111320996430456,0.00165253958557741,-0.0143710772307773,-0.00789312205531386,1.6539407733551e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0480410236259743,0.00713195072542868,0.0340624002041341,0.0620196470478145,1.6642622282307e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CDH1,Cadherin-1,28477,0.0185185073586957,0.00275472266441455,0.0131192509364431,0.0239177637809482,1.8205796980282e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CLGN,Calmegin,24195,0.0206887342962062,0.00309364482192588,0.0146251904452314,0.0267522781471809,2.31972618528809e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LHB,Lutropin subunit beta,28797,0.0398195070851236,0.00597110640178696,0.0281161385376211,0.051522875632626,2.6274994071345e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.0106660368091311,0.00160041685182389,0.00752921977955633,0.013802853838706,2.70222132020117e-11
NMR metabolomics,X23424.Total Lipids in VLDL,HMBS,Porphobilinogen deaminase,29725,0.0196690985126319,0.00295662288602001,0.0138741176560327,0.0254640793692312,2.93044396490204e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB1A1,Uteroglobin,29523,0.0252359335182278,0.00379408421496732,0.0177995284568919,0.0326723385795638,2.95406648976156e-11
NMR metabolomics,X23424.Total Lipids in VLDL,NCAN,Neurocan core protein,29694,0.0170428796539192,0.0025650080585963,0.0120154638590705,0.022070295448768,3.09766153640214e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SATB1,DNA-binding protein SATB1,24867,0.0135757753558704,0.00204324645014776,0.00957101231358076,0.01758053839816,3.11131459785222e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GZMH,Granzyme H,28916,0.0348570913935542,0.00524847344332078,0.0245700834446455,0.0451440993424629,3.16273102286235e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0134239246586942,0.0020228004597724,0.00945923575754034,0.0173886135598481,3.28493679737528e-11
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0242230205595054,0.00366176844823385,0.0170459544009671,0.0314000867180438,3.77739538784796e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.0136822375641291,0.00207147605710545,0.00962214449220245,0.0177423306360558,4.05361762210167e-11
NMR metabolomics,X23424.Total Lipids in VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.0283796433337013,0.00430087758459633,-0.0368093633995102,-0.0199499232678925,4.22258297929842e-11
NMR metabolomics,X23424.Total Lipids in VLDL,FOSB,Protein fosB,28774,0.017531249244263,0.00266078449276509,0.0123161116384435,0.0227463868500826,4.511940772672e-11
NMR metabolomics,X23424.Total Lipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0118149340653142,0.00179340938510424,0.00829985167050989,0.0153300164601185,4.53428731474347e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.0129071495321686,0.00196077104504373,-0.0167502607804543,-0.00906403828388285,4.69772502530746e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0201581865905322,0.00306338961363843,0.0141539429478009,0.0261624302332636,4.77390802720561e-11
NMR metabolomics,X23424.Total Lipids in VLDL,IFNG,Interferon gamma,28931,0.0512952133825311,0.0078118206164435,0.0359840449743018,0.0666063817907603,5.24338919566653e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CLPS,Colipase,29400,0.0318234042542439,0.00486880171128982,0.0222805529001158,0.0413662556083719,6.41391759098439e-11
NMR metabolomics,X23424.Total Lipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.0141891521186137,0.00218048216544358,0.00991540707434424,0.0184628971628831,7.7716822538812e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0148644971571448,0.00228650162317949,0.010382953975713,0.0193460403385766,8.10903923911756e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0190092180691495,0.00292522223562586,0.0132757824873228,0.0247426536509762,8.25069612062469e-11
NMR metabolomics,X23424.Total Lipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0122834420532483,0.00189231181114556,0.00857451090340304,0.0159923732030936,8.64825556889072e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CLASP1,CLIP-associating protein 1,24016,0.0326472516291779,0.00503122292535942,0.0227860546954735,0.0425084485628824,8.81340815205196e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0106338392454074,0.00164340402554661,-0.0138549111354788,-0.00741276735533605,9.91293456199038e-11
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX1,Heme oxygenase 1,29165,-0.0213364583683945,0.00329792526053064,-0.0278003918790345,-0.0148725248577544,9.97793850203952e-11
NMR metabolomics,X23424.Total Lipids in VLDL,AMPD3,AMP deaminase 3,24845,0.0314889453921832,0.0048770830483767,0.0219298626173648,0.0410480281670015,1.09123172335131e-10
NMR metabolomics,X23424.Total Lipids in VLDL,MYL3,Myosin light chain 3,24240,-0.0323976345282487,0.00503637281545618,-0.0422689252465428,-0.0225263438099546,1.27670384246818e-10
NMR metabolomics,X23424.Total Lipids in VLDL,IL18BP,Interleukin-18-binding protein,29594,0.0135991403629235,0.00211843701455169,0.00944700381440217,0.0177512769114448,1.38864336508266e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SDK2,Protein sidekick-2,24381,0.0170929882741848,0.00266822748827851,0.0118632623971589,0.0223227141512107,1.51993676931267e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0115686556637499,0.00180705214346477,-0.0151104778649409,-0.00802683346255897,1.56242299423829e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0306632666521485,0.00479104515808015,0.0212728181423114,0.0400537151619856,1.58070890360413e-10
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE6,Ribonuclease K6,24828,0.0135282381003493,0.0021142308035658,0.00938434572536031,0.0176721304753383,1.59546287045957e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NRP2,Neuropilin-2,29443,-0.0125861981470724,0.00196718900099993,-0.0164418885890323,-0.00873050770511253,1.59724685902443e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0137213095392014,0.00215051831280277,0.00950629364610793,0.0179363254322948,1.79742396434206e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.0141638850748013,0.00222555210695843,0.00980180294516275,0.0185259672044398,1.99807812074828e-10
NMR metabolomics,X23424.Total Lipids in VLDL,KLK8,Kallikrein-8,28443,0.0157214239807927,0.00247240627437537,0.010875507683017,0.0205673402785684,2.06484166423047e-10
NMR metabolomics,X23424.Total Lipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0202475529145459,0.00319873214827761,0.0139780379039218,0.02651706792517,2.49563552536819e-10
NMR metabolomics,X23424.Total Lipids in VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0297445593896708,0.00469964567524112,0.0205332538661982,0.0389558649131434,2.50910077445307e-10
NMR metabolomics,X23424.Total Lipids in VLDL,MUC16,Mucin-16,29349,0.0818051328124747,0.0129735274231396,0.0563770190631212,0.107233246561828,2.91272409739017e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0227312615674625,0.00360848041483532,0.0156586399543853,0.0298038831805397,3.03820337325567e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.0123488251201732,0.00196080939504652,0.00850563870588203,0.0161920115344644,3.06101523764193e-10
NMR metabolomics,X23424.Total Lipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0152609332582829,0.00242461398666347,0.0105086898444225,0.0200131766721433,3.13481146721122e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0190707316771838,0.00303052507056653,0.0131309025388734,0.0250105608154942,3.16965504230514e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.0146900757484845,0.00233675393528605,0.0101100380353238,0.0192701134616451,3.29183675972214e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY2,Protein canopy homolog 2,28916,0.0262272464195644,0.00418310814106507,0.0180283544630769,0.034426138376052,3.66621655219911e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0116162952981603,0.00185491541416329,0.00798066108640027,0.0152519295099203,3.85204733043841e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0161528891946573,0.00258291033511147,0.0110903849378388,0.0212153934514758,4.06201269356058e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SNU13,NHP2-like protein 1,24111,0.0269461928498862,0.00431068377285002,0.0184972526551002,0.0353951330446723,4.14603058778759e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN2,Contactin-2,29725,0.0191449204104729,0.00306364518792048,0.0131401758421488,0.0251496649787971,4.1851458896122e-10
NMR metabolomics,X23424.Total Lipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.0352614846712179,0.00564396835441992,0.0241993066965549,0.0463236626458809,4.22365191781989e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0167164908829614,0.00269207189310412,0.0114400299724773,0.0219929517934455,5.38709443632633e-10
NMR metabolomics,X23424.Total Lipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0263861836888013,0.00425073834983472,-0.0347176308544774,-0.0180547365231253,5.45653926928698e-10
NMR metabolomics,X23424.Total Lipids in VLDL,EXTL1,Exostosin-like 1,24111,0.0203553630735201,0.00328047860870249,0.0139256250004632,0.026785101146577,5.55883098842503e-10
NMR metabolomics,X23424.Total Lipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0125279788988806,0.0020214723679104,0.00856589305777617,0.0164900647399849,5.81534838092657e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SPON1,Spondin-1,29497,0.0139570626753902,0.00225384550891756,0.00953952547791174,0.0183745998728686,5.99772879452557e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.0120472847044801,0.0019463942336778,0.00823235200647163,0.0158622174024886,6.11348376157681e-10
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0151989894100967,0.00245681974357611,-0.0200143561075059,-0.0103836227126875,6.23366204202289e-10
NMR metabolomics,X23424.Total Lipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0262065749270145,0.00424393379852377,0.0178884646819079,0.0345246851721211,6.7015467900287e-10
NMR metabolomics,X23424.Total Lipids in VLDL,RLN1,Prorelaxin H1,24867,-0.0292750273401494,0.00474125182271757,-0.0385678809126759,-0.019982173767623,6.73857182614629e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CD55,Complement decay-accelerating factor,28490,0.0111442492983411,0.00180496654896494,0.00760651486236981,0.0146819837343124,6.73911074955349e-10
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0205440251927723,0.00332785801399768,0.0140214234853369,0.0270666269002078,6.79222076971615e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CDH15,Cadherin-15,29639,0.02445471505109,0.00396830267124212,0.0166768418154554,0.0322325882867245,7.25215678466659e-10
NMR metabolomics,X23424.Total Lipids in VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.0405120249211169,0.00658923086106193,0.0275971324334355,0.0534269174087983,7.95826089675249e-10
NMR metabolomics,X23424.Total Lipids in VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0254833321418952,0.00414533849863948,-0.0336081955992286,-0.0173584686845618,7.97410953042182e-10
NMR metabolomics,X23424.Total Lipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0147025401081777,0.00239333450424789,-0.0193934757365036,-0.0100116044798518,8.19479342035988e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0146552374014655,0.00238652565345608,0.00997764712069161,0.0193328276822394,8.31299190418044e-10
NMR metabolomics,X23424.Total Lipids in VLDL,DLL4,Delta-like protein 4,24240,0.0362049048531684,0.00592023233405476,0.024601249478421,0.0478085602279157,9.77556958025949e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GM2A,Ganglioside GM2 activator,24421,0.0161389468212925,0.00264446758000374,0.0109557903644851,0.0213221032780998,1.05723391671256e-09
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0177307283833576,0.00290780214129687,0.0120314361864157,0.0234300205802995,1.09232966303647e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0162754239655538,0.0026697606410021,0.0110426931091897,0.0215081548219179,1.09965787833871e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.0121482003808855,0.00199304051537846,0.00824184097074371,0.0160545597910273,1.10605697439837e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PCDHB15,Protocadherin beta-15,24793,-0.0167750488194984,0.00275561395110948,-0.022176052163673,-0.0113740454753239,1.16306289284402e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.00340797105172028,0.00056049146534281,-0.00450653432379219,-0.00230940777964838,1.21709176965438e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MRC1,Macrophage mannose receptor 1,24951,0.0118437182172583,0.00194921159724407,0.00802326348665996,0.0156641729478567,1.24879193346105e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MUC2,Mucin-2,24938,0.038162921882228,0.00630098212477103,0.0258129969176768,0.0505128468467793,1.40963918018787e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PMS1,PMS1 protein homolog 1,24195,0.0211644257777907,0.00349645296324641,0.0143113779698277,0.0280174735857536,1.4416444811477e-09
NMR metabolomics,X23424.Total Lipids in VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0132482857284347,0.00219284646025876,0.0089503066663275,0.0175462647905418,1.54826682351489e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CCL21,C-C motif chemokine 21,29581,0.0167956455140498,0.00278593430932744,0.011335214267768,0.0222560767603316,1.6720932728812e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CHI3L1,Chitinase-3-like protein 1,28935,0.0325611890229974,0.00540341747481851,0.0219704907723531,0.0431518872736417,1.70059728088551e-09
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK2,Protein AHNAK2,24240,0.0123158359782918,0.00204928514297325,0.0082992370980642,0.0163324348585193,1.88382106327727e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SYT1,Synaptotagmin-1,24845,0.0163530435633147,0.00272116684997319,0.0110195565373673,0.0216865305892622,1.88607519871231e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB2A2,Mammaglobin-A,24111,-0.0130431626480732,0.002176689099796,-0.0173094732836733,-0.00877685201247298,2.09956797617898e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LIF,Leukemia inhibitory factor,28774,0.0211222334961988,0.00352977607193974,0.0142038723951969,0.0280405945972007,2.20276563432954e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAM,Integrin alpha-M,29443,-0.0129716655342697,0.00217205121849236,-0.0172288859225147,-0.00871444514602462,2.3693109415104e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.0120858823891521,0.00202809098048794,0.00811082406739572,0.0160609407109084,2.56291502474192e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.022119298317311,0.00371389531734621,0.0148400634953124,0.0293985331393096,2.6234322288882e-09
NMR metabolomics,X23424.Total Lipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0122564672841846,0.00206062370274001,0.00821764482681416,0.016295289741555,2.74669422045303e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.0115390694406116,0.00194034900797425,0.00773598538498205,0.0153421534962411,2.76985607898575e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0256506792474181,0.0043228887321233,0.0171778173324564,0.0341235411623798,3.00227076070431e-09
NMR metabolomics,X23424.Total Lipids in VLDL,APOBR,Apolipoprotein B receptor,24240,-0.0174050212629496,0.00293370930629584,-0.0231550915032894,-0.0116549510226097,3.01912170896179e-09
NMR metabolomics,X23424.Total Lipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0163075846348131,0.00275177960103526,0.010914096616784,0.0217010726528422,3.14131220179496e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VWF,von Willebrand factor,29820,-0.0295010159579644,0.00497948305784007,-0.0392608027513309,-0.0197412291645978,3.16657788130997e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0186568601474337,0.00315316456482296,0.0124766576003807,0.0248370626944867,3.32501330031742e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PROCR,Endothelial protein C receptor,24111,-0.0145673891653459,0.00247080281032235,-0.0194101626735777,-0.00972461565711412,3.77810786911514e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0208591203580057,0.00354314864976443,0.0139145490044675,0.027803691711544,3.98067810761647e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH12,Protocadherin-12,24867,0.0103493100084217,0.00175862246062054,0.00690240998560546,0.013796210031238,4.03412254859354e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TNC,Tenascin,29594,-0.0192171551462487,0.00327378112610797,-0.0256337661534203,-0.012800544139077,4.40391410169681e-09
NMR metabolomics,X23424.Total Lipids in VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.0235083855994256,0.00401184389752351,0.0156451715602795,0.0313715996385717,4.69426966780954e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0239223445664198,0.00409457300234936,0.015896981481815,0.0319477076510245,5.20812279240787e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.00986895316023485,0.0016904790180377,-0.0131822920355887,-0.00655561428488096,5.33901313458945e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN10,Ataxin-10,28774,0.0291301507640132,0.00499505181221061,0.0193398492120804,0.038920452315946,5.54181210670315e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.0283659999786281,0.0048784225091667,0.0188042918606614,0.0379277080965948,6.14279908173212e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAC1,Cartilage acidic protein 1,29820,0.0119771700622045,0.00206475318776428,0.00793025381418649,0.0160240863102225,6.66753993491917e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0158506782315611,0.00273637631410492,0.0104873806559155,0.0212139758072068,7.00342639983733e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD1,Leiomodin-1,24867,-0.0141475469050805,0.00244262046845067,-0.0189350830232438,-0.0093600107869172,7.04101859075486e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.0083606043633448,0.0014439820589102,0.00553039952788081,0.0111908091988088,7.11129084234704e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB1,Lamin-B1,24756,0.0233235145288633,0.0040484675948816,0.0153885180428953,0.0312585110148312,8.45718697094398e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA7A,Semaphorin-7A,29736,0.010909970539749,0.0018981059013191,0.00718968297316359,0.0146302581063345,9.12847706981798e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00829902156832347,0.00144495872165594,0.00546690247387783,0.0111311406627691,9.3692558091129e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT2,Angiopoietin-2,29725,-0.0150225060838132,0.00261735471545555,-0.0201525213261061,-0.00989249084152033,9.5836398441996e-09
NMR metabolomics,X23424.Total Lipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0264063124769978,0.00460256670669612,0.0173852817318734,0.0354273432221223,9.73171788420179e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PGA4,Pepsin A-4,24951,0.0279523304854074,0.0048954813467395,0.018357187045798,0.0375474739250168,1.14378199313241e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO3,R-spondin-3,29725,0.0111077675702025,0.00194684790782274,0.00729194567086989,0.014923589469535,1.17094106002116e-08
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.0178723612954281,0.00313443119566682,0.0117288761519212,0.0240158464389351,1.19812152708646e-08
NMR metabolomics,X23424.Total Lipids in VLDL,EDN1,Endothelin-1,24240,0.0114525897187601,0.00201084956141905,0.00751132457837874,0.0153938548591414,1.24508824907446e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NTF3,Neurotrophin-3,29434,0.0135216204195592,0.00238373095165093,0.00884950775432336,0.018193733084795,1.42080357135453e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ERC2,ERC protein 2,24195,0.0294220235020187,0.00519286157760687,0.0192440148099092,0.0396000321941281,1.47951915162277e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CTSB,Cathepsin B,29480,-0.020396623366838,0.00360087090781689,-0.0274543303461591,-0.0133389163875168,1.48949342874476e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IL17C,Interleukin-17C,28931,-0.0273776847617797,0.00483855618476193,-0.036861254883913,-0.0178941146396463,1.54382832926543e-08
NMR metabolomics,X23424.Total Lipids in VLDL,STX3,Syntaxin-3,24845,0.0149356860560191,0.00264206641569002,0.00975723588126661,0.0201141362307715,1.5937090557636e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0133976663568456,0.00237325649350214,0.00874608362958145,0.0180492490841098,1.66447047793879e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171B,Protein FAM171B,24793,0.0105432882477138,0.00186914231635025,0.00687976930766736,0.0142068071877603,1.71196710692598e-08
NMR metabolomics,X23424.Total Lipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0146389036728533,0.00259526338407269,-0.0197256199056358,-0.00955218744007084,1.71327691270193e-08
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.0170342102817751,0.00303729093649523,0.0110811200462444,0.0229873005173057,2.06495382689354e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0152777380234589,0.00273440098270645,-0.0206371639495635,-0.00991831209735421,2.33123173059019e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0143451622979851,0.00257164357896136,0.00930474088322081,0.0193855837127493,2.45543983540075e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0235224220525334,0.00422396543128593,0.015243449807213,0.0318013942978539,2.59141745330724e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SDC1,Syndecan-1,29478,0.015365762579215,0.00275943985817958,0.00995726045718297,0.0207742647012469,2.59275460595331e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ITGBL1,Integrin beta-like protein 1,24938,0.0142725239394391,0.00256516083427203,0.00924480870426589,0.0193002391746123,2.66386239105248e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0161199204239379,0.00289864021231569,-0.0218012552400767,-0.0104385856077991,2.70256466957555e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL1,Follistatin-related protein 1,24240,-0.00874774264082539,0.00157382683828666,-0.0118324432438672,-0.00566304203778354,2.75341280757159e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.0263282188992851,0.00474010521887008,-0.0356188251282704,-0.0170376126702997,2.81054965338918e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0393707514136897,0.00710544913390377,0.0254440711112384,0.0532974317161411,3.0346198978905e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0198595373649114,0.00360003239555306,-0.0269156008601954,-0.0128034738696274,3.48747518856409e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0258312534084421,0.00468695957140171,-0.0350176941683895,-0.0166448126484948,3.5972557391031e-08
NMR metabolomics,X23424.Total Lipids in VLDL,B2M,Beta-2-microglobulin,24966,0.0117986831429165,0.00214139715900338,0.00760154471126989,0.0159958215745631,3.62776490643304e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0160844006595905,0.00292357359897301,0.0103541964056034,0.0218146049135776,3.7942615443007e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GBP2,Guanylate-binding protein 2,28931,0.0226396784149585,0.00411825442123326,0.0145678997493414,0.0307114570805757,3.88692580387101e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MELTF,Melanotransferrin,24922,0.011186788636292,0.00203981516517355,0.00718875091255189,0.0151848263600322,4.19339647876821e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NME3,Nucleoside diphosphate kinase 3,29497,0.00898544028001189,0.00164072631924668,0.00576961669428839,0.0122012638657354,4.37355590679355e-08
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0106457533570538,0.00194562940522819,-0.0144591869913011,-0.00683231972280655,4.503066537025e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.0189667061440137,0.0034880461549887,0.0121301356802358,0.0258032766077915,5.45011881996842e-08
NMR metabolomics,X23424.Total Lipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0100177858438062,0.00184722509717346,0.00639722465334622,0.0136383470342662,5.90160493399364e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0118044516880653,0.00217986436559613,-0.0160769858446337,-0.00753191753149687,6.16911689143359e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CPA4,Carboxypeptidase A4,23902,0.0163613178832887,0.00302258938997626,0.0104370426789352,0.0222855930876421,6.25694334476243e-08
NMR metabolomics,X23424.Total Lipids in VLDL,L1CAM,Neural cell adhesion molecule L1,29566,0.0107366294589978,0.00198809176782278,0.00683996959406519,0.0146332893239305,6.69788899741329e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NINJ1,Ninjurin-1,28797,0.0205086801380544,0.00380168752796217,0.0130573725832485,0.0279599876928602,6.92077845678567e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.0193912888245253,0.00359477113052971,0.0123455374086871,0.0264370402403635,6.9314108995591e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RCC1,Regulator of chromosome condensation,24793,0.0190586149351428,0.00354464817795872,0.0121111045063437,0.0260061253639419,7.65367179022126e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ARG1,Arginase-1,29216,0.0189902662511666,0.00355739903015596,0.0120177641520609,0.0259627683502722,9.45505625785096e-08
NMR metabolomics,X23424.Total Lipids in VLDL,OLFM4,Olfactomedin-4,23498,0.0452742384312514,0.0084912837419651,0.0286313222969998,0.061917154565503,9.8115907425479e-08
NMR metabolomics,X23424.Total Lipids in VLDL,BCAN,Brevican core protein,29218,0.0124488981357842,0.00233581904197746,0.00787069281350836,0.01702710345806,9.91779688135145e-08
NMR metabolomics,X23424.Total Lipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0176468724090354,0.00331548130167019,-0.024145215760309,-0.0111485290577618,1.03061539055713e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RAB44,Ras-related protein Rab-44,24793,0.0154109990534606,0.00289973774670549,0.0097275130699179,0.0210944850370034,1.07804826527824e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0138632988382465,0.00261288753906498,-0.0189845584148138,-0.0087420392616791,1.13208807616243e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.0235565082134106,0.00444176227093874,0.0148506541623707,0.0322623622644505,1.14653149386236e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0128416966392196,0.00242215725276315,0.00809426842380384,0.0175891248546354,1.15518017228867e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0115145081880681,0.00217360750057862,-0.0157747788892022,-0.00725423748693399,1.18482178654194e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RPS10,40S ribosomal protein S10,24111,-0.0152769479538689,0.00289199847887621,-0.0209452649724663,-0.0096086309352715,1.2854725379315e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR1,Cadherin-related family member 1,28774,0.0154890506273548,0.00293797338669479,0.00973062278943296,0.0212474784652766,1.35904588908306e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0192076633801046,0.00364619081104014,0.012061129390466,0.0263541973697433,1.39186939099693e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CD248,Endosialin,24938,-0.0145858481488837,0.0027699415523033,-0.0200149335913981,-0.00915676270636918,1.40767556492993e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.0115612129877531,0.00219576350045141,-0.0158649094486378,-0.00725751652686829,1.41205203060775e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CALB1,Calbindin,29349,0.0157634248061131,0.00299820833756435,0.00988693646448693,0.0216399131477392,1.46956765905851e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0277671662458843,0.00528499618680837,0.0174085737197399,0.0381257587720287,1.50132361205455e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0120028787472866,0.00228706015085277,-0.016485516642958,-0.00752024085161516,1.54918813611078e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0116305360884773,0.00221785661531159,-0.015977535054488,-0.00728353712246655,1.58406089899509e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CASP1,Caspase-1,28774,0.0244200973034279,0.00466458984792974,0.0152775012014857,0.0335626934053702,1.65956133913328e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0157781412351045,0.00302375158000512,0.00985158813829446,0.0217046943319145,1.82274994020627e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0148089014469612,0.00284743111835909,-0.0203898664389451,-0.00922793645497744,2.00060800054929e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DDI2,Protein DDI1 homolog 2,24381,0.0274184469863844,0.0052778128303465,0.0170739338389052,0.0377629601338635,2.06322869032623e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO4,Roundabout homolog 4,24240,-0.0064434146740647,0.00124064264416688,-0.00887507425663178,-0.00401175509149763,2.07921695510632e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD6,Programmed cell death protein 6,29478,-0.0248918205433608,0.00480805354605407,-0.0343156054936267,-0.0154680355930948,2.26828314366383e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0129217985567449,0.00249619178194759,0.00802926266412763,0.0178143344493622,2.27712867033487e-07
NMR metabolomics,X23424.Total Lipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0197038833454332,0.00381770181091031,0.0122211877960489,0.0271865788948174,2.47013996248957e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0513350880132898,0.00996590237194965,0.0318019193642685,0.0708682566623111,2.60708080363124e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0198841822843707,0.00386311554275684,0.0123124758205673,0.0274558887481742,2.6650382131451e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,0.0216980239500436,0.00422101886122959,0.0134248269820336,0.0299712209180537,2.75802914112846e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CD27,CD27 antigen,29566,-0.0146558884387281,0.00285646869877772,-0.0202545670883325,-0.00905720978912379,2.90379891003095e-07
NMR metabolomics,X23424.Total Lipids in VLDL,BRD3,Bromodomain-containing protein 3,24111,0.0169409914304493,0.00330183725182384,0.0104693904168746,0.023412592444024,2.90785146665911e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0228961746538719,0.00446843300776185,0.0141380459586587,0.0316543033490851,3.01423587080773e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.017834574678385,0.00348928995479019,0.0109955663669963,0.0246735829897738,3.22438755510191e-07
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0157965540725331,0.00309304387975835,0.00973418806820673,0.0218589200768595,3.29523700733854e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00788102453555088,0.00154388081246844,0.00485501814311273,0.010907030927989,3.33418719965691e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SAFB2,Scaffold attachment factor B2,24867,0.00959234382619997,0.00188916989655049,0.00588957082896101,0.0132951168234389,3.85104237369064e-07
NMR metabolomics,X23424.Total Lipids in VLDL,REG1A,Lithostathine-1-alpha,29353,-0.0171583551629609,0.00337940525591347,-0.0237819894645513,-0.0105347208613705,3.85115108348352e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EP300,Histone acetyltransferase p300,24229,0.0105724637501715,0.00208224463558117,0.00649126426443243,0.0146536632359106,3.85396584867328e-07
NMR metabolomics,X23424.Total Lipids in VLDL,BLVRB,Flavin reductase,29443,0.0226351359492922,0.00446915825758817,0.0138755857644194,0.031394686134165,4.11420219995016e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0248088295126132,0.00490903341389759,0.0151871240213739,0.0344305350038525,4.36381463726329e-07
NMR metabolomics,X23424.Total Lipids in VLDL,APOA4,Apolipoprotein A-IV,24966,0.0124269409270231,0.00246218641730876,0.00760105554909788,0.0172528263049482,4.51679132786024e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.0125495020349272,0.00248805309716733,-0.0174260861053752,-0.00767291796447927,4.58856754271253e-07
NMR metabolomics,X23424.Total Lipids in VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.0148011532946211,0.00293764199025781,0.00904337499371578,0.0205589315955264,4.72661456547403e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.0211827145986188,0.00420486967918136,0.0129411700274233,0.0294242591698143,4.74560471584453e-07
NMR metabolomics,X23424.Total Lipids in VLDL,STX5,Syntaxin-5,24229,0.0141662235408312,0.00281665478421175,0.00864558016377619,0.0196868669178863,4.95402107085133e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD9,Enhancer of filamentation 1,24229,0.0115343465571828,0.00229854506170873,0.00702919823623372,0.0160394948781319,5.25523323655801e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0169160006494588,0.00337684202233908,-0.0235346110132434,-0.0102973902856742,5.49108637133837e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0132584531784051,0.00264966711601085,0.00806510563102382,0.0184518007257864,5.65890758059492e-07
NMR metabolomics,X23424.Total Lipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0244000677475104,0.00488573123752514,0.0148240345219612,0.0339761009730597,5.9430761148288e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0634464809598907,0.0127244536833355,0.0385065517405532,0.0883864101792283,6.19341153953351e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.036426312065875,0.00731358034387505,0.0220916945918799,0.0507609295398701,6.3810081318893e-07
NMR metabolomics,X23424.Total Lipids in VLDL,KEL,Kell blood group glycoprotein,28774,0.0122672127771699,0.00246567099649595,0.00743449762403782,0.0170999279303019,6.55550588019365e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0187888421442535,0.00378050916359956,0.0113790441835984,0.0261986401049087,6.7424659529308e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SNX18,Sorting nexin-18,24805,0.0152600817711191,0.00307249980161891,0.00923798215994604,0.0212821813822922,6.85661209004992e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00771482527609373,0.00156126494769836,0.00465474597860494,0.0107749045735825,7.79860544556477e-07
NMR metabolomics,X23424.Total Lipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0197950091983265,0.00401101694822152,0.0119334159798123,0.0276566024168407,8.06120240757657e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0216053978645169,0.00439028026239907,0.0130004485502147,0.0302103471788191,8.65017790163827e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0288928695147447,0.00587388374503946,-0.0404056816550221,-0.0173800573744674,8.75300499063568e-07
NMR metabolomics,X23424.Total Lipids in VLDL,VIM,Vimentin,28916,0.0393756238353598,0.00801038275155403,0.0236752736423139,0.0550759740284057,8.90075528860871e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CD7,T-cell antigen CD7,24177,0.0147561001613589,0.00300996232726866,0.00885657399991237,0.0206556263228055,9.52767293635821e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0189774143552537,0.00387223236446201,0.0113878389209082,0.0265669897895993,9.60191609415524e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA1,Ephrin-A1,29390,0.00950572316699879,0.00194063805194591,0.00570207258518481,0.0133093737488128,9.72094542266499e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0165085486168638,0.00338224596826788,-0.0231377507146688,-0.00987934651905874,1.06130575736166e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.0134875759170569,0.00276585572504187,0.00806649869597488,0.018908653138139,1.08675804424041e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0112887817443986,0.00233362930061036,0.00671486831520225,0.0158626951735949,1.32189725731617e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.00795547652408697,0.00164658479883559,-0.0111827827298047,-0.00472817031836922,1.36191068547903e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.00945118783219993,0.00196329330311174,-0.0132992427062989,-0.00560313295810093,1.48718388456766e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.0159917122250619,0.0033266200194526,0.00947153698693479,0.022511887463189,1.53830808218907e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RA,Interleukin-17 receptor A,29443,0.0144983510554163,0.00302611249628467,0.00856717056269837,0.0204295315481343,1.66692590317069e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0172026585453058,0.0036014153172133,0.0101438845235678,0.0242614325670439,1.79294433447191e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0286074579630395,0.00599562257474131,0.0168560377165465,0.0403588782095325,1.84024295452532e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.0116457708541263,0.00244096971967225,0.00686147020356868,0.0164300715046839,1.8424737544561e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00635148774258997,0.00133909459452605,-0.00897611314786103,-0.00372686233731891,2.11613473757461e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CTRC,Chymotrypsin-C,29456,0.0207900375668309,0.00438434337863511,0.0121967245447061,0.0293833505889557,2.12732670497055e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,0.00884065723276411,0.00186605147849239,0.00518319633491902,0.0124981181306092,2.17234924000601e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0227590931972995,0.00480794958869373,0.0133355120034598,0.0321826743911392,2.21542908318714e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.019342135104989,0.00409461859572782,0.0113166826573625,0.0273675875526155,2.32794087080391e-06
NMR metabolomics,X23424.Total Lipids in VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.0199846949508048,0.00423336103614199,-0.0282820825816432,-0.0116873073199665,2.36061293639204e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.0119764715130286,0.00254471521685752,-0.0169641133380693,-0.00698882968798781,2.53513464434113e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0337284051547641,0.00718444400200093,0.0196468949108423,0.0478099153986859,2.6828354295988e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NTF4,Neurotrophin-4,28797,0.0126964182590054,0.0027112221318411,0.00738242288059683,0.0180104136374139,2.84115738786347e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0106988081432972,0.0022891096629588,0.00621215320389796,0.0151854630826965,2.97249448927049e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.012175989009593,0.00261385178034039,0.0070528395201258,0.0172991384990601,3.20279203298613e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0289956538889616,0.00622871223131577,0.0167873779155827,0.0412039298623405,3.25452669818296e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SELENOP,Selenoprotein P,24966,0.00724004876862943,0.00155860282086113,0.00418518723974161,0.0102949102975173,3.41451366175974e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.0117806823204664,0.00253965492675435,0.0068029586640279,0.0167584059769049,3.52434181617894e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NDRG1,Protein NDRG1,28774,0.0214810365276302,0.00463369347784361,0.0123989973110567,0.0305630757442037,3.57060659965771e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MATN3,Matrilin-3,29169,-0.0102374823056406,0.00220915991323029,-0.0145674357355719,-0.00590752887570919,3.60032436973511e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00822153827886033,0.00179220840040868,0.00470880981405932,0.0117342667436613,4.50701676593942e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0129057240185535,0.00281391865646233,-0.0184210045852197,-0.00739044345188732,4.53247269171499e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CENPJ,Centromere protein J,24445,0.0226334473883377,0.0049491144166478,0.012933183131708,0.0323337116449674,4.82614458218381e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0153587901732967,0.00336028446508003,0.00877263262173987,0.0219449477248536,4.8847996965244e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MSLN,Mesothelin,29293,0.0175641859918187,0.00384483452799319,0.0100283103169521,0.0251000616666854,4.93804839174698e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0194206853057177,0.00425574600771091,0.0110794231306043,0.0277619474808311,5.05793962607019e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN2,Calsyntenin-2,29786,-0.0123958681024028,0.00271817130654094,-0.0177234838632231,-0.00706825234158259,5.12667527469027e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.00999464014349939,0.00219195133158018,0.00569841553360224,0.0142908647533965,5.14349808997365e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SPP1,Osteopontin,29757,-0.0144291163735797,0.00316574691487264,-0.0206339803267301,-0.00822425242042934,5.18763332918917e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0130766850540189,0.002870491505955,0.00745052170234709,0.0187028484056907,5.24583739074298e-06
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.0176945788010048,0.00388888185866993,0.0100723703580118,0.0253167872439979,5.38953646933351e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.013078390603566,0.00287724053905338,0.00743899914702141,0.0187177820601106,5.50820184438159e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0180447295739316,0.00400267760171934,0.0101994814745617,0.0258899776733015,6.56472995834702e-06
NMR metabolomics,X23424.Total Lipids in VLDL,FCRLB,Fc receptor-like B,28797,0.0186778630209036,0.0042065820081698,0.0104329622848908,0.0269227637569164,9.02295990712615e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.00986585713378833,0.00222612925113758,-0.014229070466018,-0.00550264380155868,9.38381402606392e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00834821772368482,0.00188411992138982,0.00465534267776077,0.0120410927696089,9.42047331145997e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ARTN,Artemin,28931,0.0136097507166734,0.00307682386509453,0.00757917594108815,0.0196403254922587,9.75538634096069e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.00975234436137683,0.00221000698149259,-0.0140839580451023,-0.00542073067765136,1.02407266365683e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ACHE,Acetylcholinesterase,24381,0.0100417390748119,0.00227597893344081,0.00558082036526786,0.0145026577843558,1.02834125594767e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.016901321782706,0.00384204019668237,0.00937092299720852,0.0244317205682034,1.09186106918451e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.0100888281676115,0.00229716869999982,-0.0145912788196111,-0.00558637751561184,1.12851293449119e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00564204858796198,0.00128660131738456,0.00312031000588824,0.00816378717003571,1.16334696350696e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN1,Calsyntenin-1,28774,0.0154856171034265,0.00354950505856864,0.00852858718863198,0.022442647018221,1.28882149135971e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0129345373984167,0.00297137005355534,0.00711065209344824,0.0187584227033852,1.34787568815825e-05
NMR metabolomics,X23424.Total Lipids in VLDL,KLK11,Kallikrein-11,29296,0.00922290475984918,0.00211901988234057,0.00506962579046166,0.0133761837292367,1.35087161262312e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GDF15,Growth/differentiation factor 15,29820,-0.0132340781759144,0.00304981539685635,-0.0192117163537528,-0.00725643999807596,1.43404205743186e-05
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00847817056861648,0.00197084974370003,0.00461530507096442,0.0123410360662685,1.70076555770535e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CAPS,Calcyphosin,24845,0.0280312790455057,0.00652657407261276,0.0152391938631847,0.0408233642278267,1.75399620317471e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0143529702994059,0.00334256803816421,0.00780153694460401,0.0209044036542077,1.76058142945835e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.00632551741353198,0.00147342945862261,-0.0092134391524323,-0.00343759567463166,1.76802952922935e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0205521530505514,0.00479225577478698,-0.0299449743691339,-0.011159331731969,1.80377771845575e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0122848969336401,0.00286640861124549,-0.0179030578116812,-0.00666673605559891,1.82779698700492e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TMOD4,Tropomodulin-4,24016,-0.0121171586246666,0.00282804275993272,-0.0176601224341348,-0.00657419481519851,1.83743608918462e-05
NMR metabolomics,X23424.Total Lipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0120006827526656,0.00280252377927835,0.00650773614528007,0.0174936293600512,1.85851152718342e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0115984269810824,0.0027150787980173,-0.0169199814251963,-0.00627687253696846,1.94570926099622e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L,Seizure 6-like protein,29566,0.00806123447059517,0.00188831780944558,0.00436013156408183,0.0117623373771085,1.96960376425976e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0254817601873304,0.00597232081715035,0.0137760113857158,0.0371875089889451,1.99069900964005e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0195252814997242,0.00458621056411236,-0.0285142542053845,-0.010536308794064,2.07470627452973e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PRKCQ,Protein kinase C theta type,28931,0.0127473893839616,0.00299480693677267,0.00687756778788715,0.018617210980036,2.08307882072022e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.00786685307641699,0.00185086783302453,0.00423915212368892,0.0114945540291451,2.14081985542872e-05
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0203996999041301,0.00479976924216051,0.0109921521894955,0.0298072476187647,2.14427104495788e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,0.00428613181663286,0.00102076591000828,0.00228543063301662,0.00628683300024909,2.69103256134177e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CA14,Carbonic anhydrase 14,29725,-0.0102060682673254,0.00244262446304094,-0.0149936122148857,-0.00541852431976519,2.94508061851051e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00612947638374394,0.00147704681751057,0.00323446462142323,0.00902448814606466,3.33848577536728e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL3,Follistatin-related protein 3,29351,0.00908226229358723,0.00218979498980178,0.00479026411357574,0.0133742604735987,3.3701178641816e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00836706232626027,0.00202900262726061,0.00439021717682947,0.0123439074756911,3.74025949455502e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CTSV,Cathepsin L2,29618,0.0117340707346779,0.00284612551183769,0.00615566473147599,0.0173124767378797,3.75277307312912e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0152423968649549,0.00370457862716128,0.00798142275571878,0.022503370974191,3.89141055908105e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SOX9,Transcription factor SOX-9,24195,0.00771259661536752,0.00188281832932354,0.00402227268989338,0.0114029205408417,4.21164603676685e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CRNN,Cornulin,28580,0.0186059354539686,0.0045944184800431,0.00960087523308415,0.0276109956748531,5.142247255374e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0148452749365838,0.00367271313702119,-0.0220437926851454,-0.00764675718802231,5.3151455309958e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB7,Integrin beta-7,29725,0.0127199484506469,0.00314796824497176,0.00654993069050223,0.0188899662107915,5.34292878115764e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.0110955338457895,0.00274664427903595,-0.0164789566326999,-0.005712111058879,5.36925064469527e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.00817912843436132,0.00202509599440723,-0.0121483165833995,-0.00420994028532315,5.38714934509611e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CST7,Cystatin-F,29498,0.0257438784607778,0.00638540188937977,0.0132284907575935,0.0382592661639622,5.5519390125795e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0121355187001319,0.00301059312456229,-0.018036281224274,-0.00623475617598979,5.56940932725951e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NEFL,Neurofilament light polypeptide,28674,0.0123781008141372,0.0030792258082967,0.00634281822987569,0.0184133833983988,5.83780405941629e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TSC1,Hamartin,24229,0.0207697536908085,0.00517719548138925,0.0106224505472856,0.0309170568343314,6.04443846118287e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,0.00740248162517558,0.00185412632882605,0.00376839402067651,0.0110365692296747,6.55557398313155e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NRTN,Neurturin,28931,0.0135379483111447,0.00339845643678852,0.00687697369503918,0.0201989229272502,6.80572835331064e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CCL28,C-C motif chemokine 28,29327,0.0162041698373605,0.00407048316582377,0.0082260228323459,0.0241823168423751,6.88213780932452e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD48,CD48 antigen,29536,0.00818769324576701,0.00205695799160966,0.00415605558221208,0.0122193309093219,6.89388270678016e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ACE,Angiotensin-converting enzyme,24951,-0.0071700593377903,0.00180365929758711,-0.010705231561061,-0.00363488711451958,7.04930924371384e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0169778671112576,0.00427206736036662,0.00860461508493903,0.0253511191375762,7.08335741906658e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0140893943288012,0.0035526033105939,0.00712629184003716,0.0210524968175653,7.3285543905938e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00997580671674084,0.00252240870613037,0.00503188565272531,0.0149197277807564,7.67930779595352e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.0099545439133138,0.00251719153607797,0.00502084850260097,0.0148882393240266,7.68753340528495e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00712554370371952,0.00180216719147726,-0.010657791399015,-0.00359329600842408,7.71140543119514e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB5,Integrin beta-5,29566,0.0102177999395027,0.00258834789207437,0.0051446380710369,0.0152909618079684,7.91164248028336e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0205877915538055,0.00521518545525963,-0.0308095550461143,-0.0103660280614966,7.91352125660904e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM1,Myomesin-1,24101,0.0129847806561411,0.00328923918054831,0.00653787186226641,0.0194316894500158,7.9144657586745e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SHISA5,Protein shisa-5,24938,0.00688309430509242,0.00174395236933471,0.00346494766119638,0.0103012409489885,7.94078891498548e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DRAXIN,Draxin,29218,0.011627914989434,0.00294833488562701,0.00584917861360511,0.017406651365263,8.03567970873676e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PLAU,Urokinase-type plasminogen activator,29443,0.00786485482713741,0.00199798332292601,0.00394880751420242,0.0117809021400724,8.29044045582026e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TLR4,Toll-like receptor 4,24229,0.00769913985650206,0.0019558434915188,0.00386568661312521,0.0115325930998789,8.29164290458664e-05
NMR metabolomics,X23424.Total Lipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.00789554679732142,0.00201814619292776,-0.0118511133354598,-0.003939980259183,9.16346607026893e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL12,Stromal cell-derived factor 1,28931,0.0107006783412028,0.0027521910160086,0.00530638394982591,0.0160949727325796,0.000101275142887479
NMR metabolomics,X23424.Total Lipids in VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.00906154066034528,0.00233096953020835,-0.0136302409395537,-0.0044928403811369,0.000101571852015738
NMR metabolomics,X23424.Total Lipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.0100777225429985,0.00259363423054554,0.00499419945112923,0.0151612456348677,0.000102326607456638
NMR metabolomics,X23424.Total Lipids in VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.00666915197301074,0.00171719267559678,-0.0100348496171804,-0.00330345432884105,0.000103078370722699
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00823431866106938,0.00212189539452567,0.00407540368779906,0.0123932336343397,0.000104449669496419
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00707398849468118,0.00183112580328184,-0.0106629950691136,-0.00348498192024877,0.000112198739830015
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.0177379813350248,0.00459276190291784,0.00873616800530587,0.0267397946647438,0.00011268264819867
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.00702718948398785,0.0018228043368113,-0.010599885984138,-0.0034544929838377,0.000115947545476338
NMR metabolomics,X23424.Total Lipids in VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0338640060499897,0.00881424538526611,-0.0511399270051113,-0.0165880850948682,0.000122308030905118
NMR metabolomics,X23424.Total Lipids in VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0140410994945118,0.0036586134140387,0.00687021720299595,0.0212119817860277,0.000124443889053018
NMR metabolomics,X23424.Total Lipids in VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.00947843203226841,0.00247014134911553,0.00463695498800197,0.0143199090765348,0.000124751676207949
NMR metabolomics,X23424.Total Lipids in VLDL,SELL,L-selectin,24966,0.00612162757788882,0.00159845837452908,0.00298864916381183,0.00925460599196582,0.000128609468175758
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00784497418965766,0.00204893816528233,0.00382905538570428,0.011860892993611,0.000129094235703416
NMR metabolomics,X23424.Total Lipids in VLDL,GUCA2A,Guanylin,29333,-0.00900432414356297,0.00235269841635633,-0.0136156130396214,-0.00439303524750457,0.000129860975745659
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0146124197127415,0.00382280973002868,-0.0221051267835978,-0.00711971264188533,0.000132415706650101
NMR metabolomics,X23424.Total Lipids in VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.00577376392389832,0.00151061273852479,-0.00873456489140692,-0.00281296295638973,0.000132632722435755
NMR metabolomics,X23424.Total Lipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0146207664877986,0.00382723525010299,0.00711938539759679,0.0221221475780005,0.000133627469828947
NMR metabolomics,X23424.Total Lipids in VLDL,DCC,Netrin receptor DCC,24195,0.00601989351479759,0.00157641136057513,0.00293012724807033,0.00910965978152485,0.000134473814407653
NMR metabolomics,X23424.Total Lipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0168173159935776,0.00441566470575301,-0.0254720188168535,-0.00816261317030171,0.000140122166752377
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1,Methionine aminopeptidase 1,28774,0.00781028347516759,0.00205524637719429,0.00378200057586678,0.0118385663744684,0.000144895318717197
NMR metabolomics,X23424.Total Lipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.018356231487703,0.00485457220773904,-0.0278711930148716,-0.00884126996053452,0.000156424337935711
NMR metabolomics,X23424.Total Lipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00889484832635161,0.00236544350903644,-0.013531117604063,-0.0042585790486402,0.000170090481862651
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,0.00770644986906383,0.00205032988377254,0.00368780329686965,0.011725096441258,0.000171231227624341
NMR metabolomics,X23424.Total Lipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00887435482068799,0.0023632473430543,-0.0135063196130744,-0.00424239002830156,0.000173567494221748
NMR metabolomics,X23424.Total Lipids in VLDL,LEG1,Protein LEG1 homolog,23603,-0.0180704196956293,0.00482665175794182,-0.0275306571411952,-0.0086101822500633,0.000181628283357912
NMR metabolomics,X23424.Total Lipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0181652144685245,0.00485570743565958,0.00864802789463169,0.0276824010424172,0.000183706574906019
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN5,Contactin-5,29511,0.00952240928776239,0.00254570566056812,0.00453282619304887,0.0145119923824759,0.000183945361503983
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.00802587647849412,0.00214868230850034,0.00381445915383345,0.0122372938031548,0.000187879938685682
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,0.00832802496992273,0.00223378822518117,0.00394980004856765,0.0127062498912778,0.000193286017700926
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA11,Integrin alpha-11,29434,-0.00875663385376302,0.00235360332446996,-0.0133696963697241,-0.0041435713378019,0.00019918077522816
NMR metabolomics,X23424.Total Lipids in VLDL,AMBN,Ameloblastin,28931,-0.00730036376222775,0.00196532370152975,-0.0111523982172261,-0.00344832930722943,0.000203919428378529
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.0081729289341403,0.0022017012877956,0.00385759441006091,0.0124882634582197,0.000205928064508371
NMR metabolomics,X23424.Total Lipids in VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0160658788316763,0.00433562538363979,0.00756805307974233,0.0245637045836103,0.000211325110930919
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G1B,Phospholipase A2,29787,-0.0109607801274239,0.00295955441074822,-0.0167615067724904,-0.00516005348235738,0.000213009229961148
NMR metabolomics,X23424.Total Lipids in VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00773079048245183,0.0020919927896395,0.00363048461475841,0.0118310963501453,0.000219994271349246
NMR metabolomics,X23424.Total Lipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.00959724697533463,0.00259708127224187,-0.0146875262689287,-0.00450696768174057,0.000220029173353272
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA6C,Semaphorin-6C,24229,0.00666827879132473,0.00180680859857702,0.00312693393811378,0.0102096236445357,0.000224181464483291
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00735838504853056,0.00199624259685865,-0.0112710205383735,-0.0034457495586876,0.000228198625169674
NMR metabolomics,X23424.Total Lipids in VLDL,SCGN,Secretagogin,28931,-0.0111623163769617,0.00303131533052345,-0.0171036944247877,-0.00522093832913577,0.000231528658441931
NMR metabolomics,X23424.Total Lipids in VLDL,CDH17,Cadherin-17,29478,-0.0171718339750041,0.00466532924689464,-0.0263158792989176,-0.00802778865109057,0.000232978590922503
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.011480248731075,0.00312627433776263,-0.0176077464330898,-0.00535275102906024,0.000240910178518977
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00687195342736188,0.00187428299057448,0.0031983587658359,0.0105455480888879,0.000246387442287753
NMR metabolomics,X23424.Total Lipids in VLDL,OMD,Osteomodulin,29581,-0.0108398815803341,0.00296137813760862,-0.016644182730047,-0.0050355804306212,0.000252242438031089
NMR metabolomics,X23424.Total Lipids in VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.0190069232945256,0.00523482203364326,0.00874667210858479,0.0292671744804664,0.000282964634955903
NMR metabolomics,X23424.Total Lipids in VLDL,MYO6,Unconventional myosin-VI,24867,0.00930303448998718,0.00257364497025036,0.00425869034829647,0.0143473786316779,0.000301253454622199
NMR metabolomics,X23424.Total Lipids in VLDL,TYMP,Thymidine phosphorylase,29301,0.0164519084588444,0.00456641469598114,0.00750173565472135,0.0254020812629674,0.00031532106242177
NMR metabolomics,X23424.Total Lipids in VLDL,PRR4,Proline-rich protein 4,24203,-0.0172921817695466,0.00480656029369755,-0.0267130399451938,-0.00787132359389936,0.00032178156137986
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0141878169311507,0.0039502853592429,0.00644525762703456,0.0219303762352668,0.000329313178859958
NMR metabolomics,X23424.Total Lipids in VLDL,ENO1,Alpha-enolase,29392,0.0194347847517975,0.00541657764187166,0.00881829257372906,0.030051276929866,0.00033374123448101
NMR metabolomics,X23424.Total Lipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.00867315560940188,0.0024176856773326,0.00393449168182999,0.0134118195369738,0.000334569374620378
NMR metabolomics,X23424.Total Lipids in VLDL,DCN,Decorin,28916,-0.00562638839077228,0.00157278671015632,-0.00870905034267865,-0.0025437264388659,0.000347679347033046
NMR metabolomics,X23424.Total Lipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.0100014479447408,0.0027974893048543,0.00451836890722638,0.0154845269822552,0.000350581366262169
NMR metabolomics,X23424.Total Lipids in VLDL,KLK15,Kallikrein-15,24754,0.0127220787553499,0.00356465605673673,0.0057353528841459,0.0197088046265539,0.000359093106057945
NMR metabolomics,X23424.Total Lipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00716127607800057,0.00201060382387958,0.00322049258319659,0.0111020595728045,0.000369092308056483
NMR metabolomics,X23424.Total Lipids in VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0150873101626904,0.00425012517120479,-0.0234175554982518,-0.00675706482712901,0.00038618372424603
NMR metabolomics,X23424.Total Lipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0102723451546477,0.00290402030296351,0.00458046536083927,0.0159642249484562,0.000404886249618407
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK3,NT-3 growth factor receptor,29694,-0.00524762828069129,0.00148725478206754,-0.00816264765354367,-0.00233260890783891,0.000418713171854003
NMR metabolomics,X23424.Total Lipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,0.0102270221497241,0.00290431742020792,0.00453456000611656,0.0159194842933316,0.000430055795761969
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.00720021802955269,0.00205013704121119,0.00318194942877876,0.0112184866303266,0.000445302324496772
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0126555565863939,0.00360339052325261,0.00559291116081874,0.019718202011969,0.000445341607283498
NMR metabolomics,X23424.Total Lipids in VLDL,GUK1,Guanylate kinase,24111,-0.00969966734617897,0.00276671932994168,-0.0151224372328647,-0.00427689745949328,0.000456000803263076
NMR metabolomics,X23424.Total Lipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,0.0141035734974684,0.00402644462370513,0.0062117420350064,0.0219954049599305,0.000461181620465411
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.00876131374202758,0.00250965114506961,-0.013680229986364,-0.00384239749769115,0.000481833617873857
NMR metabolomics,X23424.Total Lipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0113826468440726,0.00326430106588046,0.00498461675494694,0.0177806769331983,0.000489183963529744
NMR metabolomics,X23424.Total Lipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.00881283437647841,0.00252766330811068,-0.0137670544603753,-0.00385861429258148,0.000490000121532495
NMR metabolomics,X23424.Total Lipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0125599098931937,0.00360408057459174,0.00549591196699386,0.0196239078193935,0.000493026425548181
NMR metabolomics,X23424.Total Lipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0128164353028681,0.00368177076938225,0.00560016459487885,0.0200327060108573,0.000500320419103034
NMR metabolomics,X23424.Total Lipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00909585624049198,0.00262223393525977,0.00395627772738284,0.0142354347536011,0.000523809010739429
NMR metabolomics,X23424.Total Lipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0119054946982743,0.00344180898226091,0.00515954909304295,0.0186514403035057,0.000542807563812912
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0134082136599878,0.00388069958676761,0.00580204246992325,0.0210143848500523,0.000551031398664853
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE1,Ribonuclease pancreatic,24951,0.00580053481591143,0.00167888674949685,0.00250991678689761,0.00909115284492525,0.000551230898356712
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00611314492801273,0.00177040012056977,-0.00958312916432948,-0.00264316069169598,0.000555367088767817
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.00947959524266062,0.00274684400289107,0.00409578099699413,0.0148634094883271,0.000559136933615367
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0110062216879138,0.00319309366193603,-0.0172646852653085,-0.00474775811051922,0.000567877399776736
NMR metabolomics,X23424.Total Lipids in VLDL,IL6,Interleukin-6,29349,0.0174382763924983,0.00506406301484449,0.00751271288340314,0.0273638399015935,0.000574964615684859
NMR metabolomics,X23424.Total Lipids in VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.00574169232877654,0.00166974864131735,-0.00901439966575854,-0.00246898499179454,0.000585417626251607
NMR metabolomics,X23424.Total Lipids in VLDL,OSM,Oncostatin-M,29293,0.0167697296185427,0.00487898697208517,0.00720691515325573,0.0263325440838296,0.000588722385704954
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.00999871743425736,0.00291659806306408,0.00428218523065175,0.015715249637863,0.000608589772792222
NMR metabolomics,X23424.Total Lipids in VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.0113138630739754,0.00330086563293037,-0.0177835597145189,-0.00484416643343186,0.000610084441119745
NMR metabolomics,X23424.Total Lipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0154399521281571,0.00451177482532744,0.00659687347051537,0.0242830307857989,0.00062213692669622
NMR metabolomics,X23424.Total Lipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00965691867568411,0.00282437323259088,0.00412114713980598,0.0151926902115622,0.000629041778277513
NMR metabolomics,X23424.Total Lipids in VLDL,INHBB,Inhibin beta B chain,24381,0.0121930690985938,0.00357301887020516,0.00518995211299171,0.0191961860841959,0.000644651290763903
NMR metabolomics,X23424.Total Lipids in VLDL,SAG,S-arrestin,24101,-0.0123954879041757,0.00364086505130175,-0.0195315834047272,-0.00525939240362431,0.000663824643283139
NMR metabolomics,X23424.Total Lipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00582909586053969,0.0017127896058441,-0.00918616348799413,-0.00247202823308526,0.000666877958633808
NMR metabolomics,X23424.Total Lipids in VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.00915912273083631,0.00269129650154157,0.00388418158781483,0.0144340638738578,0.000667000349327462
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN2,Neuroligin-2,24101,-0.0111291925302912,0.00327697429699173,-0.017552062152395,-0.00470632290818742,0.000684439215796477
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.00942133338978924,0.00277885565922184,-0.014867890481864,-0.00397477629771444,0.000698921295455434
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.00668449168158025,0.00197208837049141,0.00281919847541709,0.0105497848877434,0.00070118454347969
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0172087918083593,0.00508971323632965,0.00723295386515316,0.0271846297515654,0.000723091111504039
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00738192121247804,0.00218708899001775,-0.0116686156329128,-0.00309522679204324,0.000738708557549896
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0137841862762108,0.00408451218518587,0.00577854239324648,0.0217898301591751,0.00073979785897093
NMR metabolomics,X23424.Total Lipids in VLDL,ELAVL4,ELAV-like protein 4,24101,0.0196000497019023,0.00583751438869717,0.0081585215000558,0.0310415779037487,0.000787434438401226
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00929566915074299,0.00276902873388085,-0.0147229654691495,-0.00386837283233652,0.000789108574711515
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,0.0106326022183728,0.00316938882296153,0.00442060012536821,0.0168446043113774,0.000795285514171519
NMR metabolomics,X23424.Total Lipids in VLDL,CD109,CD109 antigen,29443,-0.00777365802804204,0.0023179877985894,-0.0123169141132773,-0.00323040194280683,0.000798614514289076
NMR metabolomics,X23424.Total Lipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.0118112223809345,0.00352578214643454,0.00490068937392279,0.0187217553879462,0.000809482868834194
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0104012070428113,0.00310837108005572,0.00430879972590212,0.0164936143597205,0.000820316481277027
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP1,Dipeptidase 1,29163,-0.0111460276754409,0.0033375225372297,-0.0176875718484111,-0.00460448350247065,0.000840009385352256
NMR metabolomics,X23424.Total Lipids in VLDL,CFD,Complement factor D,24966,0.00449907025740163,0.0013474480063413,0.00185807216497269,0.00714006834983057,0.000842168234129026
NMR metabolomics,X23424.Total Lipids in VLDL,MYH7B,Myosin-7B,24016,-0.0101899220408014,0.00306180464962973,-0.0161910591540757,-0.00418878492752711,0.000875791146722734
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0118749190472641,0.00357535373178996,0.00486722573295582,0.0188826123615725,0.000897199714602191
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GL3,Endophilin-A3,24307,0.0191777709431038,0.00577562386572696,0.00785754816627895,0.0304979937199286,0.000899991976033003
NMR metabolomics,X23424.Total Lipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0128822073031419,0.00388903924425971,0.00525969038439289,0.0205047242218909,0.000926222130450249
NMR metabolomics,X23424.Total Lipids in VLDL,TNN,Tenascin-N,24938,0.00992343170413885,0.00299633880884113,0.00405060763881024,0.0157962557694675,0.00092812215159947
NMR metabolomics,X23424.Total Lipids in VLDL,CLMP,CXADR-like membrane protein,29725,0.0048162477331208,0.00145454928838468,0.00196533112788683,0.00766716433835476,0.00093020257133177
NMR metabolomics,X23424.Total Lipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.00911236037285868,0.00275596935681381,0.00371066043350361,0.0145140603122138,0.000946383469235111
NMR metabolomics,X23424.Total Lipids in VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.00956208102763172,0.00289371559086717,-0.0152337635857314,-0.00389039846953207,0.000953043779298664
NMR metabolomics,X23424.Total Lipids in VLDL,MBL2,Mannose-binding protein C,24610,-0.0246088165376184,0.00744917408279156,-0.0392091977398899,-0.010008435335347,0.000956007507725116
NMR metabolomics,X23424.Total Lipids in VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.0222437332761756,0.00676540924145866,0.00898353116291661,0.0355039353894345,0.00101096002988468
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0123727415552905,0.00377589326872721,0.00497199074858516,0.0197734923619958,0.00105145383072169
NMR metabolomics,X23424.Total Lipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0132796298528293,0.00408489703607128,0.0052732316621296,0.021286028043529,0.00115167433694538
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0659043781436096,0.0202730377879703,0.0261692240791878,0.105639532208031,0.00115194354190261
NMR metabolomics,X23424.Total Lipids in VLDL,CLSPN,Claspin,28719,0.00775485063212899,0.00238741780746469,0.00307551172949821,0.0124341895347598,0.00116264170999539
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX2,Peroxiredoxin-2,24556,0.0137643506170285,0.00424465026998896,0.00544483608785016,0.0220838651462069,0.00118539066613752
NMR metabolomics,X23424.Total Lipids in VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00616305915806776,0.00190188462134115,-0.00989075301589642,-0.0024353653002391,0.00119481705964546
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0110079593205846,0.00340007785815105,0.00434380671860853,0.0176721119225606,0.00120714706930114
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0102066406266545,0.00315999803227036,0.00401304448340464,0.0164002367699044,0.00123977152282368
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0109402175418685,0.00338857617518767,0.00429860823850065,0.0175818268452363,0.00124555169513353
NMR metabolomics,X23424.Total Lipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00609526903006224,0.0018959462772193,0.00237921432671241,0.00981132373341207,0.00130632099277771
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0134522250513275,0.00418870962638283,0.00524235418361712,0.0216620959190378,0.00132166745226938
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM1,Neural cell adhesion molecule 1,29594,0.00664083478018512,0.00207415157884185,0.00257549768565509,0.0107061718747151,0.00136758204360095
NMR metabolomics,X23424.Total Lipids in VLDL,NGF,Beta-nerve growth factor,29218,0.00266046901007677,0.000836014790913583,0.00102188001988615,0.00429905800026739,0.00146251808597124
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00739608234183171,0.00232907503465502,-0.0119610694097556,-0.00283109527390787,0.00149709553423532
NMR metabolomics,X23424.Total Lipids in VLDL,UNG,Uracil-DNA glycosylase,24793,0.00753121820441896,0.00237185414131741,0.00288238408743685,0.0121800523214011,0.00149893241639544
NMR metabolomics,X23424.Total Lipids in VLDL,CDH6,Cadherin-6,29478,-0.00833079679835074,0.00263447427506636,-0.0134943663774808,-0.00316722721922066,0.00156728017228766
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.00730793685614471,0.00231550042409929,-0.0118463176873793,-0.00276955602491011,0.00160058211153319
NMR metabolomics,X23424.Total Lipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.014737425771139,0.00467949983745831,0.00556560608972067,0.0239092454525573,0.00163796377793122
NMR metabolomics,X23424.Total Lipids in VLDL,NMI,N-myc-interactor,24706,0.0156272772077718,0.00496328817714581,0.00589923238056605,0.0253553220349776,0.00164264874831051
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00747263382516504,0.00237460486566153,0.00281840828846845,0.0121268593618616,0.00165177074031543
NMR metabolomics,X23424.Total Lipids in VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.00999142825848281,0.00317819485504266,-0.0162206901743664,-0.00376216634259919,0.00166969046646375
NMR metabolomics,X23424.Total Lipids in VLDL,TTN,Titin,24111,-0.0145615011404975,0.0046327656447834,-0.023641721804273,-0.00548128047672204,0.00167339882221563
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00559475315509779,0.00178232377960321,0.0021013985470755,0.00908810776312008,0.00169718551146254
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM25,Transmembrane protein 25,24867,-0.00976992573665122,0.00311306058739397,-0.0158715244879434,-0.00366832698535903,0.00170090785578783
NMR metabolomics,X23424.Total Lipids in VLDL,TEF,Thyrotroph embryonic factor,24111,0.00924762664867173,0.00295627248894724,0.00345333257033515,0.0150419207270083,0.00176127475170933
NMR metabolomics,X23424.Total Lipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.014653033068614,0.00469640682704588,0.00544807568760405,0.0238579904496239,0.00181026057604988
NMR metabolomics,X23424.Total Lipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0120298424410374,0.0038573647121491,0.00446940760522515,0.0195902772768496,0.00181877834514562
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0125710014013042,0.00404497312219831,-0.0204991487208129,-0.00464285408179557,0.00188699454014334
NMR metabolomics,X23424.Total Lipids in VLDL,NRXN3,Neurexin-3,24195,0.00753835086422396,0.00243281028988465,0.00277004269605004,0.0123066590323979,0.00194648150147925
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00435530010747614,0.00140638725633453,0.00159878108506047,0.00711181912989182,0.00195845279678771
NMR metabolomics,X23424.Total Lipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.014430685251678,0.00467576627619327,0.00526618335033915,0.0235951871530168,0.00202876048045891
NMR metabolomics,X23424.Total Lipids in VLDL,LY96,Lymphocyte antigen 96,29218,-0.00752313300500991,0.00244448963683176,-0.0123143326932002,-0.00273193331681966,0.00208876135783519
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.00573285009409915,0.00186388781531675,0.00207962997607831,0.00938607021211998,0.00210203060217127
NMR metabolomics,X23424.Total Lipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.01285063584513,0.00419003437159746,-0.021063103213461,-0.00463816847679901,0.00216491762321857
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.00934863138555778,0.00305034363350437,0.00336995786388921,0.0153273049072264,0.00218067798443554
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN4,Nectin-4,29566,-0.00672131296808539,0.00219565326932214,-0.0110247933759568,-0.00241783256021399,0.00220656575858711
NMR metabolomics,X23424.Total Lipids in VLDL,BOC,Brother of CDO,28916,-0.00489958850747464,0.00161015330232978,-0.008055488980041,-0.00174368803490827,0.00234494830192383
NMR metabolomics,X23424.Total Lipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00918952867524775,0.00302503520440571,-0.0151185976758829,-0.00326045967461256,0.00238543491385442
NMR metabolomics,X23424.Total Lipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00587245329168233,0.00193462282876559,0.00208059254730178,0.00966431403606288,0.00240423794071232
NMR metabolomics,X23424.Total Lipids in VLDL,VASN,Vasorin,29065,0.0057212750672252,0.00188932602484402,0.00201819605853092,0.00942435407591948,0.00246223267170595
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1B,Protein phosphatase 1B,24229,0.0130550289752357,0.00431175942302455,0.00460398050610755,0.0215060774443638,0.00246622197301091
NMR metabolomics,X23424.Total Lipids in VLDL,RALB,Ras-related protein Ral-B,24229,0.00617066547892915,0.00203935970670398,0.00217352045378934,0.010167810504069,0.00248248227798085
NMR metabolomics,X23424.Total Lipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0245327016708663,0.00811131001054266,0.00863453405020266,0.0404308692915299,0.0024925845731207
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.00730094977665636,0.00241607473897157,-0.0120364562650406,-0.00256544328827208,0.00251473484945008
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B4,Protein ATP1B4,24016,-0.00876035599388438,0.00290178333951219,-0.0144478513393283,-0.00307286064844048,0.00253913774063311
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0082956214453453,0.00274942434610117,0.00290674972698701,0.0136844931637036,0.00255333324994963
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN3,Perilipin-3,29478,0.0087983773275859,0.0029219686157482,0.00307131884071943,0.0145254358144524,0.0026051260465152
NMR metabolomics,X23424.Total Lipids in VLDL,PI3,Elafin,29014,0.0113294415338289,0.00378344109164897,0.0039138969941969,0.0187449860734609,0.00275144309360152
NMR metabolomics,X23424.Total Lipids in VLDL,FGF9,Fibroblast growth factor 9,23970,0.00840459692003772,0.00281669224391872,0.00288388012195703,0.0139253137181184,0.00284929996359267
NMR metabolomics,X23424.Total Lipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.01261744973044,0.00423276496734238,-0.020913669066431,-0.00432123039444888,0.00287689595212846
NMR metabolomics,X23424.Total Lipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00795868951019614,0.0026970769487005,0.00267241869074316,0.0132449603296491,0.00317189125347215
NMR metabolomics,X23424.Total Lipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00653391531092842,0.00221515017759501,0.00219222096284219,0.0108756096590146,0.003184410596021
NMR metabolomics,X23424.Total Lipids in VLDL,LTO1,Protein LTO1 homolog,28931,0.00831870124106127,0.00282959289102492,0.00277269917465243,0.0138647033074701,0.00328585019346519
NMR metabolomics,X23424.Total Lipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00469016361523495,0.00160997287094586,0.00153461678818106,0.00784571044228884,0.00358079028404405
NMR metabolomics,X23424.Total Lipids in VLDL,STX1B,Syntaxin-1B,24195,0.00832222668941904,0.00287075582843625,0.00269554526568398,0.0139489081131541,0.00374730811811853
NMR metabolomics,X23424.Total Lipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0173007087717769,0.00596909165524458,0.00560128912749752,0.0290001284160563,0.00375432758076782
NMR metabolomics,X23424.Total Lipids in VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.0091677728047949,0.00316355579345574,0.00296720344962165,0.0153683421599682,0.00375969278644061
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3G,Semaphorin-3G,24381,0.00882598499082441,0.00304893889520483,0.00285006475622295,0.0148019052254259,0.00379769990142916
NMR metabolomics,X23424.Total Lipids in VLDL,SPARCL1,SPARC-like protein 1,29489,-0.00545290854423081,0.00188674456826393,-0.00915092789802812,-0.0017548891904335,0.0038538199112086
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF8,SLAM family member 8,28797,0.0106329784444579,0.00368220014737391,0.00341586615560508,0.0178500907333108,0.00388396000049302
NMR metabolomics,X23424.Total Lipids in VLDL,BMP10,Bone morphogenetic protein 10,24381,0.00567211601105674,0.00196601359683823,0.00181872936125381,0.00952550266085967,0.00391651324072523
NMR metabolomics,X23424.Total Lipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0113460935531159,0.00395580512817875,0.0035927155018855,0.0190994716043462,0.00413156650741354
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0131039377806205,0.00458645000044268,0.00411449577975286,0.0220933797814882,0.00427897767152974
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5A,Cytochrome b5,24016,0.0142463897189537,0.00498778542112465,0.0044703302935494,0.024022449144358,0.00429037935678958
NMR metabolomics,X23424.Total Lipids in VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0150506556156042,0.00527507666703105,0.00471150534822335,0.0253898058829851,0.00433232395102278
NMR metabolomics,X23424.Total Lipids in VLDL,GKN1,Gastrokine-1,28114,0.0055110853460427,0.00193184559063244,0.00172466798840312,0.00929750270368227,0.00433734349075729
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00738672414061694,0.00259373835362523,0.00230299696751148,0.0124704513137224,0.00440446783682825
NMR metabolomics,X23424.Total Lipids in VLDL,PTTG1,Securin,24445,0.00811260149305221,0.00285287586316155,0.00252096480125558,0.0137042381848488,0.00446359914661474
NMR metabolomics,X23424.Total Lipids in VLDL,EPN1,Epsin-1,24445,0.00856623039681786,0.00301319875413922,0.002660360838705,0.0144720999549307,0.0044741803638718
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL2,Chordin-like protein 2,29478,0.0104085028390665,0.00366640929209415,0.00322234062656193,0.017594665051571,0.0045302878487988
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD7,FERM domain-containing protein 7,24195,0.00654919858476136,0.00231257831393045,0.00201654508945767,0.011081852080065,0.0046297515773898
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00587581420859399,0.0020795748055449,-0.009951780827462,-0.00179984758972599,0.00472463426598452
NMR metabolomics,X23424.Total Lipids in VLDL,SHPK,Sedoheptulokinase,24445,-0.00807392224143164,0.00286146669098164,-0.0136823969557556,-0.00246544752710763,0.00478228856180866
NMR metabolomics,X23424.Total Lipids in VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.00979552284197674,0.00347856677515688,-0.0166135137212842,-0.00297753196266925,0.00486704369566209
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4C,Semaphorin-4C,29349,0.00543067098641799,0.00193348303672288,0.00164104423444115,0.00922029773839484,0.0049767083594111
NMR metabolomics,X23424.Total Lipids in VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00540114628565762,0.00192751573950875,0.00162321543622046,0.00917907713509478,0.00508069962067979
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA11,Serpin A11,29820,-0.00787299146144292,0.00281234336764455,-0.0133851844620262,-0.0023607984608596,0.00512239551235748
NMR metabolomics,X23424.Total Lipids in VLDL,TCN1,Transcobalamin-1,24546,0.00659079563722749,0.00235507989117982,0.00197483905051504,0.01120675222394,0.00513735565377768
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.00962946087851505,0.00344763457283991,-0.0163868246412813,-0.00287209711574883,0.00522526974874653
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00843924261241883,0.00302342339241551,0.00251333276328443,0.0143651524615532,0.00525402096699179
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00739999317043698,0.00265555502265254,0.00219510532603801,0.012604881014836,0.00533042700470283
NMR metabolomics,X23424.Total Lipids in VLDL,CDH23,Cadherin-23,24845,-0.00506025331401765,0.00182783700120146,-0.00864281383637251,-0.00147769279166278,0.00563674606989946
NMR metabolomics,X23424.Total Lipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0109251418605724,0.00394749182872745,0.0031880578762666,0.0186622258448782,0.00565031674124232
NMR metabolomics,X23424.Total Lipids in VLDL,ADA2,Adenosine deaminase 2,29328,-0.00809758011275015,0.0029394496905701,-0.0138589015062675,-0.00233625871923277,0.00587652161603355
NMR metabolomics,X23424.Total Lipids in VLDL,MB,Myoglobin,29820,-0.00991867487033048,0.00360381643667575,-0.016982155086215,-0.002855194654446,0.00592195358585056
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3D,Protein FAM3D,24805,0.0160199283085976,0.00582383492800124,0.00460521184971518,0.0274346447674801,0.00595016903286039
NMR metabolomics,X23424.Total Lipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.010920371886294,0.00398684889718269,0.00310614804781595,0.0187345957247721,0.00616532156269908
NMR metabolomics,X23424.Total Lipids in VLDL,IL11,Interleukin-11,28931,0.0117322600432737,0.00429156631141622,0.00332079007289796,0.0201437300136495,0.00626472051400437
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00569220034021708,0.00208489094289587,0.00160581409214118,0.00977858658829298,0.00633302261165179
NMR metabolomics,X23424.Total Lipids in VLDL,CPE,Carboxypeptidase E,29468,-0.00723887568853659,0.00265253722034866,-0.01243784864042,-0.00203990273665322,0.00635570212872341
NMR metabolomics,X23424.Total Lipids in VLDL,GSN,Gelsolin,24845,0.003577742012506,0.00131272343360134,0.00100480408264738,0.00615067994236462,0.00642618686511884
NMR metabolomics,X23424.Total Lipids in VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.0147717147393349,0.00544561400019415,0.00409831129895438,0.0254451181797155,0.00667984140321611
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.0078918743256564,0.00291378800583565,0.00218084983421853,0.0136028988170943,0.00676365183643734
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD9,COMM domain-containing protein 9,24793,0.00734539837872119,0.00271814802226371,0.00201782825508432,0.0126729685023581,0.00688972874849903
NMR metabolomics,X23424.Total Lipids in VLDL,LY6D,Lymphocyte antigen 6D,29283,0.00712242030438683,0.00263879906308201,0.00195037414074609,0.0122944664680276,0.0069564202520043
NMR metabolomics,X23424.Total Lipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00522081353822186,0.00193766460715328,0.00142299090820143,0.00901863616824229,0.00705673817931161
NMR metabolomics,X23424.Total Lipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0171326925633918,0.00638625783836778,0.00461562720019097,0.0296497579265927,0.00730709581236678
NMR metabolomics,X23424.Total Lipids in VLDL,RGMA,Repulsive guidance molecule A,29694,-0.00579567625015799,0.00216151874327156,-0.0100322529869702,-0.00155909951334574,0.00733776814488144
NMR metabolomics,X23424.Total Lipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0112522493009756,0.00419776746336206,0.00302462507278599,0.0194798735291653,0.00735469606186032
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_DRA,,29322,-0.0066409401766646,0.00248290217743734,-0.0115074284444418,-0.00177445190888742,0.00748446900545269
NMR metabolomics,X23424.Total Lipids in VLDL,CDH3,Cadherin-3,29694,0.00662774826555827,0.00248656664567081,0.00175407764004349,0.011501418891073,0.00769334890652528
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.00682847898729676,0.00256456370484117,0.00180193412580808,0.0118550238487854,0.00775831616031494
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.00644491161633055,0.0024232441695553,0.00169535304400215,0.0111944701886589,0.00782800649899643
NMR metabolomics,X23424.Total Lipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0160759563364961,0.00605501821994374,0.00420812062540641,0.0279437920475859,0.00793653942796483
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00785632896704663,0.0029646712918785,-0.0136670846991285,-0.00204557323496477,0.00805483641843821
NMR metabolomics,X23424.Total Lipids in VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00834436854587885,0.00318350635512828,-0.0145840410019303,-0.00210469608982742,0.00876951133553788
NMR metabolomics,X23424.Total Lipids in VLDL,JUN,Transcription factor AP-1,28931,0.00902741029496647,0.00344715580881404,0.00227098490969095,0.015783835680242,0.00882857881784551
NMR metabolomics,X23424.Total Lipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0151712734539736,0.00581816281571875,0.00376767433516481,0.0265748725727823,0.00912431321316917
NMR metabolomics,X23424.Total Lipids in VLDL,SCG3,Secretogranin-3,29497,-0.00595695813295357,0.00228456286768236,-0.010434701353611,-0.00147921491229614,0.00912566267109493
NMR metabolomics,X23424.Total Lipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,0.010747602360367,0.00413208880723604,0.00264870829818436,0.0188464964225496,0.0093004976010001
NMR metabolomics,X23424.Total Lipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,-0.00473199817903349,0.00182105293370648,-0.0083012619290982,-0.00116273442896879,0.00936883065367868
NMR metabolomics,X23424.Total Lipids in VLDL,MYH4,Myosin-4,24111,-0.00835990551879244,0.00322158258276894,-0.0146742073810196,-0.00204560365656532,0.00946568856974626
NMR metabolomics,X23424.Total Lipids in VLDL,RYR1,Ryanodine receptor 1,24111,-0.00610074126398822,0.00235393343759878,-0.0107144508016818,-0.0014870317262946,0.00955544839595544
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00703976949454213,0.00271751593258778,0.00171343826667008,0.0123661007224142,0.00958897721809708
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00805851329907034,0.00311456515228169,0.00195396560059823,0.0141630609975424,0.00967617260226627
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00531149849943792,0.00206010186951811,0.00127369883518243,0.00934929816369341,0.0099345419663856
NMR metabolomics,X23424.Total Lipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,0.00679698989713609,0.00263960533711134,0.00162336343639786,0.0119706163578743,0.0100288915928921
NMR metabolomics,X23424.Total Lipids in VLDL,MERTK,Tyrosine-protein kinase Mer,29786,0.0044626906250103,0.00174825594618817,0.00103610897048148,0.00788927227953912,0.0106955421047348
NMR metabolomics,X23424.Total Lipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00622257355584463,0.00243897913533571,0.00144217445058665,0.0110029726611026,0.0107382051773493
NMR metabolomics,X23424.Total Lipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,0.0083397643356803,0.00327977704192207,0.00191140133351305,0.0147681273378475,0.011002398718576
NMR metabolomics,X23424.Total Lipids in VLDL,NPTN,Neuroplastin,28797,0.0142489465986172,0.00561064513463032,0.00325208213474174,0.0252458110624926,0.0111022845085649
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB2,Integrin beta-2,29274,0.00500911007168521,0.00197505624700171,0.00113799982756186,0.00888022031580856,0.0112118729397369
NMR metabolomics,X23424.Total Lipids in VLDL,IL15,Interleukin-15,29434,0.00570992828015778,0.00225324042736253,0.00129357704252722,0.0101262795177883,0.0112789160730421
NMR metabolomics,X23424.Total Lipids in VLDL,RBP7,Retinoid-binding protein 7,24805,0.0104752276979792,0.00414659394095389,0.00234790357370957,0.0186025518222488,0.0115357465722833
NMR metabolomics,X23424.Total Lipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.00662857895922911,0.00263827887965801,-0.0117996055633588,-0.00145755235509941,0.0119946188684097
NMR metabolomics,X23424.Total Lipids in VLDL,CST6,Cystatin-M,28830,0.00840436348188859,0.00335435996493802,0.00182981795061007,0.0149789090131671,0.0122331597367613
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0107614768049206,0.00430357602579395,0.00232646779436445,0.0191964858154767,0.0124052461968147
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN1,Contactin-1,29820,-0.00466400988988878,0.00187218103742972,-0.00833348472325104,-0.000994535056526524,0.0127360173797987
NMR metabolomics,X23424.Total Lipids in VLDL,F3,Tissue factor,29541,-0.00466330150100622,0.00187695741513234,-0.0083421380346656,-0.000984464967346846,0.0129788334910449
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00930298694135015,0.00374753626155412,-0.0166481580139962,-0.00195781586870407,0.0130558227447098
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0119150752987228,0.00481208223487602,-0.0213467564790798,-0.0024833941183658,0.0132901708804483
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00565920756340409,0.00228570689127988,0.00117922205649553,0.0101391930703126,0.0132964399088737
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.00442666609905065,0.00179164880861901,-0.00793829776394391,-0.000915034434157395,0.0134896115403885
NMR metabolomics,X23424.Total Lipids in VLDL,LAYN,Layilin,29163,-0.0059247775711854,0.00240300806920846,-0.010634673386834,-0.00121488175553681,0.0136853726968549
NMR metabolomics,X23424.Total Lipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,0.0106347075437849,0.0043311315041169,0.00214568979571582,0.0191237252918541,0.0140793740646307
NMR metabolomics,X23424.Total Lipids in VLDL,MTR,Methionine synthase,24111,0.0110355167670893,0.0045018330850094,0.00221192392047092,0.0198591096137078,0.0142396534849511
NMR metabolomics,X23424.Total Lipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.0088595555328737,0.00361553992371521,-0.0159460137833555,-0.00177309728239188,0.0142764591961211
NMR metabolomics,X23424.Total Lipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00797389746755436,0.00326749476910026,0.00156960772011785,0.0143781872149909,0.014679166907437
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00804282352361626,0.00330348582215597,-0.014517655735042,-0.00156799131219055,0.0149135110169571
NMR metabolomics,X23424.Total Lipids in VLDL,KLK14,Kallikrein-14,29725,-0.0077040803308621,0.00316696132536029,-0.0139113245285683,-0.00149683613315594,0.0149950110050306
NMR metabolomics,X23424.Total Lipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00837094076184131,0.00344164176517416,0.00162532290209995,0.0151165586215827,0.0150124860253767
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC1,Sialoadhesin,29581,0.00708841083822685,0.00291588640658584,0.00137327348131861,0.0128035481951351,0.0150646715032341
NMR metabolomics,X23424.Total Lipids in VLDL,HCG22,Protein PBMUCL2,24111,-0.00929524235757074,0.00382546311104177,-0.0167931500552126,-0.00179733465992887,0.0151129715740432
NMR metabolomics,X23424.Total Lipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0140552225527819,0.00578931964966265,0.00270815603944309,0.0254022890661207,0.0151986003754182
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00802852156578812,0.00331506456534701,-0.0145260481138683,-0.00153099501770799,0.0154498802429865
NMR metabolomics,X23424.Total Lipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00812754252911106,0.00337845089491057,-0.0147493062831358,-0.00150577877508635,0.0161489306653854
NMR metabolomics,X23424.Total Lipids in VLDL,PADI2,Protein-arginine deiminase type-2,28931,0.00931187332232122,0.00387888609536779,0.00170925657540036,0.0169144900692421,0.0163719660591824
NMR metabolomics,X23424.Total Lipids in VLDL,KLK3,Prostate-specific antigen,24938,-0.0146509571535708,0.00612813905560893,-0.0266621097025643,-0.00263980460457732,0.0168205603349736
NMR metabolomics,X23424.Total Lipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0150276066642711,0.00629496510899506,0.00268947505064078,0.0273657382779014,0.016982966742135
NMR metabolomics,X23424.Total Lipids in VLDL,TFF3,Trefoil factor 3,29426,-0.00759491912136219,0.00318239746847176,-0.0138324181595668,-0.00135742008315754,0.0170140361004112
NMR metabolomics,X23424.Total Lipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00486788282572392,0.00204286900017716,-0.00887190606607114,-0.000863859585376688,0.01718592177945
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00516391210288264,0.00217481071475964,-0.00942654110381154,-0.000901283101953752,0.0175828815904351
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0199998505171861,0.00847793676482625,0.00338309445812666,0.0366166065762456,0.0183285816316516
NMR metabolomics,X23424.Total Lipids in VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.00832239059099535,0.00354249130294235,-0.0152656735447624,-0.00137910763722834,0.0188163275323698
NMR metabolomics,X23424.Total Lipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.00596751110275312,0.00254464787617045,0.00098000126545904,0.0109550209400472,0.0190274484032291
NMR metabolomics,X23424.Total Lipids in VLDL,EPO,Erythropoietin,29434,0.0122206467416063,0.00521311680665484,0.0020029378005628,0.0224383556826498,0.0190739869795126
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00419308300152861,0.00179269221804995,0.000679406254150704,0.00770675974890651,0.0193428089440354
NMR metabolomics,X23424.Total Lipids in VLDL,PAPPA,Pappalysin-1,28931,0.00757014022319611,0.00324210400313606,0.00121561637704943,0.0139246640693428,0.0195530075800054
NMR metabolomics,X23424.Total Lipids in VLDL,FABP1,"Fatty acid-binding protein, liver",29454,0.0150002436277867,0.00645278329083181,0.00235278837775638,0.0276476988778171,0.0200992655516089
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00977689168894193,0.00420767891922907,0.00152984100725295,0.0180239423706309,0.0201561244962526
NMR metabolomics,X23424.Total Lipids in VLDL,SSB,Lupus La protein,28774,0.00950998559526146,0.00409763193622609,0.00147862700025832,0.0175413441902646,0.0203019431829365
NMR metabolomics,X23424.Total Lipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.00763734783385307,0.00329947670794014,-0.0141043221814157,-0.0011703734862904,0.0206369026978484
NMR metabolomics,X23424.Total Lipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00423460461558172,0.00183080290457518,0.000646230922614368,0.00782297830854907,0.0207323273435936
NMR metabolomics,X23424.Total Lipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00520602966244151,0.0022527229456303,0.000790692689006117,0.0096213666358769,0.0208415729850264
NMR metabolomics,X23424.Total Lipids in VLDL,WIF1,Wnt inhibitory factor 1,29725,0.00539479764839251,0.00233962397182994,0.000809134663605827,0.0099804606331792,0.0211264467446009
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00433690243852186,0.00189588828803808,0.000620961393967226,0.00805284348307649,0.0221718741513562
NMR metabolomics,X23424.Total Lipids in VLDL,VCAN,Versican core protein,29694,-0.00470921728452099,0.00206402533035689,-0.0087547069320205,-0.000663727637021477,0.0225218160766739
NMR metabolomics,X23424.Total Lipids in VLDL,AOC3,Membrane primary amine oxidase,29594,-0.00472219551491232,0.00207328672372527,-0.00878583749341386,-0.00065855353641079,0.0227552892970782
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.00787142084651937,0.00346172681612366,0.00108643628691699,0.0146564054061217,0.0229841953912235
NMR metabolomics,X23424.Total Lipids in VLDL,CTNNA1,Catenin alpha-1,24101,-0.00550462580802765,0.00242262222358377,-0.0102529653662518,-0.000756286249803457,0.0230846141855423
NMR metabolomics,X23424.Total Lipids in VLDL,NOP56,Nucleolar protein 56,24111,0.0173890085548302,0.00765926811520157,0.00237684304903509,0.0324011740606253,0.023196813626589
NMR metabolomics,X23424.Total Lipids in VLDL,IL36G,Interleukin-36 gamma,24149,0.0106543285671735,0.0046954727957529,0.00145120188749778,0.0198574552468491,0.0232732180767307
NMR metabolomics,X23424.Total Lipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0110477645056991,0.00487770936702017,-0.0206080748650587,-0.00148745414633961,0.0235246306815731
NMR metabolomics,X23424.Total Lipids in VLDL,C9orf40,Uncharacterized protein C9orf40,24805,0.0125019213107524,0.00552584236077629,0.00167127028363084,0.0233325723378739,0.0236784630322
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00792398820020006,0.00350498173894352,-0.0147937524085294,-0.00105422399187076,0.023781842550701
NMR metabolomics,X23424.Total Lipids in VLDL,DLL1,Delta-like protein 1,29566,-0.00463663516889265,0.00205376715100246,-0.00866201878485746,-0.000611251552927836,0.0239763419473429
NMR metabolomics,X23424.Total Lipids in VLDL,TJP3,Tight junction protein ZO-3,24101,-0.00664157166500699,0.00295395703481608,-0.0124313274532465,-0.000851815876767467,0.0245619702628614
NMR metabolomics,X23424.Total Lipids in VLDL,PALM3,Paralemmin-3,24111,0.0114478426365778,0.00509473545859418,0.00146216113773326,0.0214335241354224,0.0246493901962267
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00968456310982256,0.00432140222678035,0.00121461474533308,0.018154511474312,0.0250305885671225
NMR metabolomics,X23424.Total Lipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0182390793139005,0.00816418457950099,0.00223727753807856,0.0342408810897225,0.025489868027395
NMR metabolomics,X23424.Total Lipids in VLDL,MN1,Transcriptional activator MN1,24195,-0.00902972775147921,0.00408325125553598,-0.0170329002123297,-0.00102655529062868,0.0270170283862554
NMR metabolomics,X23424.Total Lipids in VLDL,ENG,Endoglin,29820,0.00261315187447558,0.00118232797033397,0.000295789052620999,0.00493051469633016,0.0271005790215756
NMR metabolomics,X23424.Total Lipids in VLDL,TFF2,Trefoil factor 2,29536,0.00873414043023779,0.00395996532900792,0.000972608385382265,0.0164956724750933,0.0274189718321422
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.00868661147454237,0.00395280482139561,0.000939114024606963,0.0164341089244778,0.0279868727676795
NMR metabolomics,X23424.Total Lipids in VLDL,S100G,Protein S100-G,24867,-0.00701841426990958,0.00319964048609352,-0.0132897096226529,-0.000747118917166286,0.0282805390605931
NMR metabolomics,X23424.Total Lipids in VLDL,MYL4,Myosin light chain 4,24240,-0.00786069218663094,0.00358790457708695,-0.0148929851577214,-0.000828399215540517,0.0284694891672581
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB118,Beta-defensin 118,24101,0.0086717414794329,0.00397202426639082,0.000886573917306886,0.0164569090415589,0.0290303678046785
NMR metabolomics,X23424.Total Lipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0144587492425603,0.00669353112278863,0.00133942824189456,0.027578070243226,0.0307738776264943
NMR metabolomics,X23424.Total Lipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00304212551852272,0.00140961851897328,-0.00580497781571035,-0.000279273221335097,0.0309283715014714
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0126274815183427,0.00585961771614523,-0.0241123322419873,-0.00114263079469803,0.0311715852062244
NMR metabolomics,X23424.Total Lipids in VLDL,PRND,Prion-like protein doppel,24845,-0.00763692947395683,0.00355102808306798,-0.0145969445167701,-0.000676914431143582,0.0315154388492892
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0127597544706504,0.00598665949343559,-0.0244936070777841,-0.0010259018635166,0.0330689239101911
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.00569332923488181,0.00267301680151396,0.000454216303914446,0.0109324421658492,0.0331859535956843
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL2,Podocalyxin-like protein 2,29566,0.00407663292929619,0.00191688694133439,0.000319534524280776,0.0078337313343116,0.0334537355643864
NMR metabolomics,X23424.Total Lipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.014452765470722,0.00679773951318289,-0.0277763349165604,-0.00112919602488353,0.0335039503515532
NMR metabolomics,X23424.Total Lipids in VLDL,GAL,Galanin peptides,29581,-0.00939983050635778,0.00442887454612603,-0.0180804246167648,-0.000719236395950765,0.0338126938448246
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00492394585611,0.00232296512443686,-0.00947695750000626,-0.000370934212213751,0.0340431210625682
NMR metabolomics,X23424.Total Lipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00689774368754295,0.00326452723235472,-0.0132962170629582,-0.000499270312127707,0.0346162925067847
NMR metabolomics,X23424.Total Lipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00517796181015064,0.00246007865640588,0.000356207643595114,0.00999971597670617,0.0353194276629359
NMR metabolomics,X23424.Total Lipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0216887781411009,0.010305213285033,0.00149056010243628,0.0418869961797656,0.0353309973924388
NMR metabolomics,X23424.Total Lipids in VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.00868227060122324,0.00412569404046614,-0.0167686309205369,-0.000595910281909596,0.0353501699048637
NMR metabolomics,X23424.Total Lipids in VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00407137214255014,0.00193990467295739,-0.00787358530154664,-0.000269158983553652,0.0358494554530238
NMR metabolomics,X23424.Total Lipids in VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00796701013370461,0.00381940509355521,0.000480976150336388,0.0154530441170728,0.0369952035481014
NMR metabolomics,X23424.Total Lipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0179063761325285,0.00859622930819287,0.00105776668847044,0.0347549855765865,0.0372554634952218
NMR metabolomics,X23424.Total Lipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00938730155947642,0.00452729572923917,0.000513801930167644,0.0182608011887852,0.0381372657541024
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00698835663156002,0.00338928037726945,0.000345367092111891,0.0136313461710081,0.03922797585776
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.0106310371006906,0.00516736032291618,-0.0207590633336063,-0.000503010867774876,0.0396639005048378
NMR metabolomics,X23424.Total Lipids in VLDL,MYOC,Myocilin,29443,0.00642216026648111,0.00313771784161372,0.000272233296918212,0.012572087236044,0.0406903650224187
NMR metabolomics,X23424.Total Lipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00471010196038834,0.00230316698116628,-0.00922430924347424,-0.000195894677302438,0.0408583905333573
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.00835641722254823,0.004092353920848,0.000335403537686145,0.0163774309074103,0.0411646932514362
NMR metabolomics,X23424.Total Lipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.00432413970384951,0.00212305170013379,-0.00848532103611174,-0.000162958371587285,0.0416833341008939
NMR metabolomics,X23424.Total Lipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00563609220884442,0.00277555032269917,-0.0110761708413348,-0.00019601357635404,0.0423043027343109
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA2,Ephrin type-A receptor 2,28347,0.00438284111409741,0.00216243847240493,0.000144461708183736,0.00862122052001108,0.0426917046463344
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.00299756256487839,0.00148491669923596,8.71258343759121e-05,0.00590799929538087,0.0435318137487019
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00446788131118083,0.00221522881195597,0.000126032839747135,0.00880972978261453,0.0437173269636471
NMR metabolomics,X23424.Total Lipids in VLDL,UNC5D,Netrin receptor UNC5D,24229,0.0036391690695497,0.00182178528089271,6.84699189999935e-05,0.0072098682200994,0.0457729501049007
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00596509948444782,0.00299131467892002,-0.0118280762551311,-0.000102122713764575,0.0461480338732608
NMR metabolomics,X23424.Total Lipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00575743668719925,0.00288808939443574,9.67814741052071e-05,0.0114180919002933,0.0462164804569746
NMR metabolomics,X23424.Total Lipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00684470010146068,0.00344638588635527,8.97837642043556e-05,0.013599616438717,0.0470392065460773
NMR metabolomics,X23424.Total Lipids in VLDL,PGM2,Phosphoglucomutase-2,24195,0.00815368658274081,0.00415030685445356,1.90851480118236e-05,0.0162882880174698,0.0494721603031779
NMR metabolomics,X23424.Total Lipids in VLDL,TLR1,Toll-like receptor 1,24229,0.00357580782439616,0.00182045601055981,7.71404369894228e-06,0.00714390160509338,0.049513984840162
NMR metabolomics,X23424.Total Lipids in VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.00583359949073694,0.00297210604878434,-0.0116589273463542,-8.27163511962596e-06,0.0496828305590204
NMR metabolomics,X23424.Total Lipids in VLDL,SPRING1,SREBP regulating gene protein,24016,0.00806651110450819,0.0041105501303107,9.83284909921063e-06,0.0161231893599172,0.0497283869454733
NMR metabolomics,X23424.Total Lipids in VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.00727830829127292,0.00372110896165542,-0.0145716818561175,1.50652735717077e-05,0.0504805457397667
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.0104519481222875,0.00536859057284019,-7.04894004793059e-05,0.0209743856450543,0.0515599917233518
NMR metabolomics,X23424.Total Lipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00475200619510524,0.00244311769007642,-3.65044774445359e-05,0.00954051686765503,0.0517794263492741
NMR metabolomics,X23424.Total Lipids in VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00681886819487328,0.00350704726546982,-0.0136926808351941,5.49444454475577e-05,0.0518669128948825
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.019711883518733,0.0101492679838442,-0.0001806817296016,0.0396044487670675,0.0521244990291973
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00424043018446001,0.00218529280409112,-4.27437115585756e-05,0.0085236040804786,0.0523359174426998
NMR metabolomics,X23424.Total Lipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.0050878195204959,0.00262256070803376,-5.23994672502644e-05,0.0102280385082421,0.0523888818900054
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG4,Proteasome assembly chaperone 4,24229,0.0074803582459847,0.00387053606833502,-0.000105892447951949,0.0150666089399213,0.0532920356920413
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.00619964231674531,0.00321071811033922,-9.33651795195561e-05,0.0124926498130102,0.053504209724872
NMR metabolomics,X23424.Total Lipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.00833269348132892,0.00434545174437875,-0.0168497789003113,0.000184391937653426,0.0551777454010978
NMR metabolomics,X23424.Total Lipids in VLDL,IFNW1,Interferon omega-1,24111,-0.00476489206213807,0.00248725076413897,-0.00963990355985044,0.000110119435574307,0.0554117452735399
NMR metabolomics,X23424.Total Lipids in VLDL,MSLNL,Mesothelin-like protein,24195,-0.00497267580935028,0.00259817665664897,-0.0100651020563823,0.000119750437681704,0.055643471657017
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.0087849683579564,0.00460954634653227,-0.0178196791971596,0.000249742481246838,0.0566853318147883
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00611896765756936,0.00322153923747533,-0.000195249247882292,0.012433184563021,0.0575226520624794
NMR metabolomics,X23424.Total Lipids in VLDL,IL1A,Interleukin-1 alpha,28931,0.00724431761324813,0.00382639949634301,-0.00025542539958418,0.0147440606260804,0.0583350649201585
NMR metabolomics,X23424.Total Lipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00394952616984493,0.00208811351860994,-0.00804222866632041,0.00014317632663054,0.0585786366835948
NMR metabolomics,X23424.Total Lipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00375636442704007,0.00200181217416797,-0.000167187434329156,0.00767991628840929,0.0605995325067916
NMR metabolomics,X23424.Total Lipids in VLDL,TG,Thyroglobulin,24793,-0.0144164762133282,0.00769373565798123,-0.0294961981029715,0.000663245676314964,0.0609705739663001
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.00432378852533622,0.00230938402668082,-0.000202604166958186,0.00885018121763063,0.061181474543792
NMR metabolomics,X23424.Total Lipids in VLDL,CD5L,CD5 antigen-like,24833,0.00608560775443846,0.00325771350573198,-0.000299510716796222,0.0124707262256731,0.0617653343374034
NMR metabolomics,X23424.Total Lipids in VLDL,RTKN2,Rhotekin-2,24111,-0.00665940089155114,0.00357286340670714,-0.0136622131686971,0.000343411385594845,0.0623502288387124
NMR metabolomics,X23424.Total Lipids in VLDL,OTOA,Otoancorin,24101,-0.00686479972721414,0.00370420186435755,-0.0141250353813549,0.000395435926926655,0.0638592331822742
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN4,Contactin-4,29443,-0.00305691318187018,0.001653605917465,-0.00629798078010158,0.000184154416361219,0.0645206110743751
NMR metabolomics,X23424.Total Lipids in VLDL,GLI2,Zinc finger protein GLI2,24229,-0.00424194401140337,0.00230255799605859,-0.0087549576836782,0.000271069660871459,0.0654472180152924
NMR metabolomics,X23424.Total Lipids in VLDL,EDNRB,Endothelin receptor type B,24229,0.00580699341138803,0.00315363404558633,-0.000374129317961187,0.0119881161407372,0.0655802163263106
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00705378315687226,0.00383644374138061,-0.0145732128899783,0.000465646576233734,0.0659825493196557
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.0106003711407467,0.00579374854198209,-0.0219561182830316,0.000755376001538176,0.0673188444148054
NMR metabolomics,X23424.Total Lipids in VLDL,SOX2,Transcription factor SOX-2,24826,0.00299373164085555,0.00164250956263859,-0.00022558710191609,0.00621305038362719,0.0683673777917098
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.0032842929492935,0.0018051659772784,-0.000253832366172165,0.00682241826475916,0.0688646512749328
NMR metabolomics,X23424.Total Lipids in VLDL,COPE,Coatomer subunit epsilon,28774,0.00591154061250011,0.00325639100221698,-0.000470985751845184,0.0122940669768454,0.0694781348350905
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR1,Folate receptor alpha,29383,0.00359870927618869,0.00198397158866798,-0.000289875037600556,0.00748729358997794,0.0697046263213776
NMR metabolomics,X23424.Total Lipids in VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00412515216866642,0.0022759518940305,-0.00858601788096619,0.000335713543633357,0.069920061593129
NMR metabolomics,X23424.Total Lipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00628506086546277,0.00347483600091365,-0.0130957394272535,0.000525617696327979,0.0705044906808994
NMR metabolomics,X23424.Total Lipids in VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.0115203035399851,0.00638382738775036,-0.000991998140005612,0.0240326052199758,0.0711485238609259
NMR metabolomics,X23424.Total Lipids in VLDL,CD209,CD209 antigen,29527,-0.00481954497341097,0.00267171401626094,-0.0100561044452824,0.000417014498460465,0.0712548263541041
NMR metabolomics,X23424.Total Lipids in VLDL,MUCL3,Mucin-like protein 3,24016,-0.00541787000394895,0.00303056568952668,-0.0113577787554212,0.000522038747523333,0.0738302305299648
NMR metabolomics,X23424.Total Lipids in VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.00902333702967311,0.00505074777895863,-0.000876128617085806,0.018922802676432,0.0740252691666426
NMR metabolomics,X23424.Total Lipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00435071776800665,0.00243540922112635,-0.00042268430540099,0.00912411984141429,0.0740382124269451
NMR metabolomics,X23424.Total Lipids in VLDL,TCN2,Transcobalamin-2,29757,-0.00368077487871273,0.00206079748354744,-0.00771993794646571,0.000358388189040249,0.074094469875116
NMR metabolomics,X23424.Total Lipids in VLDL,IL17A,Interleukin-17A,28879,-0.00524498125993541,0.00293682613936541,-0.0110011604930916,0.000511197973220794,0.0741202402414951
NMR metabolomics,X23424.Total Lipids in VLDL,S100A3,Protein S100-A3,24793,0.00543493006114525,0.00306018161920907,-0.00056302591250454,0.011432886034795,0.0757426273050364
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS4,Galectin-4,29454,-0.0066206310902597,0.00374470472811161,-0.0139602523573585,0.000718990176839069,0.0770715658432937
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00653757711704997,0.00372981612505116,-0.0138480167221502,0.000772862488050297,0.0796511118033381
NMR metabolomics,X23424.Total Lipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00463403538702817,0.0026525549047118,-0.00983304300026329,0.000564972226206959,0.0806486407666766
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00443488593990301,0.00255097341954703,-0.00943479384221518,0.000565021962409158,0.0821342859505406
NMR metabolomics,X23424.Total Lipids in VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00611956843257151,0.00353708259252357,-0.0130522503139177,0.000813113448774699,0.0836221416321616
NMR metabolomics,X23424.Total Lipids in VLDL,PI16,Peptidase inhibitor 16,24951,0.00292451932055328,0.0016904758702214,-0.00038881338508067,0.00623785202618723,0.0836430639843115
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN4,Alpha-actinin-4,28931,0.00380262871688915,0.00220054963421576,-0.000510448566173745,0.00811570599995204,0.0839924682871509
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.00393329975957381,0.00228023665257915,-0.000535964079481313,0.00840256359862894,0.0845467801632394
NMR metabolomics,X23424.Total Lipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.00530026611505745,0.0030749280749675,-0.0113271251419938,0.000726592911878857,0.0847716571861903
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00342763102612772,0.00199192338696973,-0.0073318008645884,0.000476538812332954,0.0853064114276002
NMR metabolomics,X23424.Total Lipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00718473072875795,0.00420868311337049,-0.0154337496309641,0.00106428817344821,0.0878124736616239
NMR metabolomics,X23424.Total Lipids in VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00556123854879369,0.0032700870261122,-0.000848132022386229,0.0119706091199736,0.0890236406029944
NMR metabolomics,X23424.Total Lipids in VLDL,IL22,Interleukin-22,24793,-0.00790607356019753,0.00465996230639594,-0.0170395996807336,0.00122745256033851,0.0897856203399891
NMR metabolomics,X23424.Total Lipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00424061859307174,0.00250080747561082,-0.000660964059125455,0.00914220124526894,0.0899556304528177
NMR metabolomics,X23424.Total Lipids in VLDL,FBN2,Fibrillin-2,24195,0.00706141608427944,0.00416719074980162,-0.00110627778533173,0.0152291099538906,0.0901781148196295
NMR metabolomics,X23424.Total Lipids in VLDL,DBH,Dopamine beta-hydroxylase,24919,0.0127155133644918,0.00752780357200362,-0.00203898163663531,0.0274700083656189,0.0912051407590951
NMR metabolomics,X23424.Total Lipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00627886768727086,0.0037331260388955,-0.00103805934896433,0.013595794723506,0.0925948511071286
NMR metabolomics,X23424.Total Lipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,0.00842691662032796,0.00501445437425258,-0.00140141395320709,0.018255247193863,0.0928681542711553
NMR metabolomics,X23424.Total Lipids in VLDL,MMP13,Collagenase 3,28774,-0.00377283103170233,0.00225072923257849,-0.00818426032755617,0.000638598264151523,0.0936960880646379
NMR metabolomics,X23424.Total Lipids in VLDL,CD58,Lymphocyte function-associated antigen 3,29409,0.00202415802379878,0.00121152098185197,-0.000350423100631075,0.00439873914822864,0.0947801899895214
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,0.00539905973627908,0.00323281820325914,-0.000937263942108827,0.011735383414667,0.0949147335830365
NMR metabolomics,X23424.Total Lipids in VLDL,BEX3,Protein BEX3,24016,-0.00544325048897936,0.0032606513048895,-0.0118341270465628,0.000947626068604069,0.0950560824320284
NMR metabolomics,X23424.Total Lipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00346007719454443,0.00207461673931328,-0.00752632600359845,0.000606171614509597,0.0953654294624961
NMR metabolomics,X23424.Total Lipids in VLDL,SLC4A1,Band 3 anion transport protein,24938,-0.00536000803571996,0.00322339875333418,-0.0116778695922549,0.000957853520815025,0.0963563171486578
NMR metabolomics,X23424.Total Lipids in VLDL,PRR5,Proline-rich protein 5,24229,0.00546030987386395,0.00328854561660386,-0.000985239534679602,0.0119058592824075,0.0968464236647117
NMR metabolomics,X23424.Total Lipids in VLDL,IL4,Interleukin-4,28931,0.0104391586332655,0.00631277668514873,-0.00193388366962597,0.022812200936157,0.0982083594487311
NMR metabolomics,X23424.Total Lipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00559633992743875,0.00339838131293471,-0.0122571673007908,0.00106448744591328,0.0996190786388498
NMR metabolomics,X23424.Total Lipids in VLDL,RELB,Transcription factor RelB,24229,0.00559629433443613,0.00340802741278879,-0.00108343939462991,0.0122760280635022,0.100583937663509
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.00884285236402998,0.00539545074455288,-0.00173223109529367,0.0194179358233536,0.101235446416995
NMR metabolomics,X23424.Total Lipids in VLDL,CD177,CD177 antigen,29413,-0.0143326445288549,0.00879728624378924,-0.0315753255666819,0.00291003650897198,0.103278856351026
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN7,Septin-7,24445,0.00590361209248098,0.00363468735305535,-0.00122037511950749,0.0130275993044695,0.104337056748866
NMR metabolomics,X23424.Total Lipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00524227804661415,0.003229461180867,-0.00108746586788516,0.0115720219611135,0.104542941972206
NMR metabolomics,X23424.Total Lipids in VLDL,CORO6,Coronin-6,24101,-0.00420496326110147,0.00259168929570067,-0.00928467428067479,0.000874747758471846,0.104713764220475
NMR metabolomics,X23424.Total Lipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00406863699160183,0.00251213183311583,-0.000855141401305208,0.00899241538450886,0.105332139908431
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00383267310207882,0.00238781500288684,-0.00851279050773703,0.000847444303579384,0.108485283976077
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00301087124762358,0.00187821375632694,-0.000670427714777217,0.00669217021002437,0.108934222146377
NMR metabolomics,X23424.Total Lipids in VLDL,HYAL1,Hyaluronidase-1,29265,0.00252805522622628,0.00158039455367969,-0.000569518098985924,0.00562562855143847,0.10969026905757
NMR metabolomics,X23424.Total Lipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.00346604430725705,0.00217408076916423,-0.000795154000304849,0.00772724261481894,0.110889328650114
NMR metabolomics,X23424.Total Lipids in VLDL,GH2,Growth hormone variant,28797,0.0180835857211789,0.0113747558845177,-0.00421093581247581,0.0403781072548336,0.111890900212935
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB116,Beta-defensin 116,24101,-0.00845531802564814,0.00532328227202466,-0.0188889512788165,0.0019783152275202,0.112216834230674
NMR metabolomics,X23424.Total Lipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00681859101022677,0.00429624298248227,-0.00160204523543848,0.015239227255892,0.112501504391883
NMR metabolomics,X23424.Total Lipids in VLDL,REG1B,Lithostathine-1-beta,29820,-0.00614276202763028,0.00387105167871139,-0.0137300233179046,0.00144449926264404,0.112558184710849
NMR metabolomics,X23424.Total Lipids in VLDL,LPO,Lactoperoxidase,28452,-0.00654833293874487,0.00414277250449066,-0.0146681670475466,0.00157150117005681,0.113965917922205
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC8,Histone deacetylase 8,24229,0.00669065499122641,0.00423373959395513,-0.00160747461292564,0.0149887845953785,0.114047115185352
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00601537952262852,0.00383960006320118,-0.00151023660124578,0.0135409956465028,0.117205024590107
NMR metabolomics,X23424.Total Lipids in VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.00748099049829573,0.0047838849721993,-0.0168574050438064,0.00189542404721489,0.117880027686988
NMR metabolomics,X23424.Total Lipids in VLDL,MET,Hepatocyte growth factor receptor,29507,-0.00211531839614297,0.00135792821175515,-0.00477685769118306,0.000546220898897127,0.119302252940042
NMR metabolomics,X23424.Total Lipids in VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.00639217874967007,0.00413193680189486,-0.014490774881384,0.00170641738204385,0.12186966448797
NMR metabolomics,X23424.Total Lipids in VLDL,CD99,CD99 antigen,29443,-0.00208915737284834,0.00135137230681517,-0.00473784709420607,0.000559532348509397,0.122126796804903
NMR metabolomics,X23424.Total Lipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00611128418873047,0.0039631349030413,-0.00165646022123048,0.0138790285986914,0.123078795485898
NMR metabolomics,X23424.Total Lipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00388811417180963,0.00254811917142071,-0.00110619940417496,0.00888242774779423,0.127053457317684
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00429140577762642,0.00282292722966399,-0.00982434314776785,0.00124153159251501,0.128474421960652
NMR metabolomics,X23424.Total Lipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00543329899841593,0.00358775805369529,-0.00159870678682684,0.0124653047836587,0.129937301063834
NMR metabolomics,X23424.Total Lipids in VLDL,OGN,Mimecan,29443,-0.00437613780686678,0.00289295509630202,-0.0100463297956187,0.00129405418188517,0.130369724588267
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00486133462732109,0.00323239825782625,-0.0111968352126605,0.00147416595801835,0.132609847075215
NMR metabolomics,X23424.Total Lipids in VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00371053985911706,0.00246892551777423,-0.00854963387395454,0.00112855415572042,0.132876430357274
NMR metabolomics,X23424.Total Lipids in VLDL,IL33,Interleukin-33,28931,0.00400585689006594,0.00267950321284725,-0.00124596940711468,0.00925768318724655,0.134925394602206
NMR metabolomics,X23424.Total Lipids in VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.00652497760317106,0.00436970890456883,-0.00203965184978385,0.015089607056126,0.135390305314883
NMR metabolomics,X23424.Total Lipids in VLDL,ABO,Histo-blood group ABO system transferase,24951,0.0148417515076082,0.00993960645178667,-0.00463987713789367,0.0343233801531101,0.135399306219518
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.00492884652968773,0.0033033127259536,-0.00154564641318132,0.0114033394725568,0.135685994410281
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.00438051760490649,0.00293832534047327,-0.00137860006242113,0.0101396352722341,0.136019171472487
NMR metabolomics,X23424.Total Lipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00481633894377305,0.00323332801078685,-0.00152098395736919,0.0111536618449153,0.136344682801018
NMR metabolomics,X23424.Total Lipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00545189495899277,0.00366830181889294,-0.0017379766060374,0.0126417665240229,0.137235249917155
NMR metabolomics,X23424.Total Lipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.0110192994008567,0.00746280851571686,-0.00360780528994831,0.0256464040916618,0.139806159512046
NMR metabolomics,X23424.Total Lipids in VLDL,PRTN3,Myeloblastin,28671,-0.0048168548862926,0.00326348268152517,-0.0112132809420819,0.00157957116949674,0.139958626672599
NMR metabolomics,X23424.Total Lipids in VLDL,MSMB,Beta-microseminoprotein,29313,0.00705410197466038,0.00477954989099942,-0.00231381581169849,0.0164220197610192,0.139983491971335
NMR metabolomics,X23424.Total Lipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00241709387228035,0.00164126787456055,-0.00563397890641903,0.000799791161858328,0.140844828148105
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00551114347438949,0.00374793286713602,-0.0128570918939761,0.00183480494519711,0.141453136409677
NMR metabolomics,X23424.Total Lipids in VLDL,THBS2,Thrombospondin-2,29443,-0.00376321856655441,0.00257012520795852,-0.00880066397415311,0.00127422684104429,0.143145609121989
NMR metabolomics,X23424.Total Lipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.00320013758548762,0.00218723112525341,-0.00108683542000905,0.0074871105909843,0.143450719118196
NMR metabolomics,X23424.Total Lipids in VLDL,TFRC,Transferrin receptor protein 1,29565,-0.00386240934061556,0.0026482577942709,-0.00905299461738653,0.00132817593615542,0.144721167504572
NMR metabolomics,X23424.Total Lipids in VLDL,IL25,Interleukin-25,23913,0.00345598325109074,0.00238861860767902,-0.00122570921996014,0.00813767572214162,0.147950832996952
NMR metabolomics,X23424.Total Lipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00336832506660265,0.00233090437435384,-0.00120024750713087,0.00793689764033617,0.148450220075894
NMR metabolomics,X23424.Total Lipids in VLDL,LCN15,Lipocalin-15,24867,-0.00618807319698083,0.00429090911507703,-0.0145982550625318,0.00222210866857015,0.149276698186716
NMR metabolomics,X23424.Total Lipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00544985475705236,0.00378107942049457,-0.00196106090711699,0.0128607704212217,0.149497019520261
NMR metabolomics,X23424.Total Lipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.00577462341001933,0.00400903407737668,-0.00208308338163896,0.0136323302016776,0.149764228145889
NMR metabolomics,X23424.Total Lipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00644704830845291,0.00448289188947211,-0.0152335164118182,0.00233941979491242,0.150405924348279
NMR metabolomics,X23424.Total Lipids in VLDL,GFRAL,GDNF family receptor alpha-like,24025,-0.00620763215456436,0.00432094133344606,-0.0146766771681186,0.00226141285898992,0.15083366994664
NMR metabolomics,X23424.Total Lipids in VLDL,CPLX2,Complexin-2,24016,-0.00303526665005151,0.00212493719718399,-0.00720014355653213,0.00112961025642911,0.153188910619458
NMR metabolomics,X23424.Total Lipids in VLDL,NXPE4,NXPE family member 4,24111,-0.0033879879075123,0.00237289630779533,-0.00803886467079114,0.00126288885576654,0.153366449500888
NMR metabolomics,X23424.Total Lipids in VLDL,DUOX2,Dual oxidase 2,28916,0.00695407495638612,0.0049062260564373,-0.00266212811423099,0.0165702780270032,0.156377379544552
NMR metabolomics,X23424.Total Lipids in VLDL,TEX33,Testis-expressed protein 33,24445,-0.00379250137009788,0.00268939341251926,-0.00906371245863562,0.00147870971843987,0.158502281751893
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0133277172523036,0.00950399250587931,-0.031955542563827,0.00530010805921987,0.160829700516022
NMR metabolomics,X23424.Total Lipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00804797467916231,0.00574975185956268,-0.0193174883239052,0.00322153896558055,0.161613422244238
NMR metabolomics,X23424.Total Lipids in VLDL,TPSG1,Tryptase gamma,24229,0.00258297434490866,0.00184537742474076,-0.00103396540758324,0.00619991409740055,0.161616055246324
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00674729693481731,0.00483750286051973,-0.016228802541436,0.00273420867180137,0.163092266690742
NMR metabolomics,X23424.Total Lipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00436700506022289,0.00314247622844133,-0.0105262584679679,0.00179224834752211,0.164641940970926
NMR metabolomics,X23424.Total Lipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00298727314869646,0.00215264783518196,-0.00123191660826018,0.0072064629056531,0.165232923438096
NMR metabolomics,X23424.Total Lipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00598245329913425,0.00433214785272586,-0.0144734630904769,0.00250855649220844,0.16730901189705
NMR metabolomics,X23424.Total Lipids in VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.00307563813446698,0.00223637765819828,-0.00130766207560165,0.00745893834453561,0.169056382571244
NMR metabolomics,X23424.Total Lipids in VLDL,REST,RE1-silencing transcription factor,24016,-0.0033246219513134,0.00242087104895086,-0.00806952920725708,0.00142028530463028,0.169666829459576
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.00461043865078986,0.0033822352560869,-0.0112396197527202,0.00201874245114046,0.172850802781353
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.00604940196557229,0.00444466624686927,-0.00266214387829148,0.0147609478094361,0.173509062045773
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.00292214779693553,0.00215359853053142,-0.00714320091677711,0.00129890532290606,0.174835989444733
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00359361544029798,0.00267397833877356,-0.0016473821036982,0.00883461298429416,0.1789864391328
NMR metabolomics,X23424.Total Lipids in VLDL,CD200,OX-2 membrane glycoprotein,29434,-0.00244622845303039,0.00182293275903237,-0.00601917666073383,0.00112671975467305,0.179632554921293
NMR metabolomics,X23424.Total Lipids in VLDL,CDH22,Cadherin-22,24445,-0.00262456124848816,0.00197076592246199,-0.00648726245651365,0.00123813995953733,0.182955822928837
NMR metabolomics,X23424.Total Lipids in VLDL,FGF12,Fibroblast growth factor 12,24229,0.00428341990949984,0.00323066748876663,-0.00204868836848275,0.0106155281874824,0.184897851823518
NMR metabolomics,X23424.Total Lipids in VLDL,FBLN2,Fibulin-2,24938,-0.00285035470928212,0.00216416634338525,-0.00709212074231722,0.00139141132375297,0.187827867660244
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.00592091587003598,0.00449827740353635,-0.00289570784089526,0.0147375395809672,0.188096292910572
NMR metabolomics,X23424.Total Lipids in VLDL,FZD8,Frizzled-8,24101,0.0039867709828,0.00303506774968961,-0.00196196180659163,0.00993550377219163,0.189003789844957
NMR metabolomics,X23424.Total Lipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.00305503914735381,0.00233316395139628,-0.00151796219738289,0.00762804049209051,0.190409926925414
NMR metabolomics,X23424.Total Lipids in VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00544475041494176,0.00415823513436656,-0.0027053904484167,0.0135948912783002,0.190412774630698
NMR metabolomics,X23424.Total Lipids in VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00788059732945586,0.00602587961305938,-0.00393012671214052,0.0196913213710522,0.190956383864437
NMR metabolomics,X23424.Total Lipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.00253022318124855,0.00195207464007707,-0.00129584311330251,0.00635628947579961,0.194928530955889
NMR metabolomics,X23424.Total Lipids in VLDL,PRG3,Proteoglycan 3,24938,-0.00445494790947587,0.00343983876052377,-0.0111970318801025,0.00228713606115072,0.195296454437867
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.0102722826447466,0.00795678982556249,-0.00532302541335588,0.0258675907028491,0.196712766814608
NMR metabolomics,X23424.Total Lipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00617916496620678,0.00479445806442949,-0.00321797284007502,0.0155763027724886,0.197475066333753
NMR metabolomics,X23424.Total Lipids in VLDL,CBX2,Chromobox protein homolog 2,24111,-0.00358215059352048,0.00278051446691028,-0.00903195894866463,0.00186765776162368,0.197652195222505
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD5,Sushi domain-containing protein 5,24273,-0.00304666990047927,0.00236491582832934,-0.00768190492400478,0.00158856512304625,0.197661367980619
NMR metabolomics,X23424.Total Lipids in VLDL,PXDNL,Peroxidasin-like protein,24793,0.00513326465897388,0.00398761908183952,-0.00268246874143159,0.0129489980593793,0.198001538907333
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.00751674523662468,0.00584039724129653,-0.00393043335631652,0.0189639238295659,0.198095224306042
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00431836414304402,0.00335530380755471,-0.00225803131976322,0.0108947596058513,0.198095439310013
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.00620940038308994,0.00483398360642554,-0.00326520748550411,0.015684008251684,0.198968309513639
NMR metabolomics,X23424.Total Lipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00281938499087693,0.00220173742820384,-0.00713479035015646,0.00149602036840261,0.200372106828289
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,0.00515975730296233,0.00404616117622503,-0.00277071860243873,0.0130902332083634,0.202240316396437
NMR metabolomics,X23424.Total Lipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00362659884279863,0.00284433454068166,-0.00920149454253469,0.00194829685693742,0.202312542888581
NMR metabolomics,X23424.Total Lipids in VLDL,CD160,CD160 antigen,29786,0.00406451191639406,0.00322108432687857,-0.00224881336428793,0.0103778371970761,0.207014142721967
NMR metabolomics,X23424.Total Lipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00496615705316673,0.00395275948576228,-0.0127135656452608,0.00278125153892733,0.208991414197605
NMR metabolomics,X23424.Total Lipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00319512434018024,0.00256197577124999,-0.00821659685183022,0.00182634817146974,0.212360882666036
NMR metabolomics,X23424.Total Lipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00576477310573117,0.00462376596779016,-0.0148273544025999,0.00329780819113756,0.212493929590574
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN15,Tetraspanin-15,24111,-0.00435033262394321,0.00349102913679877,-0.0111927497320688,0.00249208448418238,0.212722848029524
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.00509363385646168,0.00409138156371907,-0.0131127417213511,0.0029254740084277,0.213154075234039
NMR metabolomics,X23424.Total Lipids in VLDL,HRAS,GTPase Hras,24421,0.00845424080431418,0.00679563326499501,-0.00486520039507604,0.0217736820037044,0.213485893255422
NMR metabolomics,X23424.Total Lipids in VLDL,WNT9A,Protein Wnt-9a,28931,0.00245178271705819,0.00198400136813003,-0.00143685996447666,0.00634042539859305,0.216551606794171
NMR metabolomics,X23424.Total Lipids in VLDL,GPA33,Cell surface A33 antigen,29349,0.0114558857883063,0.00927108665162165,-0.00671544404887213,0.0296272156254847,0.216595875402858
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP2,Dipeptidase 2,29349,0.0024832022404835,0.00201277843013648,-0.001461843482584,0.006428247963551,0.217317655011163
NMR metabolomics,X23424.Total Lipids in VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.00539281585180317,0.004376317144061,-0.0031847657505564,0.0139703974541627,0.217859329874028
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00278307977028445,0.00226062389692649,-0.00721390260826037,0.00164774306769147,0.21829323614921
NMR metabolomics,X23424.Total Lipids in VLDL,ESPL1,Separin,24016,-0.00470026333200097,0.00382886496962519,-0.0122048386724663,0.00280431200846441,0.219614233512048
NMR metabolomics,X23424.Total Lipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00599088204206217,0.00488431610211219,-0.0155641416022021,0.00358237751807772,0.220001903684047
NMR metabolomics,X23424.Total Lipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00313763445232651,0.00256014949346223,-0.00188025855485946,0.00815552745951248,0.220371685435648
NMR metabolomics,X23424.Total Lipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00655742437647894,0.00535373632554018,-0.00393589882157981,0.0170507475745377,0.220650681580374
NMR metabolomics,X23424.Total Lipids in VLDL,SHH,Sonic hedgehog protein,24229,-0.0036338281793242,0.0029669187497431,-0.00944898892882068,0.00218133257017227,0.220669346502474
NMR metabolomics,X23424.Total Lipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00282244967474026,0.00230942334477665,-0.00170402008102198,0.0073489194305025,0.221664885106209
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,0.00482531846008126,0.0039560280843541,-0.00292849658525278,0.0125791335054153,0.22257382866613
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00335640197179026,0.00276808785341032,-0.00878185416447448,0.00206905022089397,0.225319576273853
NMR metabolomics,X23424.Total Lipids in VLDL,PSCA,Prostate stem cell antigen,24805,0.0214615284832632,0.0178748908294142,-0.0135732575423886,0.056496314508915,0.229897582933158
NMR metabolomics,X23424.Total Lipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00359582883497555,0.00300230751506123,-0.00228869389454446,0.00948035156449557,0.231049804164275
NMR metabolomics,X23424.Total Lipids in VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.00345769982138929,0.00289450672339758,-0.00913093299924855,0.00221553335646997,0.232265566075744
NMR metabolomics,X23424.Total Lipids in VLDL,IL36A,Interleukin-36 alpha,24229,-0.00479098672927134,0.00401903153115026,-0.0126682885303259,0.00308631507178318,0.23324354838186
NMR metabolomics,X23424.Total Lipids in VLDL,TNNI3,"Troponin I, cardiac muscle",28916,0.00689254309328168,0.0057892167301816,-0.00445432169787426,0.0182394078844376,0.23382710222416
NMR metabolomics,X23424.Total Lipids in VLDL,MAPT,Microtubule-associated protein tau,28774,0.00430525570243283,0.0036370507848347,-0.00282336383584319,0.0114338752407089,0.236533055330115
NMR metabolomics,X23424.Total Lipids in VLDL,ERVV_1,,24111,-0.0037615032476722,0.00318490904623134,-0.0100039249782856,0.00248091848294123,0.237598705927859
NMR metabolomics,X23424.Total Lipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.00550139318513571,0.00465843164778899,-0.0146319192148021,0.00362913284453072,0.237630588608416
NMR metabolomics,X23424.Total Lipids in VLDL,ENPEP,Glutamyl aminopeptidase,24111,0.00359716919522894,0.00307376610912191,-0.00242741237865001,0.00962175076910789,0.241899594434015
NMR metabolomics,X23424.Total Lipids in VLDL,CDAN1,Codanin-1,24845,0.0018035577794143,0.00155532601216971,-0.00124488120443834,0.00485199676326693,0.24622239655819
NMR metabolomics,X23424.Total Lipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00392252224113803,0.00338502625512324,-0.0105571737011796,0.00271212921890352,0.246554808845071
NMR metabolomics,X23424.Total Lipids in VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.00682518252835258,0.00590095880449735,-0.0183910617851674,0.00474069672846222,0.247435988559075
NMR metabolomics,X23424.Total Lipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00202904756554096,0.00175563122413481,-0.00547008476484519,0.00141198963376328,0.247800346189296
NMR metabolomics,X23424.Total Lipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00565684976299038,0.00491714937874303,-0.00398076301934595,0.0152944625453267,0.24997704755096
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.00171087680795261,0.00149668926528505,-0.00122263415200609,0.00464438776791132,0.253005238691562
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS2,Podocin,24229,-0.00809784461783376,0.00712985070044608,-0.0220723519907081,0.00587666275504056,0.25606559783834
NMR metabolomics,X23424.Total Lipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00676636655049046,0.00595904234240079,-0.00491335644061509,0.018446089541596,0.256185877381165
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.0060061090101234,0.00531361162782705,-0.0164207878006644,0.00440856978041762,0.258350483946964
NMR metabolomics,X23424.Total Lipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00290133719434323,0.00257293330039452,-0.00794428646311649,0.00214161207443004,0.259484086561287
NMR metabolomics,X23424.Total Lipids in VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00615224443131489,0.00550803565532211,-0.0169479943157462,0.00464350545311644,0.264023490309857
NMR metabolomics,X23424.Total Lipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00321313460885326,0.00287776988484653,-0.00242729436544593,0.00885356358315246,0.264203725080923
NMR metabolomics,X23424.Total Lipids in VLDL,KLK1,Kallikrein-1,29199,-0.00975342984415583,0.00875999417530385,-0.0269230184277514,0.00741615873943971,0.265543280430377
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00290020805452765,0.00260655051234138,-0.00800904705871676,0.00220863094966146,0.265864954923084
NMR metabolomics,X23424.Total Lipids in VLDL,IL5,Interleukin-5,28931,0.010864289451164,0.00977439327087891,-0.00829352135975863,0.0300221002620867,0.266360171978162
NMR metabolomics,X23424.Total Lipids in VLDL,DCLRE1C,Protein artemis,24016,-0.00237843238578061,0.002147817565528,-0.0065881548142155,0.00183129004265428,0.268144354185962
NMR metabolomics,X23424.Total Lipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,0.00939096582393043,0.00848199792562366,-0.00723375011029194,0.0260156817581528,0.268233870392195
NMR metabolomics,X23424.Total Lipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00418696628432133,0.00380054633785104,-0.0116360371065094,0.00326210453786671,0.270614105408419
NMR metabolomics,X23424.Total Lipids in VLDL,CDH4,Cadherin-4,24101,0.00364942983666366,0.0033180650796513,-0.0028539777194529,0.0101528373927802,0.271401125842373
NMR metabolomics,X23424.Total Lipids in VLDL,CD82,CD82 antigen,24445,-0.0031456706654562,0.00286844886888286,-0.0087678304484666,0.0024764891175542,0.27280733243775
NMR metabolomics,X23424.Total Lipids in VLDL,MMP8,Neutrophil collagenase,29640,0.00545165297025475,0.00497317662218649,-0.00429577320923076,0.0151990791497403,0.272995177005663
NMR metabolomics,X23424.Total Lipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00552984650996765,0.00505601022363843,-0.015439626548299,0.00437993352836368,0.274089864683277
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.00604180056005193,0.00553962643763784,-0.0168994683778221,0.00481586725771824,0.275437313065284
NMR metabolomics,X23424.Total Lipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.00587502449480904,0.00538724954566555,-0.00468398461469543,0.0164340336043135,0.27548500568578
NMR metabolomics,X23424.Total Lipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00367065893040138,0.00337675004987559,-0.00294777116735477,0.0102890890281575,0.277030403128039
NMR metabolomics,X23424.Total Lipids in VLDL,RETN,Resistin,29362,-0.00315222670648146,0.00290048353602465,-0.00883717443708977,0.00253272102412685,0.277136998806522
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_A,,24867,0.00244740667029742,0.00225257607554435,-0.00196764243776951,0.00686245577836434,0.27727176183159
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00594647528288544,0.00548633310229203,-0.0166996881633778,0.00480673759760694,0.278432862241068
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.00576119573045294,0.00531680259544292,-0.0161821288175211,0.00465973735661518,0.278558906550416
NMR metabolomics,X23424.Total Lipids in VLDL,TAP1,Antigen peptide transporter 1,24445,-0.00447354652902314,0.00414170781347963,-0.0125912938434432,0.00364420078539693,0.280098862621033
NMR metabolomics,X23424.Total Lipids in VLDL,FZD10,Frizzled-10,24195,0.00447879775745388,0.00415352127688992,-0.00366210394525037,0.0126196994601581,0.280904663852246
NMR metabolomics,X23424.Total Lipids in VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.00235154526362778,0.00219201858342887,-0.0019448111598928,0.00664790168714835,0.28338055678114
NMR metabolomics,X23424.Total Lipids in VLDL,OSTN,Osteocrin,24195,-0.0030896636279406,0.00288380448444261,-0.00874192041744811,0.00256259316156691,0.284007240754582
NMR metabolomics,X23424.Total Lipids in VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00713576669080837,0.00666663745675756,-0.00593084272443645,0.0202023761060532,0.284463660578354
NMR metabolomics,X23424.Total Lipids in VLDL,CHGB,Secretogranin-1,29590,0.00300403921049912,0.00282787384245571,-0.00253859352071406,0.00854667194171231,0.288109981136283
NMR metabolomics,X23424.Total Lipids in VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.00318036395177687,0.00299471563729259,-0.00905000660087034,0.0026892786973166,0.288248205388549
NMR metabolomics,X23424.Total Lipids in VLDL,PMCH,Pro-MCH,24111,-0.00609003142976803,0.00577451332036018,-0.017408077537674,0.00522801467813792,0.291600679303694
NMR metabolomics,X23424.Total Lipids in VLDL,FGF7,Fibroblast growth factor 7,24016,-0.00574062484403383,0.00548261264002768,-0.0164865456184881,0.00500529593042043,0.295082411903294
NMR metabolomics,X23424.Total Lipids in VLDL,MMP15,Matrix metalloproteinase-15,24922,0.00353781871993279,0.00339209387458011,-0.00311068527424422,0.0101863227141098,0.296976874024316
NMR metabolomics,X23424.Total Lipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00355575972316259,0.0034263533701924,-0.0102714123287397,0.00315989288241452,0.299388513156748
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF830,Zinc finger protein 830,24793,-0.00566331736545572,0.00546094149551147,-0.0163667626966582,0.00504012796574677,0.29971858038812
NMR metabolomics,X23424.Total Lipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,0.0035685963436848,0.00345018113866212,-0.00319375868809295,0.0103309513754626,0.300996003606297
NMR metabolomics,X23424.Total Lipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00419516286768567,0.00406533072890858,-0.00377288536097515,0.0121632110963465,0.302112260911973
NMR metabolomics,X23424.Total Lipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00408058589811803,0.00398319427770231,-0.00372647488617849,0.0118876466824146,0.305632801619903
NMR metabolomics,X23424.Total Lipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00234620783011532,0.00229491373060139,-0.00215182308186341,0.00684423874209405,0.306623260642891
NMR metabolomics,X23424.Total Lipids in VLDL,NEB,Nebulin,24111,-0.00267145800701709,0.00261599226904079,-0.00779880285433704,0.00245588684030286,0.307168730839971
NMR metabolomics,X23424.Total Lipids in VLDL,OPTC,Opticin,29349,-0.00313290713143903,0.00310191725033915,-0.00921266494210378,0.00294685067922571,0.312508144678111
NMR metabolomics,X23424.Total Lipids in VLDL,COL5A1,Collagen alpha-1(V) chain,24381,0.00279837519035094,0.00278371385726675,-0.0026577039698919,0.00825445435059377,0.314778367478832
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL6,Fc receptor-like protein 6,29434,0.00468915832014495,0.00466729103270744,-0.00445873210396163,0.0138370487442515,0.315056710109916
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00509770107009869,0.00508255251296725,-0.00486410185531713,0.0150595039955145,0.31588034448915
NMR metabolomics,X23424.Total Lipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.0029939639264818,0.00300957929610093,-0.00290481149387603,0.00889273934683963,0.319837831715096
NMR metabolomics,X23424.Total Lipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00425459227623348,0.00431480688651385,-0.0127116137738006,0.00420242922133366,0.324121103895351
NMR metabolomics,X23424.Total Lipids in VLDL,TCP11,T-complex protein 11 homolog,24445,-0.00401988321735701,0.0040941209786227,-0.0120443603354575,0.00400459390074348,0.326174985647422
NMR metabolomics,X23424.Total Lipids in VLDL,RRP15,RRP15-like protein,24101,-0.00613771162946487,0.00627852789818466,-0.0184436263099068,0.00616820305097706,0.328295983098572
NMR metabolomics,X23424.Total Lipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00297279498126069,0.00305546212388618,-0.00896150074407761,0.00301591078155622,0.330590705639486
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1,DNA topoisomerase 1,24805,0.00757124901211271,0.00780507189160598,-0.00772669189543501,0.0228691899196604,0.332034927651415
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA3,GDNF family receptor alpha-3,29157,0.0018664611865235,0.00193645361350664,-0.00192898789594951,0.00566191026899651,0.335126446702238
NMR metabolomics,X23424.Total Lipids in VLDL,COL3A1,Collagen alpha-1(III) chain,24938,-0.0015477764996366,0.0016059217529019,-0.00469538313532434,0.00159983013605113,0.335158956504051
NMR metabolomics,X23424.Total Lipids in VLDL,HSP90B1,Endoplasmin,28626,0.00443151100800413,0.00461301714276325,-0.00461000259181185,0.0134730246078201,0.336734542973477
NMR metabolomics,X23424.Total Lipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00417843610959965,0.0043498329202705,-0.00434723641413053,0.0127041086333298,0.336764384098876
NMR metabolomics,X23424.Total Lipids in VLDL,TNXB,Tenascin-X,29443,0.00169311477597505,0.00177376155895467,-0.00178345787957611,0.0051696874315262,0.339821515845311
NMR metabolomics,X23424.Total Lipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00479597448454888,0.00502850835797236,-0.0146518508661747,0.00505990189707695,0.340216283587631
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.0029152785296677,0.0030613853618989,-0.00891559383898955,0.00308503677965415,0.340967405101815
NMR metabolomics,X23424.Total Lipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.00481579861520768,0.00505736368812298,-0.00509663421351336,0.0147282314439287,0.340985648878188
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,0.00177667830897096,0.00187060266888456,-0.00188970292204278,0.00544305953998471,0.342227049363424
NMR metabolomics,X23424.Total Lipids in VLDL,CD2,T-cell surface antigen CD2,24111,0.00250152466342314,0.00265175160968617,-0.00269590849156175,0.00769895781840803,0.345512372685868
NMR metabolomics,X23424.Total Lipids in VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.00328269704013107,0.00351024053656223,-0.00359737441153091,0.010162768491793,0.349704820185413
NMR metabolomics,X23424.Total Lipids in VLDL,NENF,Neudesin,24793,0.00707180233803553,0.00757382880079796,-0.00777290211152847,0.0219165067875995,0.350459698037615
NMR metabolomics,X23424.Total Lipids in VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00174697043838047,0.00187954174746344,-0.00193693138664787,0.00543087226340882,0.35265682323045
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.0040981101450756,0.00445069378146272,-0.0128214699567425,0.00462524966659133,0.357174352500613
NMR metabolomics,X23424.Total Lipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00161268440970809,0.00175145585049072,-0.00504553787666989,0.00182016905725371,0.357180504158864
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00238175516134582,0.00258884681655691,-0.00269238459910571,0.00745589492179736,0.357578720865241
NMR metabolomics,X23424.Total Lipids in VLDL,CA3,Carbonic anhydrase 3,29761,0.00378366479288017,0.00412211496995269,-0.0042956805482271,0.0118630101339874,0.358681780399817
NMR metabolomics,X23424.Total Lipids in VLDL,TNPO1,Transportin-1,24445,0.0022396033344351,0.00244169001264363,-0.00254610909034642,0.00702531575921663,0.359028608098224
NMR metabolomics,X23424.Total Lipids in VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00529789515975464,0.00579102916719665,-0.0060525220079508,0.0166483123274601,0.360282066962972
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00258202870137385,0.00283075861449685,-0.00296625818303996,0.00813031558578767,0.361707642822326
NMR metabolomics,X23424.Total Lipids in VLDL,STC2,Stanniocalcin-2,29396,-0.00162272149263265,0.0017826046839515,-0.00511662667317759,0.00187118368791229,0.362666921099501
NMR metabolomics,X23424.Total Lipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00392164311256085,0.00431880043428506,-0.0123864919637596,0.00454320573863787,0.363866222483971
NMR metabolomics,X23424.Total Lipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.00296494629206948,0.00326916606412337,-0.00937251177775128,0.00344261919361233,0.364444698508182
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.00189166037960906,0.00209109238969986,-0.00220688070420266,0.00599020146342079,0.365669932273687
NMR metabolomics,X23424.Total Lipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00409320621357469,0.00455004752190816,-0.0130112993565147,0.00482488692936531,0.368344117114497
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00358102243922787,0.00398712835414067,-0.00423374913488784,0.0113957940133436,0.369116773982001
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF75D,Zinc finger protein 75D,24445,0.00368863701732666,0.00414742090756095,-0.00444030796149281,0.0118175819961461,0.373807153269814
NMR metabolomics,X23424.Total Lipids in VLDL,DNLZ,DNL-type zinc finger protein,24101,-0.00551285794601777,0.00622906741109756,-0.017721830071769,0.00669611417973345,0.376153925259042
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00401585615974746,0.00454188583282995,-0.0129179523920942,0.00488624007259925,0.376606502717818
NMR metabolomics,X23424.Total Lipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00472055815563389,0.00536111976062612,-0.0057872365751933,0.0152283528864611,0.378587943108273
NMR metabolomics,X23424.Total Lipids in VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00550741925261124,0.00625494495574808,-0.0177671113658775,0.00675227286065501,0.378602418835799
NMR metabolomics,X23424.Total Lipids in VLDL,ACRV1,Acrosomal protein SP-10,24229,-0.00466277280700914,0.00529829744559757,-0.0150474358003804,0.0057218901863621,0.378840329617409
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.00623839597280692,0.00711320628071689,-0.00770348833739818,0.020180280283012,0.380486641022327
NMR metabolomics,X23424.Total Lipids in VLDL,UBQLN3,Ubiquilin-3,24111,-0.00304251157906408,0.00347402554356711,-0.00985160164445562,0.00376657848632746,0.38115375900877
NMR metabolomics,X23424.Total Lipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00240061234113814,0.00274556731095368,-0.00778192427060735,0.00298069958833108,0.38193132289827
NMR metabolomics,X23424.Total Lipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00212240868876194,0.00243624816930217,-0.00689745510059419,0.0026526377230703,0.383665003639606
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00253698047180652,0.00291485869944905,-0.00317614257911362,0.00825010352272666,0.384111566942934
NMR metabolomics,X23424.Total Lipids in VLDL,RBM25,RNA-binding protein 25,24016,-0.0027667729042082,0.00320767518553614,-0.00905381626785903,0.00352027045944264,0.388394805404696
NMR metabolomics,X23424.Total Lipids in VLDL,CEP350,Centrosome-associated protein 350,24016,0.00217911347073951,0.00255412395903641,-0.00282696948897186,0.00718519643045088,0.393571047524203
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00243818708410753,0.00285878040075962,-0.00804139666959639,0.00316502250138132,0.393736152841561
NMR metabolomics,X23424.Total Lipids in VLDL,CGN,Cingulin,24195,0.0023452501804509,0.00275254930703005,-0.003049746461328,0.00774024682222979,0.394206767993903
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM2,Intercellular adhesion molecule 2,29820,-0.00185686820576142,0.00218711820690582,-0.00614361989129683,0.00242988347977398,0.395886877398965
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00177670949212202,0.00210299530965251,-0.0023451613147969,0.00589858029904093,0.398203234683658
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.0029868247522063,0.00353949012886639,-0.00992422540478443,0.00395057590037183,0.398757501721132
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00193746773971969,0.00231140280032884,-0.0064678172283642,0.00259288174892483,0.401913133133681
NMR metabolomics,X23424.Total Lipids in VLDL,IL20,Interleukin-20,28931,0.00277099079460062,0.00336809158515829,-0.00383046871230963,0.00937245030151088,0.410674954610373
NMR metabolomics,X23424.Total Lipids in VLDL,PDCL2,Phosducin-like protein 2,24016,0.00298889256772554,0.00366305513964983,-0.00419069550598813,0.0101684806414392,0.414533282062364
NMR metabolomics,X23424.Total Lipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00540609307908334,0.00677289106298163,-0.00786877340436065,0.0186809595625273,0.424764750741982
NMR metabolomics,X23424.Total Lipids in VLDL,MMP9,Matrix metalloproteinase-9,29411,-0.00331451793950463,0.0041565571219181,-0.0114613698984641,0.00483233401945484,0.425214124764853
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB5,Serpin B5,28916,0.00263692323930013,0.00334534267840821,-0.00391994841037996,0.00919379488898022,0.430564491906633
NMR metabolomics,X23424.Total Lipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0143182537355229,0.0182013368864603,-0.049992874032985,0.0213563665619393,0.431488940320699
NMR metabolomics,X23424.Total Lipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00305556206710829,0.00392234463543507,-0.010743357552561,0.00463223341834445,0.43597904544774
NMR metabolomics,X23424.Total Lipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.00915990379706667,0.0118174034569588,-0.0140022069785726,0.0323220145727059,0.438275167943334
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAX,Integrin alpha-X,24445,0.0028145189251504,0.00369242635238035,-0.0044226367255151,0.0100516745758159,0.445923511140453
NMR metabolomics,X23424.Total Lipids in VLDL,ESR1,Estrogen receptor,24229,0.00302317573215329,0.00397472874014573,-0.00476729259853234,0.0108136440628389,0.446903868670459
NMR metabolomics,X23424.Total Lipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00246048158971529,0.00325383763573029,-0.00391704017631608,0.00883800335574665,0.449549624732752
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00188298324280631,0.00250110830158032,-0.00301918902829112,0.00678515551390375,0.451541653231127
NMR metabolomics,X23424.Total Lipids in VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.00354166172297007,0.00478298145408363,-0.012916305372974,0.00583298192703384,0.459021093248616
NMR metabolomics,X23424.Total Lipids in VLDL,TAGLN3,Transgelin-3,24016,-0.00308156321255279,0.00417300996271546,-0.0112606627394751,0.00509753631436951,0.460247677493035
NMR metabolomics,X23424.Total Lipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00198053536799782,0.00270328693574692,-0.00331790702606615,0.00727897776206179,0.463785328222388
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL1,Interferon lambda-1,28774,0.00227609522883231,0.00311503848415326,-0.00382938020010809,0.00838157065777271,0.464980800627926
NMR metabolomics,X23424.Total Lipids in VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.00233050995153432,0.00319797343139025,-0.0085985378770592,0.00393751797399056,0.466164172030774
NMR metabolomics,X23424.Total Lipids in VLDL,PKLR,Pyruvate kinase PKLR,29491,0.00322669918403982,0.0044327180454427,-0.00546142818502786,0.0119148265531075,0.466663498877078
NMR metabolomics,X23424.Total Lipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.00355212030861157,0.00488849176126817,-0.0131335641606972,0.00602932354347404,0.467458946894331
NMR metabolomics,X23424.Total Lipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00243244226057389,0.003354149865375,-0.0041416914755611,0.00900657599670888,0.468334048156093
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00372118278267165,0.00514273022598698,-0.0138009340256061,0.00635856846026283,0.469329928344291
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171A2,Protein FAM171A2,24867,0.00783318059483382,0.0109173426958725,-0.0135648110890762,0.0292311722787439,0.473073102528488
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00260936321910299,0.00364656179185426,-0.00975662433113735,0.00453789789293136,0.474264939117966
NMR metabolomics,X23424.Total Lipids in VLDL,GAD1,Glutamate decarboxylase 1,24016,-0.00128202554942306,0.00179673610272235,-0.00480362831075887,0.00223957721191276,0.475524642825726
NMR metabolomics,X23424.Total Lipids in VLDL,FOS,Proto-oncogene c-Fos,23970,-0.00172664361108303,0.00245036738239596,-0.00652936368057911,0.00307607645841306,0.481036897051526
NMR metabolomics,X23424.Total Lipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00155456709790036,0.00221426756659554,-0.00278539733262689,0.00589453152842761,0.482643113975944
NMR metabolomics,X23424.Total Lipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00243552367686094,0.00347730231142666,-0.00925103620725719,0.00437998885353531,0.483680424255104
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00153278713187528,0.00224600532953389,-0.00286938331401114,0.0059349575777617,0.494960785108942
NMR metabolomics,X23424.Total Lipids in VLDL,TBR1,T-box brain protein 1,24195,0.0022630079209218,0.00333271790181582,-0.0042691191666372,0.0087951350084808,0.497126781486798
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH17,Protocadherin-17,29478,0.00166200235248312,0.00247524117136844,-0.00318947034339904,0.00651347504836527,0.501938736576697
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR3,Folate receptor gamma,29461,-0.00861110912934949,0.0128818022671171,-0.033859441572899,0.0166372233142,0.503838331871508
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA5,Annexin A5,28650,0.00137758989519657,0.00209287258984432,-0.00272444038089829,0.00547962017129143,0.510396142184845
NMR metabolomics,X23424.Total Lipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.000951103209795841,0.00144784094951026,-0.00378887147083595,0.00188666505124427,0.511244134603774
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00265486787614399,0.00407139897432271,-0.0106348098658165,0.00532507411352853,0.514357366700765
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00421030407599693,0.00645759381093484,-0.0168671879454292,0.00844657979343535,0.514412119711321
NMR metabolomics,X23424.Total Lipids in VLDL,BRD2,Bromodomain-containing protein 2,24101,0.00156043698020753,0.00239337808997921,-0.00313058407615171,0.00625145803656677,0.514419666744847
NMR metabolomics,X23424.Total Lipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,-0.00205285031244996,0.00315719779643187,-0.00824095799345644,0.00413525736855651,0.515559887842114
NMR metabolomics,X23424.Total Lipids in VLDL,NRN1,Neuritin,24867,-0.0015930665996034,0.00246207790305981,-0.00641873928960062,0.00323260609039382,0.517611055472456
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.0018403291243361,0.00292639190631329,-0.00389539901203794,0.00757605726071014,0.529438084237863
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3B,Sodium channel subunit beta-3,24101,0.00199283946811162,0.00318171983837067,-0.00424333141509489,0.00822901035131813,0.531097671141365
NMR metabolomics,X23424.Total Lipids in VLDL,MAG,Myelin-associated glycoprotein,24195,0.00203892778308664,0.00327252135321811,-0.00437521406922085,0.00845306963539413,0.533260883720676
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.00271491111746531,0.00437762937522408,-0.0112950646929045,0.00586524245797388,0.535145116876468
NMR metabolomics,X23424.Total Lipids in VLDL,S100A16,Protein S100-A16,28722,-0.00261450176967116,0.00422855304154842,-0.0109024657311061,0.00567346219176375,0.536384467196908
NMR metabolomics,X23424.Total Lipids in VLDL,IGFL4,Insulin growth factor-like family member 4,24229,0.0032045121099826,0.00519958021012718,-0.00698666510186668,0.0133956893218319,0.537700958270841
NMR metabolomics,X23424.Total Lipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00205404399164233,0.00333612185923911,-0.00859284283575098,0.00448475485246632,0.538099558190209
NMR metabolomics,X23424.Total Lipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00235600798362886,0.00386984682188888,-0.00522889178727335,0.00994090775453107,0.542655005596111
NMR metabolomics,X23424.Total Lipids in VLDL,KLK12,Kallikrein-12,28797,-0.00578968842219835,0.00952620713673824,-0.0244610544102053,0.0128816775658086,0.543348618228328
NMR metabolomics,X23424.Total Lipids in VLDL,POF1B,Protein POF1B,24229,-0.00191560909051549,0.00316563496983095,-0.00812025363138414,0.00428903545035316,0.545100727247697
NMR metabolomics,X23424.Total Lipids in VLDL,TP73,Tumor protein p73,24195,0.00143078164487379,0.00238508727499265,-0.0032439894141118,0.00610555270385938,0.548587504746352
NMR metabolomics,X23424.Total Lipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00224532806893996,0.00374503373658981,-0.00509493805477607,0.009585594192656,0.548813047089301
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB2,Beta-crystallin B2,24845,0.00284098570474098,0.00476703584686417,-0.00650240455511279,0.0121843759645948,0.551204154756893
NMR metabolomics,X23424.Total Lipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.0011634372295821,0.00195630258813546,-0.00499779030232761,0.0026709158431634,0.552040382879636
NMR metabolomics,X23424.Total Lipids in VLDL,IL31,Interleukin-31,24229,-0.00233570167073121,0.00392811578165221,-0.0100348086027695,0.00536340526130713,0.552108941872706
NMR metabolomics,X23424.Total Lipids in VLDL,SHC1,SHC-transforming protein 1,24016,-0.00476782235808573,0.00805559787019429,-0.0205567941836665,0.0110211494674951,0.553946906078369
NMR metabolomics,X23424.Total Lipids in VLDL,STEAP4,Metalloreductase STEAP4,24101,0.0030177095899864,0.00510961002560813,-0.00699712606020553,0.0130325452401783,0.554797428099729
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00130070745452096,0.00220354838224348,-0.00561966228371818,0.00301824737467626,0.555009421504891
NMR metabolomics,X23424.Total Lipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00104601023593576,0.00178600432396193,-0.00245455823902963,0.00454657871090115,0.558102375026569
NMR metabolomics,X23424.Total Lipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00196503195615963,0.00336657346528695,-0.00856351594812205,0.00463345203580279,0.559434131682896
NMR metabolomics,X23424.Total Lipids in VLDL,KLHL41,Kelch-like protein 41,24867,0.00199157318638591,0.00342635725711191,-0.00472408703755344,0.00870723341032526,0.561076648762136
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.00111218379979547,0.00193818345214093,-0.00268665576640075,0.00491102336599169,0.566088610842578
NMR metabolomics,X23424.Total Lipids in VLDL,SHD,SH2 domain-containing adapter protein D,24059,0.00337562930742679,0.00588318495029822,-0.00815541319515773,0.0149066718100113,0.566124875540584
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.00192310915345395,0.00336214642219987,-0.00851291614096569,0.00466669783405778,0.567335041905481
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00169416214010931,0.00299615948782718,-0.00756663473625059,0.00417831045603197,0.57177664915825
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.0022156730009652,0.00393967810968523,-0.00550609609401785,0.00993744209594826,0.573848130815166
NMR metabolomics,X23424.Total Lipids in VLDL,HEBP1,Heme-binding protein 1,28916,-0.00205517348105294,0.00366226947455256,-0.00923322165117596,0.00512287468907008,0.574682704700105
NMR metabolomics,X23424.Total Lipids in VLDL,THY1,Thy-1 membrane glycoprotein,29694,-0.0010852736912246,0.00196162329828945,-0.00493005535587192,0.00275950797342273,0.580094445682451
NMR metabolomics,X23424.Total Lipids in VLDL,SLC51B,Organic solute transporter subunit beta,24111,-0.00290809834332592,0.00527107652146502,-0.0132394083253974,0.00742321163874553,0.581153120528014
NMR metabolomics,X23424.Total Lipids in VLDL,BSND,Barttin,24016,-0.00128583418414911,0.00233979550581934,-0.00587183337555501,0.0033001650072568,0.582633302026932
NMR metabolomics,X23424.Total Lipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00105324794612539,0.00193761258891667,-0.00274447272815128,0.00485096862040206,0.586735229794102
NMR metabolomics,X23424.Total Lipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00222843238477667,0.00410516933532432,-0.005817699512459,0.0102745642820123,0.587247965602952
NMR metabolomics,X23424.Total Lipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00298037398082043,0.00550715952881243,-0.00781365869565193,0.0137744066572928,0.588387369253867
NMR metabolomics,X23424.Total Lipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.00128546162840452,0.00237678756686446,-0.00337304200264981,0.00594396525945886,0.58862292580197
NMR metabolomics,X23424.Total Lipids in VLDL,FGF3,Fibroblast growth factor 3,24229,0.00109965930785181,0.00207203894777989,-0.00296153702979677,0.0051608556455004,0.595622107657472
NMR metabolomics,X23424.Total Lipids in VLDL,CLINT1,Clathrin interactor 1,24016,0.00171516849481959,0.00329331834149098,-0.00473973545450272,0.0081700724441419,0.602509151011627
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00273055403380785,0.0052706564264128,-0.00759993256196124,0.0130610406295769,0.604416020023427
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00118290925504343,0.00230185002600448,-0.00569453530601222,0.00332871679592536,0.607329321289687
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.0017366598331075,0.0033873805879942,-0.00490260611936112,0.00837592578557613,0.608176258012786
NMR metabolomics,X23424.Total Lipids in VLDL,TPT1,Translationally-controlled tumor protein,28931,0.00228958988894596,0.00448995774002686,-0.00651072728150669,0.0110899070593986,0.61010037917093
NMR metabolomics,X23424.Total Lipids in VLDL,PROK1,Prokineticin-1,29434,0.00213815659777448,0.00421835995116982,-0.00612982890651837,0.0104061421020673,0.612250419306974
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA10,Annexin A10,28774,0.00283956157486435,0.00564205503089142,-0.00821886628568283,0.0138979894354115,0.614767776735887
NMR metabolomics,X23424.Total Lipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,-0.00173872728480761,0.00347022248376559,-0.00854036335298816,0.00506290878337293,0.616345998650912
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN4,Prefoldin subunit 4,24016,0.00183469030148915,0.00369615277470035,-0.00540976913692354,0.00907914973990184,0.619632026198205
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.000972823703720878,0.00198285034969264,-0.0029135629816767,0.00485921038911846,0.623699682906855
NMR metabolomics,X23424.Total Lipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.0010029283306538,0.0020481825813556,-0.00501736619011077,0.00301150952880317,0.624373554815377
NMR metabolomics,X23424.Total Lipids in VLDL,GAGE2A,G antigen 2A,24016,0.00212465776106209,0.0043882514224538,-0.00647631502694735,0.0107256305490715,0.628269955592441
NMR metabolomics,X23424.Total Lipids in VLDL,HBZ,Hemoglobin subunit zeta,24922,0.00351560026568926,0.00729794768523904,-0.0107883771973793,0.0178195777287578,0.63000589521027
NMR metabolomics,X23424.Total Lipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00166768197361613,0.00346354953127155,-0.00512087510767611,0.00845623905490836,0.630169067278982
NMR metabolomics,X23424.Total Lipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.000900366635939159,0.00188936080823847,-0.00460351382008656,0.00280278054820824,0.633689265782145
NMR metabolomics,X23424.Total Lipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00167720498263991,0.00353798879819403,-0.00861166302710021,0.00525725306182039,0.635464221037802
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00207579562827904,0.00440577648276716,-0.00655952627794459,0.0107111175345027,0.63753562830899
NMR metabolomics,X23424.Total Lipids in VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.00133157292052432,0.0028400538764935,-0.00689807851845158,0.00423493267740294,0.639177646118224
NMR metabolomics,X23424.Total Lipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00181522645608656,0.00389554249203434,-0.00945048974047388,0.00582003682830075,0.641237417203183
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.000883918708755321,0.00190160252638439,-0.00284322224295808,0.00461105966046873,0.642057844030531
NMR metabolomics,X23424.Total Lipids in VLDL,CHIT1,Chitotriosidase-1,29579,0.0047816329970879,0.0104730160261027,-0.0157454784140733,0.0253087444082491,0.64798569219705
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00241054211746755,0.00528218767406944,-0.0127636299586437,0.00794254572370855,0.648140167325525
NMR metabolomics,X23424.Total Lipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00178563198758822,0.00391370933159995,-0.00945650227752412,0.00588523830234769,0.648213939431571
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00152806060101743,0.0033718353608068,-0.00813685790819875,0.0050807367061639,0.650420613113309
NMR metabolomics,X23424.Total Lipids in VLDL,CAPN3,Calpain-3,24793,0.00118393318669176,0.00261460235657665,-0.00394068743219847,0.00630855380558199,0.650685369527195
NMR metabolomics,X23424.Total Lipids in VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.0015973642564197,0.00356492556161306,-0.00858461835718129,0.00538988984434189,0.65410090370441
NMR metabolomics,X23424.Total Lipids in VLDL,CNTF,Ciliary neurotrophic factor,24101,-0.00105281337173833,0.00235338033882504,-0.0056654388358354,0.00355981209235875,0.654617596923134
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00126858900944045,0.00287435085961059,-0.00690231669427721,0.0043651386753963,0.658965020522953
NMR metabolomics,X23424.Total Lipids in VLDL,IGLON5,IgLON family member 5,24016,-0.00283320488891268,0.00644358504764448,-0.0154626315822959,0.0097962218044705,0.660162796928051
NMR metabolomics,X23424.Total Lipids in VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.00196456855567276,0.00448309426544619,-0.00682229620460177,0.0107514333159473,0.661232189257371
NMR metabolomics,X23424.Total Lipids in VLDL,PGR,Progesterone receptor,24229,0.00307243710670767,0.00702666787495036,-0.010699831928195,0.0168447061416104,0.661931208637663
NMR metabolomics,X23424.Total Lipids in VLDL,CDSN,Corneodesmosin,29676,0.00127847293451295,0.00298029365414533,-0.0045629026276119,0.00711984849663779,0.667944176105136
NMR metabolomics,X23424.Total Lipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00202551149148694,0.0047867785141227,-0.0114075973791674,0.00735657439619354,0.672191709304267
NMR metabolomics,X23424.Total Lipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,0.00135377757454389,0.00320934457738351,-0.00493653779712779,0.00764409294621557,0.67315736981635
NMR metabolomics,X23424.Total Lipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00181310822703915,0.00437500926429004,-0.00676190993096932,0.0103881263850476,0.678567421396641
NMR metabolomics,X23424.Total Lipids in VLDL,HMCN2,Hemicentin-2,24343,0.00164607865830657,0.00397387761315807,-0.00614272146348324,0.00943487878009638,0.678713132996535
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF174,Zinc finger protein 174,24229,0.00106492293107789,0.00260998671687249,-0.00405065103399219,0.00618049689614796,0.683263681848686
NMR metabolomics,X23424.Total Lipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00201044313018557,0.00493048935322596,-0.0116742022625084,0.00765331600213731,0.683455422758674
NMR metabolomics,X23424.Total Lipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00117906755368166,0.00291019697565773,-0.00688305362597082,0.00452491851860749,0.685370427135232
NMR metabolomics,X23424.Total Lipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.000718208864694765,0.00178691786242079,-0.00278415014564997,0.0042205678750395,0.687741884207392
NMR metabolomics,X23424.Total Lipids in VLDL,KHDC3L,KH domain-containing protein 3,24016,-0.00186587386186259,0.00466661666513068,-0.0110124425255187,0.00728069480179355,0.689282051839869
NMR metabolomics,X23424.Total Lipids in VLDL,EPB41L5,Band 4.1-like protein 5,24195,0.00173202399808202,0.00433777425274755,-0.00677001353730318,0.0102340615334672,0.689684060115594
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2B,Alpha-amylase 2B,27585,-0.00131734858875304,0.00337359564727669,-0.00792959605741536,0.00529489887990928,0.69617875013993
NMR metabolomics,X23424.Total Lipids in VLDL,IL9,Interleukin-9,24445,-0.00152768825311258,0.00391587894166287,-0.0092028109787718,0.00614743447254665,0.696446388995562
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS5,Transmembrane protease serine 5,29079,0.00102139975179379,0.00261914351186436,-0.00411212153146036,0.00615492103504793,0.696558099723855
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC9,Histone deacetylase 9,24101,-0.00173702193321192,0.00447174651988026,-0.0105016451121772,0.00702760124575339,0.697691115251246
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.000918513560504852,0.00236575916643478,-0.00371837440570732,0.00555540152671703,0.697831459454958
NMR metabolomics,X23424.Total Lipids in VLDL,CLNS1A,Methylosome subunit pICln,24195,0.000890851503422871,0.00231195710834827,-0.00364058442893973,0.00542228743578547,0.700001110428255
NMR metabolomics,X23424.Total Lipids in VLDL,DAND5,DAN domain family member 5,24229,-0.00143452559503456,0.00375646945628863,-0.00879720572936028,0.00592815453929116,0.702552731718187
NMR metabolomics,X23424.Total Lipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.000525297266886032,0.00139026648383907,-0.00325021957521062,0.00219962504143856,0.705552710627637
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.0011542885381436,0.00307487674371044,-0.00487246987952887,0.00718104695581606,0.707371100990483
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00441866397276863,0.0118865289073853,-0.0277162606312438,0.0188789326857066,0.71009176484357
NMR metabolomics,X23424.Total Lipids in VLDL,EVI2B,Protein EVI2B,24016,-0.00104471559103763,0.00283700390171033,-0.00660524323838987,0.0045158120563146,0.712692994609434
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN7,Tetraspanin-7,24101,-0.00238119243364358,0.00649638203716817,-0.0151141012264932,0.010351716359206,0.713964406814531
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.00106521991144287,0.00291095293456338,-0.00464024784030135,0.00677068766318709,0.714416099134564
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,0.0012092046331836,0.00330831711069503,-0.00527509690377866,0.00769350617014585,0.714737515830426
NMR metabolomics,X23424.Total Lipids in VLDL,CYTH3,Cytohesin-3,24016,0.00184579492519899,0.00506388872691229,-0.0080794269795491,0.0117710168299471,0.715486781458695
NMR metabolomics,X23424.Total Lipids in VLDL,RLN2,Prorelaxin H2,24326,0.00277631080546277,0.00782348644525133,-0.0125577226272298,0.0181103442381554,0.722691003607125
NMR metabolomics,X23424.Total Lipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.000965286035827539,0.00277976732002074,-0.0044830579114131,0.00641362998306818,0.728403266688228
NMR metabolomics,X23424.Total Lipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00118448776074961,0.00341217122626871,-0.00787234336423629,0.00550336784273707,0.728492128727255
NMR metabolomics,X23424.Total Lipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.000970459739463004,0.00281749417169845,-0.00455182883706597,0.00649274831599198,0.730517856261385
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00161420083198816,0.00474249308846686,-0.00768108562140689,0.0109094872853832,0.733581078976232
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA2,Protein disulfide-isomerase A2,24016,0.000951805167190358,0.00281596991503063,-0.00456749586626968,0.0064711062006504,0.735364180733242
NMR metabolomics,X23424.Total Lipids in VLDL,EXOSC10,Exosome component 10,24111,-0.00141042686723058,0.00418707880863373,-0.00961710133215268,0.00679624759769152,0.736231225272683
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000836114663959534,0.00251709346444351,-0.0057696178542688,0.00409738852634974,0.739760178681295
NMR metabolomics,X23424.Total Lipids in VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.00102027655652001,0.00313021934688541,-0.0051149533633754,0.00715550647641541,0.744469394578284
NMR metabolomics,X23424.Total Lipids in VLDL,TPSD1,Tryptase delta,24867,-0.000823881447088926,0.00257718293709842,-0.00587516000380183,0.00422739710962397,0.749211372208426
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN1,Neuroligin-1,24195,-0.00147978570063592,0.0047196867209874,-0.0107303716737712,0.00777080027249939,0.753877143655704
NMR metabolomics,X23424.Total Lipids in VLDL,EPGN,Epigen,24793,-0.00103112392602968,0.00330723434663402,-0.00751330324543236,0.00545105539337301,0.755211634369777
NMR metabolomics,X23424.Total Lipids in VLDL,IL21R,Interleukin-21 receptor,24229,0.00117786271840907,0.00379848783659871,-0.00626717344132439,0.00862289887814254,0.756497262052595
NMR metabolomics,X23424.Total Lipids in VLDL,AKAP12,A-kinase anchor protein 12,24381,0.000457237061728544,0.00148482279933302,-0.00245301562496417,0.00336748974842126,0.758130246648887
NMR metabolomics,X23424.Total Lipids in VLDL,RBP1,Retinol-binding protein 1,24195,0.00146920740992232,0.00478548668401592,-0.00791034649074889,0.0108487613105935,0.758835995788193
NMR metabolomics,X23424.Total Lipids in VLDL,CASP4,Caspase-4,24445,-0.00346417970962484,0.0116097927882308,-0.0262193735745573,0.0192910141553076,0.76541242012248
NMR metabolomics,X23424.Total Lipids in VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.000916140317071907,0.00308108959229152,-0.00695507591796329,0.00512279528381948,0.766207210267817
NMR metabolomics,X23424.Total Lipids in VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.000823556409033646,0.00279462590022137,-0.00630102317346754,0.00465391035540024,0.768231036598445
NMR metabolomics,X23424.Total Lipids in VLDL,FGF20,Fibroblast growth factor 20,24229,-0.000878343448022169,0.00303066031778449,-0.00681843767087977,0.00506175077483543,0.771957065396068
NMR metabolomics,X23424.Total Lipids in VLDL,PCARE,Photoreceptor cilium actin regulator,24101,0.00168916079195163,0.00584190032398003,-0.00976096384304922,0.0131392854269525,0.772472314554435
NMR metabolomics,X23424.Total Lipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.00283664401441628,0.00991446744884232,-0.0222690002141472,0.0165957121853147,0.77479512656476
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN6,Prefoldin subunit 6,24195,0.00127647439045539,0.00451264699036623,-0.00756831371066242,0.0101212624915732,0.777281982126454
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3A,Uroplakin-3a,24101,0.000930483982491925,0.00339720871310116,-0.00572804509518636,0.00758901306017021,0.784166418072953
NMR metabolomics,X23424.Total Lipids in VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.00072764381068266,0.00273746377096219,-0.00609307280176855,0.00463778518040323,0.790388218855634
NMR metabolomics,X23424.Total Lipids in VLDL,SKIV2L,Helicase SKI2W,24111,-0.000727376974238928,0.00276306286520917,-0.00614298019004891,0.00468822624157105,0.792359957508899
NMR metabolomics,X23424.Total Lipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,0.00105779807389744,0.00414054081108762,-0.00705766191583429,0.00917325806362917,0.798359660665215
NMR metabolomics,X23424.Total Lipids in VLDL,MYL6B,Myosin light chain 6B,24195,-0.0015858924218265,0.00632911515712179,-0.0139909581297852,0.0108191732861322,0.802147969739118
NMR metabolomics,X23424.Total Lipids in VLDL,CASQ2,Calsequestrin-2,24111,0.0008453071609461,0.00337374600111702,-0.00576723500124326,0.00745784932313546,0.802160718240441
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD4,Sushi domain-containing protein 4,24793,-0.00071951456196331,0.00288695145084049,-0.00637793940561068,0.00493891028168406,0.803185033814664
NMR metabolomics,X23424.Total Lipids in VLDL,EFNB2,Ephrin-B2,24195,-0.000978429961558027,0.0039837983029445,-0.00878667463532925,0.0068298147122132,0.805992205500805
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.000805809389903273,0.0033613294705826,-0.00578239637243863,0.00739401515224517,0.810542105305051
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.00106959038216967,0.00450234717627019,-0.0077550100833199,0.00989419084765924,0.812221829024357
NMR metabolomics,X23424.Total Lipids in VLDL,IL10,Interleukin-10,28931,0.00132800788117374,0.00562621609639071,-0.00969937566775206,0.0123553914300995,0.813403877755469
NMR metabolomics,X23424.Total Lipids in VLDL,TFF1,Trefoil factor 1,29319,-0.00125905049107195,0.00542310497630144,-0.0118883362446228,0.00937023526247887,0.816412151843381
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,0.000799185366414171,0.00346546671787438,-0.00599312940061961,0.00759150013344795,0.81761659088772
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,-0.000775555336177058,0.00337416273874098,-0.00738891430410939,0.00583780363175527,0.818209292036391
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR1B,Cornifin-B,24445,0.00134270550370884,0.0059023105594265,-0.0102258231927671,0.0129112342001848,0.820046113379638
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.000952040039864111,0.00434140023513074,-0.00946118450072036,0.00755710442099213,0.826423126945784
NMR metabolomics,X23424.Total Lipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000596786692323963,0.00276976638159447,-0.0048319554156012,0.00602552880024912,0.829406908853326
NMR metabolomics,X23424.Total Lipids in VLDL,GJA8,Gap junction alpha-8 protein,24016,0.0009228041645119,0.00429519400183969,-0.00749577607909389,0.00934138440811769,0.829889409830701
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,0.000825005465128287,0.00384598000806068,-0.00671311535067064,0.00836312628092721,0.830150321423078
NMR metabolomics,X23424.Total Lipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.000497250061212544,0.00234910280910509,-0.00510149156705852,0.00410699144463343,0.832361153622127
NMR metabolomics,X23424.Total Lipids in VLDL,RUVBL1,RuvB-like 1,28797,0.00149067035094968,0.00711194657874922,-0.0124487449433988,0.0154300856452982,0.83398066636441
NMR metabolomics,X23424.Total Lipids in VLDL,TEX101,Testis-expressed protein 101,24195,0.000729497065561812,0.00349274178226909,-0.00611627682768561,0.00757527095880924,0.834558615783728
NMR metabolomics,X23424.Total Lipids in VLDL,SCIN,Adseverin,24101,0.00105062973962076,0.00506717714199643,-0.00888103745869223,0.0109822969379338,0.835745900385428
NMR metabolomics,X23424.Total Lipids in VLDL,OMP,Olfactory marker protein,24101,-0.000689428828446134,0.00340470558592188,-0.00736265177685302,0.00598379411996075,0.839533090938789
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2BP,LRP2-binding protein,24195,-0.00114418455350277,0.00570294862242251,-0.0123219638534509,0.0100335947464453,0.840989315406559
NMR metabolomics,X23424.Total Lipids in VLDL,IKZF2,Zinc finger protein Helios,28797,0.00123459429863335,0.00628024245876511,-0.0110746809205463,0.013543869517813,0.844154590629273
NMR metabolomics,X23424.Total Lipids in VLDL,ISM2,Isthmin-2,24938,-0.000592535692224819,0.00303097729413552,-0.00653325118873044,0.00534817980428081,0.845008391741722
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A14,Zinc transporter ZIP14,28774,0.000449261296751349,0.0023039231450156,-0.00406642806747923,0.00496495066098193,0.845395587907489
NMR metabolomics,X23424.Total Lipids in VLDL,PALLD,Palladin,24229,0.000536343760080736,0.00275552160682468,-0.00486447858929563,0.0059371661094571,0.845673852364786
NMR metabolomics,X23424.Total Lipids in VLDL,TP53BP1,TP53-binding protein 1,24229,0.00114804031253238,0.00603184356330998,-0.0106743730715552,0.0129704536966199,0.849052203597991
NMR metabolomics,X23424.Total Lipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00108545272413891,0.0059563234447065,-0.0105889412274858,0.0127598466757637,0.855399560293329
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.000729855149920448,0.00410799191170416,-0.00878151929686061,0.00732180899701971,0.858985891707928
NMR metabolomics,X23424.Total Lipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.000767080126592208,0.00434324840755041,-0.00927984700539101,0.0077456867522066,0.859812761662132
NMR metabolomics,X23424.Total Lipids in VLDL,NCLN,Nicalin,28931,-0.000603356958102284,0.00359768280035127,-0.00765481524679077,0.0064481013305862,0.866814881136626
NMR metabolomics,X23424.Total Lipids in VLDL,IL13,Interleukin-13,28931,-0.000536687479908519,0.00331276003525607,-0.00702969714901042,0.00595632218919338,0.871302147334978
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.00132072196533702,0.00816071094481969,-0.0146742714865096,0.0173157154171836,0.871433686997512
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,0.000450499258492839,0.00284409253314063,-0.0051239221064628,0.00602492062344848,0.874144085827351
NMR metabolomics,X23424.Total Lipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.000843339525057535,0.00539298721193883,-0.00972691541034258,0.0114135944604576,0.87573711774732
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2A,Pancreatic alpha-amylase,28334,0.00048571638817166,0.00329409171997134,-0.00597070338297217,0.00694213615931549,0.882777277804257
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.000663621867067135,0.00453873382476278,-0.00955954016360218,0.00823229642946791,0.883754465904072
NMR metabolomics,X23424.Total Lipids in VLDL,ANK2,Ankyrin-2,24111,0.000691869004169723,0.00497928185000433,-0.00906752342183876,0.0104512614301782,0.889491171564291
NMR metabolomics,X23424.Total Lipids in VLDL,TNR,Tenascin-R,29218,0.000394163343825539,0.00290059649133089,-0.00529100577918301,0.00607933246683409,0.891908826936907
NMR metabolomics,X23424.Total Lipids in VLDL,CD70,CD70 antigen,29434,-0.000393139594660585,0.00293673878927527,-0.00614914762164011,0.00536286843231894,0.893506727032801
NMR metabolomics,X23424.Total Lipids in VLDL,IL24,Interleukin-24,28931,-0.00043445486736075,0.00335165617532833,-0.00700370097100429,0.00613479123628278,0.896864865971508
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD2,Leiomodin-2,24101,0.000539285252919902,0.00436861017719511,-0.00802319069438252,0.00910176120022232,0.901755361434454
NMR metabolomics,X23424.Total Lipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,0.000308251301080412,0.00252697322278466,-0.00464461621557752,0.00526111881773834,0.902912390199866
NMR metabolomics,X23424.Total Lipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.000761694056680997,0.0062609264384025,-0.0115097217625879,0.0130331098759499,0.903170599812213
NMR metabolomics,X23424.Total Lipids in VLDL,PSMA1,Proteasome subunit alpha type-1,28797,-0.000379690684447183,0.00318668011409579,-0.00662558370807493,0.00586620233918057,0.905157909757673
NMR metabolomics,X23424.Total Lipids in VLDL,TLR2,Toll-like receptor 2,24445,0.000188272358113925,0.0015869567762433,-0.00292216292332295,0.0032987076395508,0.905563642860505
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.000392568451837416,0.00340086671577199,-0.00627313031107569,0.00705826721475052,0.908103756855829
NMR metabolomics,X23424.Total Lipids in VLDL,BTNL10,Butyrophilin-like protein 10,24016,-0.000321528427854182,0.00282377566582266,-0.00585612873286659,0.00521307187715823,0.909345984691082
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.000397233030008313,0.00348953147168822,-0.00644224865450059,0.00723671471451722,0.909368872271021
NMR metabolomics,X23424.Total Lipids in VLDL,FGF6,Fibroblast growth factor 6,24229,0.000317064603427039,0.00284205610122853,-0.00525336535498087,0.00588749456183495,0.911171867884862
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO1,R-spondin-1,29218,0.000256853834573201,0.00240965283962879,-0.00446606573109923,0.00497977340024563,0.915112041474511
NMR metabolomics,X23424.Total Lipids in VLDL,TET2,Methylcytosine dioxygenase TET2,24421,-0.000728826856497625,0.00692288454576509,-0.0142976805661972,0.012840026853202,0.916156151326594
NMR metabolomics,X23424.Total Lipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.000389573495496438,0.00372422874222757,-0.00768906183026248,0.0069099148392696,0.91668998900093
NMR metabolomics,X23424.Total Lipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.000477542819700075,0.00456724667828704,-0.00942934630914267,0.00847426066974252,0.916727289954227
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00051111925567071,0.00532862306700159,-0.00993298195565241,0.0109552204669938,0.923585246256643
NMR metabolomics,X23424.Total Lipids in VLDL,IL3,Interleukin-3,24016,0.000384341171114922,0.0041814236297249,-0.00781124914314588,0.00857993148537572,0.926765273194837
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL2,Interferon lambda-2,24101,-0.000380813836714109,0.00427043468501397,-0.0087508658193415,0.00798923814591328,0.928943979719238
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN1,Cerebellin-1,24101,-0.000580652407461802,0.00658943995647502,-0.0134959547221528,0.0123346499072292,0.929783123611224
NMR metabolomics,X23424.Total Lipids in VLDL,HK2,Hexokinase-2,28916,-0.000141274569266808,0.0018868752167229,-0.00383954999404369,0.00355700085551008,0.94031688402464
NMR metabolomics,X23424.Total Lipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.000374563907828403,0.00506613191956867,-0.010304182470183,0.00955505465452619,0.941062798643777
NMR metabolomics,X23424.Total Lipids in VLDL,IL17F,Interleukin-17F,28931,-0.000384299147802843,0.00527055510536701,-0.0107145871543222,0.00994598885871651,0.941874771717654
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,0.000162514169490286,0.00258962439704649,-0.00491314964872084,0.00523817798770141,0.949961329417381
NMR metabolomics,X23424.Total Lipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.000229291741459189,0.00375785898714796,-0.00759469535626919,0.00713611187335081,0.951346500241275
NMR metabolomics,X23424.Total Lipids in VLDL,HMMR,Hyaluronan mediated motility receptor,23975,0.000190781102721587,0.0033451020549019,-0.00636561892488615,0.00674718113032932,0.954519407747528
NMR metabolomics,X23424.Total Lipids in VLDL,TXK,Tyrosine-protein kinase TXK,24445,0.000281861816129408,0.00514035843509323,-0.00979324071665333,0.0103569643489121,0.956271874095053
NMR metabolomics,X23424.Total Lipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.000188123651171722,0.00362290685818665,-0.00691277379087412,0.00728902109321756,0.958587957939771
NMR metabolomics,X23424.Total Lipids in VLDL,MORN4,MORN repeat-containing protein 4,24016,0.000255925394886122,0.00541756575853266,-0.0103625034918379,0.0108743542816101,0.962322401274261
NMR metabolomics,X23424.Total Lipids in VLDL,IL19,Interleukin-19,28654,0.000190582772521633,0.00483604332927999,-0.00928806215286715,0.00966922769791042,0.968564720828722
NMR metabolomics,X23424.Total Lipids in VLDL,EVPL,Envoplakin,24445,7.61297777718501e-05,0.00234058384842033,-0.004511414565132,0.0046636741206757,0.974052865578274
NMR metabolomics,X23424.Total Lipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.000228513376133495,0.00782060438360576,-0.0150998712157338,0.0155568979680008,0.976689849994464
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-5.95211704660447e-05,0.00203910216230259,-0.00405616140857911,0.00393711906764702,0.976713383927319
NMR metabolomics,X23424.Total Lipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.000129393443813924,0.00462129815041472,-0.00918713781862678,0.00892835093099893,0.977662881100707
NMR metabolomics,X23424.Total Lipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-4.8456634118908e-05,0.0018245459247662,-0.00362456664666065,0.00352765337842284,0.978812303090539
NMR metabolomics,X23424.Total Lipids in VLDL,CRX,Cone-rod homeobox protein,28916,0.000180755171266362,0.00737712675589085,-0.0142784132702797,0.0146399236128124,0.980452269838422
NMR metabolomics,X23424.Total Lipids in VLDL,IL2,Interleukin-2,28931,-4.89904609537488e-05,0.00217130756297145,-0.00430475328437778,0.00420677236247028,0.981999289823096
NMR metabolomics,X23424.Total Lipids in VLDL,SLC1A4,Neutral amino acid transporter A,24195,-6.59284595246352e-05,0.00356284728992662,-0.00704910914778081,0.00691725222873154,0.985236595933225
NMR metabolomics,X23424.Total Lipids in VLDL,MAGEA3,Melanoma-associated antigen 3,24445,-9.88133946204875e-05,0.00586919353595328,-0.0116024327250889,0.0114048059358479,0.986567634862216
NMR metabolomics,X23424.Total Lipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,1.319842331649e-05,0.00205416007412567,-0.00401295532196983,0.00403935216860281,0.994873505606839
NMR metabolomics,X23424.Total Lipids in VLDL,MLLT1,Protein ENL,24016,7.90116187694225e-06,0.00477619412785874,-0.00935343932872618,0.00936924165248006,0.998680089969822
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN1,Tetraspanin-1,28916,-5.44989010948384e-06,0.0039002223452206,-0.00764988568674186,0.00763898590652289,0.998885103523993
NMR metabolomics,X23424.Total Lipids in VLDL,ARG2,"Arginase-2, mitochondrial",24793,8.86708265614572e-07,0.00298706786639567,-0.00585376630986989,0.00585553972640112,0.999763151117299
